LOINC Code,Query,Name,Predicted Score,Actual Score
15152-2,bilirubin in plasma,bilirubin conjugated mass volume serum plasma,0.9424286043732837,0.5888754
32303-0,bilirubin in plasma,bilirubin total mole volume specimen,0.9424286043732837,0.78951716
14424-6,bilirubin in plasma,bilirubin total mass volume gastric fluid,0.9424286043732837,0.7963963
14152-3,bilirubin in plasma,bilirubin direct mass volume body fluid,0.9424286043732837,0.47476116
89871-8,bilirubin in plasma,bilirubin total mole volume venous blood,0.9424286043732837,0.7839001
43428-2,bilirubin in plasma,bilirubin microscopic observation identifier tissue hall stain,0.9424286043732837,0.43869346
1968-7,bilirubin in plasma,bilirubin direct mass volume serum plasma,0.9424286043732837,0.5795989
97770-2,bilirubin in plasma,bilirubin total mole volume capillary blood,0.9424286043732837,0.7866891
57566-2,bilirubin in plasma,25 hydroxyvitamin d3 mole volume serum plasma pre dose calcium,0.9424286043732837,0.17517626
1974-5,bilirubin in plasma,bilirubin total mass volume body fluid,0.9424286043732837,0.7950558
29210-2,bilirubin in plasma,bilirubin indirect mass volume body fluid,0.9424286043732837,0.47299352
39462-7,bilirubin in plasma,bilirubin conjugated mole volume body fluid,0.9424286043732837,0.4513553
35192-4,bilirubin in plasma,bilirubin indirect mass mole volume serum plasma,0.9424286043732837,0.57394505
70199-5,bilirubin in plasma,bilirubin total mole volume urine,0.9424286043732837,0.78064775
78441-3,bilirubin in plasma,bilirubin conjugated mole volume peritoneal fluid,0.9424286043732837,0.45233002
48623-3,bilirubin in plasma,bilirubin direct mass volume cord blood,0.9424286043732837,0.46970794
33870-7,bilirubin in plasma,bilirubin total presence specimen,0.9424286043732837,0.7713787
53415-6,bilirubin in plasma,bilirubin total presence cerebral spinal fluid,0.9424286043732837,0.7693551
14420-4,bilirubin in plasma,bilirubin total mass volume dialysis fluid,0.9424286043732837,0.7950166
1373-0,bilirubin in plasma,calcitonin mass volume serum plasma 10 minute post 2 4 mg kg calcium short iv,0.1452953298009632,0.17230852
9050-6,bilirubin in plasma,calcium intake 12 hour,0.1452953298009632,0.04962919
21643-2,bilirubin in plasma,cacna1s gene p arg1239his presence blood tissue molecular genetics method,0.1452953298009632,0.05029253
50181-7,bilirubin in plasma,calcitonin mass volume serum plasma 5 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.1452953298009632,0.16761431
94392-8,bilirubin in plasma,bordetella pertussis parapertussis bronchiseptica gida gene presence lower respiratory specimen naa probe detection,0.1452953298009632,0.04537433
33412-8,bilirubin in plasma,blast leukocyte pericardial fluid,0.1452953298009632,0.0743217
50839-0,bilirubin in plasma,calcium creatinine molar ratio 24 hour urine,0.1452953298009632,0.095177785
9051-4,bilirubin in plasma,calcium intake mole time 24 hour,0.1452953298009632,0.047935754
71669-6,bilirubin in plasma,blast leukocyte pure number fraction blood manual count,0.1452953298009632,0.09005003
52041-1,bilirubin in plasma,blood glucose monitor attachment,0.1452953298009632,0.044375595
59473-9,bilirubin in plasma,calcium ionized mass volume adjusted ph 7 4 venous blood ion selective membrane electrode ise,0.1452953298009632,0.08543636
45389-4,bilirubin in plasma,calcium carbonate crystal area urine sediment microscopy low power field,0.1452953298009632,0.06351282
33374-0,bilirubin in plasma,blast leukocyte synovial fluid,0.1452953298009632,0.071119666
21645-7,bilirubin in plasma,cacna1s gene mutation tested blood tissue molecular genetics method nominal,0.1452953298009632,0.05137194
50179-1,bilirubin in plasma,calcitonin calcium pentagastrin challenge panel serum plasma,0.1452953298009632,0.15240504
49935-0,bilirubin in plasma,calcium ionized calcium total corrected albumin serum plasma,0.1452953298009632,0.16562796
2003-2,bilirubin in plasma,deprecated calcium,0.08066121502317082,0.044187725
18488-7,bilirubin in plasma,calcium mass volume 24 hour urine,0.08066121502317082,0.07001871
50836-6,bilirubin in plasma,calcium mole mass hair,0.08066121502317082,0.043505322
99898-9,bilirubin in plasma,calcium oxalate dihydrate crystal area urine sediment computer assisted method,0.08066121502317082,0.056690115
99897-1,bilirubin in plasma,calcium oxalate dihydrate crystal presence urine sediment computer assisted method,0.08066121502317082,0.05005127
61435-4,bilirubin in plasma,deprecated deprecated calcium intake daily protocol phenx,0.08066121502317082,0.046449114
35675-8,bilirubin in plasma,calcium mass volume urine collected unspecified duration,0.08066121502317082,0.06262031
48215-8,bilirubin in plasma,crab triggered leukotriene release mass volume leukocyte,0.08066121502317082,0.07600933
40084-6,bilirubin in plasma,calcium mass volume serum plasma 36 hour post xxx challenge,0.08066121502317082,0.17447992
40067-1,bilirubin in plasma,calcium mass volume serum plasma baseline,0.08066121502317082,0.17538506
16520-9,bilirubin in plasma,calcium mole volume urine 2nd specimen post xxx challenge,0.08066121502317082,0.0604235
5775-2,bilirubin in plasma,calcium phosphate crystal presence urine sediment light microscopy,0.08066121502317082,0.058524862
16271-9,bilirubin in plasma,calcium mass volume serum plasma 30 minute post xxx challenge,0.08066121502317082,0.17342219
99899-7,bilirubin in plasma,calcium oxalate dihydrate crystal volume urine sediment computer assisted method,0.08066121502317082,0.07356844
54366-0,bilirubin in plasma,calcium ionized mole volume adjusted ph 7 4 cord blood,0.08066121502317082,0.08355782
42593-4,bilirubin in plasma,calcium mole volume capillary blood,0.08066121502317082,0.07366279
40073-9,bilirubin in plasma,calcium mass volume serum plasma 5 hour post xxx challenge,0.08066121502317082,0.17364162
50838-2,bilirubin in plasma,calcium ionized mole volume adjusted ph 7 4 body fluid,0.08066121502317082,0.075195774
40068-9,bilirubin in plasma,calcium mass volume serum plasma 45 minute post xxx challenge,0.08066121502317082,0.17205215
38251-5,bilirubin in plasma,calcium oxalate mass time 24 hour urine,0.08066121502317082,0.045821898
16512-6,bilirubin in plasma,calcium ionized mole volume serum plasma 2nd specimen post xxx challenge,0.08066121502317082,0.17475826
53296-0,bilirubin in plasma,calcium oxalate crystal volume urine computer assisted method,0.08066121502317082,0.07433538
13959-2,bilirubin in plasma,calcium ionized mole volume serum plasma calculation,0.08066121502317082,0.19317302
9467-2,bilirubin in plasma,calcium mass volume water,0.08066121502317082,0.04728395
40243-8,bilirubin in plasma,calcium mole volume serum plasma 20 hour post xxx challenge,0.08066121502317082,0.17214753
16270-1,bilirubin in plasma,calcium mass volume serum plasma 1 hour post xxx challenge,0.08066121502317082,0.17649542
33791-5,bilirubin in plasma,calcium mole volume urine 5th specimen post xxx challenge,0.08066121502317082,0.061113086
99894-8,bilirubin in plasma,calcium oxalate monohydrate crystal presence urine sediment computer assisted method,0.08066121502317082,0.050417956
29276-3,bilirubin in plasma,calcium presence urine,0.08066121502317082,0.052604612
46093-1,bilirubin in plasma,calcium ionized mole volume dialysis fluid,0.08066121502317082,0.072039455
27916-6,bilirubin in plasma,calcium mass volume serum plasma 2nd specimen post xxx challenge,0.08066121502317082,0.17491436
18186-7,bilirubin in plasma,calcium mass time 12 hour urine,0.08066121502317082,0.061408564
40245-3,bilirubin in plasma,calcium mole volume serum plasma 36 hour post xxx challenge,0.08066121502317082,0.17304486
32137-2,bilirubin in plasma,calcium phosphate total stone,0.08066121502317082,0.046853375
40074-7,bilirubin in plasma,calcium mass volume serum plasma 6 hour post xxx challenge,0.08066121502317082,0.17637952
47836-2,bilirubin in plasma,deprecated carnitine acyltransferase enzymatic activity mass leukocyte,0.08066121502317082,0.0858822
12511-2,bilirubin in plasma,calcium mass volume 4 hour urine,0.08066121502317082,0.07506185
13448-6,bilirubin in plasma,calcium osmolality ratio serum plasma,0.08066121502317082,0.18081768
40241-2,bilirubin in plasma,calcium mole volume serum plasma 14 hour post xxx challenge,0.08066121502317082,0.17391956
40075-4,bilirubin in plasma,calcium mass volume serum plasma 6 5 hour post xxx challenge,0.08066121502317082,0.17594549
32155-4,bilirubin in plasma,basophil eosinophil monocyte leukocyte blood automated count,0.05801012210940984,0.0937225
13520-2,bilirubin in plasma,deprecated basophil 100 leukocyte body fluid manual count,0.05801012210940984,0.09337985
24049-9,bilirubin in plasma,alpha galactosidase enzymatic activity mass leukocyte,0.05801012210940984,0.09275111
13519-4,bilirubin in plasma,basophil leukocyte cerebral spinal fluid manual count,0.05801012210940984,0.08798652
87543-5,bilirubin in plasma,beta n acetylhexosaminidase beta n acetylhexosaminidase reflex hexa gene panel enzymatic activity mass leukocyte,0.05801012210940984,0.05634401
48211-7,bilirubin in plasma,beef triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.076671846
21094-8,bilirubin in plasma,basophil leukocyte sputum manual count,0.05801012210940984,0.088357426
48198-6,bilirubin in plasma,amoxicillin triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.08554183
71675-3,bilirubin in plasma,basophil leukocyte pure number fraction blood manual count,0.05801012210940984,0.108345166
47550-9,bilirubin in plasma,adenosine deaminase entitic catalytic activity leukocyte,0.05801012210940984,0.082959406
69910-8,bilirubin in plasma,basophil mast cell leukocyte body fluid,0.05801012210940984,0.08038154
48220-8,bilirubin in plasma,oat triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.07680888
70219-1,bilirubin in plasma,basic metabolic 2008 panel ionized calcium serum plasma,0.05801012210940984,0.1650337
24071-3,bilirubin in plasma,beta n acetylhexosaminidase b beta n acetylhexosaminidase total leukocyte,0.05801012210940984,0.0618879
24073-9,bilirubin in plasma,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.05801012210940984,0.09314922
71631-6,bilirubin in plasma,basophil leukocyte pure number fraction peritoneal fluid manual count,0.05801012210940984,0.10038531
79451-1,bilirubin in plasma,adenosine deaminase enzymatic activity mass leukocyte,0.05801012210940984,0.08592267
69913-2,bilirubin in plasma,basophil mast cell leukocyte cerebral spinal fluid,0.05801012210940984,0.0765161
24068-9,bilirubin in plasma,beta mannosidase enzymatic activity mass leukocyte,0.05801012210940984,0.0947443
48255-4,bilirubin in plasma,giant ragweed triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.08297177
24065-5,bilirubin in plasma,beta glucuronidase enzymatic activity mass leukocyte,0.05801012210940984,0.09978358
48299-2,bilirubin in plasma,new coccine triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08180526
40002-8,bilirubin in plasma,glucose mass volume serum plasma 80 minute post xxx challenge,0.044429765451561576,0.17911541
75585-0,bilirubin in plasma,comment fetal prader willi syndrome risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.044429765451561576,0.14253446
54255-5,bilirubin in plasma,glucose mole volume serum plasma 6 minute post dose glucagon,0.044429765451561576,0.17636812
48284-4,bilirubin in plasma,pancuronium triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08985836
50215-3,bilirubin in plasma,glucose mass volume serum plasma 5th specimen,0.044429765451561576,0.19454736
55507-8,bilirubin in plasma,somatotropin mass volume serum plasma 2 hour post dose glucose,0.044429765451561576,0.15846543
71609-2,bilirubin in plasma,macrophage leukocyte pure number fraction pleural fluid manual count,0.044429765451561576,0.07496335
16912-8,bilirubin in plasma,glucose presence urine 9th specimen post xxx challenge,0.044429765451561576,0.04785218
12627-6,bilirubin in plasma,glucose mass volume serum plasma 15th specimen post xxx challenge,0.044429765451561576,0.18465778
4659-9,bilirubin in plasma,leukocyte phosphatase enzymatic activity volume leukocyte,0.044429765451561576,0.10293679
47275-3,bilirubin in plasma,s100 calcium binding protein b mass volume serum,0.044429765451561576,0.07771569
20408-1,bilirubin in plasma,leukocyte volume urine test strip,0.044429765451561576,0.095052905
6747-0,bilirubin in plasma,glucose presence urine test strip 1 hour post 50 g lactose po,0.044429765451561576,0.05510125
54274-6,bilirubin in plasma,glucose mole volume serum plasma 30 minute post dose ornithine alpha ketoglutarate,0.044429765451561576,0.18071713
18342-6,bilirubin in plasma,glucose mass volume serum plasma 3 hour post xxx challenge,0.044429765451561576,0.17976099
30120-0,bilirubin in plasma,igd lymphocyte volume leukocyte,0.044429765451561576,0.06870681
29331-6,bilirubin in plasma,glucose mass volume serum plasma 5 hour post xxx challenge,0.044429765451561576,0.18162753
26547-0,bilirubin in plasma,glucose presence urine test strip 2 hour post dose glucose,0.044429765451561576,0.058686484
806-0,bilirubin in plasma,leukocyte volume cerebral spinal fluid manual count,0.044429765451561576,0.08137365
40280-0,bilirubin in plasma,glucose mole volume serum plasma 3 hour post dose lactose po,0.044429765451561576,0.17676982
2186-5,bilirubin in plasma,cytochrome component oxidase enzymatic activity volume leukocyte,0.044429765451561576,0.08841199
40005-1,bilirubin in plasma,glucose mass volume serum plasma 110 minute post xxx challenge,0.044429765451561576,0.17989796
48206-7,bilirubin in plasma,lactalbumin alpha triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08946377
46090-7,bilirubin in plasma,leukocyte volume cerebral spinal fluid 4th tube,0.044429765451561576,0.08901061
92819-2,bilirubin in plasma,glucose mass volume serum plasma 10 minute post dose glucagon,0.044429765451561576,0.17639112
813-6,bilirubin in plasma,leukocyte volume synovial fluid automated count,0.044429765451561576,0.092592254
40169-5,bilirubin in plasma,glucose mole volume serum plasma 8 hour post xxx challenge,0.044429765451561576,0.17382342
75551-2,bilirubin in plasma,fetal trisomy 13 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.044429765451561576,0.15128586
27861-4,bilirubin in plasma,insulin unit volume serum plasma 3 hour post 75 g glucose po,0.044429765451561576,0.16658388
76670-9,bilirubin in plasma,glucose mole volume cerebral spinal fluid 2nd tube,0.044429765451561576,0.074779145
74802-0,bilirubin in plasma,glucose challenge hydrogen breath test interpretation exhaled gas,0.044429765451561576,0.05125542
18228-7,bilirubin in plasma,glucose 6 phosphate dehydrogenase presence tissue,0.044429765451561576,0.05507597
71597-9,bilirubin in plasma,lymphocyte leukocyte pure number fraction bronchial specimen manual count,0.044429765451561576,0.06952286
68545-3,bilirubin in plasma,nucleated erythrocyte leukocyte ratio synovial fluid,0.044429765451561576,0.076850116
40203-2,bilirubin in plasma,glucose mole volume serum plasma 9 minute post xxx challenge,0.044429765451561576,0.17583118
1491-0,bilirubin in plasma,glucose mass volume urine 30 minute post 100 g glucose po,0.044429765451561576,0.06679436
30267-9,bilirubin in plasma,glucose mole volume serum plasma 2 3 hour post dose glucose,0.044429765451561576,0.17971085
40030-9,bilirubin in plasma,glucose mass volume serum plasma 16 minute post xxx challenge,0.044429765451561576,0.1766511
32761-9,bilirubin in plasma,leukocyte presence specimen wet preparation,0.044429765451561576,0.06918304
55479-0,bilirubin in plasma,insulin mole volume serum plasma 7 minute post dose glucose iv,0.044429765451561576,0.18414888
48297-6,bilirubin in plasma,chromotrope 2b triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08071549
40168-7,bilirubin in plasma,glucose mole volume serum plasma 7 5 hour post xxx challenge,0.044429765451561576,0.17524451
95106-1,bilirubin in plasma,glucose mass volume serum plasma 3 hour post meal,0.044429765451561576,0.17131594
40004-4,bilirubin in plasma,glucose mass volume serum plasma 100 minute post xxx challenge,0.044429765451561576,0.17814326
50216-1,bilirubin in plasma,glucose mass volume serum plasma 6th specimen,0.044429765451561576,0.19480886
75561-1,bilirubin in plasma,fetal trisomy 21 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.044429765451561576,0.15057306
5565-7,bilirubin in plasma,terminal deoxyribonucleotidyl transferase unit volume leukocyte,0.044429765451561576,0.08629033
40001-0,bilirubin in plasma,glucose mass volume serum plasma 5 minute post xxx challenge,0.044429765451561576,0.17818257
40166-1,bilirubin in plasma,glucose mole volume serum plasma 6 5 hour post xxx challenge,0.044429765451561576,0.1754754
48187-9,bilirubin in plasma,chloramin triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08907305
94348-0,bilirubin in plasma,voltage gated calcium channel n type binding igg igm ab mole volume serum immunoassay,0.044429765451561576,0.081453495
100795-4,bilirubin in plasma,s100 calcium binding protein b mass volume body fluid,0.044429765451561576,0.05600122
53114-5,bilirubin in plasma,fasting glucose mole volume urine,0.044429765451561576,0.06386991
48302-4,bilirubin in plasma,indigo carmine triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08315411
48230-7,bilirubin in plasma,cat dander triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.07481948
54248-0,bilirubin in plasma,glucose mole volume serum plasma 10 minute pre dose glucagon,0.044429765451561576,0.17656213
71619-1,bilirubin in plasma,mononuclear cell leukocyte pure number fraction synovial fluid manual count,0.044429765451561576,0.07843152
48268-7,bilirubin in plasma,minor determinant mixture triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.089199096
10966-0,bilirubin in plasma,glucose presence urine test strip 2 5 hour post 75 g glucose po,0.044429765451561576,0.05922902
40163-8,bilirubin in plasma,glucose mole volume serum plasma 4 hour post xxx challenge,0.044429765451561576,0.17466916
53316-6,bilirubin in plasma,leukocyte presence urine automated,0.044429765451561576,0.059053242
75596-7,bilirubin in plasma,fetal 5p deletion risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.044429765451561576,0.14366284
25666-9,bilirubin in plasma,glucose mole volume serum plasma 2 5 hour post dose glucose,0.044429765451561576,0.17557107
2353-1,bilirubin in plasma,glucose phosphate isomerase enzymatic activity volume serum,0.044429765451561576,0.11037289
40153-9,bilirubin in plasma,glucose mole volume serum plasma 5 minute post xxx challenge,0.044429765451561576,0.17084046
30405-5,bilirubin in plasma,leukocyte volume urine,0.044429765451561576,0.08455303
98020-1,bilirubin in plasma,leukocyte volume lower respiratory specimen manual count,0.044429765451561576,0.082016684
26779-9,bilirubin in plasma,glucose mass volume serum plasma 1 5 hour post dose lactose po,0.044429765451561576,0.17508703
26540-5,bilirubin in plasma,glucose mass volume urine 3 hour post dose glucose,0.044429765451561576,0.07299993
104877-6,bilirubin in plasma,hematocrit volume fraction blood 1 5 hour post dose glucose,0.044429765451561576,0.09402474
14811-4,bilirubin in plasma,leukocyte volume pericardial fluid manual count,0.044429765451561576,0.0993262
32782-5,bilirubin in plasma,leukocyte esterase nitrite presence urine test strip,0.044429765451561576,0.063286684
59814-4,bilirubin in plasma,glucose mole volume serum plasma 7 specimen,0.044429765451561576,0.18113382
1514-9,bilirubin in plasma,glucose mass volume serum plasma 2 hour post 100 g glucose po,0.044429765451561576,0.17925093
25664-4,bilirubin in plasma,glucose mass volume urine 1 hour post dose glucose,0.044429765451561576,0.0670678
20439-6,bilirubin in plasma,glucose mass volume serum plasma 30 minute post dose glucose,0.044429765451561576,0.18168263
71666-2,bilirubin in plasma,promyelocytes leukocyte pure number fraction blood manual count,0.044429765451561576,0.09362746
72604-2,bilirubin in plasma,insulin unit volume serum plasma 4 5 hour post 75 g glucose po,0.044429765451561576,0.16973384
16907-8,bilirubin in plasma,glucose presence urine 4th specimen post xxx challenge,0.044429765451561576,0.05048288
46406-5,bilirubin in plasma,somatotropin mass volume serum plasma 30 minute post 1 g kg glucose po,0.044429765451561576,0.15562966
40294-1,bilirubin in plasma,insulin mole volume serum plasma pre post dose glucose,0.044429765451561576,0.18007948
47761-2,bilirubin in plasma,somatotropin unit volume serum plasma 1 hour post dose glucose po,0.044429765451561576,0.15998814
40259-4,bilirubin in plasma,glucose mass volume serum plasma 10 5 hour post xxx challenge,0.044429765451561576,0.1813578
26778-1,bilirubin in plasma,glucose mass volume serum plasma 1 hour post dose lactose po,0.044429765451561576,0.17427139
1498-5,bilirubin in plasma,glucose mass volume serum plasma 10 minute post 0 5 g kg glucose iv,0.044429765451561576,0.17999162
48253-9,bilirubin in plasma,english plantain triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.07775954
48281-0,bilirubin in plasma,sulfamethoxazole triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.081225224
6759-5,bilirubin in plasma,glucose presence urine test strip 6 hour post 75 g glucose po,0.044429765451561576,0.055105463
34689-0,bilirubin in plasma,sulfatidase enzymatic activity volume leukocyte,0.044429765451561576,0.085320115
57350-1,bilirubin in plasma,glucose mass volume serum plasma 1 minute post xxx challenge,0.044429765451561576,0.1814748
1550-3,bilirubin in plasma,glucose mass volume serum plasma pre 12 hour fast,0.044429765451561576,0.17931764
54250-6,bilirubin in plasma,glucose mole volume serum plasma 15 minute pre dose glucagon,0.044429765451561576,0.17648588
21309-0,bilirubin in plasma,glucose mass volume serum plasma 45 minute post xxx challenge,0.044429765451561576,0.17640866
71618-3,bilirubin in plasma,macrophage leukocyte pure number fraction synovial fluid manual count,0.044429765451561576,0.0795284
1512-3,bilirubin in plasma,glucose mass volume serum plasma 1 minute post 0 5 g kg glucose iv,0.044429765451561576,0.18249854
27860-6,bilirubin in plasma,insulin unit volume serum plasma 2 hour post 75 g glucose po,0.044429765451561576,0.16732001
48984-9,bilirubin in plasma,glucose mass volume serum plasma 10 minute post dose glucose,0.044429765451561576,0.17864388
105102-8,bilirubin in plasma,leukocyte clump volume urine,0.044429765451561576,0.08806961
46405-7,bilirubin in plasma,somatotropin mass volume serum plasma 30 minute pre 1 g kg glucose po,0.044429765451561576,0.15656328
12657-3,bilirubin in plasma,glucose mass volume serum plasma 40 minute post xxx challenge,0.044429765451561576,0.18325561
50218-7,bilirubin in plasma,glucose mass volume serum plasma 9th specimen,0.044429765451561576,0.1921401
13351-2,bilirubin in plasma,leukocyte volume cerebral spinal fluid manual count,0.044429765451561576,0.09247235
105921-1,bilirubin in plasma,leukocyte volume urethra wet preparation,0.044429765451561576,0.07855425
75594-2,bilirubin in plasma,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.044429765451561576,0.14585115
88365-2,bilirubin in plasma,glucose mass volume blood pre meal,0.044429765451561576,0.08155468
2349-9,bilirubin in plasma,glucose presence urine,0.044429765451561576,0.0547874
6883-3,bilirubin in plasma,glucose protein bound mass volume serum plasma,0.044429765451561576,0.19272526
61182-2,bilirubin in plasma,leukocyte volume corrected nucleated erythrocyte blood fetus,0.044429765451561576,0.10321258
10968-6,bilirubin in plasma,glucose presence urine test strip 4 5 hour post 75 g glucose po,0.044429765451561576,0.05746134
68431-6,bilirubin in plasma,leukocyte volume synovial fluid manual count,0.044429765451561576,0.08690801
75597-5,bilirubin in plasma,comment fetal 5p deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.044429765451561576,0.13496104
21680-4,bilirubin in plasma,g6pd gene mutation found identifier blood tissue molecular genetics method nominal,0.044429765451561576,0.045531947
48271-1,bilirubin in plasma,tetracycline triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08106001
1630-3,bilirubin in plasma,somatotropin mass volume serum plasma 2 hour post 1 g kg glucose po,0.044429765451561576,0.155072
40222-2,bilirubin in plasma,glucose mole volume serum plasma 2 day post xxx challenge,0.044429765451561576,0.17676167
33765-9,bilirubin in plasma,leukocyte volume blood product unit platelet pheresis automated count,0.044429765451561576,0.100665174
71665-4,bilirubin in plasma,variant lymphocyte leukocyte pure number fraction blood manual count,0.044429765451561576,0.08267477
12636-7,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 7th specimen,0.044429765451561576,0.0833743
14770-2,bilirubin in plasma,fasting glucose mole volume capillary blood glucometer,0.044429765451561576,0.07823322
807-8,bilirubin in plasma,leukocyte volume pleural fluid automated count,0.044429765451561576,0.087183185
12637-5,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 8th specimen post xxx challenge,0.044429765451561576,0.07090942
40016-8,bilirubin in plasma,glucose mass volume serum plasma 18 hour post xxx challenge,0.044429765451561576,0.17933166
27353-2,bilirubin in plasma,glucose mean value mass volume blood estimated glycated hemoglobin,0.044429765451561576,0.107989326
12646-6,bilirubin in plasma,glucose mass volume serum plasma 1 hour post xxx challenge,0.044429765451561576,0.1856816
47666-3,bilirubin in plasma,insulin unit volume serum plasma 5 minute pre dose glucose,0.044429765451561576,0.17036071
1553-7,bilirubin in plasma,glucose mass volume serum plasma pre dose insulin iv,0.044429765451561576,0.18112111
75590-0,bilirubin in plasma,fetal angelman syndrome risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.044429765451561576,0.1509517
62440-3,bilirubin in plasma,nucleated erythrocyte leukocyte ratio body fluid automated count,0.044429765451561576,0.07217304
58596-8,bilirubin in plasma,corticotropin mass volume plasma 3 hour post dose glucose,0.044429765451561576,0.24046844
2800-1,bilirubin in plasma,deprecated glucose phosphate isomerase enzymatic activity volume serum,0.044429765451561576,0.100200064
16913-6,bilirubin in plasma,fasting glucose presence urine,0.044429765451561576,0.04692742
6777-7,bilirubin in plasma,deprecated glucose mass volume serum plasma,0.044429765451561576,0.1728521
32825-2,bilirubin in plasma,leukocyte presence semen,0.044429765451561576,0.06549724
62239-9,bilirubin in plasma,leukocyte volume blood fetus automated count,0.044429765451561576,0.099168174
35054-6,bilirubin in plasma,leukocyte volume peritoneal fluid,0.044429765451561576,0.10532071
55352-9,bilirubin in plasma,glucose mole volume serum plasma 45 minute post 75 g glucose po,0.044429765451561576,0.17306095
9307-0,bilirubin in plasma,insulin mass volume serum plasma 30 minute post 75 g glucose po,0.044429765451561576,0.1545647
40007-7,bilirubin in plasma,glucose mass volume serum plasma 9 5 hour post xxx challenge,0.044429765451561576,0.179832
30404-8,bilirubin in plasma,leukocyte volume stool,0.044429765451561576,0.08344641
58413-6,bilirubin in plasma,nucleated erythrocyte leukocyte ratio blood automated count,0.044429765451561576,0.085907616
46222-6,bilirubin in plasma,glucose mole volume dialysis fluid 4 hour specimen,0.044429765451561576,0.0693928
40019-2,bilirubin in plasma,glucose mass volume serum plasma 20 hour post xxx challenge,0.044429765451561576,0.17872158
39479-1,bilirubin in plasma,glucose mole volume pericardial fluid,0.044429765451561576,0.070751734
25673-5,bilirubin in plasma,glucose mole volume serum plasma 45 minute post dose glucose,0.044429765451561576,0.17527235
54253-0,bilirubin in plasma,glucose mole volume serum plasma 4 minute post dose glucagon,0.044429765451561576,0.1757822
6291-9,bilirubin in plasma,complement ic3b receptor presence leukocyte,0.044429765451561576,0.076901086
16994-6,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas 5 hour post dose glucose,0.044429765451561576,0.06317645
53484-2,bilirubin in plasma,glucose mole volume serum plasma 30 minute pre dose betaxolol,0.044429765451561576,0.18522532
13608-5,bilirubin in plasma,insulin mass volume serum plasma 1 5 hour post 75 g glucose po,0.044429765451561576,0.15988474
47274-6,bilirubin in plasma,s100 calcium binding protein b mass volume cerebral spinal fluid,0.044429765451561576,0.05630664
44716-9,bilirubin in plasma,creatinine calcium mass ratio urine,0.044429765451561576,0.06859133
72649-7,bilirubin in plasma,glucose serum glucose peritoneal fluid molar concentration difference,0.044429765451561576,0.18189158
12724-1,bilirubin in plasma,voltage gated calcium channel igg ab unit volume serum,0.044429765451561576,0.09279566
50404-3,bilirubin in plasma,cell leukocyte identifier synovial fluid,0.044429765451561576,0.06466503
40018-4,bilirubin in plasma,glucose mass volume serum plasma 19 5 hour post xxx challenge,0.044429765451561576,0.17825384
50672-5,bilirubin in plasma,leukocyte toxic vacuole presence blood light microscopy,0.044429765451561576,0.10109893
16165-3,bilirubin in plasma,glucose mass volume serum plasma 10 specimen,0.044429765451561576,0.18405454
40193-5,bilirubin in plasma,glucose mole volume serum plasma pre meal,0.044429765451561576,0.17138928
97507-8,bilirubin in plasma,average glucose mass volume interstitial fluid reporting period,0.044429765451561576,0.08476121
12609-4,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 4 hour dwell specimen,0.044429765451561576,0.07064613
33768-3,bilirubin in plasma,leukocyte clump volume urine automated count,0.044429765451561576,0.09225547
56937-6,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas 30 minute post dose glucose,0.044429765451561576,0.06543266
51767-2,bilirubin in plasma,glucose mass volume serum plasma 1 5 hour post dose fructose po,0.044429765451561576,0.18108526
58528-1,bilirubin in plasma,corticotropin mass volume plasma 1 5 hour post dose glucose,0.044429765451561576,0.24284387
40165-3,bilirubin in plasma,glucose mole volume serum plasma 6 hour post xxx challenge,0.044429765451561576,0.17573814
6748-8,bilirubin in plasma,glucose presence urine test strip 1 hour post 75 g glucose po,0.044429765451561576,0.053375077
11156-7,bilirubin in plasma,leukocyte morphology finding identifier blood,0.044429765451561576,0.07864618
99775-9,bilirubin in plasma,leukocyte volume peritoneal dialysis fluid automated count,0.044429765451561576,0.081537485
47663-0,bilirubin in plasma,insulin unit volume serum plasma 30 minute post dose glucose,0.044429765451561576,0.1716945
1531-3,bilirubin in plasma,deprecated glucose mass volume serum plasma 3 hour post 100 g glucose po,0.044429765451561576,0.068572536
2357-2,bilirubin in plasma,glucose 6 phosphate dehydrogenase enzymatic activity volume red blood cell,0.044429765451561576,0.113779515
20584-9,bilirubin in plasma,leukocyte volume specimen automated count,0.044429765451561576,0.075481646
48191-1,bilirubin in plasma,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08212077
47589-7,bilirubin in plasma,component peptide mole volume serum plasma 30 minute post dose glucose,0.044429765451561576,0.17100962
13865-1,bilirubin in plasma,glucose mass volume serum plasma 2 5 hour post 50 g lactose po,0.044429765451561576,0.18434726
50206-2,bilirubin in plasma,glucose mass volume serum plasma 1st specimen,0.044429765451561576,0.19282568
53553-4,bilirubin in plasma,glucose mean value mole volume blood estimated glycated hemoglobin,0.044429765451561576,0.10721623
812-8,bilirubin in plasma,leukocyte volume semen manual count,0.044429765451561576,0.085848354
75595-9,bilirubin in plasma,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.044429765451561576,0.14352767
14761-1,bilirubin in plasma,glucose mole volume serum plasma 2 hour post meal,0.044429765451561576,0.17811826
48192-9,bilirubin in plasma,sunset yellow fcf triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08792602
15075-5,bilirubin in plasma,glucose mole volume dialysis fluid,0.044429765451561576,0.07429891
40217-2,bilirubin in plasma,glucose mole volume serum plasma 28 hour post xxx challenge,0.044429765451561576,0.17943464
1568-5,bilirubin in plasma,insulin mass volume serum plasma 4 hour post 75 g glucose po,0.044429765451561576,0.15467763
6750-4,bilirubin in plasma,glucose presence urine test strip 2 hour post 50 g lactose po,0.044429765451561576,0.054072537
12641-7,bilirubin in plasma,glucose mass volume serum plasma 7 hour post xxx challenge,0.044429765451561576,0.18636145
55351-1,bilirubin in plasma,glucose mole volume serum plasma 1 5 hour post 75 g glucose po,0.044429765451561576,0.17422125
1523-0,bilirubin in plasma,glucose mass volume serum plasma 30 minute post 0 05 0 15 u insulin kg iv post 12h cfst,0.044429765451561576,0.18128072
68433-2,bilirubin in plasma,leukocyte volume vitreous fluid manual count,0.044429765451561576,0.09482028
95078-2,bilirubin in plasma,glucose mass volume serum plasma 15 min post meal,0.044429765451561576,0.17319523
40179-4,bilirubin in plasma,glucose mole volume serum plasma 13 5 hour post xxx challenge,0.044429765451561576,0.17137256
1513-1,bilirubin in plasma,glucose mass volume serum plasma 20 minute post 0 5 g kg glucose iv,0.044429765451561576,0.18011567
14328-9,bilirubin in plasma,leukocyte presence sputum light microscopy,0.044429765451561576,0.07726384
48196-0,bilirubin in plasma,cephalosporin component triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.07497807
1549-5,bilirubin in plasma,glucose mass volume serum plasma pre 100 g glucose po,0.044429765451561576,0.18081935
48988-0,bilirubin in plasma,glucose mass volume serum plasma 12 pm specimen,0.044429765451561576,0.18070358
48236-4,bilirubin in plasma,european house dust mite triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.067823276
102032-0,bilirubin in plasma,glucose mass volume serum plasma 2 hour post dose insulin iv,0.044429765451561576,0.18029359
6758-7,bilirubin in plasma,glucose presence urine test strip 5 hour post 75 g glucose po,0.044429765451561576,0.054284785
33405-2,bilirubin in plasma,glucose mass volume pericardial fluid,0.044429765451561576,0.072845146
59815-1,bilirubin in plasma,glucose mole volume serum plasma 3 pm specimen,0.044429765451561576,0.17994514
94704-4,bilirubin in plasma,voltage gated calcium channel n type binding ab mole volume serum immunoassay,0.044429765451561576,0.08767115
55498-0,bilirubin in plasma,insulin mole volume serum plasma 7 minute pre dose glucose,0.044429765451561576,0.18186243
26467-1,bilirubin in plasma,leukocyte volume pleural fluid,0.044429765451561576,0.09146947
16996-1,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas pre dose glucose,0.044429765451561576,0.066489
46223-4,bilirubin in plasma,glucose mole volume dialysis fluid overnight,0.044429765451561576,0.071005635
27297-1,bilirubin in plasma,leukocyte esterase unit volume urine,0.044429765451561576,0.06680299
45056-9,bilirubin in plasma,glucose mole volume serum plasma 8 pm specimen,0.044429765451561576,0.17837444
26542-1,bilirubin in plasma,glucose mass volume urine 5 hour post dose glucose,0.044429765451561576,0.07347837
25706-3,bilirubin in plasma,ketone mass volume urine test strip 2 hour post dose glucose,0.044429765451561576,0.08474221
48036-8,bilirubin in plasma,glucose mass volume stool,0.044429765451561576,0.06564781
49688-5,bilirubin in plasma,glucose tolerance interpretation serum plasma narrative post 75 g glucose po,0.044429765451561576,0.15295318
20406-5,bilirubin in plasma,deprecated glucose mass volume urine test strip,0.044429765451561576,0.06423639
97778-5,bilirubin in plasma,glucose mole volume dialysis fluid 1 hour specimen,0.044429765451561576,0.07003445
53485-9,bilirubin in plasma,glucose mole volume serum plasma 45 minute post dose betaxolol,0.044429765451561576,0.18221633
40211-5,bilirubin in plasma,glucose mole volume serum plasma 3 5 hour post xxx challenge,0.044429765451561576,0.17795292
2346-5,bilirubin in plasma,glucose mass volume pleural fluid,0.044429765451561576,0.06953874
13606-9,bilirubin in plasma,glucose mass volume serum plasma 3 hour post 50 g lactose po,0.044429765451561576,0.18157566
6300-8,bilirubin in plasma,glucose mass volume amniotic fluid,0.044429765451561576,0.084022515
16915-1,bilirubin in plasma,glucose mass volume serum plasma post meal,0.044429765451561576,0.17042266
71678-7,bilirubin in plasma,lymphocyte leukocyte pure number fraction blood automated count,0.044429765451561576,0.08317967
40875-7,bilirubin in plasma,glucose mass volume specimen 3rd specimen,0.044429765451561576,0.068714544
48605-0,bilirubin in plasma,glucose mass volume serum plasma 1 hour post dose fructose po,0.044429765451561576,0.17752323
25669-3,bilirubin in plasma,glucose mole volume serum plasma 3 5 hour post dose glucose,0.044429765451561576,0.17564987
25667-7,bilirubin in plasma,glucose mass volume urine 2 hour post dose glucose,0.044429765451561576,0.06744678
5914-7,bilirubin in plasma,glucose presence blood test strip,0.044429765451561576,0.07478495
48247-1,bilirubin in plasma,white oak triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.066721834
6753-8,bilirubin in plasma,glucose presence urine test strip 30 minute post 50 g lactose po,0.044429765451561576,0.054652233
40024-2,bilirubin in plasma,glucose mass volume serum plasma 1 day post xxx challenge,0.044429765451561576,0.18003334
57004-4,bilirubin in plasma,glucose creatinine mass ratio 24 hour urine,0.044429765451561576,0.09039669
48216-6,bilirubin in plasma,hazelnut triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.07526256
48983-1,bilirubin in plasma,glucose mass volume serum plasma 20 minute pre xxx challenge,0.044429765451561576,0.17663066
19104-9,bilirubin in plasma,glucose interpretation serum plasma 1 hour post dose glucose,0.044429765451561576,0.16113399
55482-4,bilirubin in plasma,insulin mole volume serum plasma 4 hour post dose glucose iv,0.044429765451561576,0.1831623
40324-6,bilirubin in plasma,glucose mole volume serum plasma 3 hour post dose triple bolus,0.044429765451561576,0.18835318
14763-7,bilirubin in plasma,glucose mole volume serum plasma 30 minute post dose glucose,0.044429765451561576,0.18786812
12659-9,bilirubin in plasma,glucose mass volume serum plasma 70 minute post xxx challenge,0.044429765451561576,0.18262723
40849-2,bilirubin in plasma,glucose mass volume urine test strip 1st specimen post xxx challenge,0.044429765451561576,0.07484939
48213-3,bilirubin in plasma,tomato triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.07235558
48295-0,bilirubin in plasma,food colorant mix ii triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.08549085
21310-8,bilirubin in plasma,glucose mass volume serum plasma 75 minute post xxx challenge,0.044429765451561576,0.17572758
12610-2,bilirubin in plasma,glucose mass volume serum plasma 2 hour post xxx challenge,0.044429765451561576,0.18421319
26777-3,bilirubin in plasma,glucose mass volume serum plasma 30 minute post dose lactose po,0.044429765451561576,0.17572778
48261-2,bilirubin in plasma,perennial rye grass triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.07778538
75577-7,bilirubin in plasma,fetal 22q11 2 deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.044429765451561576,0.14780746
2359-8,bilirubin in plasma,glucose 6 phosphate dehydrogenase enzymatic activity volume serum,0.044429765451561576,0.10986476
48262-0,bilirubin in plasma,meadow fescue triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.07733173
33352-6,bilirubin in plasma,glucose creatinine mass ratio urine,0.044429765451561576,0.092226535
14748-8,bilirubin in plasma,glucose mole volume peritoneal fluid,0.044429765451561576,0.08393017
48190-3,bilirubin in plasma,phthalic anhydride triggered leukotriene release mass volume leukocyte,0.044429765451561576,0.0879388
39563-2,bilirubin in plasma,glucose mass volume serum plasma 3rd specimen post dose lactose,0.044429765451561576,0.17952016
1564-4,bilirubin in plasma,insulin mass volume serum plasma 2 hour post 75 g glucose po,0.044429765451561576,0.15495984
58805-3,bilirubin in plasma,leukocyte volume urine automated test strip,0.044429765451561576,0.089387864
12642-5,bilirubin in plasma,glucose mass volume serum plasma 7 5 hour post xxx challenge,0.044429765451561576,0.18710028
47750-5,bilirubin in plasma,somatotropin unit volume serum plasma 1 5 hour post dose glucose po,0.044429765451561576,0.15980946
30252-1,bilirubin in plasma,glucose mole volume serum plasma 3 3 hour post dose glucose,0.044429765451561576,0.18193556
54273-8,bilirubin in plasma,glucose mole volume serum plasma 3 hour post dose ornithine alpha ketoglutarate,0.044429765451561576,0.18101627
47658-0,bilirubin in plasma,insulin unit volume serum plasma 1 5 hour post dose glucose,0.044429765451561576,0.17118987
39998-0,bilirubin in plasma,glucose mass volume serum plasma 30 minute pre xxx challenge,0.044429765451561576,0.17871937
39562-4,bilirubin in plasma,glucose mass volume serum plasma 2nd specimen post dose lactose,0.044429765451561576,0.17915893
71614-2,bilirubin in plasma,monocyte leukocyte pure number fraction pleural fluid manual count,0.044429765451561576,0.07758121
72650-5,bilirubin in plasma,glucose serum glucose pericard field molar concentration difference,0.044429765451561576,0.18324208
54254-8,bilirubin in plasma,glucose mole volume serum plasma 5 minute pre dose glucagon,0.044429765451561576,0.17628896
16914-4,bilirubin in plasma,glucose mass volume serum plasma post xxx challenge,0.044429765451561576,0.17744055
12633-4,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 4th specimen,0.044429765451561576,0.07816339
101976-9,bilirubin in plasma,voltage gated calcium channel p q type binding ab mass volume serum immunoassay,0.044429765451561576,0.08473828
71648-0,bilirubin in plasma,monocyte leukocyte pure number fraction body fluid manual count,0.044429765451561576,0.07865233
30253-9,bilirubin in plasma,glucose mole volume serum plasma 3 6 hour post dose glucose,0.044429765451561576,0.1806397
96979-0,bilirubin in plasma,trisomy 13 trisomy 18 triploidy risk interpretation plasma cell free wbc dna qualitative calculation,0.044429765451561576,0.141208
75573-6,bilirubin in plasma,comment fetal triploidy risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.044429765451561576,0.15967041
19105-6,bilirubin in plasma,glucose interpretation serum plasma 3 hour post dose glucose,0.044429765451561576,0.16162507
40014-3,bilirubin in plasma,glucose mass volume serum plasma 16 hour post xxx challenge,0.044429765451561576,0.18051006
32359-2,bilirubin in plasma,glucose mole volume serum plasma 10 minute post dose glucose,0.044429765451561576,0.17787403
12635-9,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 6th specimen,0.044429765451561576,0.08036642
1555-2,bilirubin in plasma,glucose mass volume urine 12 hour fasting,0.044429765451561576,0.067328885
30402-2,bilirubin in plasma,leukocyte volume gastric fluid,0.044429765451561576,0.097029656
51766-4,bilirubin in plasma,glucose mass volume serum plasma 2 5 hour post dose fructose po,0.044429765451561576,0.18072866
1540-4,bilirubin in plasma,glucose mass volume serum plasma 5 hour post 100 g glucose po,0.044429765451561576,0.17962335
46088-1,bilirubin in plasma,leukocyte volume cerebral spinal fluid 2nd tube,0.044429765451561576,0.0911139
33979-6,bilirubin in plasma,voltage gated calcium channel n type binding ab mole volume serum,0.044429765451561576,0.09559434
48034-3,bilirubin in plasma,leukocyte volume corrected nucleated erythrocyte cerebral spinal fluid,0.044429765451561576,0.08797596
43740-0,bilirubin in plasma,glucose insulin mass ratio serum plasma,0.044429765451561576,0.17622377
16995-3,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas 6 hour post dose glucose,0.044429765451561576,0.063864246
1551-1,bilirubin in plasma,glucose mass volume serum plasma pre 50 g lactose po,0.044429765451561576,0.17761268
75637-9,bilirubin in plasma,glucose mole volume serum plasma 45 minute post 50 g lactose po,0.044429765451561576,0.16967458
75589-2,bilirubin in plasma,fetal angelman syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.044429765451561576,0.1506167
40185-1,bilirubin in plasma,glucose mole volume serum plasma 18 5 hour post xxx challenge,0.044429765451561576,0.17470452
40174-5,bilirubin in plasma,glucose mole volume serum plasma 10 75 hour post xxx challenge,0.044429765451561576,0.1729597
46089-9,bilirubin in plasma,leukocyte volume cerebral spinal fluid 3rd tube,0.044429765451561576,0.08900785
78535-2,bilirubin in plasma,glucose mole volume peritoneal dialysis fluid 4 hour dwell specimen,0.044429765451561576,0.059889596
56771-9,bilirubin in plasma,eosinophil leukocyte bronchial specimen flow cytometry fc,0.0,0.0688149
14384-2,bilirubin in plasma,mononuclear cell leukocyte urine sediment manual count,0.0,0.066929385
50588-3,bilirubin in plasma,glucose tolerance 5 hour panel serum plasma,0.0,0.15433346
34985-2,bilirubin in plasma,unidentified cell leukocyte body fluid,0.0,0.07381011
30465-9,bilirubin in plasma,prolymphocytes leukocyte blood,0.0,0.09386409
49940-0,bilirubin in plasma,glutamate dehydrogenase enzymatic activity mass leukocyte,0.0,0.09743482
58090-2,bilirubin in plasma,glucose 6 phosphate dehydrogenase newborn screening comment discussion,0.0,0.061673235
68378-9,bilirubin in plasma,leukocyte disintegrated leukocyte blood,0.0,0.09115016
35020-7,bilirubin in plasma,monocyte macrophage leukocyte peritoneal fluid,0.0,0.07689017
5489-0,bilirubin in plasma,deprecated cd47 cell 100 cell blood,0.0,0.059812862
30457-6,bilirubin in plasma,nonhematic cell leukocyte body fluid,0.0,0.07179855
12208-5,bilirubin in plasma,eosinophil leukocyte cerebral spinal fluid manual count,0.0,0.06882264
5440-3,bilirubin in plasma,deprecated cd16 cd57 cell 100 cell blood,0.0,0.055532034
32177-8,bilirubin in plasma,granulocyte leukocyte vaginal fluid,0.0,0.07518866
95219-2,bilirubin in plasma,variant lymphocyte leukocyte stem cell product manual count,0.0,0.05679289
55598-7,bilirubin in plasma,leukocyte disintegrated leukocyte body fluid manual count,0.0,0.074502595
5526-9,bilirubin in plasma,deprecated cd72 cell 100 cell blood,0.0,0.06240067
41899-6,bilirubin in plasma,glucose meter device vendor serial number,0.0,0.030912386
10329-1,bilirubin in plasma,monocyte leukocyte cerebral spinal fluid manual count,0.0,0.0651329
32200-8,bilirubin in plasma,segmented neutrophil leukocyte blood automated count,0.0,0.088566914
56960-8,bilirubin in plasma,segmented neutrophil leukocyte bone marrow manual count,0.0,0.06635439
36934-8,bilirubin in plasma,ct heart calcium scoring,0.0,0.011282423
5415-5,bilirubin in plasma,deprecated cd10 cd20,0.0,0.043199692
713-8,bilirubin in plasma,eosinophil leukocyte blood automated count,0.0,0.078877494
13524-4,bilirubin in plasma,leukocyte leukocyte body fluid manual count,0.0,0.07240981
5462-7,bilirubin in plasma,deprecated cd31 cell 100 cell blood,0.0,0.060817193
5466-8,bilirubin in plasma,deprecated cd34 dr cell 100 cell blood,0.0,0.06046156
40490-5,bilirubin in plasma,macrophage leukocyte synovial fluid manual count,0.0,0.065726615
5529-3,bilirubin in plasma,deprecated cd77 cell 100 cell blood,0.0,0.060282115
5512-9,bilirubin in plasma,deprecated cd62l cell 100 cell blood,0.0,0.063358724
17800-4,bilirubin in plasma,myelocyte leukocyte body fluid,0.0,0.079960704
32540-7,bilirubin in plasma,glucosylceramidase enzymatic activity mass leukocyte,0.0,0.07817548
34923-3,bilirubin in plasma,monoblast leukocyte blood,0.0,0.09164394
57391-5,bilirubin in plasma,eosinophil leukocyte synovial fluid manual count,0.0,0.066399835
32833-6,bilirubin in plasma,monocyte macrophage leukocyte bronchial specimen,0.0,0.069248445
14857-7,bilirubin in plasma,leukocyte leukocyte pericardial fluid manual count,0.0,0.07878273
30427-9,bilirubin in plasma,macrophage leukocyte body fluid,0.0,0.07304469
51770-6,bilirubin in plasma,leukocyte area stool microscopy high power field,0.0,0.08342355
34982-9,bilirubin in plasma,unidentified cell leukocyte peritoneal fluid,0.0,0.07775388
49926-9,bilirubin in plasma,glucose 6 phosphate dehydrogenase enzymatic activity mass red blood cell method,0.0,0.08637604
5535-0,bilirubin in plasma,deprecated cd82 cell 100 cell blood,0.0,0.060475025
34921-7,bilirubin in plasma,lymphocyte plasmacytoid leukocyte blood,0.0,0.091955364
5517-8,bilirubin in plasma,deprecated cd66b cell 100 cell blood,0.0,0.06738103
26483-8,bilirubin in plasma,lymphocyte leukocyte synovial fluid,0.0,0.066186205
12230-9,bilirubin in plasma,macrophage leukocyte body fluid manual count,0.0,0.07778786
83289-9,bilirubin in plasma,ct calcium scoring wo contrast cta w contrast iv heart coronary artery,0.0,0.029171916
77355-6,bilirubin in plasma,non hematopoietic stem cell leukocyte body fluid manual count,0.0,0.065901294
75196-6,bilirubin in plasma,leukocyte count protein test performed csf test finding cdc component,0.0,0.052571114
5500-4,bilirubin in plasma,deprecated cd51 cell 100 cell blood,0.0,0.06490829
2794-6,bilirubin in plasma,phosphofructokinase f subunit phosphofructokinase total leukocyte,0.0,0.07177251
26506-6,bilirubin in plasma,segmented neutrophil leukocyte cerebral spinal fluid,0.0,0.07270017
26521-5,bilirubin in plasma,granulocyte leukocyte semen,0.0,0.082165316
53797-7,bilirubin in plasma,neutrophil immature leukocyte blood,0.0,0.092315905
30462-6,bilirubin in plasma,granulocyte leukocyte urine,0.0,0.08016432
11031-2,bilirubin in plasma,lymphocyte leukocyte body fluid,0.0,0.07359192
69017-2,bilirubin in plasma,immature granulocyte leukocyte synovial fluid,0.0,0.078579806
40653-8,bilirubin in plasma,myelocyte leukocyte body fluid manual count,0.0,0.07450246
63554-0,bilirubin in plasma,leukocyte 24 hour urine sediment microscopy,0.0,0.06383219
32013-5,bilirubin in plasma,eosinophil leukocyte pericardial fluid manual count,0.0,0.07315029
51385-3,bilirubin in plasma,plasma cell leukocyte cerebral spinal fluid manual count,0.0,0.08269487
40543-1,bilirubin in plasma,leukocyte leukocyte bronchial specimen manual count,0.0,0.06435719
26514-0,bilirubin in plasma,neutrophil leukocyte peritoneal fluid,0.0,0.083193
5533-5,bilirubin in plasma,deprecated cd80 cell 100 cell blood,0.0,0.059397686
26513-2,bilirubin in plasma,neutrophil leukocyte body fluid,0.0,0.078444086
9443-3,bilirubin in plasma,igm lymphocyte lymphocyte leukocyte,0.0,0.054818965
33388-0,bilirubin in plasma,band form neutrophil leukocyte pericardial fluid,0.0,0.07965473
4528-6,bilirubin in plasma,deprecated complement receptor 2,0.0,0.07913388
33369-0,bilirubin in plasma,variant lymphocyte leukocyte peritoneal fluid,0.0,0.07251638
66133-0,bilirubin in plasma,mononuclear cell atypical leukocyte body fluid manual count,0.0,0.06626197
5470-0,bilirubin in plasma,deprecated cd38 cell 100 cell blood,0.0,0.060063373
62850-3,bilirubin in plasma,deprecated phenx measure fasting plasma glucose diabetes screening blood draw,0.0,0.057932597
51384-6,bilirubin in plasma,mononuclear cell leukocyte blood manual count,0.0,0.087525
14822-1,bilirubin in plasma,lymphocyte leukocyte synovial fluid manual count,0.0,0.069841616
5994-9,bilirubin in plasma,platelet aggregation calcium ionophore induced platelet rich plasma,0.0,0.053656466
13047-6,bilirubin in plasma,plasma cell leukocyte blood,0.0,0.11253793
74437-5,bilirubin in plasma,galactokinase enzymatic activity mass leukocyte,0.0,0.09075612
5543-4,bilirubin in plasma,deprecated cd91 cell 100 cell blood,0.0,0.058363795
33857-4,bilirubin in plasma,sezary cell leukocyte blood manual count,0.0,0.08676366
5437-9,bilirubin in plasma,deprecated cd16 cell 100 cell blood,0.0,0.056308717
90422-7,bilirubin in plasma,taci cell cell cd19 blood,0.0,0.0568938
24078-8,bilirubin in plasma,cerebroside sulfatase enzymatic activity mass leukocyte,0.0,0.09095242
30436-0,bilirubin in plasma,monocyte macrophage leukocyte cerebral spinal fluid,0.0,0.064741835
97506-0,bilirubin in plasma,glucose management indicator,0.0,0.06966804
14830-4,bilirubin in plasma,mesothelial cell leukocyte peritoneal fluid manual count,0.0,0.090232305
55436-0,bilirubin in plasma,myeloblast leukocyte cerebral spinal fluid manual count,0.0,0.073073626
96798-4,bilirubin in plasma,cortisol glucose somatotropin post arginine stimulation panel serum plasma,0.0,0.12806824
5481-7,bilirubin in plasma,deprecated cd43 cell 100 cell blood,0.0,0.054683797
5542-6,bilirubin in plasma,deprecated cd9 cell 100 cell blood,0.0,0.05928538
14847-8,bilirubin in plasma,neutrophil leukocyte pericardial fluid manual count,0.0,0.08314106
40650-4,bilirubin in plasma,mesothelial cell leukocyte blood manual count,0.0,0.091286086
50608-9,bilirubin in plasma,glucose tolerance 3 hour gestational panel serum plasma,0.0,0.15369968
14829-6,bilirubin in plasma,mesothelial cell leukocyte pleural fluid manual count,0.0,0.08273693
62856-0,bilirubin in plasma,phenx oral glucose tolerance test protocol 141001,0.0,0.047280014
30423-8,bilirubin in plasma,lymphoma cell leukocyte blood,0.0,0.07802884
5491-6,bilirubin in plasma,deprecated cd49a cell 100 cell blood,0.0,0.056706138
5510-3,bilirubin in plasma,deprecated cd61 cell 100 cell blood,0.0,0.06150305
5484-1,bilirubin in plasma,deprecated cd45 cell 100 cell blood,0.0,0.054824766
9727-9,bilirubin in plasma,eosinophil leukocyte nose manual count,0.0,0.054289345
49224-9,bilirubin in plasma,leukocyte area semen microscopy high power field,0.0,0.08365099
5555-8,bilirubin in plasma,deprecated fmc7 cell 100 cell blood,0.0,0.06738351
59816-9,bilirubin in plasma,neutrophil immature leukocyte body fluid,0.0,0.0785066
26496-0,bilirubin in plasma,mononuclear cell leukocyte semen,0.0,0.07436107
27906-7,bilirubin in plasma,immature lymphocyte leukocyte amniotic fluid,0.0,0.074223764
770-8,bilirubin in plasma,neutrophil leukocyte blood automated count,0.0,0.08319859
5454-4,bilirubin in plasma,deprecated cd25 cell 100 cell blood,0.0,0.06002829
33228-8,bilirubin in plasma,wbc cast area urine computer assisted method,0.0,0.073790774
56774-3,bilirubin in plasma,lymphocyte leukocyte tissue,0.0,0.06142127
5544-2,bilirubin in plasma,deprecated cd93 cell 100 cell blood,0.0,0.05947698
51621-1,bilirubin in plasma,macrophage leukocyte dialysis fluid manual count,0.0,0.07112892
13046-8,bilirubin in plasma,variant lymphocyte leukocyte blood,0.0,0.087012164
34915-9,bilirubin in plasma,malignant cell leukocyte blood,0.0,0.08069325
74425-0,bilirubin in plasma,myelocyte neutrophilic leukocyte blood manual count,0.0,0.09070508
17802-0,bilirubin in plasma,prolymphocytes leukocyte body fluid,0.0,0.08009291
58089-4,bilirubin in plasma,glucose 6 phosphate dehydrogenase newborn screen interpretation,0.0,0.07057775
51927-2,bilirubin in plasma,cell leukocyte bronchial specimen manual count,0.0,0.07041074
14382-6,bilirubin in plasma,mononuclear cell leukocyte synovial fluid manual count,0.0,0.0723877
40491-3,bilirubin in plasma,neutrophil leukocyte synovial fluid manual count,0.0,0.06919499
101977-7,bilirubin in plasma,cortisol glucose somatotropin post glucagon stimulation panel serum plasma,0.0,0.11903698
70040-1,bilirubin in plasma,granulocyte leukocyte synovial fluid automated count,0.0,0.07404688
43151-0,bilirubin in plasma,glucose meter device panel,0.0,0.03117547
5421-3,bilirubin in plasma,deprecated cd106 cell 100 cell blood,0.0,0.05755893
5467-6,bilirubin in plasma,deprecated cd35 cell 100 cell blood,0.0,0.05621858
5429-6,bilirubin in plasma,deprecated cd120a cell 100 cell blood,0.0,0.058722332
30410-5,bilirubin in plasma,leukocyte leukocyte synovial fluid,0.0,0.07119633
30438-6,bilirubin in plasma,monocyte macrophage leukocyte synovial fluid,0.0,0.06803843
41900-2,bilirubin in plasma,glucose meter device vendor software version,0.0,0.03289439
24104-2,bilirubin in plasma,lymphoma cell leukocyte blood manual count,0.0,0.07745661
101978-5,bilirubin in plasma,glucose somatotropin post glucagon stimulation panel serum plasma,0.0,0.13101527
45060-1,bilirubin in plasma,protein glucose panel urine test strip,0.0,0.057497878
96077-3,bilirubin in plasma,hedis 2020 value set glucose test,0.0,0.04546205
41898-8,bilirubin in plasma,vendor device model code glucose meter,0.0,0.03249814
33837-6,bilirubin in plasma,malignant cell leukocyte blood manual count,0.0,0.07883191
68403-5,bilirubin in plasma,eosinophil leukocyte vitreous fluid manual count,0.0,0.06919982
5905-5,bilirubin in plasma,monocyte leukocyte blood automated count,0.0,0.082542785
21394-2,bilirubin in plasma,monocyte macrophage leukocyte body fluid manual count,0.0,0.06587111
5490-8,bilirubin in plasma,deprecated cd48 cell 100 cell blood,0.0,0.055540875
5556-6,bilirubin in plasma,deprecated gpa blood,0.0,0.05377768
97510-2,bilirubin in plasma,glucose measurement range total glucose measurement reporting period,0.0,0.061525498
74950-7,bilirubin in plasma,deprecated galactocerebrosidase enzymatic activity mass leukocyte,0.0,0.087279186
30439-4,bilirubin in plasma,monocyte macrophage leukocyte specimen,0.0,0.06408547
14326-3,bilirubin in plasma,eosinophil leukocyte stool manual count,0.0,0.06364674
74428-4,bilirubin in plasma,metamyelocytes neutrophilic leukocyte blood manual count,0.0,0.08584476
5541-8,bilirubin in plasma,deprecated cd89,0.0,0.048602823
5492-4,bilirubin in plasma,deprecated cd49b cell 100 cell blood,0.0,0.05933725
5418-9,bilirubin in plasma,deprecated cd103 cell 100 cell blood,0.0,0.056857467
14773-6,bilirubin in plasma,granulocyte leukocyte bronchial specimen manual count,0.0,0.083784506
5433-8,bilirubin in plasma,deprecated cd128 cell 100 cell blood,0.0,0.05669557
5558-2,bilirubin in plasma,deprecated myeloperoxidase cell 100 cell unspecified specimen,0.0,0.078251384
5523-6,bilirubin in plasma,deprecated cd7 cell 100 cell blood,0.0,0.059946578
5498-1,bilirubin in plasma,deprecated cd5 cd2 cell 100 cell blood,0.0,0.048763547
9045-6,calcium in serum,calcium intake estimated,0.986034890517866,0.47271505
2005-7,calcium in serum,calcium mole time 2 hour urine 12 hour fasting,0.986034890517866,0.46506137
24518-3,calcium in serum,calcium creatinine molar ratio urine,0.986034890517866,0.47638276
59473-9,calcium in serum,calcium ionized mass volume adjusted ph 7 4 venous blood ion selective membrane electrode ise,0.986034890517866,0.44950062
16266-9,calcium in serum,calcium hydrogen phosphate crystal presence stone infrared spectroscopy,0.986034890517866,0.44357276
59276-6,calcium in serum,calcium hydrogen phosphate dihydrate crystal presence stone x ray diffraction,0.986034890517866,0.4411045
54439-5,calcium in serum,calcium bilirubinate total stone,0.986034890517866,0.45644674
16272-7,calcium in serum,calcium mass volume serum plasma 2 hour post xxx challenge,0.986034890517866,0.57614493
33794-9,calcium in serum,calcium mole volume urine 8th specimen post xxx challenge,0.986034890517866,0.46886942
53296-0,calcium in serum,calcium oxalate crystal volume urine computer assisted method,0.986034890517866,0.46171817
15153-0,calcium in serum,deprecated indirect bilirubin mass volume serum plasma,0.986034890517866,0.21677224
51950-4,calcium in serum,calcium mass volume serum plasma post dialysis,0.986034890517866,0.58266777
40081-2,calcium in serum,calcium mass volume serum plasma 16 hour post xxx challenge,0.986034890517866,0.57032394
40066-3,calcium in serum,calcium mass volume serum plasma 15 minute pre xxx challenge,0.986034890517866,0.5715026
25584-4,calcium in serum,calcium mole volume urine 5 hour post 500 mg calcium po,0.986034890517866,0.48388088
40615-7,calcium in serum,deprecated calcium oxalate crystal presence urine sediment microscopy low power field,0.986034890517866,0.45485312
9321-1,calcium in serum,calcium creatinine mass ratio urine,0.986034890517866,0.47915366
25149-6,calcium in serum,calcium phosphate crystal area urine sediment microscopy high power field,0.986034890517866,0.46307757
27182-5,calcium in serum,calcium presence blood,0.986034890517866,0.8051637
50839-0,calcium in serum,calcium creatinine molar ratio 24 hour urine,0.986034890517866,0.47510248
57467-3,calcium in serum,calcitriol mass volume serum plasma pre dose calcium,0.986034890517866,0.5867879
55178-8,calcium in serum,calcium phosphate crystal presence specimen light microscopy,0.986034890517866,0.445602
42593-4,calcium in serum,calcium mole volume capillary blood,0.986034890517866,0.81239325
29276-3,calcium in serum,calcium presence urine,0.986034890517866,0.79374516
11132-8,calcium in serum,deprecated bilirubin mass volume body fluid,0.986034890517866,0.08614287
47839-6,calcium in serum,deprecated carnitine acyltransferase ii enzymatic activity mass leukocyte,0.986034890517866,0.10872919
105896-5,calcium in serum,calcium oxalate crystal area urine sediment,0.986034890517866,0.45190525
13454-4,calcium in serum,calcium phosphorus product mole volume 2 serum plasma,0.986034890517866,0.58185345
40068-9,calcium in serum,calcium mass volume serum plasma 45 minute post xxx challenge,0.986034890517866,0.5704495
1993-5,calcium in serum,calcium renal clearance 24 hour urine serum plasma,0.986034890517866,0.56775194
33791-5,calcium in serum,calcium mole volume urine 5th specimen post xxx challenge,0.986034890517866,0.46974716
32137-2,calcium in serum,calcium phosphate total stone,0.986034890517866,0.45987138
40231-3,calcium in serum,calcium mole volume serum plasma 2 hour post xxx challenge,0.986034890517866,0.5823763
54366-0,calcium in serum,calcium ionized mole volume adjusted ph 7 4 cord blood,0.986034890517866,0.47032097
27916-6,calcium in serum,calcium mass volume serum plasma 2nd specimen post xxx challenge,0.986034890517866,0.57334405
13959-2,calcium in serum,calcium ionized mole volume serum plasma calculation,0.986034890517866,0.6034123
40225-5,calcium in serum,calcium mole volume serum plasma 15 minute pre xxx challenge,0.986034890517866,0.58015454
40084-6,calcium in serum,calcium mass volume serum plasma 36 hour post xxx challenge,0.986034890517866,0.5726696
35246-8,calcium in serum,calcium mass mole volume serum plasma,0.986034890517866,0.910328
41645-3,calcium in serum,calcium ionized mole volume venous blood,0.986034890517866,0.48032522
17864-0,calcium in serum,calcium ionized mass volume serum plasma ion selective membrane electrode ise,0.986034890517866,0.5806057
10746-6,calcium in serum,calcium microscopic observation identifier tissue von kossa stain,0.986034890517866,0.43530437
53299-4,calcium in serum,calcium phosphate crystal volume urine computer assisted method,0.986034890517866,0.46264273
40236-2,calcium in serum,calcium mole volume serum plasma 6 5 hour post xxx challenge,0.986034890517866,0.58099717
16518-3,calcium in serum,calcium mass time 2 hour urine,0.986034890517866,0.8081856
16268-5,calcium in serum,calcium phosphate crystal presence stone infrared spectroscopy,0.986034890517866,0.44822538
16524-1,calcium in serum,calcium mole volume serum plasma 6 hour post xxx challenge,0.986034890517866,0.57986665
40237-0,calcium in serum,calcium mole volume serum plasma 7 5 hour post xxx challenge,0.986034890517866,0.5808003
32541-5,calcium in serum,calcium molar amount urine collected unspecified duration,0.986034890517866,0.8081425
40233-9,calcium in serum,calcium mole volume serum plasma 3 hour post xxx challenge,0.986034890517866,0.5823838
48240-6,calcium in serum,candida albicans triggered leukotriene release mass volume leukocyte,0.986034890517866,0.07209492
17863-2,calcium in serum,calcium ionized mass volume serum plasma,0.986034890517866,0.5982882
45389-4,calcium in serum,calcium carbonate crystal area urine sediment microscopy low power field,0.986034890517866,0.4449234
1994-3,calcium in serum,calcium ionized mole volume blood,0.986034890517866,0.50366265
1380-5,calcium in serum,calcium phosphate parathyroid challenge test mass ratio serum,0.986034890517866,0.63303626
53088-1,calcium in serum,calcium ionized mole volume nonbiological fluid ion selective membrane electrode ise,0.986034890517866,0.4727395
16516-7,calcium in serum,calcium ionized mole volume serum plasma 6th specimen post xxx challenge,0.986034890517866,0.57983446
5773-7,calcium in serum,calcium carbonate crystal presence urine sediment light microscopy,0.986034890517866,0.4460609
105053-3,calcium in serum,calcium oxalate crystal presence urine sediment microscopy,0.986034890517866,0.44818297
14417-0,calcium in serum,calcium mole volume peritoneal fluid,0.986034890517866,0.82417476
48238-0,calcium in serum,cockroach triggered leukotriene release mass volume leukocyte,0.986034890517866,0.07604808
57471-5,calcium in serum,calcitriol mole volume serum plasma 3 hour post dose calcium,0.986034890517866,0.5917642
74909-3,calcium in serum,calcium oxalate dihydrate total stone,0.986034890517866,0.46151772
2003-2,calcium in serum,deprecated calcium,0.986034890517866,0.7998533
40073-9,calcium in serum,calcium mass volume serum plasma 5 hour post xxx challenge,0.986034890517866,0.57358176
70035-1,calcium in serum,siderophages leukocyte cerebral spinal fluid manual count,0.5358804412302101,0.083150245
54246-4,calcium in serum,protein glucose panel mass volume body fluid,0.5358804412302101,0.097609565
14848-6,calcium in serum,neutrophil leukocyte pleural fluid manual count,0.5358804412302101,0.0753373
30469-1,calcium in serum,unspecified cell leukocyte body fluid,0.5358804412302101,0.08468047
30073-1,calcium in serum,voltage gated calcium channel ab presence serum,0.5358804412302101,0.6182095
74425-0,calcium in serum,myelocyte neutrophilic leukocyte blood manual count,0.5358804412302101,0.08597862
14107-7,calcium in serum,segmented neutrophil leukocyte cerebral spinal fluid manual count,0.5358804412302101,0.08001154
30468-3,calcium in serum,unidentified cell leukocyte cerebral spinal fluid,0.5358804412302101,0.085902296
12238-2,calcium in serum,neutrophil leukocyte body fluid manual count,0.5358804412302101,0.073202096
44097-4,calcium in serum,unidentified cell leukocyte blood,0.5358804412302101,0.09186986
71657-1,calcium in serum,band form neutrophil leukocyte pure number fraction cerebral spinal fluid manual count,0.5358804412302101,0.081219696
100795-4,calcium in serum,s100 calcium binding protein b mass volume body fluid,0.5358804412302101,0.4528761
47413-0,calcium in serum,plasma cell leukocyte cerebral spinal fluid,0.5358804412302101,0.090332106
71666-2,calcium in serum,promyelocytes leukocyte pure number fraction blood manual count,0.5358804412302101,0.094073504
47275-3,calcium in serum,s100 calcium binding protein b mass volume serum,0.5358804412302101,0.64218706
62856-0,calcium in serum,phenx oral glucose tolerance test protocol 141001,0.5358804412302101,0.06717258
94705-1,calcium in serum,voltage gated calcium channel p q type binding ab mole volume serum immunoassay,0.5358804412302101,0.64318866
17800-4,calcium in serum,myelocyte leukocyte body fluid,0.5358804412302101,0.09320386
33990-3,calcium in serum,normoblasts leukocyte blood,0.5358804412302101,0.09563923
30453-5,calcium in serum,segmented neutrophil leukocyte body fluid,0.5358804412302101,0.071802616
13516-0,calcium in serum,neutrophil leukocyte cerebral spinal fluid manual count,0.5358804412302101,0.08230339
71616-7,calcium in serum,neutrophil leukocyte pure number fraction pleural fluid manual count,0.5358804412302101,0.07598633
764-1,calcium in serum,band form neutrophil leukocyte blood manual count,0.5358804412302101,0.079936735
104637-4,calcium in serum,percentage time continuous glucose monitor device worn reporting period calculated,0.5358804412302101,0.07195284
74403-7,calcium in serum,normoblasts leukocyte cord blood,0.5358804412302101,0.066767074
56960-8,calcium in serum,segmented neutrophil leukocyte bone marrow manual count,0.5358804412302101,0.07318766
33387-2,calcium in serum,segmented neutrophil leukocyte pericardial fluid,0.5358804412302101,0.06955394
94704-4,calcium in serum,voltage gated calcium channel n type binding ab mole volume serum immunoassay,0.5358804412302101,0.64741224
749-2,calcium in serum,myelocyte leukocyte blood manual count,0.5358804412302101,0.091751546
747-6,calcium in serum,myeloblast leukocyte blood manual count,0.5358804412302101,0.08417875
33388-0,calcium in serum,band form neutrophil leukocyte pericardial fluid,0.5358804412302101,0.0728984
30450-1,calcium in serum,neutrophil hypersegmented leukocyte blood,0.5358804412302101,0.07975619
23761-0,calcium in serum,neutrophil leukocyte blood manual count,0.5358804412302101,0.08389163
75658-5,calcium in serum,plasma cell leukocyte bronchial specimen,0.5358804412302101,0.08182529
77356-4,calcium in serum,non hematopoietic stem cell leukocyte cerebral spinal fluid manual count,0.5358804412302101,0.072744235
770-8,calcium in serum,neutrophil leukocyte blood automated count,0.5358804412302101,0.083123855
62852-9,calcium in serum,phenx fasting plasma glucose diabetes screening glucometer protocol 140802,0.5358804412302101,0.05890716
30455-0,calcium in serum,neutrophil leukocyte pleural fluid,0.5358804412302101,0.071434066
12724-1,calcium in serum,voltage gated calcium channel igg ab unit volume serum,0.5358804412302101,0.6374768
71650-6,calcium in serum,segmented neutrophil leukocyte pure number fraction body fluid manual count,0.5358804412302101,0.07523466
26508-2,calcium in serum,band form neutrophil leukocyte blood,0.5358804412302101,0.08983301
30467-5,calcium in serum,promyelocytes leukocyte cerebral spinal fluid,0.5358804412302101,0.08641085
53520-3,calcium in serum,neutrophil leukocyte dialysis fluid,0.5358804412302101,0.06986054
71606-8,calcium in serum,neutrophil leukocyte pure number fraction pericardial fluid manual count,0.5358804412302101,0.07947805
6746-2,calcium in serum,prolymphocytes leukocyte blood manual count,0.5358804412302101,0.095219634
56770-1,calcium in serum,neutrophil leukocyte bronchial specimen flow cytometry fc,0.5358804412302101,0.07192259
71637-3,calcium in serum,unspecified cell leukocyte pure number fraction body fluid manual count,0.5358804412302101,0.089064345
41900-2,calcium in serum,glucose meter device vendor software version,0.5358804412302101,0.052131698
74820-2,calcium in serum,plasma cell centrocytes leukocyte blood manual count,0.5358804412302101,0.08550812
74236-1,calcium in serum,unidentified cell leukocyte pericardial fluid manual count,0.5358804412302101,0.07849243
30447-7,calcium in serum,myelocyte leukocyte cerebral spinal fluid,0.5358804412302101,0.09092659
55437-8,calcium in serum,neoplastic cell leukocyte cerebral spinal fluid manual count,0.5358804412302101,0.0786562
48191-1,calcium in serum,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.0868281
75057-0,calcium in serum,sialidase enzymatic activity mass leukocyte,0.18452496192815013,0.116911314
24098-6,calcium in serum,n acetylglucosamine 6 sulfatase enzymatic activity mass leukocyte,0.18452496192815013,0.1134761
5562-4,calcium in serum,deprecated smig lambda,0.18452496192815013,0.055307973
17836-8,calcium in serum,neutrophil leukocyte synovial fluid,0.18452496192815013,0.07500183
95225-9,calcium in serum,band form neutrophil leukocyte stem cell product manual count,0.18452496192815013,0.06662155
48291-9,calcium in serum,potassium metabisulfite triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.09304161
47771-1,calcium in serum,somatotropin unit volume serum plasma 3 hour post dose glucose po,0.18452496192815013,0.20977943
48284-4,calcium in serum,pancuronium triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.09196372
97534-2,calcium in serum,somatotropin mass volume serum plasma 3 hour post dose glucose,0.18452496192815013,0.2049765
48182-0,calcium in serum,european hornet triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.08466175
33988-7,calcium in serum,thymidine phosphorylase enzymatic activity mass leukocyte,0.18452496192815013,0.114637695
48285-1,calcium in serum,propofol triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.092253536
48232-3,calcium in serum,tyrophagus putrescentiae triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.07690903
46407-3,calcium in serum,somatotropin mass volume serum plasma 1 5 hour post 1 g kg glucose po,0.18452496192815013,0.20794308
2648-4,calcium in serum,n acetylgalactosamine 4 sulfatase enzymatic activity volume leukocyte,0.18452496192815013,0.10055556
47881-8,calcium in serum,pyruvate carboxylase enzymatic activity mass leukocyte,0.18452496192815013,0.10844152
47769-5,calcium in serum,somatotropin unit volume serum plasma 30 minute post dose glucose po,0.18452496192815013,0.21257058
48293-5,calcium in serum,tartrazine triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.07943903
48299-2,calcium in serum,new coccine triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.08788043
47875-0,calcium in serum,propionyl coa carboxylase enzymatic activity mass leukocyte,0.18452496192815013,0.106985405
48298-4,calcium in serum,pigweed triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.08189892
48287-7,calcium in serum,deprecated suxamethonium triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.08913556
47719-0,calcium in serum,parathyrin mass volume serum plasma pre dose calcium,0.18452496192815013,0.5701069
48192-9,calcium in serum,sunset yellow fcf triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.089078434
48219-0,calcium in serum,sesame seed triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.08243089
48214-1,calcium in serum,shrimp triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.07420871
48258-8,calcium in serum,cultivated rye triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.07988611
1635-2,calcium in serum,somatotropin mass volume serum plasma pre 1 g kg glucose po,0.18452496192815013,0.2053693
48259-6,calcium in serum,kentucky blue grass triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.07963256
48222-4,calcium in serum,rye triggered leukotriene release mass volume leukocyte,0.18452496192815013,0.085849255
57971-4,calcium in serum,glucose mass volume serum plasma 4th specimen post lactose,0.15909204868833826,0.20066853
40011-9,calcium in serum,glucose mass volume serum plasma 13 5 hour post xxx challenge,0.15909204868833826,0.20053205
9307-0,calcium in serum,insulin mass volume serum plasma 30 minute post 75 g glucose po,0.15909204868833826,0.19442138
53487-5,calcium in serum,glucose mole volume serum plasma 1 5 hour post dose betaxolol,0.15909204868833826,0.21675526
21309-0,calcium in serum,glucose mass volume serum plasma 45 minute post xxx challenge,0.15909204868833826,0.20573841
16915-1,calcium in serum,glucose mass volume serum plasma post meal,0.15909204868833826,0.2004232
26695-7,calcium in serum,glucose mass volume serum plasma 7th specimen post xxx challenge,0.15909204868833826,0.20463793
40169-5,calcium in serum,glucose mole volume serum plasma 8 hour post xxx challenge,0.15909204868833826,0.21141125
40323-8,calcium in serum,glucose mole volume serum plasma 2 hour post dose triple bolus,0.15909204868833826,0.20690796
47585-5,calcium in serum,component peptide mole volume serum plasma 15 minute post dose glucose,0.15909204868833826,0.21267377
40206-5,calcium in serum,glucose mole volume serum plasma 16 minute post xxx challenge,0.15909204868833826,0.21398489
40041-6,calcium in serum,glucose mass volume serum plasma 29 hour post xxx challenge,0.15909204868833826,0.20070742
40002-8,calcium in serum,glucose mass volume serum plasma 80 minute post xxx challenge,0.15909204868833826,0.20380081
44050-3,calcium in serum,glucose phosphate isomerase enzymatic activity mass red blood cell,0.15909204868833826,0.09931067
40025-9,calcium in serum,glucose mass volume serum plasma 3 minute post xxx challenge,0.15909204868833826,0.20275152
40215-6,calcium in serum,glucose mole volume serum plasma 26 hour post xxx challenge,0.15909204868833826,0.21500684
54255-5,calcium in serum,glucose mole volume serum plasma 6 minute post dose glucagon,0.15909204868833826,0.21135716
53474-3,calcium in serum,glucose mole volume serum plasma 4 specimen,0.15909204868833826,0.21149814
40000-2,calcium in serum,glucose mass volume serum plasma 5 minute pre xxx challenge,0.15909204868833826,0.2053782
47660-6,calcium in serum,insulin unit volume serum plasma 2 5 hour post dose glucose,0.15909204868833826,0.19695234
26554-6,calcium in serum,glucose mass volume serum plasma 2 5 hour post dose glucose,0.15909204868833826,0.21138334
59796-3,calcium in serum,glucose molar concentration difference serum plasma 4 hour post xxx challenge,0.15909204868833826,0.1999621
14753-8,calcium in serum,glucose mole volume serum plasma 1 hour post 100 g glucose po,0.15909204868833826,0.21850325
104873-5,calcium in serum,glucose dumping syndrome panel serum plasma blood,0.15909204868833826,0.1698949
45298-7,calcium in serum,glucose mole volume serum plasma 2 5 hour post 50 g lactose po,0.15909204868833826,0.21331845
53485-9,calcium in serum,glucose mole volume serum plasma 45 minute post dose betaxolol,0.15909204868833826,0.2173143
10579-1,calcium in serum,leukocyte volume semen,0.15909204868833826,0.0910239
30362-8,calcium in serum,insulin unit volume serum plasma 30 minute post 75 g glucose po,0.15909204868833826,0.19245194
25673-5,calcium in serum,glucose mole volume serum plasma 45 minute post dose glucose,0.15909204868833826,0.21771234
1572-7,calcium in serum,insulin mass volume serum plasma pre 75 g glucose po,0.15909204868833826,0.19613443
55352-9,calcium in serum,glucose mole volume serum plasma 45 minute post 75 g glucose po,0.15909204868833826,0.21308321
58514-1,calcium in serum,component peptide mass volume serum plasma 45 minute post dose glucose,0.15909204868833826,0.19651292
14764-5,calcium in serum,glucose mole volume serum plasma 3 hour post 100 g glucose po,0.15909204868833826,0.21953818
12623-5,calcium in serum,glucose mass volume serum plasma 11th specimen post xxx challenge,0.15909204868833826,0.19739446
1521-4,calcium in serum,glucose mass volume serum plasma 2 hour post meal,0.15909204868833826,0.1967419
1539-6,calcium in serum,glucose mass volume serum plasma 4 hour post 75 g glucose po,0.15909204868833826,0.20610757
16168-7,calcium in serum,glucose mass volume serum plasma 3 pm specimen,0.15909204868833826,0.20933628
26817-7,calcium in serum,glucose mass volume serum plasma 11 hour post xxx challenge,0.15909204868833826,0.20401797
58518-2,calcium in serum,component peptide mass volume serum plasma 5 hour post dose glucose,0.15909204868833826,0.19934656
72651-3,calcium in serum,glucose serum glucose pleural fluid molar concentration difference,0.15909204868833826,0.20778278
1540-4,calcium in serum,glucose mass volume serum plasma 5 hour post 100 g glucose po,0.15909204868833826,0.20873994
25668-5,calcium in serum,glucose mole volume serum plasma 2 hour post xxx challenge,0.15909204868833826,0.21274918
1545-3,calcium in serum,deprecated glucose mass volume serum plasma 6 hour post 100 g glucose po,0.15909204868833826,0.2778233
40192-7,calcium in serum,glucose mole volume serum plasma 1 day post xxx challenge,0.15909204868833826,0.20912693
1517-2,calcium in serum,glucose mass volume serum plasma 2 hour post 50 g lactose po,0.15909204868833826,0.20456603
48109-3,calcium in serum,glucose mole volume serum plasma 15 minute pre dose glucose,0.15909204868833826,0.21211554
40321-2,calcium in serum,glucose mole volume serum plasma 45 minute post dose triple bolus,0.15909204868833826,0.20744835
54259-7,calcium in serum,glucose mole volume serum plasma 2 5 hour post dose insulin iv,0.15909204868833826,0.21560843
55479-0,calcium in serum,insulin mole volume serum plasma 7 minute post dose glucose iv,0.15909204868833826,0.215364
53475-0,calcium in serum,glucose mole volume serum plasma pre dose betaxolol,0.15909204868833826,0.21513455
72902-0,calcium in serum,insulin mole volume serum plasma 1 hour post 75 g glucose po,0.15909204868833826,0.21089737
16914-4,calcium in serum,glucose mass volume serum plasma post xxx challenge,0.15909204868833826,0.20436096
40201-6,calcium in serum,glucose mole volume serum plasma 6 minute post xxx challenge,0.15909204868833826,0.21399906
14755-3,calcium in serum,glucose mole volume serum plasma 1 hour post 50 g lactose po,0.15909204868833826,0.21725442
14995-5,calcium in serum,glucose mole volume serum plasma 2 hour post 75 g glucose po,0.15909204868833826,0.21969332
27861-4,calcium in serum,insulin unit volume serum plasma 3 hour post 75 g glucose po,0.15909204868833826,0.19791558
1543-8,calcium in serum,glucose mass volume serum plasma 5 minute post 0 5 g kg glucose iv,0.15909204868833826,0.21055438
47584-8,calcium in serum,component peptide mole volume serum plasma 10 minute post dose glucose,0.15909204868833826,0.21333903
12644-1,calcium in serum,glucose mass volume serum plasma 9 hour post xxx challenge,0.15909204868833826,0.19943537
51597-3,calcium in serum,glucose mole volume serum plasma 1 hour post 75 g glucose po,0.15909204868833826,0.21283379
54257-1,calcium in serum,glucose mole volume serum plasma pre dose insulin iv,0.15909204868833826,0.21221045
48992-2,calcium in serum,glucose mass volume serum plasma 12 specimen,0.15909204868833826,0.20335843
40015-0,calcium in serum,glucose mass volume serum plasma 17 5 hour post xxx challenge,0.15909204868833826,0.20375565
55481-6,calcium in serum,insulin mole volume serum plasma 10 minute pre dose glucose,0.15909204868833826,0.21012588
1558-6,calcium in serum,fasting glucose mass volume serum plasma,0.15909204868833826,0.20746997
40164-6,calcium in serum,glucose mole volume serum plasma 5 hour post xxx challenge,0.15909204868833826,0.21197402
6777-7,calcium in serum,deprecated glucose mass volume serum plasma,0.15909204868833826,0.20672747
40155-4,calcium in serum,glucose mole volume serum plasma 15 minute post xxx challenge,0.15909204868833826,0.20803128
25663-6,calcium in serum,glucose mole volume serum plasma 15 minute post dose glucose,0.15909204868833826,0.21505824
40179-4,calcium in serum,glucose mole volume serum plasma 13 5 hour post xxx challenge,0.15909204868833826,0.2079194
59792-2,calcium in serum,glucose molar concentration difference serum plasma 1 hour post xxx challenge,0.15909204868833826,0.19992694
26543-9,calcium in serum,glucose mass volume serum plasma 5 hour post dose glucose,0.15909204868833826,0.21249467
48985-6,calcium in serum,glucose mass volume serum plasma 20 minute post dose glucose,0.15909204868833826,0.20599099
40152-1,calcium in serum,glucose mole volume serum plasma 5 minute pre xxx challenge,0.15909204868833826,0.20904432
34060-4,calcium in serum,glucose mole volume serum plasma pre post dose insulin,0.15909204868833826,0.21070115
54270-4,calcium in serum,glucose mole volume serum plasma 2 5 hour post dose ornithine alpha ketoglutarate,0.15909204868833826,0.19996838
26555-3,calcium in serum,glucose mass volume serum plasma 3 5 hour post dose glucose,0.15909204868833826,0.21115217
40186-9,calcium in serum,glucose mole volume serum plasma 19 5 hour post xxx challenge,0.15909204868833826,0.2085676
58508-3,calcium in serum,component peptide mass volume serum plasma 3 5 hour post dose glucose,0.15909204868833826,0.2005083
14377-6,calcium in serum,granulocyte leukocyte semen manual count,0.15909204868833826,0.089476205
47588-9,calcium in serum,component peptide mole volume serum plasma 2 hour post dose glucose,0.15909204868833826,0.21329641
58511-7,calcium in serum,component peptide mass volume serum plasma 3 hour post dose glucose,0.15909204868833826,0.19641672
59794-8,calcium in serum,glucose molar concentration difference serum plasma 2 hour post xxx challenge,0.15909204868833826,0.20110242
6749-6,calcium in serum,glucose mass volume serum plasma 2 5 hour post 75 g glucose po,0.15909204868833826,0.20664161
30263-8,calcium in serum,glucose mole volume serum plasma 20 minute post dose glucose,0.15909204868833826,0.21243355
47661-4,calcium in serum,insulin unit volume serum plasma 20 minute post dose glucose,0.15909204868833826,0.19423746
40166-1,calcium in serum,glucose mole volume serum plasma 6 5 hour post xxx challenge,0.15909204868833826,0.21041009
47593-9,calcium in serum,component peptide mole volume serum plasma 5 minute pre dose glucose,0.15909204868833826,0.21276562
53482-6,calcium in serum,glucose mole volume serum plasma 3 hour post dose betaxolol,0.15909204868833826,0.21640694
92670-9,calcium in serum,glucose mass volume serum plasma 2 hour post dose clonidine,0.15909204868833826,0.20008463
95102-0,calcium in serum,glucose post fasting meal stimulation panel serum plasma,0.15909204868833826,0.16971318
40280-0,calcium in serum,glucose mole volume serum plasma 3 hour post dose lactose po,0.15909204868833826,0.21335942
14996-3,calcium in serum,glucose mole volume serum plasma pre 75 g glucose po,0.15909204868833826,0.21943168
50206-2,calcium in serum,glucose mass volume serum plasma 1st specimen,0.15909204868833826,0.21175645
40318-8,calcium in serum,glucose mole volume serum plasma pre dose triple bolus,0.15909204868833826,0.20650141
27432-4,calcium in serum,glucose mass volume serum plasma 8th specimen post xxx challenge,0.15909204868833826,0.19993523
14766-0,calcium in serum,glucose mole volume serum plasma 4 hour post dose glucose,0.15909204868833826,0.21778156
40028-3,calcium in serum,glucose mass volume serum plasma 12 minute post xxx challenge,0.15909204868833826,0.20250286
72648-9,calcium in serum,glucose serum glucose synovial fluid molar concentration difference,0.15909204868833826,0.19799529
12616-9,calcium in serum,glucose mass volume serum plasma 2nd specimen post xxx challenge,0.15909204868833826,0.20009512
55495-6,calcium in serum,insulin mole volume serum plasma 45 minute post dose glucose iv,0.15909204868833826,0.2150833
12641-7,calcium in serum,glucose mass volume serum plasma 7 hour post xxx challenge,0.15909204868833826,0.2020178
40173-7,calcium in serum,glucose mole volume serum plasma 10 hour post xxx challenge,0.15909204868833826,0.21188582
49689-3,calcium in serum,glucose tolerance interpretation serum plasma narrative post 100 g glucose po,0.15909204868833826,0.17777216
32321-2,calcium in serum,glucose mole volume serum plasma 4 hour post 75 g glucose po,0.15909204868833826,0.2070831
47589-7,calcium in serum,component peptide mole volume serum plasma 30 minute post dose glucose,0.15909204868833826,0.21379544
40320-4,calcium in serum,glucose mole volume serum plasma 30 minute post dose triple bolus,0.15909204868833826,0.20695512
40261-0,calcium in serum,glucose mass volume serum plasma 13 minute pre xxx challenge,0.15909204868833826,0.2020035
43740-0,calcium in serum,glucose insulin mass ratio serum plasma,0.15909204868833826,0.20482945
40043-2,calcium in serum,glucose mass volume serum plasma 31 hour post xxx challenge,0.15909204868833826,0.20216988
40162-0,calcium in serum,glucose mole volume serum plasma 3 hour post xxx challenge,0.15909204868833826,0.21072021
32322-0,calcium in serum,glucose mole volume serum plasma 5 hour post 75 g glucose po,0.15909204868833826,0.21053068
1492-8,calcium in serum,glucose mass volume serum plasma 1 5 hour post 0 5 g kg glucose iv,0.15909204868833826,0.21544391
1561-0,calcium in serum,insulin mass volume serum plasma 1 hour post 75 g glucose po,0.15909204868833826,0.19507663
6752-0,calcium in serum,glucose mass volume serum plasma 3 5 hour post 75 g glucose po,0.15909204868833826,0.2044522
26521-5,calcium in serum,granulocyte leukocyte semen,0.15909204868833826,0.09246931
56751-1,calcium in serum,glucose mass volume serum plasma 2 17 hour post xxx challenge,0.15909204868833826,0.199053
29329-0,calcium in serum,glucose mass volume serum plasma 3 5 hour post xxx challenge,0.15909204868833826,0.20212741
12650-8,calcium in serum,glucose mass volume serum plasma 3 5 hour post dose lactose po,0.15909204868833826,0.2018655
40220-6,calcium in serum,glucose mole volume serum plasma 31 hour post xxx challenge,0.15909204868833826,0.21429074
12615-1,calcium in serum,glucose mass volume serum plasma 1st specimen post xxx challenge,0.15909204868833826,0.19941327
40150-5,calcium in serum,glucose mole volume serum plasma 15 minute pre xxx challenge,0.15909204868833826,0.21012484
40018-4,calcium in serum,glucose mass volume serum plasma 19 5 hour post xxx challenge,0.15909204868833826,0.20315598
54269-6,calcium in serum,glucose mole volume serum plasma 2 hour post dose ornithine alpha ketoglutarate,0.15909204868833826,0.20136102
54251-4,calcium in serum,glucose mole volume serum plasma 20 minute post dose glucagon,0.15909204868833826,0.20927218
12656-5,calcium in serum,glucose mass volume serum plasma 4 minute post xxx challenge,0.15909204868833826,0.19949837
96798-4,calcium in serum,cortisol glucose somatotropin post arginine stimulation panel serum plasma,0.15909204868833826,0.17545095
40197-6,calcium in serum,glucose mole volume serum plasma 3 minute pre xxx challenge,0.15909204868833826,0.21022181
50587-5,calcium in serum,glucose tolerance 4 hour panel serum plasma,0.15909204868833826,0.17843923
50751-7,calcium in serum,glucose mass volume serum plasma 15 minute post 0 1 u kg insulin,0.15909204868833826,0.20716323
79196-2,calcium in serum,glucose mass volume serum plasma 1 hour post dose arginine insulin,0.15909204868833826,0.19537053
81637-1,calcium in serum,glucose meter reference method correlation ratio serum plasma blood calculation,0.15909204868833826,0.19369754
30267-9,calcium in serum,glucose mole volume serum plasma 2 3 hour post dose glucose,0.15909204868833826,0.21132948
34057-0,calcium in serum,glucose mole volume serum plasma pre post dose clonidine,0.15909204868833826,0.20852272
14754-6,calcium in serum,glucose mole volume serum plasma 1 hour post 50 g glucose po,0.15909204868833826,0.21989113
1535-4,calcium in serum,glucose mass volume serum plasma 40 minute post 0 5 g kg glucose iv,0.15909204868833826,0.21308266
40174-5,calcium in serum,glucose mole volume serum plasma 10 75 hour post xxx challenge,0.15909204868833826,0.20986839
50213-8,calcium in serum,glucose mass volume serum plasma 3rd specimen,0.15909204868833826,0.21065046
48303-2,calcium in serum,brilliant black bn triggered leukotriene release mass volume leukocyte,0.1257713843157642,0.075042576
56906-1,calcium in serum,bilirubin direct mass volume peritoneal fluid,0.1257713843157642,0.09695617
1968-7,calcium in serum,bilirubin direct mass volume serum plasma,0.1257713843157642,0.20813331
39461-9,calcium in serum,bilirubin total mole volume peritoneal fluid,0.1257713843157642,0.102978714
49763-6,calcium in serum,bilirubin total mass volume pericardial fluid,0.1257713843157642,0.09860568
56905-3,calcium in serum,bilirubin direct mass volume pleural fluid,0.1257713843157642,0.09098764
74434-2,calcium in serum,bilirubin total total stone infrared spectroscopy,0.1257713843157642,0.08877508
14152-3,calcium in serum,bilirubin direct mass volume body fluid,0.1257713843157642,0.103518695
21644-0,calcium in serum,cacna1s gene p arg528his presence blood tissue molecular genetics method,0.1257713843157642,0.08459572
57566-2,calcium in serum,25 hydroxyvitamin d3 mole volume serum plasma pre dose calcium,0.1257713843157642,0.5824805
1977-8,calcium in serum,bilirubin total presence urine,0.1257713843157642,0.07768978
68367-2,calcium in serum,bilirubin total mole volume urine automated test strip,0.1257713843157642,0.10740859
94392-8,calcium in serum,bordetella pertussis parapertussis bronchiseptica gida gene presence lower respiratory specimen naa probe detection,0.1257713843157642,0.05582005
33870-7,calcium in serum,bilirubin total presence specimen,0.1257713843157642,0.06642297
1970-3,calcium in serum,bilirubin delta mass volume serum plasma,0.1257713843157642,0.20757392
33412-8,calcium in serum,blast leukocyte pericardial fluid,0.1257713843157642,0.07040777
50551-1,calcium in serum,bilirubin total presence urine automated test strip,0.1257713843157642,0.075106055
1971-1,calcium in serum,bilirubin indirect mass volume serum plasma,0.1257713843157642,0.21271865
57567-0,calcium in serum,25 hydroxyvitamin d3 mole volume serum plasma 2 hour post dose calcium,0.1257713843157642,0.5813367
49649-7,calcium in serum,cacna1a gene allele 1 cag repeat entitic number blood tissue molecular genetics method,0.1257713843157642,0.1239607
21642-4,calcium in serum,cacna1s gene p arg1239gly presence blood tissue molecular genetics method,0.1257713843157642,0.08658919
42719-5,calcium in serum,bilirubin total mass volume blood,0.1257713843157642,0.11341656
97770-2,calcium in serum,bilirubin total mole volume capillary blood,0.1257713843157642,0.099871986
33373-2,calcium in serum,blast leukocyte pleural fluid,0.1257713843157642,0.06422858
33655-2,calcium in serum,beta n acetylhexosaminidase mole volume leukocyte,0.05801012210940984,0.09897091
17833-5,calcium in serum,basophil leukocyte synovial fluid,0.05801012210940984,0.07453305
24059-8,calcium in serum,aspartylglucosaminidase enzymatic activity mass leukocyte,0.05801012210940984,0.10470295
74407-8,calcium in serum,basophil leukocyte cord blood,0.05801012210940984,0.067868724
53516-1,calcium in serum,basophil leukocyte dialysis fluid manual count,0.05801012210940984,0.062476233
71602-7,calcium in serum,basophil leukocyte pure number fraction pericardial fluid manual count,0.05801012210940984,0.07890609
48203-4,calcium in serum,celery triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.08291182
35069-4,calcium in serum,basophil leukocyte peritoneal fluid,0.05801012210940984,0.07706975
59244-4,calcium in serum,arylsulfatase component enzymatic activity mass leukocyte,0.05801012210940984,0.10670478
48282-8,calcium in serum,atracurium triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.092734255
24068-9,calcium in serum,beta mannosidase enzymatic activity mass leukocyte,0.05801012210940984,0.10902971
71647-2,calcium in serum,basophil leukocyte pure number fraction body fluid manual count,0.05801012210940984,0.08094742
48211-7,calcium in serum,beef triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.08406216
1816-8,calcium in serum,acid alpha glucosidase enzymatic activity volume leukocyte,0.05801012210940984,0.10289092
24101-8,calcium in serum,acid sphingomyelinase enzymatic activity mass leukocyte,0.05801012210940984,0.11966495
48254-7,calcium in serum,mugwort triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.07412562
48249-7,calcium in serum,silver birch triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.08752272
12482-6,calcium in serum,ascorbate mass volume leukocyte,0.05801012210940984,0.08788472
48234-9,calcium in serum,acarus siro triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.081682116
1766-5,calcium in serum,aldosterone receptor leukocyte,0.05801012210940984,0.076955855
48239-8,calcium in serum,alternaria alternata triggered leukotriene release mass volume leukocyte,0.05801012210940984,0.07951086
24075-4,calcium in serum,beta n acetylhexosaminidase enzymatic activity mass leukocyte,0.05801012210940984,0.1043364
24073-9,calcium in serum,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.05801012210940984,0.10253011
32350-1,calcium in serum,basophil eosinophil monocyte leukocyte blood,0.05801012210940984,0.07170986
50658-4,calcium in serum,basophil band form leukocyte bone marrow,0.05801012210940984,0.07836342
1650-1,calcium in serum,1 4 alpha glucan branching enzyme enzymatic activity volume leukocyte,0.05801012210940984,0.108404085
14625-8,calcium in serum,basophil leukocyte bronchial specimen manual count,0.05801012210940984,0.07175137
24051-5,calcium in serum,acid alpha glucosidase enzymatic activity mass leukocyte,0.05801012210940984,0.11463231
48196-0,calcium in serum,cephalosporin component triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.09572791
68432-4,calcium in serum,leukocyte leukocyte vitreous fluid manual count,0.04091042901354472,0.07626517
5526-9,calcium in serum,deprecated cd72 cell 100 cell blood,0.04091042901354472,0.07202668
5471-8,calcium in serum,deprecated cd39 cell 100 cell blood,0.04091042901354472,0.06334049
26522-3,calcium in serum,granulocyte leukocyte synovial fluid,0.04091042901354472,0.08955923
2563-5,calcium in serum,leukocyte esterase enzymatic activity volume leukocyte,0.04091042901354472,0.09609792
75590-0,calcium in serum,fetal angelman syndrome risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.04091042901354472,0.0741107
48278-6,calcium in serum,mefenamate triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.088256925
48187-9,calcium in serum,chloramin triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.08709104
5476-7,calcium in serum,deprecated cd41 cell 100 cell blood,0.04091042901354472,0.06896665
48221-6,calcium in serum,barley triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.08075431
30405-5,calcium in serum,leukocyte volume urine,0.04091042901354472,0.10480469
5506-1,calcium in serum,deprecated cd57 cell 100 cell blood,0.04091042901354472,0.06634755
75577-7,calcium in serum,fetal 22q11 2 deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.04091042901354472,0.06690735
16913-6,calcium in serum,fasting glucose presence urine,0.04091042901354472,0.08098783
5528-5,calcium in serum,deprecated cd74 cell 100 cell blood,0.04091042901354472,0.070512615
6750-4,calcium in serum,glucose presence urine test strip 2 hour post 50 g lactose po,0.04091042901354472,0.082896344
5554-1,calcium in serum,deprecated cyig mu cell 100 cell blood,0.04091042901354472,0.0748112
48207-5,calcium in serum,egg yolk triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.09095166
51770-6,calcium in serum,leukocyte area stool microscopy high power field,0.04091042901354472,0.08528841
1532-1,calcium in serum,glucose mass volume urine 3 hour post 100 g glucose po,0.04091042901354472,0.10485096
48224-0,calcium in serum,codfish triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.08578281
48233-1,calcium in serum,lepidoglyphus destructor triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.06600062
74686-7,calcium in serum,glucose mole time 12 hour urine,0.04091042901354472,0.10997872
17235-3,calcium in serum,magnesium mole volume leukocyte,0.04091042901354472,0.12966152
5525-1,calcium in serum,deprecated cd71 cell 100 cell blood,0.04091042901354472,0.06782694
48235-6,calcium in serum,american house dust mite triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.07430768
12226-7,calcium in serum,leukocyte presence vaginal fluid wet preparation,0.04091042901354472,0.074600056
44092-5,calcium in serum,leukocyte area vaginal fluid wet preparation,0.04091042901354472,0.08348488
30415-4,calcium in serum,abnormal lymphocyte leukocyte synovial fluid,0.04091042901354472,0.072797626
105093-9,calcium in serum,leukocyte clump area urine sediment,0.04091042901354472,0.094247214
5546-7,calcium in serum,deprecated cd95 cell 100 cell blood,0.04091042901354472,0.068992205
42604-9,calcium in serum,glucose mass volume urine 3 hour post dose lactose po,0.04091042901354472,0.10197707
26542-1,calcium in serum,glucose mass volume urine 5 hour post dose glucose,0.04091042901354472,0.11025851
71619-1,calcium in serum,mononuclear cell leukocyte pure number fraction synovial fluid manual count,0.04091042901354472,0.07624009
5475-9,calcium in serum,deprecated cd40 cell 100 cell blood,0.04091042901354472,0.06888059
54487-4,calcium in serum,glucose mole volume water,0.04091042901354472,0.117051795
75595-9,calcium in serum,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.04091042901354472,0.06850043
105921-1,calcium in serum,leukocyte volume urethra wet preparation,0.04091042901354472,0.094368294
16910-2,calcium in serum,glucose presence urine 7th specimen post xxx challenge,0.04091042901354472,0.0773385
5509-5,calcium in serum,deprecated cd6 cell 100 cell blood,0.04091042901354472,0.06931026
48242-2,calcium in serum,cladosporium herbarum triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.07430803
72163-9,calcium in serum,leukocyte presence specimen gram stain,0.04091042901354472,0.07175648
75604-9,calcium in serum,fetal sex cell free maternal wbc dna dosage chromosome specific circulating cell free ccf dna,0.04091042901354472,0.07671094
5433-8,calcium in serum,deprecated cd128 cell 100 cell blood,0.04091042901354472,0.06881953
5421-3,calcium in serum,deprecated cd106 cell 100 cell blood,0.04091042901354472,0.06688256
2186-5,calcium in serum,cytochrome component oxidase enzymatic activity volume leukocyte,0.04091042901354472,0.09979601
50404-3,calcium in serum,cell leukocyte identifier synovial fluid,0.04091042901354472,0.056223553
5445-2,calcium in serum,deprecated cd19 kappa cell 100 cell blood,0.04091042901354472,0.070448525
75588-4,calcium in serum,fetal angelman syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.04091042901354472,0.06951699
42615-5,calcium in serum,glucose mass volume urine 30 minute post dose lactose po,0.04091042901354472,0.10115301
32142-2,calcium in serum,leukocyte presence synovial fluid light microscopy,0.04091042901354472,0.06249032
75553-8,calcium in serum,comment fetal trisomy 13 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.04091042901354472,0.07327745
5549-1,calcium in serum,deprecated cd98 cell 100 cell blood,0.04091042901354472,0.06844511
26553-8,calcium in serum,glucose presence urine test strip 1 5 hour post dose glucose,0.04091042901354472,0.0882061
18407-7,calcium in serum,leukocyte 12 hour urine sediment light microscopy,0.04091042901354472,0.08813875
45383-7,calcium in serum,leukocyte area urine sediment microscopy low power field,0.04091042901354472,0.08628522
53444-6,calcium in serum,citrate synthase enzymatic activity mass control leukocyte,0.04091042901354472,0.1147536
813-6,calcium in serum,leukocyte volume synovial fluid automated count,0.04091042901354472,0.081353344
32761-9,calcium in serum,leukocyte presence specimen wet preparation,0.04091042901354472,0.07758908
57850-0,calcium in serum,mesothelial cell leukocyte synovial fluid manual count,0.04091042901354472,0.083359934
48294-3,calcium in serum,food colorant mix triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.08710237
30381-8,calcium in serum,eosinophil leukocyte sputum,0.04091042901354472,0.067405134
75579-3,calcium in serum,comment fetal 22q11 2 deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.04091042901354472,0.07552102
48236-4,calcium in serum,european house dust mite triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.07753431
5426-2,calcium in serum,deprecated cd11a cell 100 cell blood,0.04091042901354472,0.07214237
74437-5,calcium in serum,galactokinase enzymatic activity mass leukocyte,0.04091042901354472,0.09748821
75602-3,calcium in serum,fetal 1p36 deletion risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.04091042901354472,0.07338796
48194-5,calcium in serum,lidocaine triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.079343714
34312-9,calcium in serum,glucose creatinine molar ratio urine,0.04091042901354472,0.1203631
5489-0,calcium in serum,deprecated cd47 cell 100 cell blood,0.04091042901354472,0.06681625
5482-5,calcium in serum,deprecated cd44 cell 100 cell blood,0.04091042901354472,0.06629637
5492-4,calcium in serum,deprecated cd49b cell 100 cell blood,0.04091042901354472,0.066410124
68423-3,calcium in serum,monocyte leukocyte vitreous fluid manual count,0.04091042901354472,0.07446565
26552-0,calcium in serum,glucose presence urine test strip 6 hour post dose glucose,0.04091042901354472,0.086665995
75578-5,calcium in serum,fetal 22q11 2 deletion risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.04091042901354472,0.07502483
16904-5,calcium in serum,glucose presence urine 1st specimen post xxx challenge,0.04091042901354472,0.07938308
5495-7,calcium in serum,deprecated cd49e cell 100 cell blood,0.04091042901354472,0.06738697
78963-6,calcium in serum,mannose 6 phosphate isomerase enzymatic activity mass leukocyte,0.04091042901354472,0.10610284
32174-5,calcium in serum,glucose presence 24 hour urine,0.04091042901354472,0.07714469
5553-3,calcium in serum,deprecated cyig cell 100 cell blood,0.04091042901354472,0.07094927
48206-7,calcium in serum,lactalbumin alpha triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.094357446
5469-2,calcium in serum,deprecated cd37 cell 100 cell blood,0.04091042901354472,0.06804112
94487-6,calcium in serum,galactosylceramidase enzymatic activity mass leukocyte confirmatory method,0.04091042901354472,0.10076167
5499-9,calcium in serum,deprecated cd50 cell 100 cell blood,0.04091042901354472,0.069040135
5418-9,calcium in serum,deprecated cd103 cell 100 cell blood,0.04091042901354472,0.06962183
48209-1,calcium in serum,orange triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.081978
40874-0,calcium in serum,glucose mass volume specimen 1st specimen,0.04091042901354472,0.10166633
48295-0,calcium in serum,food colorant mix ii triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.08831605
69017-2,calcium in serum,immature granulocyte leukocyte synovial fluid,0.04091042901354472,0.08447319
94489-2,calcium in serum,lysosomal storage disorder panel leukocyte,0.04091042901354472,0.06968565
5458-5,calcium in serum,deprecated cd29 cell 100 cell blood,0.04091042901354472,0.0684027
5417-1,calcium in serum,deprecated cd102 cell 100 cell blood,0.04091042901354472,0.06694334
5437-9,calcium in serum,deprecated cd16 cell 100 cell blood,0.04091042901354472,0.06672557
75597-5,calcium in serum,comment fetal 5p deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.04091042901354472,0.07766382
5467-6,calcium in serum,deprecated cd35 cell 100 cell blood,0.04091042901354472,0.06623054
61124-4,calcium in serum,granulocyte leukocyte specimen flow cytometry fc,0.04091042901354472,0.08798231
5466-8,calcium in serum,deprecated cd34 dr cell 100 cell blood,0.04091042901354472,0.071238674
5515-2,calcium in serum,deprecated cd64 cell 100 cell blood,0.04091042901354472,0.06786099
48248-9,calcium in serum,hazelnut pollen triggered leukotriene release mass volume leukocyte,0.04091042901354472,0.07450025
5441-1,calcium in serum,deprecated cd16 cd57 cell 100 cell blood,0.04091042901354472,0.061237823
104635-8,calcium in serum,continuous glucose monitor device date time reporting period end reported,0.021801744029029457,0.06776899
30413-9,calcium in serum,abnormal lymphocyte leukocyte blood,0.021801744029029457,0.090672344
46090-7,calcium in serum,leukocyte volume cerebral spinal fluid 4th tube,0.021801744029029457,0.09622438
46222-6,calcium in serum,glucose mole volume dialysis fluid 4 hour specimen,0.021801744029029457,0.10357851
55598-7,calcium in serum,leukocyte disintegrated leukocyte body fluid manual count,0.021801744029029457,0.0841045
51621-1,calcium in serum,macrophage leukocyte dialysis fluid manual count,0.021801744029029457,0.06770365
51586-6,calcium in serum,cell leukocyte blood manual count,0.021801744029029457,0.08633902
12631-8,calcium in serum,glucose mass volume peritoneal dialysis fluid 2nd specimen,0.021801744029029457,0.09424252
729-4,calcium in serum,leukocyte volume blood manual count,0.021801744029029457,0.098386385
58556-2,calcium in serum,corticotropin mass volume plasma 1 hour post dose glucose,0.021801744029029457,0.10401979
808-6,calcium in serum,leukocyte volume pleural fluid manual count,0.021801744029029457,0.08452506
30408-9,calcium in serum,leukocyte leukocyte pleural fluid,0.021801744029029457,0.07710394
35477-9,calcium in serum,ciliated columnar lining cell leukocyte ratio body fluid,0.021801744029029457,0.086899795
72649-7,calcium in serum,glucose serum glucose peritoneal fluid molar concentration difference,0.021801744029029457,0.21285154
16994-6,calcium in serum,hydrogen expired gas volume fraction exhaled gas 5 hour post dose glucose,0.021801744029029457,0.07451848
30378-4,calcium in serum,eosinophil leukocyte nose,0.021801744029029457,0.058613546
40544-9,calcium in serum,monocyte leukocyte bronchial specimen manual count,0.021801744029029457,0.06923319
14820-5,calcium in serum,lymphocyte leukocyte pleural fluid manual count,0.021801744029029457,0.08173171
75864-9,calcium in serum,hedis 2015 2018 value set glucose test,0.021801744029029457,0.054554153
56772-7,calcium in serum,macrophage leukocyte bronchial specimen flow cytometry fc,0.021801744029029457,0.0751381
71661-3,calcium in serum,eosinophil leukocyte pure number fraction cerebral spinal fluid manual count,0.021801744029029457,0.079538696
19048-8,calcium in serum,nucleated erythrocyte leukocyte ratio blood,0.021801744029029457,0.10480352
33287-4,calcium in serum,glucose 6 phosphate dehydrogenase presence db,0.021801744029029457,0.08262712
40366-7,calcium in serum,glucose mole time 24 hour body fluid,0.021801744029029457,0.10471759
30417-0,calcium in serum,variant lymphocyte leukocyte body fluid,0.021801744029029457,0.079677455
55784-3,calcium in serum,leukocyte volume corrected nucleated erythrocyte bone marrow,0.021801744029029457,0.09206636
55433-7,calcium in serum,immature cell leukocyte blood,0.021801744029029457,0.09261498
13523-6,calcium in serum,leukocyte leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.08852699
16991-2,calcium in serum,hydrogen expired gas volume fraction exhaled gas 4 5 hour post dose glucose,0.021801744029029457,0.07268028
40543-1,calcium in serum,leukocyte leukocyte bronchial specimen manual count,0.021801744029029457,0.07040708
2340-8,calcium in serum,glucose mass volume blood automated test strip,0.021801744029029457,0.10777169
56160-5,calcium in serum,glucose mass volume peritoneal dialysis fluid 4 hour post peritoneal dialysis,0.021801744029029457,0.09430876
59813-6,calcium in serum,glucose mole volume capillary blood glucometer 7 specimen,0.021801744029029457,0.10476435
1557-8,calcium in serum,fasting glucose mass volume venous blood,0.021801744029029457,0.08814711
70037-7,calcium in serum,mononuclear cell leukocyte pericardial fluid automated count,0.021801744029029457,0.07763205
74451-6,calcium in serum,cell leukocyte blood fetus,0.021801744029029457,0.08212298
99933-4,calcium in serum,leukocyte clump presence body fluid automated,0.021801744029029457,0.06651166
74244-5,calcium in serum,hedis 2014 value set glucose test,0.021801744029029457,0.05490558
66761-8,calcium in serum,lymphocyte leukocyte dialysis fluid manual count,0.021801744029029457,0.07246561
12612-8,calcium in serum,glucose mass volume dialysis fluid 2 hour specimen,0.021801744029029457,0.095453024
13350-4,calcium in serum,deprecated eosinophil 100 leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.07514072
14818-9,calcium in serum,lymphocyte leukocyte pericardial fluid manual count,0.021801744029029457,0.088149525
105273-7,calcium in serum,glucose mole volume reporting period mean interstitial fluid calculation,0.021801744029029457,0.11663511
6690-2,calcium in serum,leukocyte volume blood automated count,0.021801744029029457,0.09813801
51622-9,calcium in serum,mesothelial cell leukocyte dialysis fluid manual count,0.021801744029029457,0.07836756
50342-5,calcium in serum,ependymal choroid plexus cell leukocyte ratio cerebral spinal fluid,0.021801744029029457,0.08727048
43278-1,calcium in serum,glucose mass volume milk 2 hour post meal,0.021801744029029457,0.096635275
14379-2,calcium in serum,granulocyte leukocyte gastric fluid manual count,0.021801744029029457,0.08004283
740-1,calcium in serum,metamyelocytes leukocyte blood manual count,0.021801744029029457,0.08966234
13517-8,calcium in serum,variant lymphocyte leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.08523606
99775-9,calcium in serum,leukocyte volume peritoneal dialysis fluid automated count,0.021801744029029457,0.07963864
9727-9,calcium in serum,eosinophil leukocyte nose manual count,0.021801744029029457,0.06166163
12208-5,calcium in serum,eosinophil leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.07456766
72650-5,calcium in serum,glucose serum glucose pericard field molar concentration difference,0.021801744029029457,0.21342793
67830-0,calcium in serum,leukocyte volume pericardial fluid,0.021801744029029457,0.09411439
17790-7,calcium in serum,leukocyte left shift presence blood automated count,0.021801744029029457,0.07414213
30419-6,calcium in serum,lymphocyte clefted leukocyte blood,0.021801744029029457,0.086169526
26482-0,calcium in serum,lymphocyte leukocyte peritoneal fluid,0.021801744029029457,0.08806354
53227-5,calcium in serum,leukocyte area cervix wet preparation,0.021801744029029457,0.088708505
43151-0,calcium in serum,glucose meter device panel,0.021801744029029457,0.06342386
26451-5,calcium in serum,eosinophil leukocyte cerebral spinal fluid,0.021801744029029457,0.07944068
12244-0,calcium in serum,granulocyte leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.09010349
94240-9,calcium in serum,cdh1 gene deletion duplication full mutation analysis blood tissue molecular genetics method,0.021801744029029457,0.053583458
40533-2,calcium in serum,leukocyte volume peritoneal dialysis fluid manual count,0.021801744029029457,0.08169682
68430-8,calcium in serum,leukocyte volume pleural fluid manual count,0.021801744029029457,0.082888745
2344-0,calcium in serum,glucose mass volume body fluid,0.021801744029029457,0.106668375
46088-1,calcium in serum,leukocyte volume cerebral spinal fluid 2nd tube,0.021801744029029457,0.097729675
49782-6,calcium in serum,mononuclear cell leukocyte pericardial fluid,0.021801744029029457,0.07709047
71696-9,calcium in serum,granulocyte leukocyte body fluid automated count,0.021801744029029457,0.0885703
21372-8,calcium in serum,abnormal lymphocyte leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.08602959
35058-7,calcium in serum,hairy cell leukocyte blood,0.021801744029029457,0.09000645
58802-0,calcium in serum,mononuclear cell leukocyte peritoneal dialysis fluid,0.021801744029029457,0.06985501
33840-0,calcium in serum,monoblast leukocyte blood manual count,0.021801744029029457,0.082612954
11157-5,calcium in serum,leukocyte morphology bone marrow,0.021801744029029457,0.07040929
46221-8,calcium in serum,glucose mole volume dialysis fluid 2 hour specimen,0.021801744029029457,0.10227662
55376-8,calcium in serum,megaloblast leukocyte blood manual count,0.021801744029029457,0.0974199
71614-2,calcium in serum,monocyte leukocyte pure number fraction pleural fluid manual count,0.021801744029029457,0.078077056
74405-2,calcium in serum,eosinophil leukocyte cord blood,0.021801744029029457,0.0663117
33833-5,calcium in serum,lymphocyte immunoblastic leukocyte blood manual count,0.021801744029029457,0.08552587
19023-1,calcium in serum,granulocyte leukocyte blood automated count,0.021801744029029457,0.09650308
24106-7,calcium in serum,hairy cell leukocyte blood manual count,0.021801744029029457,0.091247685
88114-4,calcium in serum,leukocyte presence cerebral spinal fluid gram stain,0.021801744029029457,0.07814205
58557-0,calcium in serum,corticotropin mole volume plasma 1 hour post dose glucose,0.021801744029029457,0.11428158
14344-6,calcium in serum,eosinophil leukocyte pleural fluid manual count,0.021801744029029457,0.07228506
12229-1,calcium in serum,macrophage leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.0791957
62858-6,calcium in serum,micromegakaryocytes leukocyte blood manual count,0.021801744029029457,0.09157148
54234-0,calcium in serum,cell count diff panel gluc prot body fluid,0.021801744029029457,0.069571964
104598-8,calcium in serum,glucose mass volume arterial blood glucometer,0.021801744029029457,0.11462119
58528-1,calcium in serum,corticotropin mass volume plasma 1 5 hour post dose glucose,0.021801744029029457,0.103461646
39479-1,calcium in serum,glucose mole volume pericardial fluid,0.021801744029029457,0.11435928
809-4,calcium in serum,leukocyte volume peritoneal fluid automated count,0.021801744029029457,0.08913431
26471-3,calcium in serum,leukocyte leukocyte blood,0.021801744029029457,0.09678861
33765-9,calcium in serum,leukocyte volume blood product unit platelet pheresis automated count,0.021801744029029457,0.082325906
74141-3,calcium in serum,granulocyte leukocyte peritoneal dialysis fluid,0.021801744029029457,0.080805555
14748-8,calcium in serum,glucose mole volume peritoneal fluid,0.021801744029029457,0.12058751
30379-2,calcium in serum,eosinophil leukocyte pleural fluid,0.021801744029029457,0.06693229
42250-1,calcium in serum,variant lymphocyte leukocyte blood automated count,0.021801744029029457,0.07717674
73903-7,calcium in serum,cd3 cd57 cell leukocyte blood flow cytometry fc,0.021801744029029457,0.086012945
14773-6,calcium in serum,granulocyte leukocyte bronchial specimen manual count,0.021801744029029457,0.08897373
14375-0,calcium in serum,granulocyte leukocyte peritoneal fluid manual count,0.021801744029029457,0.0938118
61513-8,calcium in serum,many year take calcium alone combined something else bone health supplement antacid phenx,0.021801744029029457,0.44957423
41653-7,calcium in serum,glucose mass volume capillary blood glucometer,0.021801744029029457,0.10474916
66148-8,calcium in serum,mononuclear cell leukocyte pleural fluid fetus manual count,0.021801744029029457,0.07440894
56937-6,calcium in serum,hydrogen expired gas volume fraction exhaled gas 30 minute post dose glucose,0.021801744029029457,0.06757346
90996-0,calcium in serum,hedis 2019 2020 value set glucose test,0.021801744029029457,0.05385186
71605-0,calcium in serum,lymphocyte leukocyte pure number fraction pericardial fluid manual count,0.021801744029029457,0.08616041
3242-5,calcium in serum,recalcification time platelet poor plasma coagulation assay,0.021801744029029457,0.44534025
71634-0,calcium in serum,lymphocyte leukocyte pure number fraction peritoneal fluid manual count,0.021801744029029457,0.08688045
66133-0,calcium in serum,mononuclear cell atypical leukocyte body fluid manual count,0.021801744029029457,0.077519946
26465-5,calcium in serum,leukocyte volume cerebral spinal fluid,0.021801744029029457,0.102306396
104878-4,calcium in serum,hematocrit volume fraction blood 2 hour post dose glucose,0.021801744029029457,0.09839916
57847-6,calcium in serum,leukocyte volume dialysis fluid manual count,0.021801744029029457,0.081253126
19252-6,calcium in serum,megakaryocyte leukocyte blood,0.021801744029029457,0.09800298
51648-4,calcium in serum,monocytoid cell leukocyte cerebral spinal fluid manual count,0.021801744029029457,0.07142419
33831-9,calcium in serum,lymphoblast leukocyte blood manual count,0.021801744029029457,0.08328831
29259-9,calcium in serum,monocyte abnormal leukocyte blood manual count,0.021801744029029457,0.08114013
97510-2,calcium in serum,glucose measurement range total glucose measurement reporting period,0.021801744029029457,0.08014609
94231-8,calcium in serum,g6pd gene full mutation analysis blood tissue sequencing,0.021801744029029457,0.054721717
32174-5,glucose in blood,glucose presence 24 hour urine,1.0,0.7801514
40160-4,glucose in blood,glucose mole volume serum plasma 75 minute post xxx challenge,1.0,0.450664
25428-4,glucose in blood,glucose presence urine test strip,1.0,0.76996773
40028-3,glucose in blood,glucose mass volume serum plasma 12 minute post xxx challenge,1.0,0.4676806
9307-0,glucose in blood,insulin mass volume serum plasma 30 minute post 75 g glucose po,1.0,0.45597923
2344-0,glucose in blood,glucose mass volume body fluid,1.0,0.8146568
54251-4,glucose in blood,glucose mole volume serum plasma 20 minute post dose glucagon,1.0,0.46440563
54250-6,glucose in blood,glucose mole volume serum plasma 15 minute pre dose glucagon,1.0,0.46324998
102018-9,glucose in blood,glucose mass volume serum plasma 1 hour post dose glucagon,1.0,0.4752738
101476-0,glucose in blood,fasting glucose mole volume venous blood,1.0,0.44392818
71608-4,glucose in blood,granulocyte leukocyte pure number fraction pleural fluid manual count,1.0,0.0767128
59812-8,glucose in blood,glucose mole volume serum plasma 11 specimen,1.0,0.46241644
27940-6,glucose in blood,deprecated insulin unit volume serum plasma 1 5 hour post 75 g glucose po,1.0,0.45104522
54397-5,glucose in blood,glucose mole volume serum plasma 3rd specimen post xxx challenge,1.0,0.45231482
26543-9,glucose in blood,glucose mass volume serum plasma 5 hour post dose glucose,1.0,0.48386154
97507-8,glucose in blood,average glucose mass volume interstitial fluid reporting period,1.0,0.80991614
2341-6,glucose in blood,glucose mass volume blood test strip manual,1.0,0.98618686
30267-9,glucose in blood,glucose mole volume serum plasma 2 3 hour post dose glucose,1.0,0.4663295
1512-3,glucose in blood,glucose mass volume serum plasma 1 minute post 0 5 g kg glucose iv,1.0,0.48534527
51596-5,glucose in blood,glucose mole volume capillary blood,1.0,0.7881648
76672-5,glucose in blood,glucose mole volume cerebral spinal fluid 4th tube,1.0,0.44237986
1552-9,glucose in blood,glucose mass volume serum plasma pre 75 g glucose po,1.0,0.4802422
40209-9,glucose in blood,glucose mole volume serum plasma 25 minute post xxx challenge,1.0,0.45569202
40203-2,glucose in blood,glucose mole volume serum plasma 9 minute post xxx challenge,1.0,0.45568216
42609-8,glucose in blood,glucose mass volume urine 6 hour post dose lactose po,1.0,0.4544914
92818-4,glucose in blood,glucose mass volume serum plasma 20 minute post dose glucagon,1.0,0.47561458
26540-5,glucose in blood,glucose mass volume urine 3 hour post dose glucose,1.0,0.47468945
16985-4,glucose in blood,hydrogen expired gas volume fraction exhaled gas 1 5 hour post dose glucose,1.0,0.4342743
59793-0,glucose in blood,glucose molar concentration difference serum plasma 1 5 hour post xxx challenge,1.0,0.4454531
55479-0,glucose in blood,insulin mole volume serum plasma 7 minute post dose glucose iv,1.0,0.44974738
25670-1,glucose in blood,glucose mass volume urine 30 minute post dose glucose,1.0,0.46803093
48810-6,glucose in blood,glucose mass volume serum plasma 5 hour post 50 g glucose po,1.0,0.47651398
102032-0,glucose in blood,glucose mass volume serum plasma 2 hour post dose insulin iv,1.0,0.46480983
14743-9,glucose in blood,glucose mole volume capillary blood glucometer,1.0,0.8124786
51595-7,glucose in blood,glucose presence stool,1.0,0.75969744
40850-0,glucose in blood,glucose mass volume urine test strip 2nd specimen post xxx challenge,1.0,0.4578056
33287-4,glucose in blood,glucose 6 phosphate dehydrogenase presence db,1.0,0.5057962
45205-2,glucose in blood,glucose mass volume urine test strip 4th specimen post xxx challenge,1.0,0.45731887
12646-6,glucose in blood,glucose mass volume serum plasma 1 hour post xxx challenge,1.0,0.47303042
14771-0,glucose in blood,fasting glucose mole volume serum plasma,1.0,0.4657928
14754-6,glucose in blood,glucose mole volume serum plasma 1 hour post 50 g glucose po,1.0,0.47268397
29331-6,glucose in blood,glucose mass volume serum plasma 5 hour post xxx challenge,1.0,0.46425423
45297-9,glucose in blood,glucose mole volume 24 hour dialysis fluid,1.0,0.7905158
53093-1,glucose in blood,glucose mole volume serum plasma post xxx challenge,1.0,0.45718336
26778-1,glucose in blood,glucose mass volume serum plasma 1 hour post dose lactose po,1.0,0.4623087
74686-7,glucose in blood,glucose mole time 12 hour urine,1.0,0.808135
45204-5,glucose in blood,glucose mass volume urine test strip 3rd specimen post xxx challenge,1.0,0.4578291
6777-7,glucose in blood,deprecated glucose mass volume serum plasma,1.0,0.8127553
87422-2,glucose in blood,glucose mass volume blood post meal,1.0,0.64599246
1518-0,glucose in blood,glucose mass volume serum plasma 2 hour post 75 g glucose po,1.0,0.47970194
40154-7,glucose in blood,glucose mole volume serum plasma 10 minute post xxx challenge,1.0,0.45142335
14756-1,glucose in blood,glucose mole volume serum plasma 1 hour post dose glucose,1.0,0.47161394
25680-0,glucose in blood,glucose mole volume serum plasma pre 50 g glucose po,1.0,0.47174725
2437-2,glucose in blood,hydrogen expired gas volume fraction exhaled gas post 50 g glucose po,1.0,0.42918286
6754-6,glucose in blood,glucose presence urine test strip 30 minute post 75 g glucose po,1.0,0.44009066
72648-9,glucose in blood,glucose serum glucose synovial fluid molar concentration difference,1.0,0.4502976
40004-4,glucose in blood,glucose mass volume serum plasma 100 minute post xxx challenge,1.0,0.46686807
1513-1,glucose in blood,glucose mass volume serum plasma 20 minute post 0 5 g kg glucose iv,1.0,0.4803161
12645-8,glucose in blood,glucose mass volume serum plasma 10 hour post xxx challenge,1.0,0.46839312
6755-3,glucose in blood,glucose presence urine test strip 3 hour post 75 g glucose po,1.0,0.44193363
1508-1,glucose in blood,deprecated glucose mass volume serum plasma 1 hour post 75 g glucose po,1.0,0.46608305
48231-5,glucose in blood,glycyphagus domesticus triggered leukotriene release mass volume leukocyte,1.0,0.08918397
99602-5,glucose in blood,glucose creatinine molar ratio 24 hour urine,1.0,0.45492038
12642-5,glucose in blood,glucose mass volume serum plasma 7 5 hour post xxx challenge,1.0,0.46717584
72604-2,glucose in blood,insulin unit volume serum plasma 4 5 hour post 75 g glucose po,1.0,0.44747227
40213-1,glucose in blood,glucose mole volume serum plasma 5 5 hour post xxx challenge,1.0,0.45454183
30263-8,glucose in blood,glucose mole volume serum plasma 20 minute post dose glucose,1.0,0.46369132
10449-7,glucose in blood,glucose mass volume serum plasma 1 hour post meal,1.0,0.4732408
71627-4,glucose in blood,granulocyte leukocyte pure number fraction peritoneal fluid manual count,1.0,0.078279495
48989-8,glucose in blood,glucose mass volume serum plasma 6 pm specimen,1.0,0.47807577
12632-6,glucose in blood,glucose mass volume peritoneal dialysis fluid 3rd specimen,1.0,0.46065822
32318-8,glucose in blood,glucose mole volume specimen,1.0,0.78909767
76629-5,glucose in blood,fasting glucose mole volume blood,1.0,0.6408004
54271-2,glucose in blood,glucose mole volume serum plasma 15 minute post dose ornithine alpha ketoglutarate,1.0,0.4399378
40167-9,glucose in blood,glucose mole volume serum plasma 7 hour post xxx challenge,1.0,0.45110992
72651-3,glucose in blood,glucose serum glucose pleural fluid molar concentration difference,1.0,0.46389812
54395-9,glucose in blood,glucose mole volume serum plasma 12th specimen post xxx challenge,1.0,0.4527445
26537-1,glucose in blood,glucose presence urine test strip 2 5 hour post dose glucose,1.0,0.44164526
39479-1,glucose in blood,glucose mole volume pericardial fluid,1.0,0.78378445
54257-1,glucose in blood,glucose mole volume serum plasma pre dose insulin iv,1.0,0.454056
48244-8,glucose in blood,red cedar triggered leukotriene release mass volume leukocyte,1.0,0.08139582
12652-4,glucose in blood,glucose mass volume serum plasma 2 minute post xxx challenge,1.0,0.4662919
40183-6,glucose in blood,glucose mole volume serum plasma 17 5 hour post xxx challenge,1.0,0.4518142
48990-6,glucose in blood,glucose mass volume serum plasma 8 pm specimen,1.0,0.47750056
53084-0,glucose in blood,glucose mole volume nonbiological fluid,1.0,0.79105616
6756-1,glucose in blood,glucose mass volume serum plasma 4 5 hour post 75 g glucose po,1.0,0.47969255
12638-3,glucose in blood,glucose mass volume serum plasma pre dose lactose po,1.0,0.46350676
21309-0,glucose in blood,glucose mass volume serum plasma 45 minute post xxx challenge,1.0,0.46969658
55497-2,glucose in blood,insulin mole volume serum plasma 3 minute post dose glucose iv,1.0,0.4488303
40208-1,glucose in blood,glucose mole volume serum plasma 22 minute post xxx challenge,1.0,0.4532103
12620-1,glucose in blood,glucose mass volume serum plasma 6th specimen post xxx challenge,1.0,0.46870533
29329-0,glucose in blood,glucose mass volume serum plasma 3 5 hour post xxx challenge,1.0,0.46802318
12631-8,glucose in blood,glucose mass volume peritoneal dialysis fluid 2nd specimen,1.0,0.4602811
54260-5,glucose in blood,glucose mole volume serum plasma 15 minute post dose insulin iv,1.0,0.45389277
44919-9,glucose in blood,glucose mole volume serum plasma 1 5 hour post meal,1.0,0.4668787
40030-9,glucose in blood,glucose mass volume serum plasma 16 minute post xxx challenge,1.0,0.46572995
75405-1,glucose in blood,glucose mole volume serum plasma 1 5 hour post dose triple bolus,1.0,0.45873094
30252-1,glucose in blood,glucose mole volume serum plasma 3 3 hour post dose glucose,1.0,0.4661879
1530-5,glucose in blood,glucose mass volume serum plasma 3 hour post 100 g glucose po,1.0,0.4786369
54497-3,glucose in blood,glucose mole volume serum plasma 6th specimen post xxx challenge,1.0,0.45375976
54269-6,glucose in blood,glucose mole volume serum plasma 2 hour post dose ornithine alpha ketoglutarate,1.0,0.44544074
16906-0,glucose in blood,glucose presence urine 3rd specimen post xxx challenge,1.0,0.43105304
12639-1,glucose in blood,glucose mass volume serum plasma 15 minute post xxx challenge,1.0,0.46674183
40276-8,glucose in blood,glucose mole volume serum plasma 30 minute post dose lactose po,1.0,0.45170316
16903-7,glucose in blood,glucose mass volume vitreous fluid,1.0,0.8084692
40294-1,glucose in blood,insulin mole volume serum plasma pre post dose glucose,1.0,0.4564741
6750-4,glucose in blood,glucose presence urine test strip 2 hour post 50 g lactose po,1.0,0.43158072
53094-9,glucose in blood,glucose mole volume serum plasma post meal,1.0,0.46415836
40009-3,glucose in blood,glucose mass volume serum plasma 12 5 hour post xxx challenge,1.0,0.46851027
1943-0,glucose in blood,glucosylceramidase enzymatic activity volume leukocyte,1.0,0.123123445
25676-8,glucose in blood,glucose mole volume serum plasma 5 5 hour post dose glucose,1.0,0.4679928
1572-7,glucose in blood,insulin mass volume serum plasma pre 75 g glucose po,1.0,0.45975384
13607-7,glucose in blood,glucose mass volume serum plasma 4 hour post 50 g lactose po,1.0,0.47040856
97778-5,glucose in blood,glucose mole volume dialysis fluid 1 hour specimen,1.0,0.44892657
92819-2,glucose in blood,glucose mass volume serum plasma 10 minute post dose glucagon,1.0,0.4769411
26549-6,glucose in blood,glucose presence urine test strip 3 hour post dose glucose,1.0,0.44413754
95104-6,glucose in blood,glucose mass volume serum plasma 3 5 hour post meal,1.0,0.47407115
54398-3,glucose in blood,glucose mole volume serum plasma 4th specimen post xxx challenge,1.0,0.45169127
13865-1,glucose in blood,glucose mass volume serum plasma 2 5 hour post 50 g lactose po,1.0,0.46989384
102021-3,glucose in blood,glucose mass volume serum plasma 2 5 hour post dose glucagon,1.0,0.47130036
16991-2,glucose in blood,hydrogen expired gas volume fraction exhaled gas 4 5 hour post dose glucose,1.0,0.43776697
40165-3,glucose in blood,glucose mole volume serum plasma 6 hour post xxx challenge,1.0,0.4533117
40319-6,glucose in blood,glucose mole volume serum plasma 15 minute post dose triple bolus,1.0,0.45517504
54262-1,glucose in blood,glucose mole volume serum plasma 3 hour pre dose insulin iv,1.0,0.45300207
48605-0,glucose in blood,glucose mass volume serum plasma 1 hour post dose fructose po,1.0,0.47129127
34058-8,glucose in blood,glucose mole volume serum plasma pre post dose glucagon,1.0,0.46663132
16912-8,glucose in blood,glucose presence urine 9th specimen post xxx challenge,1.0,0.42748865
30344-6,glucose in blood,glucose mass volume serum plasma 1 hour post 1 2 g kg lactose po,1.0,0.47093293
40153-9,glucose in blood,glucose mole volume serum plasma 5 minute post xxx challenge,1.0,0.4514304
2800-1,glucose in blood,deprecated glucose phosphate isomerase enzymatic activity volume serum,1.0,0.4696756
40172-9,glucose in blood,glucose mole volume serum plasma 9 5 hour post xxx challenge,1.0,0.4525668
55493-1,glucose in blood,insulin mole volume serum plasma 3 hour post dose glucose iv,1.0,0.44953737
48991-4,glucose in blood,glucose mass volume serum plasma 10 pm specimen,1.0,0.47685462
40176-0,glucose in blood,glucose mole volume serum plasma 12 hour post xxx challenge,1.0,0.45432052
21004-7,glucose in blood,glucose tolerance interpretation serum plasma,1.0,0.45927048
12656-5,glucose in blood,glucose mass volume serum plasma 4 minute post xxx challenge,1.0,0.46653047
47658-0,glucose in blood,insulin unit volume serum plasma 1 5 hour post dose glucose,1.0,0.44928345
40186-9,glucose in blood,glucose mole volume serum plasma 19 5 hour post xxx challenge,1.0,0.45029864
48787-6,glucose in blood,glucose mass volume peritoneal fluid 24 hour post peritoneal dialysis,1.0,0.45449182
69941-3,glucose in blood,glucose mole volume serum plasma 20 minute post dose lactose po,1.0,0.45367688
2348-1,glucose in blood,glucose mass volume synovial fluid,1.0,0.7917325
53475-0,glucose in blood,glucose mole volume serum plasma pre dose betaxolol,1.0,0.45205507
104878-4,glucose in blood,hematocrit volume fraction blood 2 hour post dose glucose,1.0,0.6292718
40024-2,glucose in blood,glucose mass volume serum plasma 1 day post xxx challenge,1.0,0.46832764
1542-0,glucose in blood,glucose mass volume serum plasma 5 hour post 75 g glucose po,1.0,0.4809934
20437-0,glucose in blood,glucose mass volume serum plasma 3 hour post dose glucose,1.0,0.4839853
40196-8,glucose in blood,glucose mole volume serum plasma 8 minute pre xxx challenge,1.0,0.4499211
50212-0,glucose in blood,glucose mass volume serum plasma 2nd specimen,1.0,0.48672375
15077-1,glucose in blood,glucose mole time 24 hour urine,1.0,0.8058263
16988-8,glucose in blood,hydrogen expired gas volume fraction exhaled gas 2 hour post dose glucose,1.0,0.43477905
12610-2,glucose in blood,glucose mass volume serum plasma 2 hour post xxx challenge,1.0,0.4700143
1564-4,glucose in blood,insulin mass volume serum plasma 2 hour post 75 g glucose po,1.0,0.45793813
54392-6,glucose in blood,glucose mole volume serum plasma 1st specimen post xxx challenge,1.0,0.4556479
25667-7,glucose in blood,glucose mass volume urine 2 hour post dose glucose,1.0,0.4717731
29330-8,glucose in blood,glucose mass volume serum plasma 4 hour post xxx challenge,1.0,0.46372062
48984-9,glucose in blood,glucose mass volume serum plasma 10 minute post dose glucose,1.0,0.479148
40198-4,glucose in blood,glucose mole volume serum plasma 2 minute post xxx challenge,1.0,0.45093843
55485-7,glucose in blood,insulin mole volume serum plasma 1 hour post dose glucose iv,1.0,0.4482794
40169-5,glucose in blood,glucose mole volume serum plasma 8 hour post xxx challenge,1.0,0.45160237
2358-0,glucose in blood,glucose 6 phosphate dehydrogenase presence serum,1.0,0.43917596
1503-2,glucose in blood,glucose mass volume urine 1 hour post 100 g glucose po,1.0,0.47350976
25669-3,glucose in blood,glucose mole volume serum plasma 3 5 hour post dose glucose,1.0,0.47320253
9375-7,glucose in blood,glucose mass volume serum plasma 2 5 hour post 100 g glucose po,1.0,0.48165438
40324-6,glucose in blood,glucose mole volume serum plasma 3 hour post dose triple bolus,1.0,0.45593846
25664-4,glucose in blood,glucose mass volume urine 1 hour post dose glucose,1.0,0.4701008
54400-7,glucose in blood,glucose mole volume serum plasma pre dose glucagon,1.0,0.46807954
95108-7,glucose in blood,glucose mass volume serum plasma 4 hour post meal,1.0,0.47294727
21306-6,glucose in blood,glucose mass time 8 hour urine,1.0,0.81569076
40180-2,glucose in blood,glucose mole volume serum plasma 14 hour post xxx challenge,1.0,0.45056096
47664-8,glucose in blood,insulin unit volume serum plasma 3 minute post dose glucose,1.0,0.4491121
16170-3,glucose in blood,glucose mass volume serum plasma 5 pm specimen,1.0,0.48106122
42629-6,glucose in blood,glucose mass volume urine 4 hour post dose lactose po,1.0,0.45581427
47589-7,glucose in blood,component peptide mole volume serum plasma 30 minute post dose glucose,0.9343765535185844,0.45637947
58624-8,glucose in blood,corticotropin mass volume plasma pre dose glucose,0.9343765535185844,0.45921344
58584-4,glucose in blood,corticotropin mole volume plasma 30 minute post dose glucose,0.9343765535185844,0.44359782
48263-8,glucose in blood,cocksfoot triggered leukotriene release mass volume leukocyte,0.9343765535185844,0.09192125
58519-0,glucose in blood,component peptide mole volume serum plasma 5 hour post dose glucose,0.9343765535185844,0.4512395
58597-6,glucose in blood,corticotropin mole volume plasma 3 hour post dose glucose,0.9343765535185844,0.44588685
101977-7,glucose in blood,cortisol glucose somatotropin post glucagon stimulation panel serum plasma,0.9343765535185844,0.42432198
48224-0,glucose in blood,codfish triggered leukotriene release mass volume leukocyte,0.9343765535185844,0.09059906
104635-8,glucose in blood,continuous glucose monitor device date time reporting period end reported,0.9343765535185844,0.41795623
58509-1,glucose in blood,component peptide mole volume serum plasma 3 5 hour post dose glucose,0.9343765535185844,0.4490639
58528-1,glucose in blood,corticotropin mass volume plasma 1 5 hour post dose glucose,0.9343765535185844,0.45633167
47595-4,glucose in blood,component peptide mole volume serum plasma pre dose glucose,0.9343765535185844,0.45816588
47586-3,glucose in blood,component peptide mole volume serum plasma 1 hour post dose glucose,0.9343765535185844,0.45656312
58517-4,glucose in blood,component peptide mole volume serum plasma 4 hour post dose glucose,0.9343765535185844,0.4479485
58568-7,glucose in blood,corticotropin mole volume plasma 2 5 hour post dose glucose,0.9343765535185844,0.4442405
48264-6,glucose in blood,bermuda grass triggered leukotriene release mass volume leukocyte,0.9343765535185844,0.084401496
106793-3,glucose in blood,continuous glucose monitoring time range panel,0.9343765535185844,0.42576775
47587-1,glucose in blood,component peptide mole volume serum plasma 1 minute post dose glucose,0.9343765535185844,0.45560637
58518-2,glucose in blood,component peptide mass volume serum plasma 5 hour post dose glucose,0.9343765535185844,0.45522553
33988-7,glucose in blood,thymidine phosphorylase enzymatic activity mass leukocyte,0.746938637514291,0.08197869
74542-2,glucose in blood,pyruvate kinase glucose 6 phosphate dehydrogenase enzymatic activity ratio red blood cell,0.746938637514291,0.4426395
34689-0,glucose in blood,sulfatidase enzymatic activity volume leukocyte,0.746938637514291,0.09791119
48271-1,glucose in blood,tetracycline triggered leukotriene release mass volume leukocyte,0.746938637514291,0.07807871
48192-9,glucose in blood,sunset yellow fcf triggered leukotriene release mass volume leukocyte,0.746938637514291,0.07659041
83114-9,glucose in blood,s100 calcium binding protein b mass volume serum immunoassay,0.746938637514291,0.073066995
48222-4,glucose in blood,rye triggered leukotriene release mass volume leukocyte,0.746938637514291,0.07929592
34546-2,glucose in blood,protein glucose panel mass volume cerebral spinal fluid,0.746938637514291,0.44129762
48286-9,glucose in blood,rocuronium triggered leukotriene release mass volume leukocyte,0.746938637514291,0.0758877
17778-2,glucose in blood,zinc mass volume leukocyte,0.746938637514291,0.08574931
48260-4,glucose in blood,timothy triggered leukotriene release mass volume leukocyte,0.746938637514291,0.0805451
79469-3,glucose in blood,uridine diphosphate glucose 4 epimerase enzymatic activity mass red blood cell,0.746938637514291,0.4466566
48252-1,glucose in blood,saltwort triggered leukotriene release mass volume leukocyte,0.746938637514291,0.079818904
92666-7,glucose in blood,growth hormone glucose post clonidine stimulation panel serum plasma,0.734803507974126,0.4239261
71696-9,glucose in blood,granulocyte leukocyte body fluid automated count,0.734803507974126,0.08109137
14377-6,glucose in blood,granulocyte leukocyte semen manual count,0.734803507974126,0.078436285
5556-6,glucose in blood,deprecated gpa blood,0.734803507974126,0.08516146
70036-9,glucose in blood,granulocyte leukocyte pericardial fluid automated count,0.734803507974126,0.071183346
30396-6,glucose in blood,granulocyte leukocyte bronchial specimen,0.734803507974126,0.0664131
74141-3,glucose in blood,granulocyte leukocyte peritoneal dialysis fluid,0.734803507974126,0.07765732
58091-0,glucose in blood,glucose 6 phosphate dehydrogenase newborn screen panel,0.734803507974126,0.508068
90996-0,glucose in blood,hedis 2019 2020 value set glucose test,0.734803507974126,0.4202775
14374-3,glucose in blood,granulocyte leukocyte pleural fluid manual count,0.734803507974126,0.07350247
69004-0,glucose in blood,immature granulocyte leukocyte body fluid,0.734803507974126,0.08072696
33963-0,glucose in blood,granulocyte leukocyte cerebral spinal fluid,0.734803507974126,0.06836616
26520-7,glucose in blood,granulocyte leukocyte peritoneal fluid,0.734803507974126,0.08384349
19023-1,glucose in blood,granulocyte leukocyte blood automated count,0.734803507974126,0.26291463
30395-8,glucose in blood,granulocyte leukocyte blood,0.734803507974126,0.2653536
70067-4,glucose in blood,granulocyte leukocyte pleural fluid automated count,0.734803507974126,0.07267579
30157-2,glucose in blood,heterophils leukocyte blood,0.734803507974126,0.2537462
30462-6,glucose in blood,granulocyte leukocyte urine,0.734803507974126,0.08726317
79087-3,glucose in blood,ct heart coronary artery calcium scoring wo contrast,0.30472092425655817,0.03594061
74891-3,glucose in blood,medium chain acyl coa dehydrogenase enzymatic activity mass leukocyte,0.30472092425655817,0.08695843
48206-7,glucose in blood,lactalbumin alpha triggered leukotriene release mass volume leukocyte,0.30472092425655817,0.084554344
47718-2,glucose in blood,parathyrin mass volume serum plasma 4 hour post dose calcium,0.30472092425655817,0.08713497
48259-6,glucose in blood,kentucky blue grass triggered leukotriene release mass volume leukocyte,0.30472092425655817,0.08193062
24098-6,glucose in blood,n acetylglucosamine 6 sulfatase enzymatic activity mass leukocyte,0.30472092425655817,0.106600136
41900-2,glucose in blood,glucose meter device vendor software version,0.30472092425655817,0.10376555
104072-4,glucose in blood,mucopolysaccharidosis enzyme panel leukocyte,0.30472092425655817,0.06577234
48250-5,glucose in blood,pellitory parietaria judaica triggered leukotriene release mass volume leukocyte,0.30472092425655817,0.08361984
24819-5,glucose in blood,deprecated liver spleen nm w tc 99m calcium colloid iv,0.30472092425655817,0.04344102
48191-1,glucose in blood,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.30472092425655817,0.09497223
5560-8,glucose in blood,deprecated smig,0.30472092425655817,0.06051488
48233-1,glucose in blood,lepidoglyphus destructor triggered leukotriene release mass volume leukocyte,0.30472092425655817,0.08283736
24346-9,glucose in blood,parathyrin intact calcium panel serum plasma,0.30472092425655817,0.076547526
62875-0,glucose in blood,phenx assay human leukocyte antigen hla genotyping protocol 160601,0.30472092425655817,0.056252975
74935-8,glucose in blood,palmitoyl protein thioesterase enzymatic activity mass leukocyte,0.30472092425655817,0.07484193
58407-8,glucose in blood,leukocyte morphology panel blood,0.30472092425655817,0.25940034
24094-5,glucose in blood,n acetylgalactosamine 4 sulfatase enzymatic activity mass leukocyte,0.30472092425655817,0.095691726
24096-0,glucose in blood,n acetylgalactosamine 6 sulfatase enzymatic activity mass leukocyte,0.30472092425655817,0.10496175
48258-8,glucose in blood,cultivated rye triggered leukotriene release mass volume leukocyte,0.30472092425655817,0.07544711
50672-5,glucose in blood,leukocyte toxic vacuole presence blood light microscopy,0.17751433487810614,0.25471047
62858-6,glucose in blood,micromegakaryocytes leukocyte blood manual count,0.17751433487810614,0.2638311
13599-6,glucose in blood,promonocytes leukocyte blood manual count,0.17751433487810614,0.26387703
15197-7,glucose in blood,lymphocyte clefted leukocyte blood manual count,0.17751433487810614,0.25218248
29261-5,glucose in blood,abnormal lymphocyte leukocyte blood manual count,0.17751433487810614,0.24976112
99051-5,glucose in blood,leukocyte volume bronchoalveolar lavage manual count,0.17751433487810614,0.08849722
26471-3,glucose in blood,leukocyte leukocyte blood,0.17751433487810614,0.27026206
71673-8,glucose in blood,lymphocyte leukocyte pure number fraction blood manual count,0.17751433487810614,0.25748152
53797-7,glucose in blood,neutrophil immature leukocyte blood,0.17751433487810614,0.25344208
33857-4,glucose in blood,sezary cell leukocyte blood manual count,0.17751433487810614,0.25412768
26511-6,glucose in blood,neutrophil leukocyte blood,0.17751433487810614,0.26507
740-1,glucose in blood,metamyelocytes leukocyte blood manual count,0.17751433487810614,0.26552966
34920-9,glucose in blood,lymphocyte immunoblastic leukocyte blood,0.17751433487810614,0.25990427
4662-3,glucose in blood,lymphocyte monocyte leukocyte blood,0.17751433487810614,0.26587057
17790-7,glucose in blood,leukocyte left shift presence blood automated count,0.17751433487810614,0.24120921
30423-8,glucose in blood,lymphoma cell leukocyte blood,0.17751433487810614,0.25392067
34922-5,glucose in blood,lymphoblast leukocyte blood,0.17751433487810614,0.26786736
49550-7,glucose in blood,cd59 deficient leukocyte cell blood,0.17751433487810614,0.24823394
71678-7,glucose in blood,lymphocyte leukocyte pure number fraction blood automated count,0.17751433487810614,0.2567742
30466-7,glucose in blood,promonocytes leukocyte blood,0.17751433487810614,0.2636681
74457-3,glucose in blood,neutrophil leukocyte cord blood,0.17751433487810614,0.07643798
71671-2,glucose in blood,neutrophil leukocyte pure number fraction blood manual count,0.17751433487810614,0.2551624
26508-2,glucose in blood,band form neutrophil leukocyte blood,0.17751433487810614,0.26144075
30367-7,glucose in blood,deprecated myeloblast 100 leukocyte blood automated count,0.17751433487810614,0.25043482
30420-4,glucose in blood,large granular lymphocyte leukocyte blood,0.17751433487810614,0.25787452
71677-9,glucose in blood,monocyte leukocyte pure number fraction blood automated count,0.17751433487810614,0.2588137
48189-5,glucose in blood,formaldehyde triggered leukotriene release mass volume leukocyte,0.15982283189555604,0.08954624
71679-5,glucose in blood,eosinophil leukocyte pure number fraction blood automated count,0.15982283189555604,0.24930817
48248-9,glucose in blood,hazelnut pollen triggered leukotriene release mass volume leukocyte,0.15982283189555604,0.07534026
71674-6,glucose in blood,eosinophil leukocyte pure number fraction blood manual count,0.15982283189555604,0.25030705
13353-8,glucose in blood,deprecated eosinophil 100 leukocyte body fluid manual count,0.15982283189555604,0.065826565
104636-6,glucose in blood,day continuous glucose monitor device worn reporting period estimated,0.15982283189555604,0.41345528
105269-5,glucose in blood,fractional excretion calcium ratio urine serum plasma collected unspecified duration,0.15982283189555604,0.09834501
62441-1,glucose in blood,nucleated erythrocyte leukocyte ratio cerebral spinal fluid automated count,0.15982283189555604,0.0709396
71603-5,glucose in blood,eosinophil leukocyte pure number fraction pericardial fluid manual count,0.15982283189555604,0.059744485
75551-2,glucose in blood,fetal trisomy 13 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.15982283189555604,0.056271486
40631-4,glucose in blood,nucleated erythrocyte leukocyte ratio cerebral spinal fluid manual count,0.15982283189555604,0.0829306
48300-8,glucose in blood,erythrosine triggered leukotriene release mass volume leukocyte,0.15982283189555604,0.084987134
30378-4,glucose in blood,eosinophil leukocyte nose,0.15982283189555604,0.051571272
30393-3,glucose in blood,deprecated nucleated erythrocyte 100 leukocyte ratio blood,0.15982283189555604,0.26023704
62442-9,glucose in blood,nucleated erythrocyte leukocyte ratio synovial fluid automated count,0.15982283189555604,0.069271035
12208-5,glucose in blood,eosinophil leukocyte cerebral spinal fluid manual count,0.15982283189555604,0.05396555
4530-2,glucose in blood,deprecated complement receptor 4,0.15982283189555604,0.063758016
4527-8,glucose in blood,deprecated complement receptor 1,0.15982283189555604,0.064880595
5552-5,glucose in blood,deprecated cycd79 cell 100 cell blood,0.15982283189555604,0.06549068
75555-3,glucose in blood,fetal trisomy 18 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.15982283189555604,0.049753927
2223-6,glucose in blood,elastase leukocyte enzymatic activity volume plasma,0.15982283189555604,0.1076111
21653-1,glucose in blood,cdh1 gene mutation tested blood tissue molecular genetics method nominal,0.15354833255205466,0.14501798
74909-3,glucose in blood,calcium oxalate dihydrate total stone,0.15354833255205466,0.0638418
61435-4,glucose in blood,deprecated deprecated calcium intake daily protocol phenx,0.15354833255205466,0.03858091
14625-8,glucose in blood,basophil leukocyte bronchial specimen manual count,0.15354833255205466,0.06693947
82534-9,glucose in blood,casr gene full mutation analysis blood tissue sequencing,0.15354833255205466,0.12912479
74407-8,glucose in blood,basophil leukocyte cord blood,0.15354833255205466,0.0787473
99060-6,glucose in blood,cerebroventricular lining cell leukocyte cerebral spinal fluid,0.15354833255205466,0.058995567
54234-0,glucose in blood,cell count diff panel gluc prot body fluid,0.15354833255205466,0.43471867
26446-5,glucose in blood,blast leukocyte blood,0.15354833255205466,0.2589299
51586-6,glucose in blood,cell leukocyte blood manual count,0.15354833255205466,0.25771993
34911-8,glucose in blood,immature basophil leukocyte blood,0.15354833255205466,0.25429785
33786-5,glucose in blood,immature basophil leukocyte blood manual count,0.15354833255205466,0.25268593
9050-6,glucose in blood,calcium intake 12 hour,0.15354833255205466,0.08150019
53516-1,glucose in blood,basophil leukocyte dialysis fluid manual count,0.15354833255205466,0.070313975
95843-9,glucose in blood,neutrophil leukocyte sputum manual count,0.13999886271400172,0.06908683
13597-0,glucose in blood,neutrophil leukocyte nose,0.13999886271400172,0.06688325
33385-6,glucose in blood,segmented neutrophil leukocyte pleural fluid,0.13999886271400172,0.06287849
40491-3,glucose in blood,neutrophil leukocyte synovial fluid manual count,0.13999886271400172,0.05965725
32804-7,glucose in blood,neutrophil leukocyte bronchial specimen manual count,0.13999886271400172,0.057506785
17800-4,glucose in blood,myelocyte leukocyte body fluid,0.13999886271400172,0.09177102
14380-0,glucose in blood,mononuclear cell leukocyte pleural fluid manual count,0.13999886271400172,0.07002154
17287-4,glucose in blood,monocyte leukocyte urine manual count,0.13999886271400172,0.08905108
99604-1,glucose in blood,band form neutrophil leukocyte pleural fluid manual count,0.13999886271400172,0.06803518
26518-1,glucose in blood,deprecated polymorphonuclear cell 100 leukocyte body fluid,0.13999886271400172,0.07643308
33387-2,glucose in blood,segmented neutrophil leukocyte pericardial fluid,0.13999886271400172,0.05926169
30437-8,glucose in blood,monocyte macrophage leukocyte body fluid,0.13999886271400172,0.07070939
71614-2,glucose in blood,monocyte leukocyte pure number fraction pleural fluid manual count,0.13999886271400172,0.072400205
93952-0,glucose in blood,metamyelocytes neutrophilic leukocyte bone marrow manual count,0.13999886271400172,0.07278844
70037-7,glucose in blood,mononuclear cell leukocyte pericardial fluid automated count,0.13999886271400172,0.06598169
23904-6,glucose in blood,monocyte macrophage leukocyte cerebral spinal fluid manual count,0.13999886271400172,0.059541836
34985-2,glucose in blood,unidentified cell leukocyte body fluid,0.13999886271400172,0.081173144
40670-2,glucose in blood,smudge cell leukocyte body fluid manual count,0.13999886271400172,0.07460302
30468-3,glucose in blood,unidentified cell leukocyte cerebral spinal fluid,0.13999886271400172,0.06303679
71635-7,glucose in blood,neutrophil leukocyte pure number fraction peritoneal fluid manual count,0.13999886271400172,0.07321101
49782-6,glucose in blood,mononuclear cell leukocyte pericardial fluid,0.13999886271400172,0.07284432
95226-7,glucose in blood,segmented neutrophil leukocyte stem cell product manual count,0.13999886271400172,0.06786272
71598-7,glucose in blood,neutrophil leukocyte pure number fraction bronchial specimen manual count,0.13999886271400172,0.062829725
27930-7,glucose in blood,neutrophil leukocyte bronchial specimen,0.13999886271400172,0.06215071
33388-0,glucose in blood,band form neutrophil leukocyte pericardial fluid,0.13999886271400172,0.06532657
26488-7,glucose in blood,monocyte leukocyte peritoneal fluid,0.13999886271400172,0.076827876
32807-0,glucose in blood,mononuclear cell leukocyte bronchial specimen,0.13999886271400172,0.06357837
34982-9,glucose in blood,unidentified cell leukocyte peritoneal fluid,0.13999886271400172,0.07378877
17799-8,glucose in blood,promyelocytes leukocyte body fluid,0.13999886271400172,0.092478015
71625-8,glucose in blood,neutrophil leukocyte pure number fraction synovial fluid manual count,0.13999886271400172,0.065970294
71639-9,glucose in blood,monocyte macrophage leukocyte pure number fraction body fluid manual count,0.13999886271400172,0.07481196
71653-0,glucose in blood,promyelocytes leukocyte pure number fraction cerebral spinal fluid manual count,0.13999886271400172,0.076042354
70035-1,glucose in blood,siderophages leukocyte cerebral spinal fluid manual count,0.13999886271400172,0.05312042
17835-0,glucose in blood,monocyte leukocyte synovial fluid,0.13999886271400172,0.07383477
55437-8,glucose in blood,neoplastic cell leukocyte cerebral spinal fluid manual count,0.13999886271400172,0.05661531
17803-8,glucose in blood,plasma cell leukocyte body fluid,0.13999886271400172,0.09412932
26494-5,glucose in blood,mononuclear cell leukocyte pleural fluid,0.13999886271400172,0.07532459
30230-7,glucose in blood,segmented neutrophil leukocyte body fluid manual count,0.13999886271400172,0.06884329
33362-5,glucose in blood,monocyte leukocyte pleural fluid,0.13999886271400172,0.068440065
66132-2,glucose in blood,mononuclear mesothelial cell leukocyte body fluid manual count,0.13999886271400172,0.077523746
17802-0,glucose in blood,prolymphocytes leukocyte body fluid,0.13999886271400172,0.09464367
71610-0,glucose in blood,mononuclear cell leukocyte pure number fraction pleural fluid manual count,0.13999886271400172,0.07422211
58802-0,glucose in blood,mononuclear cell leukocyte peritoneal dialysis fluid,0.13999886271400172,0.068423
30454-3,glucose in blood,neutrophil leukocyte pericardial fluid,0.13999886271400172,0.064508446
97770-2,glucose in blood,bilirubin total mole volume capillary blood,0.0854967681000543,0.07013122
71595-3,glucose in blood,basophil leukocyte pure number fraction bronchial specimen manual count,0.0854967681000543,0.06600462
1974-5,glucose in blood,bilirubin total mass volume body fluid,0.0854967681000543,0.09716966
46093-1,glucose in blood,calcium ionized mole volume dialysis fluid,0.0854967681000543,0.07674133
54366-0,glucose in blood,calcium ionized mole volume adjusted ph 7 4 cord blood,0.0854967681000543,0.06979292
49649-7,glucose in blood,cacna1a gene allele 1 cag repeat entitic number blood tissue molecular genetics method,0.0854967681000543,0.14525703
1997-6,glucose in blood,calcium mole volume cerebral spinal fluid,0.0854967681000543,0.07359544
14636-5,glucose in blood,calcium presence stone,0.0854967681000543,0.049300008
27182-5,glucose in blood,calcium presence blood,0.0854967681000543,0.24052343
41646-1,glucose in blood,calcium ionized mole volume mixed venous blood,0.0854967681000543,0.07543731
1384-7,glucose in blood,calcium mole volume blood post calcium infusion,0.0854967681000543,0.26064655
39463-5,glucose in blood,bilirubin indirect mole volume body fluid,0.0854967681000543,0.08783374
47994-9,glucose in blood,bilirubin total mole volume cord blood,0.0854967681000543,0.07589648
16266-9,glucose in blood,calcium hydrogen phosphate crystal presence stone infrared spectroscopy,0.0854967681000543,0.056696262
42719-5,glucose in blood,bilirubin total mass volume blood,0.0854967681000543,0.27797174
29210-2,glucose in blood,bilirubin indirect mass volume body fluid,0.0854967681000543,0.098435216
47596-2,glucose in blood,calcium ionized mole volume blood ion selective membrane electrode ise,0.0854967681000543,0.26123887
104294-4,glucose in blood,cdh1 gene rearrangement interpretation blood tissue molecular genetics method narrative,0.0854967681000543,0.14476416
43887-9,glucose in blood,bilirubin total presence amniotic fluid spectrophotometry direct,0.0854967681000543,0.05960676
59471-3,glucose in blood,calcium ionized mass volume venous blood,0.0854967681000543,0.08093762
12181-4,glucose in blood,calcium mole volume body fluid,0.0854967681000543,0.085117534
14424-6,glucose in blood,bilirubin total mass volume gastric fluid,0.0854967681000543,0.09608811
21755-4,glucose in blood,cacna1a gene cag repeat presence blood tissue molecular genetics method,0.0854967681000543,0.142751
43824-2,glucose in blood,bilirubin total presence body fluid,0.0854967681000543,0.05774466
53415-6,glucose in blood,bilirubin total presence cerebral spinal fluid,0.0854967681000543,0.0420479
35477-9,glucose in blood,ciliated columnar lining cell leukocyte ratio body fluid,0.0854967681000543,0.09594086
53226-7,glucose in blood,leukocyte area urethra wet preparation,0.016696406244065792,0.06726644
32808-8,glucose in blood,leukocyte leukocyte bronchial specimen,0.016696406244065792,0.06452185
14823-9,glucose in blood,macrophage leukocyte bronchial specimen manual count,0.016696406244065792,0.060138453
68368-0,glucose in blood,leukocyte volume dialysis fluid automated count,0.016696406244065792,0.0824369
71611-8,glucose in blood,leukocyte leukocyte pure number fraction pleural fluid manual count,0.016696406244065792,0.07364331
71634-0,glucose in blood,lymphocyte leukocyte pure number fraction peritoneal fluid manual count,0.016696406244065792,0.075489596
30409-7,glucose in blood,leukocyte leukocyte peritoneal fluid,0.016696406244065792,0.07372619
11031-2,glucose in blood,lymphocyte leukocyte body fluid,0.016696406244065792,0.08399164
53316-6,glucose in blood,leukocyte presence urine automated,0.016696406244065792,0.06207342
13349-6,glucose in blood,leukocyte volume stool manual count,0.016696406244065792,0.085150346
71651-4,glucose in blood,macrophage leukocyte pure number fraction cerebral spinal fluid manual count,0.016696406244065792,0.06323551
99933-4,glucose in blood,leukocyte clump presence body fluid automated,0.016696406244065792,0.06370828
30410-5,glucose in blood,leukocyte leukocyte synovial fluid,0.016696406244065792,0.062450193
57845-0,glucose in blood,leukocyte volume body fluid automated count,0.016696406244065792,0.09062047
12229-1,glucose in blood,macrophage leukocyte cerebral spinal fluid manual count,0.016696406244065792,0.061845426
95221-8,glucose in blood,metamyelocytes leukocyte stem cell product manual count,0.016696406244065792,0.07475401
50233-6,glucose in blood,leukocyte clump area urine sediment automated count,0.016696406244065792,0.069896385
88343-9,glucose in blood,leukocyte presence ear light microscopy,0.016696406244065792,0.06951278
12224-2,glucose in blood,leukocyte area nose microscopy high power field,0.016696406244065792,0.07540878
14811-4,glucose in blood,leukocyte volume pericardial fluid manual count,0.016696406244065792,0.08079126
26472-1,glucose in blood,leukocyte leukocyte cerebral spinal fluid,0.016696406244065792,0.0711629
68430-8,glucose in blood,leukocyte volume pleural fluid manual count,0.016696406244065792,0.0832352
30417-0,glucose in blood,variant lymphocyte leukocyte body fluid,0.016696406244065792,0.07050778
18407-7,glucose in blood,leukocyte 12 hour urine sediment light microscopy,0.016696406244065792,0.092013314
72163-9,glucose in blood,leukocyte presence specimen gram stain,0.016696406244065792,0.07329555
17801-2,glucose in blood,metamyelocytes leukocyte body fluid,0.016696406244065792,0.087309785
34445-7,glucose in blood,leukocyte presence body fluid,0.016696406244065792,0.0739767
68406-8,glucose in blood,abnormal lymphocyte leukocyte vitreous fluid manual count,0.016696406244065792,0.070416406
30432-9,glucose in blood,mesothelial cell leukocyte peritoneal fluid,0.016696406244065792,0.07341607
32825-2,glucose in blood,leukocyte presence semen,0.016696406244065792,0.065404065
53964-3,glucose in blood,leukocyte presence urine visual,0.016696406244065792,0.06763313
59463-0,glucose in blood,lymphocyte leukocyte dialysis fluid,0.016696406244065792,0.07164991
46089-9,glucose in blood,leukocyte volume cerebral spinal fluid 3rd tube,0.016696406244065792,0.08558644
62239-9,glucose in blood,leukocyte volume blood fetus automated count,0.016696406244065792,0.18711326
68428-2,glucose in blood,leukocyte volume pericardial fluid manual count,0.016696406244065792,0.08048397
76674-1,glucose in blood,leukocyte volume cerebral spinal fluid 1st tube,0.016696406244065792,0.0868732
95842-1,glucose in blood,lymphocyte leukocyte sputum manual count,0.016696406244065792,0.07028476
30402-2,glucose in blood,leukocyte volume gastric fluid,0.016696406244065792,0.0916353
40520-9,glucose in blood,macrophage leukocyte pleural fluid manual count,0.016696406244065792,0.065232776
12230-9,glucose in blood,macrophage leukocyte body fluid manual count,0.016696406244065792,0.073987894
30403-0,glucose in blood,leukocyte volume pericardial fluid,0.016696406244065792,0.078737214
53286-1,glucose in blood,wbc cast volume urine computer assisted method,0.016696406244065792,0.06933561
26479-6,glucose in blood,lymphocyte leukocyte cerebral spinal fluid,0.016696406244065792,0.07083123
105104-4,glucose in blood,leukocyte area urine sediment,0.016696406244065792,0.07341794
9442-5,glucose in blood,igg lymphocyte lymphocyte leukocyte,0.016696406244065792,0.07169798
33263-5,glucose in blood,metamyelocytes leukocyte body fluid manual count,0.016696406244065792,0.078086585
32805-4,glucose in blood,variant lymphocyte leukocyte bronchial specimen manual count,0.016696406244065792,0.051300246
12234-1,glucose in blood,mesothelial cell leukocyte body fluid manual count,0.016696406244065792,0.08232328
13655-6,glucose in blood,leukocyte presence stool light microscopy,0.016696406244065792,0.07609754
71626-6,glucose in blood,mesothelial cell leukocyte pure number fraction peritoneal fluid manual count,0.016696406244065792,0.077998385
30415-4,glucose in blood,abnormal lymphocyte leukocyte synovial fluid,0.016696406244065792,0.057533376
46420-6,glucose in blood,leukocyte clump area urine sediment microscopy high power field,0.016696406244065792,0.080899075
55598-7,glucose in blood,leukocyte disintegrated leukocyte body fluid manual count,0.016696406244065792,0.07628326
55599-5,glucose in blood,leukocyte disintegrated leukocyte cerebral spinal fluid manual count,0.016696406244065792,0.064244054
96712-5,glucose in blood,leukocyte area body fluid light microscopy,0.016696406244065792,0.09230804
70126-8,glucose in blood,leukocyte volume corrected nucleated erythrocyte pleural fluid,0.016696406244065792,0.07692132
75559-5,glucose in blood,comment fetal trisomy 18 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.01230147076117924,0.06504905
87544-3,glucose in blood,beta n acetylhexosaminidase beta n acetylhexosaminidase panel enzymatic activity mass leukocyte,0.01230147076117924,0.08087359
48277-8,glucose in blood,acetaminophen triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.07365229
59148-7,glucose in blood,calcium mole volume serum plasma post dialysis,0.01230147076117924,0.09638787
35069-4,glucose in blood,basophil leukocyte peritoneal fluid,0.01230147076117924,0.07788808
68396-1,glucose in blood,basophil leukocyte vitreous fluid manual count,0.01230147076117924,0.07227961
2003-2,glucose in blood,deprecated calcium,0.01230147076117924,0.06728979
105897-3,glucose in blood,calcium oxalate crystal area urine,0.01230147076117924,0.054604713
24092-9,glucose in blood,alpha n acetylglucosaminidase enzymatic activity mass leukocyte,0.01230147076117924,0.0955529
6291-9,glucose in blood,complement ic3b receptor presence leukocyte,0.01230147076117924,0.05518876
1993-5,glucose in blood,calcium renal clearance 24 hour urine serum plasma,0.01230147076117924,0.09069251
35258-3,glucose in blood,calcium mass mole volume corrected total protein serum plasma,0.01230147076117924,0.08881445
75603-1,glucose in blood,comment fetal 1p36 deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.01230147076117924,0.0660529
75565-2,glucose in blood,comment fetal trisomy 21 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.01230147076117924,0.06435774
33412-8,glucose in blood,blast leukocyte pericardial fluid,0.01230147076117924,0.05778893
50183-3,glucose in blood,calcitonin mass volume serum plasma 1 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.01230147076117924,0.10359619
94839-8,glucose in blood,calcium mass volume urine fetus,0.01230147076117924,0.094759226
16524-1,glucose in blood,calcium mole volume serum plasma 6 hour post xxx challenge,0.01230147076117924,0.09192332
5536-8,glucose in blood,deprecated cd83 cell 100 cell blood,0.01230147076117924,0.064453885
47398-3,glucose in blood,beta mannosidase actual normal leukocyte,0.01230147076117924,0.0780055
5415-5,glucose in blood,deprecated cd10 cd20,0.01230147076117924,0.057459403
40238-8,glucose in blood,calcium mole volume serum plasma 8 hour post xxx challenge,0.01230147076117924,0.08434189
4523-7,glucose in blood,complement ic3b receptor entitic number leukocyte,0.01230147076117924,0.059112158
87477-6,glucose in blood,calcium specimen,0.01230147076117924,0.06004217
33235-3,glucose in blood,calcium phosphate crystal presence urine computer assisted method,0.01230147076117924,0.040457446
16273-5,glucose in blood,calcium mass mass red blood cell,0.01230147076117924,0.09033846
18281-6,glucose in blood,calcium mole volume corrected total protein serum plasma,0.01230147076117924,0.091084406
24073-9,glucose in blood,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.01230147076117924,0.09223351
5509-5,glucose in blood,deprecated cd6 cell 100 cell blood,0.01230147076117924,0.06957314
5426-2,glucose in blood,deprecated cd11a cell 100 cell blood,0.01230147076117924,0.07211819
5540-0,glucose in blood,deprecated cd88 cell 100 cell blood,0.01230147076117924,0.06799609
12913-0,glucose in blood,beta n acetylhexosaminidase enzymatic activity volume leukocyte,0.01230147076117924,0.10257445
82222-1,glucose in blood,amylo alpha 1 6 glucosidase enzymatic activity mass leukocyte,0.01230147076117924,0.102497645
1766-5,glucose in blood,aldosterone receptor leukocyte,0.01230147076117924,0.07479255
33657-8,glucose in blood,beta n acetylhexosaminidase mole volume leukocyte,0.01230147076117924,0.08401658
5498-1,glucose in blood,deprecated cd5 cd2 cell 100 cell blood,0.01230147076117924,0.065870695
2001-6,glucose in blood,calcium mole volume 24 hour stool,0.01230147076117924,0.07511973
50551-1,glucose in blood,bilirubin total presence urine automated test strip,0.01230147076117924,0.053763315
6294-3,glucose in blood,deprecated complement c3d c3d gg ic3b receptor entitic number leukocyte,0.01230147076117924,0.067522
5484-1,glucose in blood,deprecated cd45 cell 100 cell blood,0.01230147076117924,0.065517895
5433-8,glucose in blood,deprecated cd128 cell 100 cell blood,0.01230147076117924,0.06933789
5522-8,glucose in blood,deprecated cd69 cell 100 cell blood,0.01230147076117924,0.07096281
5547-5,glucose in blood,deprecated cd96 cell 100 cell blood,0.01230147076117924,0.06912765
57468-1,glucose in blood,calcitriol mole volume serum plasma pre dose calcium,0.01230147076117924,0.08042188
75352-5,glucose in blood,cell leukocyte pericardial fluid manual count,0.01230147076117924,0.07126098
31995-4,glucose in blood,basophil leukocyte pleural fluid manual count,0.01230147076117924,0.06823679
14630-8,glucose in blood,bilirubin indirect mole volume serum plasma,0.01230147076117924,0.10596678
48218-2,glucose in blood,peanut triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.08973535
5451-0,glucose in blood,deprecated cd22 cd19 cell 100 cell blood,0.01230147076117924,0.07012825
33374-0,glucose in blood,blast leukocyte synovial fluid,0.01230147076117924,0.054764953
48196-0,glucose in blood,cephalosporin component triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.08647218
1978-6,glucose in blood,bilirubin total mass volume urine,0.01230147076117924,0.10571585
24059-8,glucose in blood,aspartylglucosaminidase enzymatic activity mass leukocyte,0.01230147076117924,0.10119797
5412-2,glucose in blood,deprecated b b4 blood,0.01230147076117924,0.07573189
5499-9,glucose in blood,deprecated cd50 cell 100 cell blood,0.01230147076117924,0.06701897
48270-3,glucose in blood,cefazolin triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.08142407
17864-0,glucose in blood,calcium ionized mass volume serum plasma ion selective membrane electrode ise,0.01230147076117924,0.10773418
24055-6,glucose in blood,alpha n acetylgalactosaminidase enzymatic activity mass leukocyte,0.01230147076117924,0.08881701
40083-8,glucose in blood,calcium mass volume serum plasma 1 day post xxx challenge,0.01230147076117924,0.09261394
27935-6,glucose in blood,calcium mass volume serum plasma 4th specimen post xxx challenge,0.01230147076117924,0.092038386
34736-9,glucose in blood,calcium oxalate index 24 hour urine,0.01230147076117924,0.07590711
50404-3,glucose in blood,cell leukocyte identifier synovial fluid,0.01230147076117924,0.06602099
99894-8,glucose in blood,calcium oxalate monohydrate crystal presence urine sediment computer assisted method,0.01230147076117924,0.042581942
50839-0,glucose in blood,calcium creatinine molar ratio 24 hour urine,0.01230147076117924,0.089068
33793-1,glucose in blood,calcium mole volume urine 7th specimen post xxx challenge,0.01230147076117924,0.071774304
5444-5,glucose in blood,deprecated cd19 cell 100 cell blood,0.01230147076117924,0.06796383
6707-4,glucose in blood,deprecated cd16 cd57,0.01230147076117924,0.06345984
35248-4,glucose in blood,calcium mass mole volume 24 hour urine,0.01230147076117924,0.08770272
16527-4,glucose in blood,calcium sodium mass ratio serum plasma,0.01230147076117924,0.0948006
53309-1,glucose in blood,calcium phosphate crystal area urine computer assisted method,0.01230147076117924,0.04872107
5494-0,glucose in blood,deprecated cd49d cell 100 cell blood,0.01230147076117924,0.06900809
44075-0,glucose in blood,bilirubin cast presence urine sediment light microscopy,0.01230147076117924,0.061794866
5772-9,glucose in blood,calcium carbonate crystal presence synovial fluid light microscopy,0.01230147076117924,0.050634764
48255-4,glucose in blood,giant ragweed triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.08317967
1373-0,glucose in blood,calcitonin mass volume serum plasma 10 minute post 2 4 mg kg calcium short iv,0.01230147076117924,0.100208975
39461-9,glucose in blood,bilirubin total mole volume peritoneal fluid,0.01230147076117924,0.070976004
48186-1,glucose in blood,amylase triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.09618412
5414-8,glucose in blood,deprecated cd10 cell 100 cell blood,0.01230147076117924,0.068210684
40066-3,glucose in blood,calcium mass volume serum plasma 15 minute pre xxx challenge,0.01230147076117924,0.09436249
33789-9,glucose in blood,calcium mole volume urine 10th specimen post xxx challenge,0.01230147076117924,0.07241809
1969-5,glucose in blood,bilirubin total renal clearance 24 hour urine serum plasma,0.01230147076117924,0.09410065
48297-6,glucose in blood,chromotrope 2b triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.08266745
94488-4,glucose in blood,acid alpha glucosidase enzymatic activity mass leukocyte confirmatory method,0.01230147076117924,0.09221866
1970-3,glucose in blood,bilirubin delta mass volume serum plasma,0.01230147076117924,0.107922465
48228-1,glucose in blood,bovine serum albumin bsa triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.09406501
9840-0,glucose in blood,cd11 cd20 cell volume leukocyte,0.01230147076117924,0.07526132
5489-0,glucose in blood,deprecated cd47 cell 100 cell blood,0.01230147076117924,0.06729683
75355-8,glucose in blood,cell leukocyte synovial fluid manual count,0.01230147076117924,0.066004135
5418-9,glucose in blood,deprecated cd103 cell 100 cell blood,0.01230147076117924,0.06887976
1379-7,glucose in blood,calcitonin mass volume serum plasma pre 2 4 mg kg calcium short iv,0.01230147076117924,0.09850774
5770-3,glucose in blood,bilirubin total presence urine test strip,0.01230147076117924,0.057276994
48249-7,glucose in blood,silver birch triggered leukotriene release mass volume leukocyte,0.01230147076117924,0.08758572
33870-7,glucose in blood,bilirubin total presence specimen,0.01230147076117924,0.03934661
33241-1,glucose in blood,calcium carbonate crystal presence urine computer assisted method,0.01230147076117924,0.04094224
57471-5,glucose in blood,calcitriol mole volume serum plasma 3 hour post dose calcium,0.01230147076117924,0.08053198
35672-5,glucose in blood,bilirubin direct bilirubin total serum plasma,0.01230147076117924,0.08906628
57333-7,glucose in blood,calcium ionized mass volume adjusted ph 7 4 serum plasma ion selective membrane electrode ise,0.01230147076117924,0.08946356
5469-2,glucose in blood,deprecated cd37 cell 100 cell blood,0.01230147076117924,0.06874459
40064-8,glucose in blood,calcium mass volume serum plasma pre xxx challenge,0.01230147076117924,0.0930805
58450-8,glucose in blood,bilirubin presence urine confirmatory method,0.01230147076117924,0.045980897
1976-0,glucose in blood,bilirubin total presence stool,0.01230147076117924,0.047388937
78441-3,glucose in blood,bilirubin conjugated mole volume peritoneal fluid,0.01230147076117924,0.08267712
5430-4,glucose in blood,deprecated cd120b cell 100 cell blood,0.01230147076117924,0.07163589
5503-8,glucose in blood,deprecated cd54 cell 100 cell blood,0.01230147076117924,0.07170482
57567-0,glucose in blood,25 hydroxyvitamin d3 mole volume serum plasma 2 hour post dose calcium,0.01230147076117924,0.07480104
21094-8,glucose in blood,basophil leukocyte sputum manual count,0.01230147076117924,0.07120621
105053-3,glucose in blood,calcium oxalate crystal presence urine sediment microscopy,0.01230147076117924,0.046418447
72264-5,glucose in blood,bilirubin excess oxyhemoglobin methemoglobin xanthochromia albumin quotient panel serum csf,0.01230147076117924,0.080150165
100849-9,white blood cells count,leukocyte volume amniotic fluid manual count,0.30064244615139546,0.12932853
52999-0,white blood cells count,leukocyte disintegrated volume blood,0.30064244615139546,0.29456827
104876-8,white blood cells count,hematocrit volume fraction blood 1 hour post dose glucose,0.30064244615139546,0.24181736
12227-5,white blood cells count,leukocyte volume corrected nucleated erythrocyte blood,0.30064244615139546,0.29732943
33028-2,white blood cells count,leukocyte volume blood blood product unit,0.30064244615139546,0.21797888
33842-6,white blood cells count,immature monocyte leukocyte blood manual count,0.20193838467463263,0.2857217
26524-9,white blood cells count,promyelocytes leukocyte blood,0.20193838467463263,0.27454558
74455-7,white blood cells count,blast leukocyte cord blood,0.20193838467463263,0.09627211
38184-8,white blood cells count,basophil leukocyte amniotic fluid manual count,0.20193838467463263,0.107937865
51384-6,white blood cells count,mononuclear cell leukocyte blood manual count,0.20193838467463263,0.29345348
30395-8,white blood cells count,granulocyte leukocyte blood,0.20193838467463263,0.26664683
73903-7,white blood cells count,cd3 cd57 cell leukocyte blood flow cytometry fc,0.20193838467463263,0.26375058
26511-6,white blood cells count,neutrophil leukocyte blood,0.20193838467463263,0.27638176
30367-7,white blood cells count,deprecated myeloblast 100 leukocyte blood automated count,0.20193838467463263,0.2940193
74814-5,white blood cells count,plasma cell centroblasts leukocyte blood manual count,0.20193838467463263,0.2954859
30445-1,white blood cells count,myeloblast leukocyte blood,0.20193838467463263,0.27085727
764-1,white blood cells count,band form neutrophil leukocyte blood manual count,0.20193838467463263,0.2937672
44097-4,white blood cells count,unidentified cell leukocyte blood,0.20193838467463263,0.27534962
40650-4,white blood cells count,mesothelial cell leukocyte blood manual count,0.20193838467463263,0.2894273
34920-9,white blood cells count,lymphocyte immunoblastic leukocyte blood,0.20193838467463263,0.26078668
714-6,white blood cells count,eosinophil leukocyte blood manual count,0.20193838467463263,0.28737023
58407-8,white blood cells count,leukocyte morphology panel blood,0.20193838467463263,0.2680209
6746-2,white blood cells count,prolymphocytes leukocyte blood manual count,0.20193838467463263,0.29153228
30441-0,white blood cells count,monocyte abnormal leukocyte blood,0.20193838467463263,0.2673065
4662-3,white blood cells count,lymphocyte monocyte leukocyte blood,0.20193838467463263,0.27196985
62858-6,white blood cells count,micromegakaryocytes leukocyte blood manual count,0.20193838467463263,0.29391176
74457-3,white blood cells count,neutrophil leukocyte cord blood,0.20193838467463263,0.099369094
51586-6,white blood cells count,cell leukocyte blood manual count,0.20193838467463263,0.30094284
33840-0,white blood cells count,monoblast leukocyte blood manual count,0.20193838467463263,0.2965926
58409-4,white blood cells count,cell leukocyte blood automated count,0.20193838467463263,0.303631
74820-2,white blood cells count,plasma cell centrocytes leukocyte blood manual count,0.20193838467463263,0.29531372
38518-7,white blood cells count,immature granulocyte leukocyte blood,0.20193838467463263,0.26613912
40646-2,white blood cells count,leukocyte leukocyte blood automated count,0.20193838467463263,0.29513496
5905-5,white blood cells count,monocyte leukocyte blood automated count,0.20193838467463263,0.29696137
749-2,white blood cells count,myelocyte leukocyte blood manual count,0.20193838467463263,0.30451074
70028-6,white blood cells count,megakaryocytic nucleus leukocyte blood manual count,0.20193838467463263,0.2943933
74405-2,white blood cells count,eosinophil leukocyte cord blood,0.20193838467463263,0.094740644
6300-8,white blood cells count,glucose mass volume amniotic fluid,0.1446920797393349,0.07435921
42857-3,white blood cells count,calcium mole volume venous blood,0.1446920797393349,0.062322967
14770-2,white blood cells count,fasting glucose mole volume capillary blood glucometer,0.1446920797393349,0.08029845
89871-8,white blood cells count,bilirubin total mole volume venous blood,0.1446920797393349,0.06685956
104597-0,white blood cells count,glucose mass volume venous blood glucometer,0.1446920797393349,0.085492514
53553-4,white blood cells count,glucose mean value mole volume blood estimated glycated hemoglobin,0.1446920797393349,0.2684863
47598-8,white blood cells count,calcium ionized mole volume adjusted ph 7 4 blood,0.1446920797393349,0.23891059
74347-6,white blood cells count,leukocyte aggregate presence blood light microscopy,0.1446920797393349,0.28515553
47994-9,white blood cells count,bilirubin total mole volume cord blood,0.1446920797393349,0.070483886
89872-6,white blood cells count,bilirubin total mole volume arterial blood,0.1446920797393349,0.06390037
42593-4,white blood cells count,calcium mole volume capillary blood,0.1446920797393349,0.05629704
53139-2,white blood cells count,calcium ionized mole volume adjusted ph 7 4 capillary blood,0.1446920797393349,0.04649539
50672-5,white blood cells count,leukocyte toxic vacuole presence blood light microscopy,0.1446920797393349,0.27141336
49134-0,white blood cells count,glucose mass volume blood 2 hour post dose glucose,0.1446920797393349,0.25280583
1384-7,white blood cells count,calcium mole volume blood post calcium infusion,0.1446920797393349,0.23938572
14415-4,white blood cells count,calcium mole volume amniotic fluid,0.1446920797393349,0.05944721
17790-7,white blood cells count,leukocyte left shift presence blood automated count,0.1446920797393349,0.2870818
41644-6,white blood cells count,calcium ionized mole volume capillary blood,0.1446920797393349,0.058715355
13877-6,white blood cells count,bilirubin total presence amniotic fluid,0.1446920797393349,0.044894785
38230-9,white blood cells count,calcium ionized mass volume blood,0.1446920797393349,0.23552248
48623-3,white blood cells count,bilirubin direct mass volume cord blood,0.1446920797393349,0.08175871
27353-2,white blood cells count,glucose mean value mass volume blood estimated glycated hemoglobin,0.1446920797393349,0.27533254
41645-3,white blood cells count,calcium ionized mole volume venous blood,0.1446920797393349,0.06100057
47995-6,white blood cells count,glucose mole volume cord blood,0.1446920797393349,0.06551693
34469-7,white blood cells count,leukocyte presence bile fluid light microscopy,0.1446920797393349,0.10195621
54365-2,white blood cells count,calcium mole volume cord blood,0.1446920797393349,0.056932338
12653-2,white blood cells count,glucose mass volume serum plasma 8 minute post xxx challenge,0.022373692946662457,0.08636174
15075-5,white blood cells count,glucose mole volume dialysis fluid,0.022373692946662457,0.066586114
14858-5,white blood cells count,leukocyte leukocyte pleural fluid manual count,0.022373692946662457,0.11899001
48193-7,white blood cells count,succinylcholine triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09307042
55496-4,white blood cells count,insulin mole volume serum plasma 2 hour post dose glucose iv,0.022373692946662457,0.06159056
68367-2,white blood cells count,bilirubin total mole volume urine automated test strip,0.022373692946662457,0.06760903
40222-2,white blood cells count,glucose mole volume serum plasma 2 day post xxx challenge,0.022373692946662457,0.075416245
14152-3,white blood cells count,bilirubin direct mass volume body fluid,0.022373692946662457,0.08376164
40279-2,white blood cells count,glucose mole volume serum plasma 2 hour post dose lactose po,0.022373692946662457,0.066557035
40168-7,white blood cells count,glucose mole volume serum plasma 7 5 hour post xxx challenge,0.022373692946662457,0.073256314
5470-0,white blood cells count,deprecated cd38 cell 100 cell blood,0.022373692946662457,0.093808696
48184-6,white blood cells count,yellow jacket triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10491879
26781-5,white blood cells count,glucose mass volume serum plasma 3 hour post dose lactose po,0.022373692946662457,0.07001504
55479-0,white blood cells count,insulin mole volume serum plasma 7 minute post dose glucose iv,0.022373692946662457,0.06512593
104635-8,white blood cells count,continuous glucose monitor device date time reporting period end reported,0.022373692946662457,0.033642683
30469-1,white blood cells count,unspecified cell leukocyte body fluid,0.022373692946662457,0.094495036
49926-9,white blood cells count,glucose 6 phosphate dehydrogenase enzymatic activity mass red blood cell method,0.022373692946662457,0.064968586
15153-0,white blood cells count,deprecated indirect bilirubin mass volume serum plasma,0.022373692946662457,0.09535909
40024-2,white blood cells count,glucose mass volume serum plasma 1 day post xxx challenge,0.022373692946662457,0.08595583
18186-7,white blood cells count,calcium mass time 12 hour urine,0.022373692946662457,0.04040461
48194-5,white blood cells count,lidocaine triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09455506
32013-5,white blood cells count,eosinophil leukocyte pericardial fluid manual count,0.022373692946662457,0.09978517
71628-2,white blood cells count,macrophage leukocyte pure number fraction peritoneal fluid manual count,0.022373692946662457,0.11892523
46099-8,white blood cells count,calcium mass volume corrected albumin serum plasma,0.022373692946662457,0.074971296
66132-2,white blood cells count,mononuclear mesothelial cell leukocyte body fluid manual count,0.022373692946662457,0.10612812
71594-6,white blood cells count,macrophage leukocyte pure number fraction bronchial specimen manual count,0.022373692946662457,0.11285523
57845-0,white blood cells count,leukocyte volume body fluid automated count,0.022373692946662457,0.14076574
58686-7,white blood cells count,component peptide mass volume serum plasma 2 hour post dose glucose,0.022373692946662457,0.06557936
10966-0,white blood cells count,glucose presence urine test strip 2 5 hour post 75 g glucose po,0.022373692946662457,0.05315212
1530-5,white blood cells count,glucose mass volume serum plasma 3 hour post 100 g glucose po,0.022373692946662457,0.08458771
55481-6,white blood cells count,insulin mole volume serum plasma 10 minute pre dose glucose,0.022373692946662457,0.06348602
40533-2,white blood cells count,leukocyte volume peritoneal dialysis fluid manual count,0.022373692946662457,0.12459558
16513-4,white blood cells count,calcium ionized mole volume serum plasma 3rd specimen post xxx challenge,0.022373692946662457,0.07137964
75054-7,white blood cells count,glutaryl coa dehydrogenase enzymatic activity mass leukocyte,0.022373692946662457,0.099679284
32318-8,white blood cells count,glucose mole volume specimen,0.022373692946662457,0.059682805
48189-5,white blood cells count,formaldehyde triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09995404
40011-9,white blood cells count,glucose mass volume serum plasma 13 5 hour post xxx challenge,0.022373692946662457,0.078277566
96077-3,white blood cells count,hedis 2020 value set glucose test,0.022373692946662457,0.039123863
48052-5,white blood cells count,leukocyte volume corrected nucleated erythrocyte body fluid,0.022373692946662457,0.119415544
54257-1,white blood cells count,glucose mole volume serum plasma pre dose insulin iv,0.022373692946662457,0.065464504
12614-4,white blood cells count,glucose mass volume serum plasma 7 hour post meal,0.022373692946662457,0.08059925
25676-8,white blood cells count,glucose mole volume serum plasma 5 5 hour post dose glucose,0.022373692946662457,0.07965404
54253-0,white blood cells count,glucose mole volume serum plasma 4 minute post dose glucagon,0.022373692946662457,0.084133096
48993-0,white blood cells count,glucose mass volume serum plasma 3 specimen,0.022373692946662457,0.08483946
95225-9,white blood cells count,band form neutrophil leukocyte stem cell product manual count,0.022373692946662457,0.11752699
53928-8,white blood cells count,glucose mass volume serum plasma 20 minute post 50 g lactose po,0.022373692946662457,0.08020977
9050-6,white blood cells count,calcium intake 12 hour,0.022373692946662457,0.03416975
18354-1,white blood cells count,glucose mass volume serum plasma 12 hour post 50 g lactose po,0.022373692946662457,0.081481464
16985-4,white blood cells count,hydrogen expired gas volume fraction exhaled gas 1 5 hour post dose glucose,0.022373692946662457,0.03662446
79451-1,white blood cells count,adenosine deaminase enzymatic activity mass leukocyte,0.022373692946662457,0.075709574
104073-2,white blood cells count,multiple sulfatase deficiency enzyme panel leukocyte,0.022373692946662457,0.067019865
48994-8,white blood cells count,glucose mass volume serum plasma 6 specimen,0.022373692946662457,0.086378664
1546-1,white blood cells count,glucose mass volume urine 6 hour post 100 g glucose po,0.022373692946662457,0.068332456
99308-9,white blood cells count,acid alpha glucosidase cross reactive immunologic material crim presence leukocyte immunoblot,0.022373692946662457,0.09183408
99933-4,white blood cells count,leukocyte clump presence body fluid automated,0.022373692946662457,0.09337218
58508-3,white blood cells count,component peptide mass volume serum plasma 3 5 hour post dose glucose,0.022373692946662457,0.06373709
59244-4,white blood cells count,arylsulfatase component enzymatic activity mass leukocyte,0.022373692946662457,0.08067501
33794-9,white blood cells count,calcium mole volume urine 8th specimen post xxx challenge,0.022373692946662457,0.053307872
12630-0,white blood cells count,glucose mass volume peritoneal dialysis fluid 1st specimen,0.022373692946662457,0.074444644
5422-1,white blood cells count,deprecated cd107a cell 100 cell blood,0.022373692946662457,0.099225916
40670-2,white blood cells count,smudge cell leukocyte body fluid manual count,0.022373692946662457,0.114322536
5499-9,white blood cells count,deprecated cd50 cell 100 cell blood,0.022373692946662457,0.09980582
53127-7,white blood cells count,monocyte macrophage leukocyte tissue,0.022373692946662457,0.082467705
13655-6,white blood cells count,leukocyte presence stool light microscopy,0.022373692946662457,0.09207652
59812-8,white blood cells count,glucose mole volume serum plasma 11 specimen,0.022373692946662457,0.078150265
24122-4,white blood cells count,leukocyte volume urine manual count,0.022373692946662457,0.111402094
27373-0,white blood cells count,calcium mass volume dialysis fluid,0.022373692946662457,0.056230806
33870-7,white blood cells count,bilirubin total presence specimen,0.022373692946662457,0.030295117
26473-9,white blood cells count,leukocyte leukocyte body fluid,0.022373692946662457,0.09394649
1508-1,white blood cells count,deprecated glucose mass volume serum plasma 1 hour post 75 g glucose po,0.022373692946662457,0.06324421
40187-7,white blood cells count,glucose mole volume serum plasma 20 hour post xxx challenge,0.022373692946662457,0.07274507
1491-0,white blood cells count,glucose mass volume urine 30 minute post 100 g glucose po,0.022373692946662457,0.07009226
40244-6,white blood cells count,calcium mole volume serum plasma 1 day post xxx challenge,0.022373692946662457,0.06670581
5446-0,white blood cells count,deprecated cd19 lambda cell 100 cell blood,0.022373692946662457,0.09601324
68428-2,white blood cells count,leukocyte volume pericardial fluid manual count,0.022373692946662457,0.13091063
33287-4,white blood cells count,glucose 6 phosphate dehydrogenase presence db,0.022373692946662457,0.12425452
17803-8,white blood cells count,plasma cell leukocyte body fluid,0.022373692946662457,0.09718472
48282-8,white blood cells count,atracurium triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10450244
72896-4,white blood cells count,glucose mole volume serum plasma 15 minute post dose lactose po,0.022373692946662457,0.06700364
54255-5,white blood cells count,glucose mole volume serum plasma 6 minute post dose glucagon,0.022373692946662457,0.082753025
47839-6,white blood cells count,deprecated carnitine acyltransferase ii enzymatic activity mass leukocyte,0.022373692946662457,0.0736163
58500-0,white blood cells count,component peptide mass volume serum plasma 15 minute post dose glucose,0.022373692946662457,0.063104965
32805-4,white blood cells count,variant lymphocyte leukocyte bronchial specimen manual count,0.022373692946662457,0.0955415
96978-2,white blood cells count,noninvasive prenatal fetal aneuploidy 22q11 2 deletion panel plasma cell free wbc dna dosage chromosome specific cfdna,0.022373692946662457,0.08112045
5771-1,white blood cells count,bilirubin crystal presence urine sediment light microscopy,0.022373692946662457,0.042287637
26466-3,white blood cells count,leukocyte volume body fluid,0.022373692946662457,0.11855709
105105-1,white blood cells count,leukocyte presence urine sediment,0.022373692946662457,0.06294141
50215-3,white blood cells count,glucose mass volume serum plasma 5th specimen,0.022373692946662457,0.09315855
12640-9,white blood cells count,glucose mass volume serum plasma 6 5 hour post xxx challenge,0.022373692946662457,0.0897071
40175-2,white blood cells count,glucose mole volume serum plasma 11 5 hour post xxx challenge,0.022373692946662457,0.07070256
40203-2,white blood cells count,glucose mole volume serum plasma 9 minute post xxx challenge,0.022373692946662457,0.07546783
35051-2,white blood cells count,leukocyte volume body fluid,0.022373692946662457,0.120633855
61435-4,white blood cells count,deprecated deprecated calcium intake daily protocol phenx,0.022373692946662457,0.028262416
40008-5,white blood cells count,glucose mass volume serum plasma 11 5 hour post xxx challenge,0.022373692946662457,0.07892757
79196-2,white blood cells count,glucose mass volume serum plasma 1 hour post dose arginine insulin,0.022373692946662457,0.065321945
54256-3,white blood cells count,glucose mole volume serum plasma 8 minute post dose glucagon,0.022373692946662457,0.08098396
16523-3,white blood cells count,calcium mole volume serum plasma 5 minute post xxx challenge,0.022373692946662457,0.074467994
75594-2,white blood cells count,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.022373692946662457,0.07775236
40019-2,white blood cells count,glucose mass volume serum plasma 20 hour post xxx challenge,0.022373692946662457,0.08523696
17286-6,white blood cells count,monocyte leukocyte synovial fluid manual count,0.022373692946662457,0.11292147
26472-1,white blood cells count,leukocyte leukocyte cerebral spinal fluid,0.022373692946662457,0.09018699
99896-3,white blood cells count,calcium oxalate monohydrate crystal volume urine sediment computer assisted method,0.022373692946662457,0.032160465
54261-3,white blood cells count,glucose mole volume serum plasma 15 minute pre dose insulin iv,0.022373692946662457,0.058297213
40177-8,white blood cells count,glucose mole volume serum plasma 12 5 hour post xxx challenge,0.022373692946662457,0.07139615
62874-3,white blood cells count,deprecated phenx measure assay human leukocyte antigen hla genotyping,0.022373692946662457,0.0764473
805-2,white blood cells count,leukocyte volume cerebral spinal fluid automated count,0.022373692946662457,0.14411524
48191-1,white blood cells count,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.112544425
40198-4,white blood cells count,glucose mole volume serum plasma 2 minute post xxx challenge,0.022373692946662457,0.07491756
5821-4,white blood cells count,leukocyte area urine sediment microscopy high power field,0.022373692946662457,0.087032884
58557-0,white blood cells count,corticotropin mole volume plasma 1 hour post dose glucose,0.022373692946662457,0.06309702
105896-5,white blood cells count,calcium oxalate crystal area urine sediment,0.022373692946662457,0.006956492
40209-9,white blood cells count,glucose mole volume serum plasma 25 minute post xxx challenge,0.022373692946662457,0.07502876
16908-6,white blood cells count,glucose presence urine 5th specimen post xxx challenge,0.022373692946662457,0.044629283
13595-4,white blood cells count,basophil leukocyte nose,0.022373692946662457,0.07754937
88976-6,white blood cells count,wbc cast area urine sediment,0.022373692946662457,0.064987026
54394-2,white blood cells count,glucose mole volume serum plasma 11th specimen post xxx challenge,0.022373692946662457,0.07698093
33655-2,white blood cells count,beta n acetylhexosaminidase mole volume leukocyte,0.022373692946662457,0.0856705
26549-6,white blood cells count,glucose presence urine test strip 3 hour post dose glucose,0.022373692946662457,0.05224186
5505-3,white blood cells count,deprecated cd56 cell 100 cell blood,0.022373692946662457,0.09465956
72648-9,white blood cells count,glucose serum glucose synovial fluid molar concentration difference,0.022373692946662457,0.07976082
9305-4,white blood cells count,mononuclear cell leukocyte body fluid manual count,0.022373692946662457,0.118740745
56751-1,white blood cells count,glucose mass volume serum plasma 2 17 hour post xxx challenge,0.022373692946662457,0.076805495
54250-6,white blood cells count,glucose mole volume serum plasma 15 minute pre dose glucagon,0.022373692946662457,0.07432882
16273-5,white blood cells count,calcium mass mass red blood cell,0.022373692946662457,0.05749394
1628-7,white blood cells count,somatotropin mass volume serum plasma 1 hour post 1 g kg glucose po,0.022373692946662457,0.08543926
40157-0,white blood cells count,glucose mole volume serum plasma 40 minute post xxx challenge,0.022373692946662457,0.07734389
48297-6,white blood cells count,chromotrope 2b triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10879218
5484-1,white blood cells count,deprecated cd45 cell 100 cell blood,0.022373692946662457,0.089586504
61124-4,white blood cells count,granulocyte leukocyte specimen flow cytometry fc,0.022373692946662457,0.091547035
1547-9,white blood cells count,glucose mass volume serum plasma baseline,0.022373692946662457,0.08824319
17227-0,white blood cells count,lymphocyte leukocyte synovial fluid automated count,0.022373692946662457,0.11397726
51426-5,white blood cells count,glucose mole volume serum plasma pre post xxx challenge,0.022373692946662457,0.07565577
70126-8,white blood cells count,leukocyte volume corrected nucleated erythrocyte pleural fluid,0.022373692946662457,0.11688472
59796-3,white blood cells count,glucose molar concentration difference serum plasma 4 hour post xxx challenge,0.022373692946662457,0.07947322
18227-9,white blood cells count,glucose mass time 6 hour urine,0.022373692946662457,0.057555065
33792-3,white blood cells count,calcium mole volume urine 6th specimen post xxx challenge,0.022373692946662457,0.056473307
53131-9,white blood cells count,calcium oxalate crystal area urine sediment microscopy low power field,0.022373692946662457,0.024558797
40526-6,white blood cells count,plasma cell leukocyte pericardial fluid manual count,0.022373692946662457,0.111540854
48212-5,white blood cells count,pork triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10448587
35054-6,white blood cells count,leukocyte volume peritoneal fluid,0.022373692946662457,0.11340979
105112-7,white blood cells count,eosinophil leukocyte urine sediment,0.022373692946662457,0.054703206
24073-9,white blood cells count,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.022373692946662457,0.07883157
45298-7,white blood cells count,glucose mole volume serum plasma 2 5 hour post 50 g lactose po,0.022373692946662457,0.06630065
40544-9,white blood cells count,monocyte leukocyte bronchial specimen manual count,0.022373692946662457,0.09885246
40631-4,white blood cells count,nucleated erythrocyte leukocyte ratio cerebral spinal fluid manual count,0.022373692946662457,0.17038108
68433-2,white blood cells count,leukocyte volume vitreous fluid manual count,0.022373692946662457,0.13623095
13353-8,white blood cells count,deprecated eosinophil 100 leukocyte body fluid manual count,0.022373692946662457,0.10836367
24092-9,white blood cells count,alpha n acetylglucosaminidase enzymatic activity mass leukocyte,0.022373692946662457,0.08044965
75583-5,white blood cells count,fetal prader willi syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.022373692946662457,0.0807329
54439-5,white blood cells count,calcium bilirubinate total stone,0.022373692946662457,0.025036825
40217-2,white blood cells count,glucose mole volume serum plasma 28 hour post xxx challenge,0.022373692946662457,0.07505183
78442-1,white blood cells count,bilirubin indirect mole volume peritoneal fluid,0.022373692946662457,0.0614326
54401-5,white blood cells count,glucose mole volume serum plasma 10 minute post dose glucagon,0.022373692946662457,0.08286112
58529-9,white blood cells count,corticotropin mole volume plasma 1 5 hour post dose glucose,0.022373692946662457,0.062421806
48988-0,white blood cells count,glucose mass volume serum plasma 12 pm specimen,0.022373692946662457,0.08554853
40031-7,white blood cells count,glucose mass volume serum plasma 19 minute post xxx challenge,0.022373692946662457,0.08354304
1377-1,white blood cells count,calcitonin mass volume serum plasma 5 minute post 2 4 mg kg calcium short iv,0.022373692946662457,0.07393091
53050-1,white blood cells count,glucose mass volume total parental nutrition,0.022373692946662457,0.053771533
42567-8,white blood cells count,calcium ionized mass mole volume serum plasma,0.022373692946662457,0.048482783
47595-4,white blood cells count,component peptide mole volume serum plasma pre dose glucose,0.022373692946662457,0.05690402
40322-0,white blood cells count,glucose mole volume serum plasma 1 hour post dose triple bolus,0.022373692946662457,0.07499305
71630-8,white blood cells count,leukocyte leukocyte pure number fraction peritoneal fluid manual count,0.022373692946662457,0.119616054
14769-4,white blood cells count,glucose mole volume serum plasma pre 12 hour fast,0.022373692946662457,0.07892267
39998-0,white blood cells count,glucose mass volume serum plasma 30 minute pre xxx challenge,0.022373692946662457,0.07750295
5564-0,white blood cells count,deprecated tcr cd3,0.022373692946662457,0.081325166
5551-7,white blood cells count,deprecated cycd3 cell 100 cell blood,0.022373692946662457,0.09051224
40029-1,white blood cells count,glucose mass volume serum plasma 14 minute post xxx challenge,0.022373692946662457,0.08274356
72348-6,white blood cells count,leukocyte volume prostatic fluid manual count,0.022373692946662457,0.12962256
25675-0,white blood cells count,glucose mass volume urine 4 hour post dose glucose,0.022373692946662457,0.07272165
34445-7,white blood cells count,leukocyte presence body fluid,0.022373692946662457,0.0930651
14423-8,white blood cells count,bilirubin total mass volume synovial fluid,0.022373692946662457,0.07327144
6748-8,white blood cells count,glucose presence urine test strip 1 hour post 75 g glucose po,0.022373692946662457,0.04433864
102032-0,white blood cells count,glucose mass volume serum plasma 2 hour post dose insulin iv,0.022373692946662457,0.07465054
57467-3,white blood cells count,calcitriol mass volume serum plasma pre dose calcium,0.022373692946662457,0.06122035
5457-7,white blood cells count,deprecated cd28 cell 100 cell blood,0.022373692946662457,0.10081354
50725-1,white blood cells count,monoblast leukocyte bone marrow manual count,0.022373692946662457,0.11670327
53482-6,white blood cells count,glucose mole volume serum plasma 3 hour post dose betaxolol,0.022373692946662457,0.07815662
61513-8,white blood cells count,many year take calcium alone combined something else bone health supplement antacid phenx,0.022373692946662457,0.032370225
30427-9,white blood cells count,macrophage leukocyte body fluid,0.022373692946662457,0.086152814
74802-0,white blood cells count,glucose challenge hydrogen breath test interpretation exhaled gas,0.022373692946662457,0.052835166
50182-5,white blood cells count,calcitonin mass volume serum plasma 2 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.022373692946662457,0.071661584
21653-1,white blood cells count,cdh1 gene mutation tested blood tissue molecular genetics method nominal,0.022373692946662457,0.13301945
40653-8,white blood cells count,myelocyte leukocyte body fluid manual count,0.022373692946662457,0.112136915
1515-6,white blood cells count,deprecated glucose mass volume serum plasma 2 hour post 100 g glucose po,0.022373692946662457,0.06682102
70219-1,white blood cells count,basic metabolic 2008 panel ionized calcium serum plasma,0.022373692946662457,0.050743893
5454-4,white blood cells count,deprecated cd25 cell 100 cell blood,0.022373692946662457,0.09243616
12220-0,white blood cells count,glucose mass volume peritoneal fluid 12 hour post peritoneal dialysis,0.022373692946662457,0.067936756
5424-7,white blood cells count,deprecated cd115 cell 100 cell blood,0.022373692946662457,0.09169677
54249-8,white blood cells count,glucose mole volume serum plasma 15 minute post dose glucagon,0.022373692946662457,0.076087594
75356-6,white blood cells count,cell leukocyte pleural fluid manual count,0.022373692946662457,0.11939262
40286-7,white blood cells count,glucose mole volume serum plasma 105 minute post dose glucose,0.022373692946662457,0.07748645
13525-1,white blood cells count,nonhematic cell leukocyte cerebral spinal fluid manual count,0.022373692946662457,0.11056829
35020-7,white blood cells count,monocyte macrophage leukocyte peritoneal fluid,0.022373692946662457,0.08335178
45190-6,white blood cells count,casr gene mutation found identifier blood tissue molecular genetics method nominal,0.022373692946662457,0.13163856
41201-5,white blood cells count,voltage gated calcium channel igg ab mole volume serum,0.022373692946662457,0.0499563
40171-1,white blood cells count,glucose mole volume serum plasma 9 hour post xxx challenge,0.022373692946662457,0.07283603
104072-4,white blood cells count,mucopolysaccharidosis enzyme panel leukocyte,0.022373692946662457,0.08339081
62875-0,white blood cells count,phenx assay human leukocyte antigen hla genotyping protocol 160601,0.022373692946662457,0.06928222
1970-3,white blood cells count,bilirubin delta mass volume serum plasma,0.022373692946662457,0.094165094
50407-6,white blood cells count,cell leukocyte identifier cerebral spinal fluid,0.022373692946662457,0.10495388
4528-6,white blood cells count,deprecated complement receptor 2,0.022373692946662457,0.08650023
40247-9,white blood cells count,calcium mole volume serum plasma 3 day post xxx challenge,0.022373692946662457,0.06356787
76350-8,white blood cells count,cell leukocyte body fluid,0.022373692946662457,0.09548065
1532-1,white blood cells count,glucose mass volume urine 3 hour post 100 g glucose po,0.022373692946662457,0.06485787
57468-1,white blood cells count,calcitriol mole volume serum plasma pre dose calcium,0.022373692946662457,0.047027428
48266-1,white blood cells count,grass allergen mix e cocksfoot meadow fescue velvet grass perennial rye grass timothy kentucky blue grass triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09595432
95102-0,white blood cells count,glucose post fasting meal stimulation panel serum plasma,0.022373692946662457,0.043051954
48186-1,white blood cells count,amylase triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09067697
25678-4,white blood cells count,glucose mass volume urine 1 5 hour post dose glucose,0.022373692946662457,0.068114124
35194-0,white blood cells count,bilirubin total mass mole volume serum plasma,0.022373692946662457,0.06772748
26483-8,white blood cells count,lymphocyte leukocyte synovial fluid,0.022373692946662457,0.083335556
54395-9,white blood cells count,glucose mole volume serum plasma 12th specimen post xxx challenge,0.022373692946662457,0.07618802
31994-7,white blood cells count,basophil leukocyte pericardial fluid manual count,0.022373692946662457,0.11066402
40009-3,white blood cells count,glucose mass volume serum plasma 12 5 hour post xxx challenge,0.022373692946662457,0.08167113
55480-8,white blood cells count,insulin mole volume serum plasma 5 minute pre dose glucose,0.022373692946662457,0.05749753
16990-4,white blood cells count,hydrogen expired gas volume fraction exhaled gas 3 hour post dose glucose,0.022373692946662457,0.039144307
53226-7,white blood cells count,leukocyte area urethra wet preparation,0.022373692946662457,0.07438622
16512-6,white blood cells count,calcium ionized mole volume serum plasma 2nd specimen post xxx challenge,0.022373692946662457,0.072667085
75588-4,white blood cells count,fetal angelman syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.022373692946662457,0.07590601
53868-6,white blood cells count,glucose tetrasaccharide creatinine molar ratio urine,0.022373692946662457,0.05145199
10968-6,white blood cells count,glucose presence urine test strip 4 5 hour post 75 g glucose po,0.022373692946662457,0.051377602
33371-6,white blood cells count,variant lymphocyte leukocyte synovial fluid,0.022373692946662457,0.08042948
11032-0,white blood cells count,glucose mass volume serum plasma 45 minute post 50 g lactose po,0.022373692946662457,0.08404938
53083-2,white blood cells count,bilirubin conjugated mole volume dialysis fluid,0.022373692946662457,0.06264856
53481-8,white blood cells count,glucose mole volume serum plasma 15 minute pre dose betaxolol,0.022373692946662457,0.070277296
46406-5,white blood cells count,somatotropin mass volume serum plasma 30 minute post 1 g kg glucose po,0.022373692946662457,0.0819961
40208-1,white blood cells count,glucose mole volume serum plasma 22 minute post xxx challenge,0.022373692946662457,0.075171806
33370-8,white blood cells count,variant lymphocyte leukocyte pleural fluid,0.022373692946662457,0.08191301
48269-5,white blood cells count,cefamandole triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10217019
93704-5,white blood cells count,palmitoyl protein thioesterase 1 tripeptidyl peptidase 1 panel leukocyte,0.022373692946662457,0.043485433
101931-4,white blood cells count,calcium oxalate crystal energy difference urine,0.022373692946662457,0.026417928
13522-8,white blood cells count,blast leukocyte body fluid manual count,0.022373692946662457,0.10743898
50551-1,white blood cells count,bilirubin total presence urine automated test strip,0.022373692946662457,0.046977077
71601-9,white blood cells count,leukocyte leukocyte pure number fraction pericardial fluid manual count,0.022373692946662457,0.12076875
16521-7,white blood cells count,calcium mole volume urine 3rd specimen post xxx challenge,0.022373692946662457,0.060005635
53444-6,white blood cells count,citrate synthase enzymatic activity mass control leukocyte,0.022373692946662457,0.08158714
57840-1,white blood cells count,eosinophil leukocyte dialysis fluid manual count,0.022373692946662457,0.10017693
33384-9,white blood cells count,segmented neutrophil leukocyte peritoneal fluid,0.022373692946662457,0.079835
16993-8,white blood cells count,hydrogen expired gas volume fraction exhaled gas 5 5 hour post dose glucose,0.022373692946662457,0.037337117
26552-0,white blood cells count,glucose presence urine test strip 6 hour post dose glucose,0.022373692946662457,0.0546561
5432-0,white blood cells count,deprecated cd126 cell 100 cell blood,0.022373692946662457,0.09728294
71640-7,white blood cells count,mesothelial cell leukocyte pure number fraction body fluid manual count,0.022373692946662457,0.12006735
39563-2,white blood cells count,glucose mass volume serum plasma 3rd specimen post dose lactose,0.022373692946662457,0.07293666
18296-4,white blood cells count,glucose interpretation serum plasma post dose glucose,0.022373692946662457,0.075398974
53309-1,white blood cells count,calcium phosphate crystal area urine computer assisted method,0.022373692946662457,0.00829795
12233-3,white blood cells count,mesothelial cell leukocyte cerebral spinal fluid manual count,0.022373692946662457,0.10292532
14752-0,white blood cells count,glucose mole volume serum plasma 1 5 hour post dose glucose,0.022373692946662457,0.083629444
26470-5,white blood cells count,leukocyte volume cerebral spinal fluid,0.022373692946662457,0.11844879
33898-8,white blood cells count,bilirubin conjugated indirect mass volume serum plasma,0.022373692946662457,0.08621532
40539-9,white blood cells count,eosinophil leukocyte peritoneal dialysis fluid manual count,0.022373692946662457,0.09417697
53484-2,white blood cells count,glucose mole volume serum plasma 30 minute pre dose betaxolol,0.022373692946662457,0.076321185
40075-4,white blood cells count,calcium mass volume serum plasma 6 5 hour post xxx challenge,0.022373692946662457,0.069480866
40199-2,white blood cells count,glucose mole volume serum plasma 3 minute post xxx challenge,0.022373692946662457,0.07448637
82883-0,white blood cells count,lysosomal acid lipase enzymatic activity mass leukocyte 4 mu palmitate substrate,0.022373692946662457,0.08120284
30264-6,white blood cells count,glucose mole volume serum plasma 40 minute post dose glucose,0.022373692946662457,0.08149134
15077-1,white blood cells count,glucose mole time 24 hour urine,0.022373692946662457,0.0616521
32028-3,white blood cells count,monocyte macrophage leukocyte pleural fluid manual count,0.022373692946662457,0.11014794
1529-7,white blood cells count,deprecated glucose mass volume serum plasma 30 minute post dose insulin iv,0.022373692946662457,0.06361801
75601-5,white blood cells count,fetal 1p36 deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.022373692946662457,0.08361287
16992-0,white blood cells count,hydrogen expired gas volume fraction exhaled gas 4 hour post dose glucose,0.022373692946662457,0.04308345
53302-6,white blood cells count,calcium carbonate crystal volume urine computer assisted method,0.022373692946662457,0.024214972
30527-6,white blood cells count,calcium mass volume total parental nutrition,0.022373692946662457,0.036914967
53443-8,white blood cells count,carnitine palmitoyltransferase 2 enzymatic activity mass control leukocyte,0.022373692946662457,0.078037135
62855-2,white blood cells count,deprecated phenx measure oral glucose tolerance test,0.022373692946662457,0.047754586
12913-0,white blood cells count,beta n acetylhexosaminidase enzymatic activity volume leukocyte,0.022373692946662457,0.09424141
48208-3,white blood cells count,baker yeast triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10531476
40004-4,white blood cells count,glucose mass volume serum plasma 100 minute post xxx challenge,0.022373692946662457,0.087429896
13524-4,white blood cells count,leukocyte leukocyte body fluid manual count,0.022373692946662457,0.119613156
53486-7,white blood cells count,glucose mole volume serum plasma 1 hour post dose betaxolol,0.022373692946662457,0.08010181
30417-0,white blood cells count,variant lymphocyte leukocyte body fluid,0.022373692946662457,0.083236165
16272-7,white blood cells count,calcium mass volume serum plasma 2 hour post xxx challenge,0.022373692946662457,0.07393243
71602-7,white blood cells count,basophil leukocyte pure number fraction pericardial fluid manual count,0.022373692946662457,0.11997894
40176-0,white blood cells count,glucose mole volume serum plasma 12 hour post xxx challenge,0.022373692946662457,0.07449514
40161-2,white blood cells count,glucose mole volume serum plasma 2 5 hour post xxx challenge,0.022373692946662457,0.07262116
33653-7,white blood cells count,beta galactosidase entitic catalytic activity leukocyte,0.022373692946662457,0.08363069
5467-6,white blood cells count,deprecated cd35 cell 100 cell blood,0.022373692946662457,0.08521382
49500-2,white blood cells count,calcium oxalate dihydrate total stone infrared spectroscopy,0.022373692946662457,0.014199344
5486-6,white blood cells count,deprecated cd45rb cell 100 cell blood,0.022373692946662457,0.0902198
50751-7,white blood cells count,glucose mass volume serum plasma 15 minute post 0 1 u kg insulin,0.022373692946662457,0.07145313
68423-3,white blood cells count,monocyte leukocyte vitreous fluid manual count,0.022373692946662457,0.10594536
71625-8,white blood cells count,neutrophil leukocyte pure number fraction synovial fluid manual count,0.022373692946662457,0.12114828
48211-7,white blood cells count,beef triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10395576
54364-5,white blood cells count,calcium mole volume nonbiological fluid,0.022373692946662457,0.046691686
20441-2,white blood cells count,glucose mass volume serum plasma post 50 g glucose,0.022373692946662457,0.09551394
5549-1,white blood cells count,deprecated cd98 cell 100 cell blood,0.022373692946662457,0.097384125
96977-4,white blood cells count,noninvasive prenatal fetal aneuploidy panel plasma cell free wbc dna dosage chromosome specific cfdna,0.022373692946662457,0.08313933
40197-6,white blood cells count,glucose mole volume serum plasma 3 minute pre xxx challenge,0.022373692946662457,0.07195271
34546-2,white blood cells count,protein glucose panel mass volume cerebral spinal fluid,0.022373692946662457,0.05440027
40152-1,white blood cells count,glucose mole volume serum plasma 5 minute pre xxx challenge,0.022373692946662457,0.07233024
12611-0,white blood cells count,glucose mass volume serum plasma 4 hour specimen,0.022373692946662457,0.09704272
5476-7,white blood cells count,deprecated cd41 cell 100 cell blood,0.022373692946662457,0.10036756
45206-0,white blood cells count,glucose mass volume urine test strip 5th specimen post xxx challenge,0.022373692946662457,0.08511001
40277-6,white blood cells count,glucose mole volume serum plasma 1 hour post dose lactose po,0.022373692946662457,0.06698782
50342-5,white blood cells count,ependymal choroid plexus cell leukocyte ratio cerebral spinal fluid,0.022373692946662457,0.08945355
53306-7,white blood cells count,calcium oxalate crystal area urine computer assisted method,0.022373692946662457,0.005739427
48229-9,white blood cells count,dog epithelium triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09669205
9377-3,white blood cells count,glucose mass volume serum plasma 4 5 hour post 100 g glucose po,0.022373692946662457,0.08165393
48298-4,white blood cells count,pigweed triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10021491
48290-1,white blood cells count,sodium nitrite triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09303899
5516-0,white blood cells count,deprecated cd66a cell 100 cell blood,0.022373692946662457,0.0978301
10832-4,white blood cells count,glucose mass volume serum plasma 15 minute post 50 g lactose po,0.022373692946662457,0.078233086
51385-3,white blood cells count,plasma cell leukocyte cerebral spinal fluid manual count,0.022373692946662457,0.112113506
14375-0,white blood cells count,granulocyte leukocyte peritoneal fluid manual count,0.022373692946662457,0.11155239
54270-4,white blood cells count,glucose mole volume serum plasma 2 5 hour post dose ornithine alpha ketoglutarate,0.022373692946662457,0.06731231
14755-3,white blood cells count,glucose mole volume serum plasma 1 hour post 50 g lactose po,0.022373692946662457,0.076505594
12622-7,white blood cells count,glucose mass volume serum plasma 10th specimen post xxx challenge,0.022373692946662457,0.09025689
40002-8,white blood cells count,glucose mass volume serum plasma 80 minute post xxx challenge,0.022373692946662457,0.08547324
13717-4,white blood cells count,calcium creatinine mass ratio 24 hour urine,0.022373692946662457,0.041873775
97510-2,white blood cells count,glucose measurement range total glucose measurement reporting period,0.022373692946662457,0.051967796
26497-8,white blood cells count,mononuclear cell leukocyte synovial fluid,0.022373692946662457,0.09002468
54415-5,white blood cells count,transfuse leukocyte poor platelet unit,0.022373692946662457,0.08231174
71611-8,white blood cells count,leukocyte leukocyte pure number fraction pleural fluid manual count,0.022373692946662457,0.12427303
38251-5,white blood cells count,calcium oxalate mass time 24 hour urine,0.022373692946662457,0.023805737
30461-8,white blood cells count,granulocyte leukocyte stool,0.022373692946662457,0.077621266
16516-7,white blood cells count,calcium ionized mole volume serum plasma 6th specimen post xxx challenge,0.022373692946662457,0.07520807
20440-4,white blood cells count,glucose mass volume serum plasma 1 5 hour post dose glucose,0.022373692946662457,0.09020937
12244-0,white blood cells count,granulocyte leukocyte cerebral spinal fluid manual count,0.022373692946662457,0.11176809
75547-0,white blood cells count,noninvasive prenatal fetal aneuploidy microdeletion panel based plasma cell free wbc dna dosage chromosome specific circulating cell free ccf dna,0.022373692946662457,0.07982754
4523-7,white blood cells count,complement ic3b receptor entitic number leukocyte,0.022373692946662457,0.0861803
53328-1,white blood cells count,glucose mass volume urine automated test strip,0.022373692946662457,0.07583839
12654-0,white blood cells count,glucose mass volume serum plasma 10 minute post xxx challenge,0.022373692946662457,0.08996066
26452-3,white blood cells count,eosinophil leukocyte body fluid,0.022373692946662457,0.08518446
26540-5,white blood cells count,glucose mass volume urine 3 hour post dose glucose,0.022373692946662457,0.06848288
9321-1,white blood cells count,calcium creatinine mass ratio urine,0.022373692946662457,0.033479337
12646-6,white blood cells count,glucose mass volume serum plasma 1 hour post xxx challenge,0.022373692946662457,0.08686457
5799-2,white blood cells count,leukocyte esterase presence urine test strip,0.022373692946662457,0.063743785
62418-9,white blood cells count,glucose insulin ratio serum plasma,0.022373692946662457,0.0711493
13519-4,white blood cells count,basophil leukocyte cerebral spinal fluid manual count,0.022373692946662457,0.11130332
13354-6,white blood cells count,band form neutrophil leukocyte body fluid manual count,0.022373692946662457,0.11198407
20494-1,white blood cells count,deprecated lymphocyte 100 leukocyte body fluid manual count,0.022373692946662457,0.12335987
12659-9,white blood cells count,glucose mass volume serum plasma 70 minute post xxx challenge,0.022373692946662457,0.089904435
14765-2,white blood cells count,glucose mole volume serum plasma 3 hour post dose glucose,0.022373692946662457,0.08190099
26695-7,white blood cells count,glucose mass volume serum plasma 7th specimen post xxx challenge,0.022373692946662457,0.08678507
75565-2,white blood cells count,comment fetal trisomy 21 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.022373692946662457,0.08572541
16261-0,white blood cells count,calcium bilirubinate crystal presence stone infrared spectroscopy,0.022373692946662457,0.017974311
32807-0,white blood cells count,mononuclear cell leukocyte bronchial specimen,0.022373692946662457,0.08151973
54487-4,white blood cells count,glucose mole volume water,0.022373692946662457,0.055706847
56769-3,white blood cells count,lymphocyte leukocyte bronchial specimen flow cytometry fc,0.022373692946662457,0.088238835
12218-4,white blood cells count,glucose mass volume peritoneal fluid 2 hour post peritoneal dialysis,0.022373692946662457,0.06602569
56937-6,white blood cells count,hydrogen expired gas volume fraction exhaled gas 30 minute post dose glucose,0.022373692946662457,0.036119845
34907-6,white blood cells count,calcium mass volume corrected total protein serum plasma,0.022373692946662457,0.073806174
71596-1,white blood cells count,eosinophil leukocyte pure number fraction bronchial specimen manual count,0.022373692946662457,0.104499474
40219-8,white blood cells count,glucose mole volume serum plasma 30 hour post xxx challenge,0.022373692946662457,0.07483606
48187-9,white blood cells count,chloramin triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10172663
38254-9,white blood cells count,carbonated calcium phosphate presence stone,0.022373692946662457,0.0035214142
48606-8,white blood cells count,glucose mass volume serum plasma pre dose fructose po,0.022373692946662457,0.06981398
75579-3,white blood cells count,comment fetal 22q11 2 deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.022373692946662457,0.08153285
2005-7,white blood cells count,calcium mole time 2 hour urine 12 hour fasting,0.022373692946662457,0.04652951
27432-4,white blood cells count,glucose mass volume serum plasma 8th specimen post xxx challenge,0.022373692946662457,0.08721364
40205-7,white blood cells count,glucose mole volume serum plasma 14 minute post xxx challenge,0.022373692946662457,0.07658164
82877-2,white blood cells count,cytochrome component oxidase enzymatic activity mass leukocyte,0.022373692946662457,0.07646533
48279-4,white blood cells count,propyphenazone triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.097784236
25671-9,white blood cells count,glucose mole volume serum plasma 30 minute post xxx challenge,0.022373692946662457,0.08269376
1516-4,white blood cells count,glucose mass volume urine 2 hour post 100 g glucose po,0.022373692946662457,0.067173615
5412-2,white blood cells count,deprecated b b4 blood,0.022373692946662457,0.10002691
95223-4,white blood cells count,mononuclear cell leukocyte stem cell product manual count,0.022373692946662457,0.11816132
74542-2,white blood cells count,pyruvate kinase glucose 6 phosphate dehydrogenase enzymatic activity ratio red blood cell,0.022373692946662457,0.0676207
9047-2,white blood cells count,calcium intake 1 hour,0.022373692946662457,0.032175314
54251-4,white blood cells count,glucose mole volume serum plasma 20 minute post dose glucagon,0.022373692946662457,0.08343909
14418-8,white blood cells count,calcium mole volume synovial fluid,0.022373692946662457,0.054352403
5436-1,white blood cells count,deprecated cd15 cell 100 cell blood,0.022373692946662457,0.08731344
33768-3,white blood cells count,leukocyte clump volume urine automated count,0.022373692946662457,0.11495306
9051-4,white blood cells count,calcium intake mole time 24 hour,0.022373692946662457,0.03363122
12628-4,white blood cells count,glucose mass volume peritoneal dialysis fluid,0.022373692946662457,0.0720215
5531-9,white blood cells count,deprecated cd79b cell 100 cell blood,0.022373692946662457,0.100818925
32320-4,white blood cells count,glucose mole volume serum plasma 3 hour post 75 g glucose po,0.022373692946662457,0.07432094
48198-6,white blood cells count,amoxicillin triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10317763
11132-8,white blood cells count,deprecated bilirubin mass volume body fluid,0.022373692946662457,0.06326583
48234-9,white blood cells count,acarus siro triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.089664765
13606-9,white blood cells count,glucose mass volume serum plasma 3 hour post 50 g lactose po,0.022373692946662457,0.07973941
26519-9,white blood cells count,granulocyte leukocyte pleural fluid,0.022373692946662457,0.09476634
48292-7,white blood cells count,sodium salicylate triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.0928563
1536-2,white blood cells count,glucose mass volume serum plasma 45 minute post dose insulin iv,0.022373692946662457,0.076114595
1552-9,white blood cells count,glucose mass volume serum plasma pre 75 g glucose po,0.022373692946662457,0.077270605
50588-3,white blood cells count,glucose tolerance 5 hour panel serum plasma,0.022373692946662457,0.052585896
28544-5,white blood cells count,mesothelial cell leukocyte body fluid,0.022373692946662457,0.08945984
1534-7,white blood cells count,glucose mass volume serum plasma 3 minute post 0 5 g kg glucose iv,0.022373692946662457,0.08924821
2437-2,white blood cells count,hydrogen expired gas volume fraction exhaled gas post 50 g glucose po,0.022373692946662457,0.03788711
57391-5,white blood cells count,eosinophil leukocyte synovial fluid manual count,0.022373692946662457,0.09793902
62856-0,white blood cells count,phenx oral glucose tolerance test protocol 141001,0.022373692946662457,0.045925435
62442-9,white blood cells count,nucleated erythrocyte leukocyte ratio synovial fluid automated count,0.022373692946662457,0.12364982
95216-8,white blood cells count,eosinophil leukocyte stem cell product manual count,0.022373692946662457,0.111753166
16905-2,white blood cells count,glucose presence urine 2nd specimen post xxx challenge,0.022373692946662457,0.04358793
40492-1,white blood cells count,plasma cell leukocyte synovial fluid manual count,0.022373692946662457,0.11163541
1505-7,white blood cells count,glucose mass volume urine 1 hour post 50 g glucose po,0.022373692946662457,0.06687275
48259-6,white blood cells count,kentucky blue grass triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09875859
53480-0,white blood cells count,glucose mole volume serum plasma 2 5 hour post dose betaxolol,0.022373692946662457,0.08058951
88114-4,white blood cells count,leukocyte presence cerebral spinal fluid gram stain,0.022373692946662457,0.09489577
34984-5,white blood cells count,unidentified cell leukocyte synovial fluid,0.022373692946662457,0.08839893
63555-7,white blood cells count,leukocyte volume microscopy high power field urine sediment collected unspecified duration,0.022373692946662457,0.103797525
59795-5,white blood cells count,glucose molar concentration difference serum plasma 3 hour post xxx challenge,0.022373692946662457,0.07625909
53124-4,white blood cells count,calcium mole time 1 hour urine,0.022373692946662457,0.045040313
30416-2,white blood cells count,variant lymphocyte leukocyte cerebral spinal fluid,0.022373692946662457,0.07922906
97505-2,white blood cells count,glucose standard deviation calculated,0.022373692946662457,0.07036322
11123-7,white blood cells count,deprecated promyelocytes 100 cell bone marrow microscopy,0.022373692946662457,0.09507694
1973-7,white blood cells count,bilirubin total mass volume cerebral spinal fluid,0.022373692946662457,0.07733401
45056-9,white blood cells count,glucose mole volume serum plasma 8 pm specimen,0.022373692946662457,0.07769455
25705-5,white blood cells count,ketone presence urine 1 hour post 50 g glucose po,0.022373692946662457,0.03649268
11142-7,white blood cells count,glucose mass volume serum plasma 15 minute post 100 g glucose po,0.022373692946662457,0.08154294
812-8,white blood cells count,leukocyte volume semen manual count,0.022373692946662457,0.124639094
14762-9,white blood cells count,glucose mole volume serum plasma 30 minute post 50 g lactose po,0.022373692946662457,0.07750917
31996-2,white blood cells count,basophil leukocyte peritoneal fluid manual count,0.022373692946662457,0.11180898
30407-1,white blood cells count,leukocyte leukocyte pericardial fluid,0.022373692946662457,0.0833714
30396-6,white blood cells count,granulocyte leukocyte bronchial specimen,0.022373692946662457,0.07562027
30443-6,white blood cells count,mononuclear cell leukocyte gastric fluid,0.022373692946662457,0.08258885
58802-0,white blood cells count,mononuclear cell leukocyte peritoneal dialysis fluid,0.022373692946662457,0.08416238
47660-6,white blood cells count,insulin unit volume serum plasma 2 5 hour post dose glucose,0.022373692946662457,0.06805984
47587-1,white blood cells count,component peptide mole volume serum plasma 1 minute post dose glucose,0.022373692946662457,0.059625823
48288-5,white blood cells count,vecuronium triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.1073809
14756-1,white blood cells count,glucose mole volume serum plasma 1 hour post dose glucose,0.022373692946662457,0.08255052
48294-3,white blood cells count,food colorant mix triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.10183527
63372-7,white blood cells count,ketone presence urine test strip 3 hour post dose glucose,0.022373692946662457,0.042269543
75057-0,white blood cells count,sialidase enzymatic activity mass leukocyte,0.022373692946662457,0.074684665
30410-5,white blood cells count,leukocyte leukocyte synovial fluid,0.022373692946662457,0.08701604
40065-5,white blood cells count,calcium mass volume serum plasma 45 minute pre xxx challenge,0.022373692946662457,0.069104575
58781-6,white blood cells count,calcium mass volume peritoneal dialysis fluid,0.022373692946662457,0.048889875
33228-8,white blood cells count,wbc cast area urine computer assisted method,0.022373692946662457,0.06246069
35052-0,white blood cells count,leukocyte volume pleural fluid,0.022373692946662457,0.1174622
61153-3,white blood cells count,glucose mass volume peritoneal dialysis fluid baseline,0.022373692946662457,0.06122325
12633-4,white blood cells count,glucose mass volume peritoneal dialysis fluid 4th specimen,0.022373692946662457,0.07544677
95221-8,white blood cells count,metamyelocytes leukocyte stem cell product manual count,0.022373692946662457,0.11632637
74458-1,white blood cells count,large unstained cell leukocyte blood fetus automated count,0.022373692946662457,0.21240778
50724-4,white blood cells count,lymphoblast leukocyte bone marrow manual count,0.022373692946662457,0.1112768
21681-2,white blood cells count,g6pd gene mutation tested blood tissue molecular genetics method nominal,0.022373692946662457,0.1381307
21395-9,white blood cells count,monocyte macrophage leukocyte synovial fluid manual count,0.022373692946662457,0.11009199
74434-2,white blood cells count,bilirubin total total stone infrared spectroscopy,0.022373692946662457,0.037387468
26538-9,white blood cells count,glucose presence urine test strip 3 5 hour post dose glucose,0.022373692946662457,0.05111217
74244-5,white blood cells count,hedis 2014 value set glucose test,0.022373692946662457,0.041830815
54269-6,white blood cells count,glucose mole volume serum plasma 2 hour post dose ornithine alpha ketoglutarate,0.022373692946662457,0.06759507
99928-4,white blood cells count,leukocyte presence body fluid automated,0.022373692946662457,0.09434232
47771-1,white blood cells count,somatotropin unit volume serum plasma 3 hour post dose glucose po,0.022373692946662457,0.06698492
53487-5,white blood cells count,glucose mole volume serum plasma 1 5 hour post dose betaxolol,0.022373692946662457,0.07906122
5511-1,white blood cells count,deprecated cd62e cell 100 cell blood,0.022373692946662457,0.09766061
12658-1,white blood cells count,glucose mass volume serum plasma 50 minute post xxx challenge,0.022373692946662457,0.089829355
55495-6,white blood cells count,insulin mole volume serum plasma 45 minute post dose glucose iv,0.022373692946662457,0.061973963
86915-6,white blood cells count,calcium goal mass volume serum plasma,0.022373692946662457,0.06615243
74516-6,white blood cells count,calcium mole volume saliva oral fluid,0.022373692946662457,0.051064443
79469-3,white blood cells count,uridine diphosphate glucose 4 epimerase enzymatic activity mass red blood cell,0.022373692946662457,0.054614797
1504-0,white blood cells count,glucose mass volume serum plasma 1 hour post 50 g glucose po,0.022373692946662457,0.085819416
17863-2,white blood cells count,calcium ionized mass volume serum plasma,0.022373692946662457,0.07366838
47398-3,white blood cells count,beta mannosidase actual normal leukocyte,0.022373692946662457,0.08093969
5471-8,white blood cells count,deprecated cd39 cell 100 cell blood,0.022373692946662457,0.09362974
5434-6,white blood cells count,deprecated cd13 cell 100 cell blood,0.022373692946662457,0.0888599
34056-2,white blood cells count,glucose mole volume serum plasma pre post dose arginine,0.022373692946662457,0.059419446
5529-3,white blood cells count,deprecated cd77 cell 100 cell blood,0.022373692946662457,0.09310592
59148-7,white blood cells count,calcium mole volume serum plasma post dialysis,0.022373692946662457,0.06891374
29760-6,white blood cells count,bilirubin conjugated mole volume serum plasma,0.022373692946662457,0.08071957
57972-2,white blood cells count,glucose mass volume serum plasma 5th specimen post lactose,0.022373692946662457,0.07999441
95105-3,white blood cells count,glucose mass volume serum plasma 30 min post meal,0.022373692946662457,0.07190581
50589-1,white blood cells count,glucose tolerance 6 hour panel serum plasma,0.022373692946662457,0.05719508
105053-3,white blood cells count,calcium oxalate crystal presence urine sediment microscopy,0.022373692946662457,0.013540633
26522-3,white blood cells count,granulocyte leukocyte synovial fluid,0.022373692946662457,0.091443084
48973-2,white blood cells count,leukocyte presence stool methylene blue stain 2nd specimen,0.022373692946662457,0.08193442
54267-0,white blood cells count,glucose mole volume serum plasma 1 5 hour post dose insulin iv,0.022373692946662457,0.069027565
50586-7,white blood cells count,glucose tolerance 3 hour panel serum plasma,0.022373692946662457,0.054620598
71614-2,white blood cells count,monocyte leukocyte pure number fraction pleural fluid manual count,0.022373692946662457,0.12186183
12648-2,white blood cells count,glucose mass volume serum plasma 15 minute post dose lactose po,0.022373692946662457,0.073910885
25677-6,white blood cells count,glucose mole volume serum plasma 6 hour post dose glucose,0.022373692946662457,0.08387167
50183-3,white blood cells count,calcitonin mass volume serum plasma 1 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.022373692946662457,0.071185075
40158-8,white blood cells count,glucose mole volume serum plasma 50 minute post xxx challenge,0.022373692946662457,0.0758243
40202-4,white blood cells count,glucose mole volume serum plasma 8 minute post xxx challenge,0.022373692946662457,0.07630281
5495-7,white blood cells count,deprecated cd49e cell 100 cell blood,0.022373692946662457,0.1021771
5559-0,white blood cells count,rfd9 unit volume leukocyte,0.022373692946662457,0.10111799
40034-1,white blood cells count,glucose mass volume serum plasma 27 minute post xxx challenge,0.022373692946662457,0.079956904
94349-8,white blood cells count,voltage gated calcium channel p q type binding igg igm ab mole volume serum immunoassay,0.022373692946662457,0.039236236
92666-7,white blood cells count,growth hormone glucose post clonidine stimulation panel serum plasma,0.022373692946662457,0.039004788
40166-1,white blood cells count,glucose mole volume serum plasma 6 5 hour post xxx challenge,0.022373692946662457,0.07380804
24098-6,white blood cells count,n acetylglucosamine 6 sulfatase enzymatic activity mass leukocyte,0.022373692946662457,0.08517141
58568-7,white blood cells count,corticotropin mole volume plasma 2 5 hour post dose glucose,0.022373692946662457,0.05954888
48268-7,white blood cells count,minor determinant mixture triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.105415605
32177-8,white blood cells count,granulocyte leukocyte vaginal fluid,0.022373692946662457,0.08851974
14385-9,white blood cells count,mononuclear cell leukocyte gastric fluid manual count,0.022373692946662457,0.11005062
40263-6,white blood cells count,glucose mass volume serum plasma 30 minute post xxx challenge,0.022373692946662457,0.07975964
49966-5,white blood cells count,granulocyte leukocyte pericardial fluid manual count,0.022373692946662457,0.108540766
24075-4,white blood cells count,beta n acetylhexosaminidase enzymatic activity mass leukocyte,0.022373692946662457,0.07676564
54276-1,white blood cells count,glucose mole volume serum plasma 1 hour post dose ornithine alpha ketoglutarate,0.022373692946662457,0.06766
40220-6,white blood cells count,glucose mole volume serum plasma 31 hour post xxx challenge,0.022373692946662457,0.07531202
48284-4,white blood cells count,pancuronium triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.109928295
27862-2,white blood cells count,insulin unit volume serum plasma 4 hour post 75 g glucose po,0.022373692946662457,0.07107588
1495-1,white blood cells count,glucose mass volume urine 1 5 hour post 100 g glucose po,0.022373692946662457,0.070101246
33352-6,white blood cells count,glucose creatinine mass ratio urine,0.022373692946662457,0.04383741
68429-0,white blood cells count,leukocyte volume peritoneal fluid manual count,0.022373692946662457,0.13530065
30404-8,white blood cells count,leukocyte volume stool,0.022373692946662457,0.1092939
48607-6,white blood cells count,glucose mass volume serum plasma 30 minute post dose fructose po,0.022373692946662457,0.07493262
16517-5,white blood cells count,calcium ionized mole volume serum plasma 7th specimen post xxx challenge,0.022373692946662457,0.07354689
57797-3,white blood cells count,glucose mass volume stool post hydrolysis,0.022373692946662457,0.06026402
71641-5,white blood cells count,macrophage leukocyte pure number fraction body fluid manual count,0.022373692946662457,0.12244961
42629-6,white blood cells count,glucose mass volume urine 4 hour post dose lactose po,0.022373692946662457,0.06128928
26495-2,white blood cells count,mononuclear cell leukocyte peritoneal fluid,0.022373692946662457,0.08899514
27940-6,white blood cells count,deprecated insulin unit volume serum plasma 1 5 hour post 75 g glucose po,0.022373692946662457,0.0731304
77355-6,white blood cells count,non hematopoietic stem cell leukocyte body fluid manual count,0.022373692946662457,0.11884069
48291-9,white blood cells count,potassium metabisulfite triggered leukotriene release mass volume leukocyte,0.022373692946662457,0.09796029
24047-3,white blood cells count,alpha fucosidase enzymatic activity mass leukocyte,0.022373692946662457,0.087746926
15152-2,bilirubin in plasma,bilirubin conjugated mass volume serum plasma,0.9683545534905441,0.5888754
32303-0,bilirubin in plasma,bilirubin total mole volume specimen,0.9683545534905441,0.78951716
14424-6,bilirubin in plasma,bilirubin total mass volume gastric fluid,0.9683545534905441,0.7963963
14152-3,bilirubin in plasma,bilirubin direct mass volume body fluid,0.9683545534905441,0.47476116
89871-8,bilirubin in plasma,bilirubin total mole volume venous blood,0.9683545534905441,0.7839001
1968-7,bilirubin in plasma,bilirubin direct mass volume serum plasma,0.9683545534905441,0.5795989
97770-2,bilirubin in plasma,bilirubin total mole volume capillary blood,0.9683545534905441,0.7866891
1974-5,bilirubin in plasma,bilirubin total mass volume body fluid,0.9683545534905441,0.7950558
29210-2,bilirubin in plasma,bilirubin indirect mass volume body fluid,0.9683545534905441,0.47299352
39462-7,bilirubin in plasma,bilirubin conjugated mole volume body fluid,0.9683545534905441,0.4513553
70199-5,bilirubin in plasma,bilirubin total mole volume urine,0.9683545534905441,0.78064775
71669-6,bilirubin in plasma,blast leukocyte pure number fraction blood manual count,0.9683545534905441,0.09005003
78441-3,bilirubin in plasma,bilirubin conjugated mole volume peritoneal fluid,0.9683545534905441,0.45233002
48623-3,bilirubin in plasma,bilirubin direct mass volume cord blood,0.9683545534905441,0.46970794
33870-7,bilirubin in plasma,bilirubin total presence specimen,0.9683545534905441,0.7713787
53415-6,bilirubin in plasma,bilirubin total presence cerebral spinal fluid,0.9683545534905441,0.7693551
14420-4,bilirubin in plasma,bilirubin total mass volume dialysis fluid,0.9683545534905441,0.7950166
1970-3,bilirubin in plasma,bilirubin delta mass volume serum plasma,0.9683545534905441,0.5697516
72261-1,bilirubin in plasma,bilirubin excess mole volume serum csf,0.9683545534905441,0.4765115
29767-1,bilirubin in plasma,bilirubin total mole volume body fluid,0.9683545534905441,0.7880182
27198-1,bilirubin in plasma,bilirubin total unit volume amniotic fluid spectrophotometry direct,0.9683545534905441,0.8028012
71656-3,bilirubin in plasma,blast leukocyte pure number fraction cerebral spinal fluid manual count,0.9683545534905441,0.07287395
14423-8,bilirubin in plasma,bilirubin total mass volume synovial fluid,0.9683545534905441,0.79657656
33412-8,bilirubin in plasma,blast leukocyte pericardial fluid,0.7723225338997942,0.0743217
43428-2,bilirubin in plasma,bilirubin microscopic observation identifier tissue hall stain,0.7723225338997942,0.43869346
35192-4,bilirubin in plasma,bilirubin indirect mass mole volume serum plasma,0.7723225338997942,0.57394505
33374-0,bilirubin in plasma,blast leukocyte synovial fluid,0.7723225338997942,0.071119666
48211-7,bilirubin in plasma,beef triggered leukotriene release mass volume leukocyte,0.41079504811712947,0.076671846
48198-6,bilirubin in plasma,amoxicillin triggered leukotriene release mass volume leukocyte,0.41079504811712947,0.08554183
71675-3,bilirubin in plasma,basophil leukocyte pure number fraction blood manual count,0.41079504811712947,0.108345166
48220-8,bilirubin in plasma,oat triggered leukotriene release mass volume leukocyte,0.41079504811712947,0.07680888
71631-6,bilirubin in plasma,basophil leukocyte pure number fraction peritoneal fluid manual count,0.41079504811712947,0.10038531
48255-4,bilirubin in plasma,giant ragweed triggered leukotriene release mass volume leukocyte,0.41079504811712947,0.08297177
48186-1,bilirubin in plasma,amylase triggered leukotriene release mass volume leukocyte,0.41079504811712947,0.0793261
48203-4,bilirubin in plasma,celery triggered leukotriene release mass volume leukocyte,0.41079504811712947,0.07719028
32155-4,bilirubin in plasma,basophil eosinophil monocyte leukocyte blood automated count,0.21476302852637946,0.0937225
13520-2,bilirubin in plasma,deprecated basophil 100 leukocyte body fluid manual count,0.21476302852637946,0.09337985
24049-9,bilirubin in plasma,alpha galactosidase enzymatic activity mass leukocyte,0.21476302852637946,0.09275111
13519-4,bilirubin in plasma,basophil leukocyte cerebral spinal fluid manual count,0.21476302852637946,0.08798652
87543-5,bilirubin in plasma,beta n acetylhexosaminidase beta n acetylhexosaminidase reflex hexa gene panel enzymatic activity mass leukocyte,0.21476302852637946,0.05634401
21094-8,bilirubin in plasma,basophil leukocyte sputum manual count,0.21476302852637946,0.088357426
47550-9,bilirubin in plasma,adenosine deaminase entitic catalytic activity leukocyte,0.21476302852637946,0.082959406
69910-8,bilirubin in plasma,basophil mast cell leukocyte body fluid,0.21476302852637946,0.08038154
70219-1,bilirubin in plasma,basic metabolic 2008 panel ionized calcium serum plasma,0.21476302852637946,0.1650337
24071-3,bilirubin in plasma,beta n acetylhexosaminidase b beta n acetylhexosaminidase total leukocyte,0.21476302852637946,0.0618879
24073-9,bilirubin in plasma,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.21476302852637946,0.09314922
79451-1,bilirubin in plasma,adenosine deaminase enzymatic activity mass leukocyte,0.21476302852637946,0.08592267
69913-2,bilirubin in plasma,basophil mast cell leukocyte cerebral spinal fluid,0.21476302852637946,0.0765161
24068-9,bilirubin in plasma,beta mannosidase enzymatic activity mass leukocyte,0.21476302852637946,0.0947443
24065-5,bilirubin in plasma,beta glucuronidase enzymatic activity mass leukocyte,0.21476302852637946,0.09978358
38184-8,bilirubin in plasma,basophil leukocyte amniotic fluid manual count,0.21476302852637946,0.09577695
33653-7,bilirubin in plasma,beta galactosidase entitic catalytic activity leukocyte,0.21476302852637946,0.07809674
30375-0,bilirubin in plasma,basophil leukocyte sputum,0.21476302852637946,0.09228303
30180-4,bilirubin in plasma,basophil leukocyte blood,0.21476302852637946,0.10331238
24061-4,bilirubin in plasma,beta galactosidase enzymatic activity mass leukocyte,0.21476302852637946,0.09294906
40540-7,bilirubin in plasma,basophil leukocyte peritoneal dialysis fluid manual count,0.21476302852637946,0.08157181
28543-7,bilirubin in plasma,basophil leukocyte body fluid,0.21476302852637946,0.09203003
50839-0,bilirubin in plasma,calcium creatinine molar ratio 24 hour urine,0.15897530471866989,0.095177785
45389-4,bilirubin in plasma,calcium carbonate crystal area urine sediment microscopy low power field,0.15897530471866989,0.06351282
12512-0,bilirubin in plasma,calcium hydrogen phosphate dihydrate crystal presence urine sediment light microscopy,0.15897530471866989,0.06159346
9050-6,bilirubin in plasma,calcium intake 12 hour,0.11530662618133589,0.04962919
99898-9,bilirubin in plasma,calcium oxalate dihydrate crystal area urine sediment computer assisted method,0.11530662618133589,0.056690115
99897-1,bilirubin in plasma,calcium oxalate dihydrate crystal presence urine sediment computer assisted method,0.11530662618133589,0.05005127
61435-4,bilirubin in plasma,deprecated deprecated calcium intake daily protocol phenx,0.11530662618133589,0.046449114
48215-8,bilirubin in plasma,crab triggered leukotriene release mass volume leukocyte,0.11530662618133589,0.07600933
40067-1,bilirubin in plasma,calcium mass volume serum plasma baseline,0.11530662618133589,0.17538506
9051-4,bilirubin in plasma,calcium intake mole time 24 hour,0.11530662618133589,0.047935754
5775-2,bilirubin in plasma,calcium phosphate crystal presence urine sediment light microscopy,0.11530662618133589,0.058524862
99899-7,bilirubin in plasma,calcium oxalate dihydrate crystal volume urine sediment computer assisted method,0.11530662618133589,0.07356844
54366-0,bilirubin in plasma,calcium ionized mole volume adjusted ph 7 4 cord blood,0.11530662618133589,0.08355782
50838-2,bilirubin in plasma,calcium ionized mole volume adjusted ph 7 4 body fluid,0.11530662618133589,0.075195774
38251-5,bilirubin in plasma,calcium oxalate mass time 24 hour urine,0.11530662618133589,0.045821898
16512-6,bilirubin in plasma,calcium ionized mole volume serum plasma 2nd specimen post xxx challenge,0.11530662618133589,0.17475826
59473-9,bilirubin in plasma,calcium ionized mass volume adjusted ph 7 4 venous blood ion selective membrane electrode ise,0.11530662618133589,0.08543636
53296-0,bilirubin in plasma,calcium oxalate crystal volume urine computer assisted method,0.11530662618133589,0.07433538
13959-2,bilirubin in plasma,calcium ionized mole volume serum plasma calculation,0.11530662618133589,0.19317302
99894-8,bilirubin in plasma,calcium oxalate monohydrate crystal presence urine sediment computer assisted method,0.11530662618133589,0.050417956
46093-1,bilirubin in plasma,calcium ionized mole volume dialysis fluid,0.11530662618133589,0.072039455
32137-2,bilirubin in plasma,calcium phosphate total stone,0.11530662618133589,0.046853375
47836-2,bilirubin in plasma,deprecated carnitine acyltransferase enzymatic activity mass leukocyte,0.11530662618133589,0.0858822
49935-0,bilirubin in plasma,calcium ionized calcium total corrected albumin serum plasma,0.11530662618133589,0.16562796
13448-6,bilirubin in plasma,calcium osmolality ratio serum plasma,0.11530662618133589,0.18081768
32159-6,bilirubin in plasma,carbonated calcium phosphate total stone,0.11530662618133589,0.045399126
1380-5,bilirubin in plasma,calcium phosphate parathyroid challenge test mass ratio serum,0.11530662618133589,0.06431105
33234-6,bilirubin in plasma,calcium oxalate crystal presence urine computer assisted method,0.11530662618133589,0.05102818
38252-3,bilirubin in plasma,calcium oxalate monohydrate total stone,0.11530662618133589,0.047639035
105897-3,bilirubin in plasma,calcium oxalate crystal area urine,0.11530662618133589,0.053380948
45191-4,bilirubin in plasma,capn3 gene mutation found identifier blood tissue molecular genetics method nominal,0.11530662618133589,0.05194169
16513-4,bilirubin in plasma,calcium ionized mole volume serum plasma 3rd specimen post xxx challenge,0.11530662618133589,0.17444952
1373-0,bilirubin in plasma,calcitonin mass volume serum plasma 10 minute post 2 4 mg kg calcium short iv,0.09602630711180181,0.17230852
21643-2,bilirubin in plasma,cacna1s gene p arg1239his presence blood tissue molecular genetics method,0.09602630711180181,0.05029253
50181-7,bilirubin in plasma,calcitonin mass volume serum plasma 5 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.09602630711180181,0.16761431
94392-8,bilirubin in plasma,bordetella pertussis parapertussis bronchiseptica gida gene presence lower respiratory specimen naa probe detection,0.09602630711180181,0.04537433
57566-2,bilirubin in plasma,25 hydroxyvitamin d3 mole volume serum plasma pre dose calcium,0.09602630711180181,0.17517626
52041-1,bilirubin in plasma,blood glucose monitor attachment,0.09602630711180181,0.044375595
21645-7,bilirubin in plasma,cacna1s gene mutation tested blood tissue molecular genetics method nominal,0.09602630711180181,0.05137194
50179-1,bilirubin in plasma,calcitonin calcium pentagastrin challenge panel serum plasma,0.09602630711180181,0.15240504
2003-2,bilirubin in plasma,deprecated calcium,0.052357628574467824,0.044187725
18488-7,bilirubin in plasma,calcium mass volume 24 hour urine,0.052357628574467824,0.07001871
50836-6,bilirubin in plasma,calcium mole mass hair,0.052357628574467824,0.043505322
35675-8,bilirubin in plasma,calcium mass volume urine collected unspecified duration,0.052357628574467824,0.06262031
40084-6,bilirubin in plasma,calcium mass volume serum plasma 36 hour post xxx challenge,0.052357628574467824,0.17447992
16520-9,bilirubin in plasma,calcium mole volume urine 2nd specimen post xxx challenge,0.052357628574467824,0.0604235
16271-9,bilirubin in plasma,calcium mass volume serum plasma 30 minute post xxx challenge,0.052357628574467824,0.17342219
42593-4,bilirubin in plasma,calcium mole volume capillary blood,0.052357628574467824,0.07366279
40073-9,bilirubin in plasma,calcium mass volume serum plasma 5 hour post xxx challenge,0.052357628574467824,0.17364162
40068-9,bilirubin in plasma,calcium mass volume serum plasma 45 minute post xxx challenge,0.052357628574467824,0.17205215
9467-2,bilirubin in plasma,calcium mass volume water,0.052357628574467824,0.04728395
40243-8,bilirubin in plasma,calcium mole volume serum plasma 20 hour post xxx challenge,0.052357628574467824,0.17214753
16270-1,bilirubin in plasma,calcium mass volume serum plasma 1 hour post xxx challenge,0.052357628574467824,0.17649542
33791-5,bilirubin in plasma,calcium mole volume urine 5th specimen post xxx challenge,0.052357628574467824,0.061113086
29276-3,bilirubin in plasma,calcium presence urine,0.052357628574467824,0.052604612
27916-6,bilirubin in plasma,calcium mass volume serum plasma 2nd specimen post xxx challenge,0.052357628574467824,0.17491436
18186-7,bilirubin in plasma,calcium mass time 12 hour urine,0.052357628574467824,0.061408564
40245-3,bilirubin in plasma,calcium mole volume serum plasma 36 hour post xxx challenge,0.052357628574467824,0.17304486
40074-7,bilirubin in plasma,calcium mass volume serum plasma 6 hour post xxx challenge,0.052357628574467824,0.17637952
12511-2,bilirubin in plasma,calcium mass volume 4 hour urine,0.052357628574467824,0.07506185
40241-2,bilirubin in plasma,calcium mole volume serum plasma 14 hour post xxx challenge,0.052357628574467824,0.17391956
40075-4,bilirubin in plasma,calcium mass volume serum plasma 6 5 hour post xxx challenge,0.052357628574467824,0.17594549
40237-0,bilirubin in plasma,calcium mole volume serum plasma 7 5 hour post xxx challenge,0.052357628574467824,0.1765209
27919-0,bilirubin in plasma,calcium mass volume serum plasma 3rd specimen post xxx challenge,0.052357628574467824,0.17465846
40239-6,bilirubin in plasma,calcium mole volume serum plasma 12 hour post xxx challenge,0.052357628574467824,0.17322107
2002-4,bilirubin in plasma,calcium mole volume stool,0.052357628574467824,0.05720171
40246-1,bilirubin in plasma,calcium mole volume serum plasma 2 day post xxx challenge,0.052357628574467824,0.17318791
87477-6,bilirubin in plasma,calcium specimen,0.052357628574467824,0.050122965
40079-6,bilirubin in plasma,calcium mass volume serum plasma 13 hour post xxx challenge,0.052357628574467824,0.17410508
40232-1,bilirubin in plasma,calcium mole volume serum plasma 2 5 hour post xxx challenge,0.052357628574467824,0.17295024
48299-2,bilirubin in plasma,new coccine triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08180526
40002-8,bilirubin in plasma,glucose mass volume serum plasma 80 minute post xxx challenge,0.0521123130818648,0.17911541
75585-0,bilirubin in plasma,comment fetal prader willi syndrome risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.14253446
54255-5,bilirubin in plasma,glucose mole volume serum plasma 6 minute post dose glucagon,0.0521123130818648,0.17636812
48284-4,bilirubin in plasma,pancuronium triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08985836
50215-3,bilirubin in plasma,glucose mass volume serum plasma 5th specimen,0.0521123130818648,0.19454736
55507-8,bilirubin in plasma,somatotropin mass volume serum plasma 2 hour post dose glucose,0.0521123130818648,0.15846543
71609-2,bilirubin in plasma,macrophage leukocyte pure number fraction pleural fluid manual count,0.0521123130818648,0.07496335
16912-8,bilirubin in plasma,glucose presence urine 9th specimen post xxx challenge,0.0521123130818648,0.04785218
12627-6,bilirubin in plasma,glucose mass volume serum plasma 15th specimen post xxx challenge,0.0521123130818648,0.18465778
4659-9,bilirubin in plasma,leukocyte phosphatase enzymatic activity volume leukocyte,0.0521123130818648,0.10293679
47275-3,bilirubin in plasma,s100 calcium binding protein b mass volume serum,0.0521123130818648,0.07771569
20408-1,bilirubin in plasma,leukocyte volume urine test strip,0.0521123130818648,0.095052905
6747-0,bilirubin in plasma,glucose presence urine test strip 1 hour post 50 g lactose po,0.0521123130818648,0.05510125
54274-6,bilirubin in plasma,glucose mole volume serum plasma 30 minute post dose ornithine alpha ketoglutarate,0.0521123130818648,0.18071713
18342-6,bilirubin in plasma,glucose mass volume serum plasma 3 hour post xxx challenge,0.0521123130818648,0.17976099
30120-0,bilirubin in plasma,igd lymphocyte volume leukocyte,0.0521123130818648,0.06870681
29331-6,bilirubin in plasma,glucose mass volume serum plasma 5 hour post xxx challenge,0.0521123130818648,0.18162753
26547-0,bilirubin in plasma,glucose presence urine test strip 2 hour post dose glucose,0.0521123130818648,0.058686484
806-0,bilirubin in plasma,leukocyte volume cerebral spinal fluid manual count,0.0521123130818648,0.08137365
40280-0,bilirubin in plasma,glucose mole volume serum plasma 3 hour post dose lactose po,0.0521123130818648,0.17676982
2186-5,bilirubin in plasma,cytochrome component oxidase enzymatic activity volume leukocyte,0.0521123130818648,0.08841199
40005-1,bilirubin in plasma,glucose mass volume serum plasma 110 minute post xxx challenge,0.0521123130818648,0.17989796
48206-7,bilirubin in plasma,lactalbumin alpha triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08946377
46090-7,bilirubin in plasma,leukocyte volume cerebral spinal fluid 4th tube,0.0521123130818648,0.08901061
92819-2,bilirubin in plasma,glucose mass volume serum plasma 10 minute post dose glucagon,0.0521123130818648,0.17639112
813-6,bilirubin in plasma,leukocyte volume synovial fluid automated count,0.0521123130818648,0.092592254
40169-5,bilirubin in plasma,glucose mole volume serum plasma 8 hour post xxx challenge,0.0521123130818648,0.17382342
75551-2,bilirubin in plasma,fetal trisomy 13 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.15128586
27861-4,bilirubin in plasma,insulin unit volume serum plasma 3 hour post 75 g glucose po,0.0521123130818648,0.16658388
76670-9,bilirubin in plasma,glucose mole volume cerebral spinal fluid 2nd tube,0.0521123130818648,0.074779145
74802-0,bilirubin in plasma,glucose challenge hydrogen breath test interpretation exhaled gas,0.0521123130818648,0.05125542
18228-7,bilirubin in plasma,glucose 6 phosphate dehydrogenase presence tissue,0.0521123130818648,0.05507597
71597-9,bilirubin in plasma,lymphocyte leukocyte pure number fraction bronchial specimen manual count,0.0521123130818648,0.06952286
68545-3,bilirubin in plasma,nucleated erythrocyte leukocyte ratio synovial fluid,0.0521123130818648,0.076850116
40203-2,bilirubin in plasma,glucose mole volume serum plasma 9 minute post xxx challenge,0.0521123130818648,0.17583118
1491-0,bilirubin in plasma,glucose mass volume urine 30 minute post 100 g glucose po,0.0521123130818648,0.06679436
30267-9,bilirubin in plasma,glucose mole volume serum plasma 2 3 hour post dose glucose,0.0521123130818648,0.17971085
40030-9,bilirubin in plasma,glucose mass volume serum plasma 16 minute post xxx challenge,0.0521123130818648,0.1766511
32761-9,bilirubin in plasma,leukocyte presence specimen wet preparation,0.0521123130818648,0.06918304
55479-0,bilirubin in plasma,insulin mole volume serum plasma 7 minute post dose glucose iv,0.0521123130818648,0.18414888
48297-6,bilirubin in plasma,chromotrope 2b triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08071549
40168-7,bilirubin in plasma,glucose mole volume serum plasma 7 5 hour post xxx challenge,0.0521123130818648,0.17524451
95106-1,bilirubin in plasma,glucose mass volume serum plasma 3 hour post meal,0.0521123130818648,0.17131594
40004-4,bilirubin in plasma,glucose mass volume serum plasma 100 minute post xxx challenge,0.0521123130818648,0.17814326
50216-1,bilirubin in plasma,glucose mass volume serum plasma 6th specimen,0.0521123130818648,0.19480886
75561-1,bilirubin in plasma,fetal trisomy 21 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.0521123130818648,0.15057306
5565-7,bilirubin in plasma,terminal deoxyribonucleotidyl transferase unit volume leukocyte,0.0521123130818648,0.08629033
40001-0,bilirubin in plasma,glucose mass volume serum plasma 5 minute post xxx challenge,0.0521123130818648,0.17818257
40166-1,bilirubin in plasma,glucose mole volume serum plasma 6 5 hour post xxx challenge,0.0521123130818648,0.1754754
48187-9,bilirubin in plasma,chloramin triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08907305
94348-0,bilirubin in plasma,voltage gated calcium channel n type binding igg igm ab mole volume serum immunoassay,0.0521123130818648,0.081453495
100795-4,bilirubin in plasma,s100 calcium binding protein b mass volume body fluid,0.0521123130818648,0.05600122
53114-5,bilirubin in plasma,fasting glucose mole volume urine,0.0521123130818648,0.06386991
48302-4,bilirubin in plasma,indigo carmine triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08315411
48230-7,bilirubin in plasma,cat dander triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.07481948
54248-0,bilirubin in plasma,glucose mole volume serum plasma 10 minute pre dose glucagon,0.0521123130818648,0.17656213
71619-1,bilirubin in plasma,mononuclear cell leukocyte pure number fraction synovial fluid manual count,0.0521123130818648,0.07843152
48268-7,bilirubin in plasma,minor determinant mixture triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.089199096
10966-0,bilirubin in plasma,glucose presence urine test strip 2 5 hour post 75 g glucose po,0.0521123130818648,0.05922902
40163-8,bilirubin in plasma,glucose mole volume serum plasma 4 hour post xxx challenge,0.0521123130818648,0.17466916
53316-6,bilirubin in plasma,leukocyte presence urine automated,0.0521123130818648,0.059053242
75596-7,bilirubin in plasma,fetal 5p deletion risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.0521123130818648,0.14366284
25666-9,bilirubin in plasma,glucose mole volume serum plasma 2 5 hour post dose glucose,0.0521123130818648,0.17557107
2353-1,bilirubin in plasma,glucose phosphate isomerase enzymatic activity volume serum,0.0521123130818648,0.11037289
40153-9,bilirubin in plasma,glucose mole volume serum plasma 5 minute post xxx challenge,0.0521123130818648,0.17084046
30405-5,bilirubin in plasma,leukocyte volume urine,0.0521123130818648,0.08455303
98020-1,bilirubin in plasma,leukocyte volume lower respiratory specimen manual count,0.0521123130818648,0.082016684
26779-9,bilirubin in plasma,glucose mass volume serum plasma 1 5 hour post dose lactose po,0.0521123130818648,0.17508703
26540-5,bilirubin in plasma,glucose mass volume urine 3 hour post dose glucose,0.0521123130818648,0.07299993
104877-6,bilirubin in plasma,hematocrit volume fraction blood 1 5 hour post dose glucose,0.0521123130818648,0.09402474
14811-4,bilirubin in plasma,leukocyte volume pericardial fluid manual count,0.0521123130818648,0.0993262
32782-5,bilirubin in plasma,leukocyte esterase nitrite presence urine test strip,0.0521123130818648,0.063286684
59814-4,bilirubin in plasma,glucose mole volume serum plasma 7 specimen,0.0521123130818648,0.18113382
1514-9,bilirubin in plasma,glucose mass volume serum plasma 2 hour post 100 g glucose po,0.0521123130818648,0.17925093
25664-4,bilirubin in plasma,glucose mass volume urine 1 hour post dose glucose,0.0521123130818648,0.0670678
20439-6,bilirubin in plasma,glucose mass volume serum plasma 30 minute post dose glucose,0.0521123130818648,0.18168263
71666-2,bilirubin in plasma,promyelocytes leukocyte pure number fraction blood manual count,0.0521123130818648,0.09362746
72604-2,bilirubin in plasma,insulin unit volume serum plasma 4 5 hour post 75 g glucose po,0.0521123130818648,0.16973384
16907-8,bilirubin in plasma,glucose presence urine 4th specimen post xxx challenge,0.0521123130818648,0.05048288
46406-5,bilirubin in plasma,somatotropin mass volume serum plasma 30 minute post 1 g kg glucose po,0.0521123130818648,0.15562966
40294-1,bilirubin in plasma,insulin mole volume serum plasma pre post dose glucose,0.0521123130818648,0.18007948
47761-2,bilirubin in plasma,somatotropin unit volume serum plasma 1 hour post dose glucose po,0.0521123130818648,0.15998814
40259-4,bilirubin in plasma,glucose mass volume serum plasma 10 5 hour post xxx challenge,0.0521123130818648,0.1813578
26778-1,bilirubin in plasma,glucose mass volume serum plasma 1 hour post dose lactose po,0.0521123130818648,0.17427139
1498-5,bilirubin in plasma,glucose mass volume serum plasma 10 minute post 0 5 g kg glucose iv,0.0521123130818648,0.17999162
48253-9,bilirubin in plasma,english plantain triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.07775954
48281-0,bilirubin in plasma,sulfamethoxazole triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.081225224
6759-5,bilirubin in plasma,glucose presence urine test strip 6 hour post 75 g glucose po,0.0521123130818648,0.055105463
34689-0,bilirubin in plasma,sulfatidase enzymatic activity volume leukocyte,0.0521123130818648,0.085320115
57350-1,bilirubin in plasma,glucose mass volume serum plasma 1 minute post xxx challenge,0.0521123130818648,0.1814748
1550-3,bilirubin in plasma,glucose mass volume serum plasma pre 12 hour fast,0.0521123130818648,0.17931764
54250-6,bilirubin in plasma,glucose mole volume serum plasma 15 minute pre dose glucagon,0.0521123130818648,0.17648588
21309-0,bilirubin in plasma,glucose mass volume serum plasma 45 minute post xxx challenge,0.0521123130818648,0.17640866
71618-3,bilirubin in plasma,macrophage leukocyte pure number fraction synovial fluid manual count,0.0521123130818648,0.0795284
1512-3,bilirubin in plasma,glucose mass volume serum plasma 1 minute post 0 5 g kg glucose iv,0.0521123130818648,0.18249854
27860-6,bilirubin in plasma,insulin unit volume serum plasma 2 hour post 75 g glucose po,0.0521123130818648,0.16732001
48984-9,bilirubin in plasma,glucose mass volume serum plasma 10 minute post dose glucose,0.0521123130818648,0.17864388
105102-8,bilirubin in plasma,leukocyte clump volume urine,0.0521123130818648,0.08806961
46405-7,bilirubin in plasma,somatotropin mass volume serum plasma 30 minute pre 1 g kg glucose po,0.0521123130818648,0.15656328
12657-3,bilirubin in plasma,glucose mass volume serum plasma 40 minute post xxx challenge,0.0521123130818648,0.18325561
50218-7,bilirubin in plasma,glucose mass volume serum plasma 9th specimen,0.0521123130818648,0.1921401
13351-2,bilirubin in plasma,leukocyte volume cerebral spinal fluid manual count,0.0521123130818648,0.09247235
105921-1,bilirubin in plasma,leukocyte volume urethra wet preparation,0.0521123130818648,0.07855425
75594-2,bilirubin in plasma,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.0521123130818648,0.14585115
88365-2,bilirubin in plasma,glucose mass volume blood pre meal,0.0521123130818648,0.08155468
2349-9,bilirubin in plasma,glucose presence urine,0.0521123130818648,0.0547874
6883-3,bilirubin in plasma,glucose protein bound mass volume serum plasma,0.0521123130818648,0.19272526
61182-2,bilirubin in plasma,leukocyte volume corrected nucleated erythrocyte blood fetus,0.0521123130818648,0.10321258
10968-6,bilirubin in plasma,glucose presence urine test strip 4 5 hour post 75 g glucose po,0.0521123130818648,0.05746134
68431-6,bilirubin in plasma,leukocyte volume synovial fluid manual count,0.0521123130818648,0.08690801
75597-5,bilirubin in plasma,comment fetal 5p deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.13496104
21680-4,bilirubin in plasma,g6pd gene mutation found identifier blood tissue molecular genetics method nominal,0.0521123130818648,0.045531947
48271-1,bilirubin in plasma,tetracycline triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08106001
1630-3,bilirubin in plasma,somatotropin mass volume serum plasma 2 hour post 1 g kg glucose po,0.0521123130818648,0.155072
40222-2,bilirubin in plasma,glucose mole volume serum plasma 2 day post xxx challenge,0.0521123130818648,0.17676167
33765-9,bilirubin in plasma,leukocyte volume blood product unit platelet pheresis automated count,0.0521123130818648,0.100665174
71665-4,bilirubin in plasma,variant lymphocyte leukocyte pure number fraction blood manual count,0.0521123130818648,0.08267477
12636-7,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 7th specimen,0.0521123130818648,0.0833743
14770-2,bilirubin in plasma,fasting glucose mole volume capillary blood glucometer,0.0521123130818648,0.07823322
807-8,bilirubin in plasma,leukocyte volume pleural fluid automated count,0.0521123130818648,0.087183185
12637-5,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 8th specimen post xxx challenge,0.0521123130818648,0.07090942
40016-8,bilirubin in plasma,glucose mass volume serum plasma 18 hour post xxx challenge,0.0521123130818648,0.17933166
27353-2,bilirubin in plasma,glucose mean value mass volume blood estimated glycated hemoglobin,0.0521123130818648,0.107989326
12646-6,bilirubin in plasma,glucose mass volume serum plasma 1 hour post xxx challenge,0.0521123130818648,0.1856816
47666-3,bilirubin in plasma,insulin unit volume serum plasma 5 minute pre dose glucose,0.0521123130818648,0.17036071
1553-7,bilirubin in plasma,glucose mass volume serum plasma pre dose insulin iv,0.0521123130818648,0.18112111
75590-0,bilirubin in plasma,fetal angelman syndrome risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.0521123130818648,0.1509517
62440-3,bilirubin in plasma,nucleated erythrocyte leukocyte ratio body fluid automated count,0.0521123130818648,0.07217304
58596-8,bilirubin in plasma,corticotropin mass volume plasma 3 hour post dose glucose,0.0521123130818648,0.24046844
2800-1,bilirubin in plasma,deprecated glucose phosphate isomerase enzymatic activity volume serum,0.0521123130818648,0.100200064
16913-6,bilirubin in plasma,fasting glucose presence urine,0.0521123130818648,0.04692742
6777-7,bilirubin in plasma,deprecated glucose mass volume serum plasma,0.0521123130818648,0.1728521
32825-2,bilirubin in plasma,leukocyte presence semen,0.0521123130818648,0.06549724
62239-9,bilirubin in plasma,leukocyte volume blood fetus automated count,0.0521123130818648,0.099168174
35054-6,bilirubin in plasma,leukocyte volume peritoneal fluid,0.0521123130818648,0.10532071
55352-9,bilirubin in plasma,glucose mole volume serum plasma 45 minute post 75 g glucose po,0.0521123130818648,0.17306095
9307-0,bilirubin in plasma,insulin mass volume serum plasma 30 minute post 75 g glucose po,0.0521123130818648,0.1545647
40007-7,bilirubin in plasma,glucose mass volume serum plasma 9 5 hour post xxx challenge,0.0521123130818648,0.179832
30404-8,bilirubin in plasma,leukocyte volume stool,0.0521123130818648,0.08344641
58413-6,bilirubin in plasma,nucleated erythrocyte leukocyte ratio blood automated count,0.0521123130818648,0.085907616
46222-6,bilirubin in plasma,glucose mole volume dialysis fluid 4 hour specimen,0.0521123130818648,0.0693928
40019-2,bilirubin in plasma,glucose mass volume serum plasma 20 hour post xxx challenge,0.0521123130818648,0.17872158
39479-1,bilirubin in plasma,glucose mole volume pericardial fluid,0.0521123130818648,0.070751734
25673-5,bilirubin in plasma,glucose mole volume serum plasma 45 minute post dose glucose,0.0521123130818648,0.17527235
54253-0,bilirubin in plasma,glucose mole volume serum plasma 4 minute post dose glucagon,0.0521123130818648,0.1757822
6291-9,bilirubin in plasma,complement ic3b receptor presence leukocyte,0.0521123130818648,0.076901086
16994-6,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas 5 hour post dose glucose,0.0521123130818648,0.06317645
53484-2,bilirubin in plasma,glucose mole volume serum plasma 30 minute pre dose betaxolol,0.0521123130818648,0.18522532
13608-5,bilirubin in plasma,insulin mass volume serum plasma 1 5 hour post 75 g glucose po,0.0521123130818648,0.15988474
47274-6,bilirubin in plasma,s100 calcium binding protein b mass volume cerebral spinal fluid,0.0521123130818648,0.05630664
44716-9,bilirubin in plasma,creatinine calcium mass ratio urine,0.0521123130818648,0.06859133
72649-7,bilirubin in plasma,glucose serum glucose peritoneal fluid molar concentration difference,0.0521123130818648,0.18189158
12724-1,bilirubin in plasma,voltage gated calcium channel igg ab unit volume serum,0.0521123130818648,0.09279566
50404-3,bilirubin in plasma,cell leukocyte identifier synovial fluid,0.0521123130818648,0.06466503
40018-4,bilirubin in plasma,glucose mass volume serum plasma 19 5 hour post xxx challenge,0.0521123130818648,0.17825384
50672-5,bilirubin in plasma,leukocyte toxic vacuole presence blood light microscopy,0.0521123130818648,0.10109893
16165-3,bilirubin in plasma,glucose mass volume serum plasma 10 specimen,0.0521123130818648,0.18405454
40193-5,bilirubin in plasma,glucose mole volume serum plasma pre meal,0.0521123130818648,0.17138928
97507-8,bilirubin in plasma,average glucose mass volume interstitial fluid reporting period,0.0521123130818648,0.08476121
12609-4,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 4 hour dwell specimen,0.0521123130818648,0.07064613
33768-3,bilirubin in plasma,leukocyte clump volume urine automated count,0.0521123130818648,0.09225547
56937-6,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas 30 minute post dose glucose,0.0521123130818648,0.06543266
51767-2,bilirubin in plasma,glucose mass volume serum plasma 1 5 hour post dose fructose po,0.0521123130818648,0.18108526
58528-1,bilirubin in plasma,corticotropin mass volume plasma 1 5 hour post dose glucose,0.0521123130818648,0.24284387
40165-3,bilirubin in plasma,glucose mole volume serum plasma 6 hour post xxx challenge,0.0521123130818648,0.17573814
6748-8,bilirubin in plasma,glucose presence urine test strip 1 hour post 75 g glucose po,0.0521123130818648,0.053375077
11156-7,bilirubin in plasma,leukocyte morphology finding identifier blood,0.0521123130818648,0.07864618
99775-9,bilirubin in plasma,leukocyte volume peritoneal dialysis fluid automated count,0.0521123130818648,0.081537485
47663-0,bilirubin in plasma,insulin unit volume serum plasma 30 minute post dose glucose,0.0521123130818648,0.1716945
1531-3,bilirubin in plasma,deprecated glucose mass volume serum plasma 3 hour post 100 g glucose po,0.0521123130818648,0.068572536
2357-2,bilirubin in plasma,glucose 6 phosphate dehydrogenase enzymatic activity volume red blood cell,0.0521123130818648,0.113779515
20584-9,bilirubin in plasma,leukocyte volume specimen automated count,0.0521123130818648,0.075481646
48191-1,bilirubin in plasma,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08212077
47589-7,bilirubin in plasma,component peptide mole volume serum plasma 30 minute post dose glucose,0.0521123130818648,0.17100962
13865-1,bilirubin in plasma,glucose mass volume serum plasma 2 5 hour post 50 g lactose po,0.0521123130818648,0.18434726
50206-2,bilirubin in plasma,glucose mass volume serum plasma 1st specimen,0.0521123130818648,0.19282568
53553-4,bilirubin in plasma,glucose mean value mole volume blood estimated glycated hemoglobin,0.0521123130818648,0.10721623
812-8,bilirubin in plasma,leukocyte volume semen manual count,0.0521123130818648,0.085848354
75595-9,bilirubin in plasma,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.14352767
14761-1,bilirubin in plasma,glucose mole volume serum plasma 2 hour post meal,0.0521123130818648,0.17811826
48192-9,bilirubin in plasma,sunset yellow fcf triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08792602
15075-5,bilirubin in plasma,glucose mole volume dialysis fluid,0.0521123130818648,0.07429891
40217-2,bilirubin in plasma,glucose mole volume serum plasma 28 hour post xxx challenge,0.0521123130818648,0.17943464
1568-5,bilirubin in plasma,insulin mass volume serum plasma 4 hour post 75 g glucose po,0.0521123130818648,0.15467763
6750-4,bilirubin in plasma,glucose presence urine test strip 2 hour post 50 g lactose po,0.0521123130818648,0.054072537
12641-7,bilirubin in plasma,glucose mass volume serum plasma 7 hour post xxx challenge,0.0521123130818648,0.18636145
55351-1,bilirubin in plasma,glucose mole volume serum plasma 1 5 hour post 75 g glucose po,0.0521123130818648,0.17422125
1523-0,bilirubin in plasma,glucose mass volume serum plasma 30 minute post 0 05 0 15 u insulin kg iv post 12h cfst,0.0521123130818648,0.18128072
68433-2,bilirubin in plasma,leukocyte volume vitreous fluid manual count,0.0521123130818648,0.09482028
95078-2,bilirubin in plasma,glucose mass volume serum plasma 15 min post meal,0.0521123130818648,0.17319523
40179-4,bilirubin in plasma,glucose mole volume serum plasma 13 5 hour post xxx challenge,0.0521123130818648,0.17137256
1513-1,bilirubin in plasma,glucose mass volume serum plasma 20 minute post 0 5 g kg glucose iv,0.0521123130818648,0.18011567
14328-9,bilirubin in plasma,leukocyte presence sputum light microscopy,0.0521123130818648,0.07726384
48196-0,bilirubin in plasma,cephalosporin component triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.07497807
1549-5,bilirubin in plasma,glucose mass volume serum plasma pre 100 g glucose po,0.0521123130818648,0.18081935
48988-0,bilirubin in plasma,glucose mass volume serum plasma 12 pm specimen,0.0521123130818648,0.18070358
48236-4,bilirubin in plasma,european house dust mite triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.067823276
102032-0,bilirubin in plasma,glucose mass volume serum plasma 2 hour post dose insulin iv,0.0521123130818648,0.18029359
6758-7,bilirubin in plasma,glucose presence urine test strip 5 hour post 75 g glucose po,0.0521123130818648,0.054284785
33405-2,bilirubin in plasma,glucose mass volume pericardial fluid,0.0521123130818648,0.072845146
59815-1,bilirubin in plasma,glucose mole volume serum plasma 3 pm specimen,0.0521123130818648,0.17994514
94704-4,bilirubin in plasma,voltage gated calcium channel n type binding ab mole volume serum immunoassay,0.0521123130818648,0.08767115
55498-0,bilirubin in plasma,insulin mole volume serum plasma 7 minute pre dose glucose,0.0521123130818648,0.18186243
26467-1,bilirubin in plasma,leukocyte volume pleural fluid,0.0521123130818648,0.09146947
16996-1,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas pre dose glucose,0.0521123130818648,0.066489
46223-4,bilirubin in plasma,glucose mole volume dialysis fluid overnight,0.0521123130818648,0.071005635
27297-1,bilirubin in plasma,leukocyte esterase unit volume urine,0.0521123130818648,0.06680299
45056-9,bilirubin in plasma,glucose mole volume serum plasma 8 pm specimen,0.0521123130818648,0.17837444
26542-1,bilirubin in plasma,glucose mass volume urine 5 hour post dose glucose,0.0521123130818648,0.07347837
25706-3,bilirubin in plasma,ketone mass volume urine test strip 2 hour post dose glucose,0.0521123130818648,0.08474221
48036-8,bilirubin in plasma,glucose mass volume stool,0.0521123130818648,0.06564781
49688-5,bilirubin in plasma,glucose tolerance interpretation serum plasma narrative post 75 g glucose po,0.0521123130818648,0.15295318
20406-5,bilirubin in plasma,deprecated glucose mass volume urine test strip,0.0521123130818648,0.06423639
97778-5,bilirubin in plasma,glucose mole volume dialysis fluid 1 hour specimen,0.0521123130818648,0.07003445
53485-9,bilirubin in plasma,glucose mole volume serum plasma 45 minute post dose betaxolol,0.0521123130818648,0.18221633
40211-5,bilirubin in plasma,glucose mole volume serum plasma 3 5 hour post xxx challenge,0.0521123130818648,0.17795292
2346-5,bilirubin in plasma,glucose mass volume pleural fluid,0.0521123130818648,0.06953874
13606-9,bilirubin in plasma,glucose mass volume serum plasma 3 hour post 50 g lactose po,0.0521123130818648,0.18157566
6300-8,bilirubin in plasma,glucose mass volume amniotic fluid,0.0521123130818648,0.084022515
16915-1,bilirubin in plasma,glucose mass volume serum plasma post meal,0.0521123130818648,0.17042266
71678-7,bilirubin in plasma,lymphocyte leukocyte pure number fraction blood automated count,0.0521123130818648,0.08317967
40875-7,bilirubin in plasma,glucose mass volume specimen 3rd specimen,0.0521123130818648,0.068714544
48605-0,bilirubin in plasma,glucose mass volume serum plasma 1 hour post dose fructose po,0.0521123130818648,0.17752323
25669-3,bilirubin in plasma,glucose mole volume serum plasma 3 5 hour post dose glucose,0.0521123130818648,0.17564987
25667-7,bilirubin in plasma,glucose mass volume urine 2 hour post dose glucose,0.0521123130818648,0.06744678
5914-7,bilirubin in plasma,glucose presence blood test strip,0.0521123130818648,0.07478495
48247-1,bilirubin in plasma,white oak triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.066721834
6753-8,bilirubin in plasma,glucose presence urine test strip 30 minute post 50 g lactose po,0.0521123130818648,0.054652233
40024-2,bilirubin in plasma,glucose mass volume serum plasma 1 day post xxx challenge,0.0521123130818648,0.18003334
57004-4,bilirubin in plasma,glucose creatinine mass ratio 24 hour urine,0.0521123130818648,0.09039669
48216-6,bilirubin in plasma,hazelnut triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.07526256
48983-1,bilirubin in plasma,glucose mass volume serum plasma 20 minute pre xxx challenge,0.0521123130818648,0.17663066
19104-9,bilirubin in plasma,glucose interpretation serum plasma 1 hour post dose glucose,0.0521123130818648,0.16113399
55482-4,bilirubin in plasma,insulin mole volume serum plasma 4 hour post dose glucose iv,0.0521123130818648,0.1831623
40324-6,bilirubin in plasma,glucose mole volume serum plasma 3 hour post dose triple bolus,0.0521123130818648,0.18835318
14763-7,bilirubin in plasma,glucose mole volume serum plasma 30 minute post dose glucose,0.0521123130818648,0.18786812
12659-9,bilirubin in plasma,glucose mass volume serum plasma 70 minute post xxx challenge,0.0521123130818648,0.18262723
40849-2,bilirubin in plasma,glucose mass volume urine test strip 1st specimen post xxx challenge,0.0521123130818648,0.07484939
48213-3,bilirubin in plasma,tomato triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.07235558
48295-0,bilirubin in plasma,food colorant mix ii triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08549085
21310-8,bilirubin in plasma,glucose mass volume serum plasma 75 minute post xxx challenge,0.0521123130818648,0.17572758
12610-2,bilirubin in plasma,glucose mass volume serum plasma 2 hour post xxx challenge,0.0521123130818648,0.18421319
26777-3,bilirubin in plasma,glucose mass volume serum plasma 30 minute post dose lactose po,0.0521123130818648,0.17572778
48261-2,bilirubin in plasma,perennial rye grass triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.07778538
75577-7,bilirubin in plasma,fetal 22q11 2 deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.14780746
2359-8,bilirubin in plasma,glucose 6 phosphate dehydrogenase enzymatic activity volume serum,0.0521123130818648,0.10986476
48262-0,bilirubin in plasma,meadow fescue triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.07733173
33352-6,bilirubin in plasma,glucose creatinine mass ratio urine,0.0521123130818648,0.092226535
14748-8,bilirubin in plasma,glucose mole volume peritoneal fluid,0.0521123130818648,0.08393017
48190-3,bilirubin in plasma,phthalic anhydride triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.0879388
39563-2,bilirubin in plasma,glucose mass volume serum plasma 3rd specimen post dose lactose,0.0521123130818648,0.17952016
1564-4,bilirubin in plasma,insulin mass volume serum plasma 2 hour post 75 g glucose po,0.0521123130818648,0.15495984
58805-3,bilirubin in plasma,leukocyte volume urine automated test strip,0.0521123130818648,0.089387864
12642-5,bilirubin in plasma,glucose mass volume serum plasma 7 5 hour post xxx challenge,0.0521123130818648,0.18710028
47750-5,bilirubin in plasma,somatotropin unit volume serum plasma 1 5 hour post dose glucose po,0.0521123130818648,0.15980946
30252-1,bilirubin in plasma,glucose mole volume serum plasma 3 3 hour post dose glucose,0.0521123130818648,0.18193556
54273-8,bilirubin in plasma,glucose mole volume serum plasma 3 hour post dose ornithine alpha ketoglutarate,0.0521123130818648,0.18101627
47658-0,bilirubin in plasma,insulin unit volume serum plasma 1 5 hour post dose glucose,0.0521123130818648,0.17118987
39998-0,bilirubin in plasma,glucose mass volume serum plasma 30 minute pre xxx challenge,0.0521123130818648,0.17871937
39562-4,bilirubin in plasma,glucose mass volume serum plasma 2nd specimen post dose lactose,0.0521123130818648,0.17915893
71614-2,bilirubin in plasma,monocyte leukocyte pure number fraction pleural fluid manual count,0.0521123130818648,0.07758121
72650-5,bilirubin in plasma,glucose serum glucose pericard field molar concentration difference,0.0521123130818648,0.18324208
54254-8,bilirubin in plasma,glucose mole volume serum plasma 5 minute pre dose glucagon,0.0521123130818648,0.17628896
16914-4,bilirubin in plasma,glucose mass volume serum plasma post xxx challenge,0.0521123130818648,0.17744055
12633-4,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 4th specimen,0.0521123130818648,0.07816339
101976-9,bilirubin in plasma,voltage gated calcium channel p q type binding ab mass volume serum immunoassay,0.0521123130818648,0.08473828
71648-0,bilirubin in plasma,monocyte leukocyte pure number fraction body fluid manual count,0.0521123130818648,0.07865233
30253-9,bilirubin in plasma,glucose mole volume serum plasma 3 6 hour post dose glucose,0.0521123130818648,0.1806397
96979-0,bilirubin in plasma,trisomy 13 trisomy 18 triploidy risk interpretation plasma cell free wbc dna qualitative calculation,0.0521123130818648,0.141208
75573-6,bilirubin in plasma,comment fetal triploidy risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.15967041
19105-6,bilirubin in plasma,glucose interpretation serum plasma 3 hour post dose glucose,0.0521123130818648,0.16162507
40014-3,bilirubin in plasma,glucose mass volume serum plasma 16 hour post xxx challenge,0.0521123130818648,0.18051006
32359-2,bilirubin in plasma,glucose mole volume serum plasma 10 minute post dose glucose,0.0521123130818648,0.17787403
12635-9,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid 6th specimen,0.0521123130818648,0.08036642
1555-2,bilirubin in plasma,glucose mass volume urine 12 hour fasting,0.0521123130818648,0.067328885
30402-2,bilirubin in plasma,leukocyte volume gastric fluid,0.0521123130818648,0.097029656
51766-4,bilirubin in plasma,glucose mass volume serum plasma 2 5 hour post dose fructose po,0.0521123130818648,0.18072866
1540-4,bilirubin in plasma,glucose mass volume serum plasma 5 hour post 100 g glucose po,0.0521123130818648,0.17962335
46088-1,bilirubin in plasma,leukocyte volume cerebral spinal fluid 2nd tube,0.0521123130818648,0.0911139
33979-6,bilirubin in plasma,voltage gated calcium channel n type binding ab mole volume serum,0.0521123130818648,0.09559434
48034-3,bilirubin in plasma,leukocyte volume corrected nucleated erythrocyte cerebral spinal fluid,0.0521123130818648,0.08797596
43740-0,bilirubin in plasma,glucose insulin mass ratio serum plasma,0.0521123130818648,0.17622377
16995-3,bilirubin in plasma,hydrogen expired gas volume fraction exhaled gas 6 hour post dose glucose,0.0521123130818648,0.063864246
1551-1,bilirubin in plasma,glucose mass volume serum plasma pre 50 g lactose po,0.0521123130818648,0.17761268
75637-9,bilirubin in plasma,glucose mole volume serum plasma 45 minute post 50 g lactose po,0.0521123130818648,0.16967458
75589-2,bilirubin in plasma,fetal angelman syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.1506167
40185-1,bilirubin in plasma,glucose mole volume serum plasma 18 5 hour post xxx challenge,0.0521123130818648,0.17470452
40174-5,bilirubin in plasma,glucose mole volume serum plasma 10 75 hour post xxx challenge,0.0521123130818648,0.1729597
46089-9,bilirubin in plasma,leukocyte volume cerebral spinal fluid 3rd tube,0.0521123130818648,0.08900785
78535-2,bilirubin in plasma,glucose mole volume peritoneal dialysis fluid 4 hour dwell specimen,0.0521123130818648,0.059889596
45054-4,bilirubin in plasma,glucose mole volume serum plasma 12 pm specimen,0.0521123130818648,0.17889978
16911-0,bilirubin in plasma,glucose presence urine 8th specimen post xxx challenge,0.0521123130818648,0.046273194
30344-6,bilirubin in plasma,glucose mass volume serum plasma 1 hour post 1 2 g kg lactose po,0.0521123130818648,0.17338255
75569-4,bilirubin in plasma,fetal monosomy x risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.14964083
71617-5,bilirubin in plasma,granulocyte leukocyte pure number fraction synovial fluid manual count,0.0521123130818648,0.08314886
45299-5,bilirubin in plasma,glucose mole volume serum plasma 45 minute post dose lactose po,0.0521123130818648,0.17148688
75405-1,bilirubin in plasma,glucose mole volume serum plasma 1 5 hour post dose triple bolus,0.0521123130818648,0.18933527
15190-2,bilirubin in plasma,leukocyte identifier blood automated count,0.0521123130818648,0.080084406
79195-4,bilirubin in plasma,glucose mass volume serum plasma 45 minute post dose arginine insulin,0.0521123130818648,0.17528692
48288-5,bilirubin in plasma,vecuronium triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.088956945
72516-8,bilirubin in plasma,glucose mole volume blood automated test strip,0.0521123130818648,0.08373118
95105-3,bilirubin in plasma,glucose mass volume serum plasma 30 min post meal,0.0521123130818648,0.17134391
14760-3,bilirubin in plasma,glucose mole volume capillary blood 2 hour post meal,0.0521123130818648,0.075662956
48109-3,bilirubin in plasma,glucose mole volume serum plasma 15 minute pre dose glucose,0.0521123130818648,0.17440656
12644-1,bilirubin in plasma,glucose mass volume serum plasma 9 hour post xxx challenge,0.0521123130818648,0.18557869
54277-9,bilirubin in plasma,glucose mole volume serum plasma 1 5 hour post dose ornithine alpha ketoglutarate,0.0521123130818648,0.1804675
15112-6,bilirubin in plasma,leukocyte phosphatase unit volume leukocyte,0.0521123130818648,0.10361456
66145-4,bilirubin in plasma,leukocyte volume blood fetus manual count,0.0521123130818648,0.10054044
75578-5,bilirubin in plasma,fetal 22q11 2 deletion risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.0521123130818648,0.14788835
1522-2,bilirubin in plasma,glucose mass volume serum plasma 30 minute post 0 5 g kg glucose iv,0.0521123130818648,0.18325119
1519-8,bilirubin in plasma,deprecated glucose mass volume serum plasma 2 hour post 75 g glucose po,0.0521123130818648,0.06763638
54392-6,bilirubin in plasma,glucose mole volume serum plasma 1st specimen post xxx challenge,0.0521123130818648,0.17328164
18354-1,bilirubin in plasma,glucose mass volume serum plasma 12 hour post 50 g lactose po,0.0521123130818648,0.17382438
48275-2,bilirubin in plasma,ibuprofen triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08343204
75591-8,bilirubin in plasma,comment fetal angelman syndrome risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.0521123130818648,0.14070918
47668-9,bilirubin in plasma,insulin unit volume serum plasma pre dose glucose,0.0521123130818648,0.17131214
88114-4,bilirubin in plasma,leukocyte presence cerebral spinal fluid gram stain,0.0521123130818648,0.06904718
47621-8,bilirubin in plasma,glucose iv mass dose,0.0521123130818648,0.061385147
92668-3,bilirubin in plasma,glucose mass volume serum plasma 1 hour post dose clonidine,0.0521123130818648,0.18959968
32820-3,bilirubin in plasma,glucose mass volume serum plasma 45 minute post dose lactose po,0.0521123130818648,0.17911445
15076-3,bilirubin in plasma,glucose mole volume urine,0.0521123130818648,0.076928094
62441-1,bilirubin in plasma,nucleated erythrocyte leukocyte ratio cerebral spinal fluid automated count,0.0521123130818648,0.066984504
9339-3,bilirubin in plasma,insulin mass volume serum plasma 6 hour post 75 g glucose po,0.0521123130818648,0.1546147
40171-1,bilirubin in plasma,glucose mole volume serum plasma 9 hour post xxx challenge,0.0521123130818648,0.17427553
40260-2,bilirubin in plasma,glucose mass volume serum plasma 10 75 hour post xxx challenge,0.0521123130818648,0.18093213
40177-8,bilirubin in plasma,glucose mole volume serum plasma 12 5 hour post xxx challenge,0.0521123130818648,0.17292407
61153-3,bilirubin in plasma,glucose mass volume peritoneal dialysis fluid baseline,0.0521123130818648,0.06456833
48810-6,bilirubin in plasma,glucose mass volume serum plasma 5 hour post 50 g glucose po,0.0521123130818648,0.17722858
53937-9,bilirubin in plasma,hla b w4 w6 type leukocyte,0.0521123130818648,0.064771675
30411-3,bilirubin in plasma,leukocyte left shift presence blood,0.0521123130818648,0.08774865
54496-5,bilirubin in plasma,glucose mole volume serum plasma 5th specimen post xxx challenge,0.0521123130818648,0.1723856
48260-4,bilirubin in plasma,timothy triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08477509
25676-8,bilirubin in plasma,glucose mole volume serum plasma 5 5 hour post dose glucose,0.0521123130818648,0.17414369
20455-2,bilirubin in plasma,leukocyte presence urine sediment light microscopy,0.0521123130818648,0.06649321
40204-0,bilirubin in plasma,glucose mole volume serum plasma 12 minute post xxx challenge,0.0521123130818648,0.17466122
39478-3,bilirubin in plasma,glucose mole volume vitreous fluid,0.0521123130818648,0.07533654
58511-7,bilirubin in plasma,component peptide mass volume serum plasma 3 hour post dose glucose,0.0521123130818648,0.16957788
27940-6,bilirubin in plasma,deprecated insulin unit volume serum plasma 1 5 hour post 75 g glucose po,0.0521123130818648,0.16434991
74542-2,bilirubin in plasma,pyruvate kinase glucose 6 phosphate dehydrogenase enzymatic activity ratio red blood cell,0.0521123130818648,0.08946398
47588-9,bilirubin in plasma,component peptide mole volume serum plasma 2 hour post dose glucose,0.0521123130818648,0.17016193
41261-9,bilirubin in plasma,voltage gated calcium channel igg ab presence serum,0.0521123130818648,0.069922075
51768-0,bilirubin in plasma,glucose mass volume serum plasma 3 hour post dose fructose po,0.0521123130818648,0.1802116
42615-5,bilirubin in plasma,glucose mass volume urine 30 minute post dose lactose po,0.0521123130818648,0.07197136
40221-4,bilirubin in plasma,glucose mole volume serum plasma 36 hour post xxx challenge,0.0521123130818648,0.17680009
1510-7,bilirubin in plasma,glucose mass volume serum plasma 1 hour post dose insulin iv,0.0521123130818648,0.182113
40162-0,bilirubin in plasma,glucose mole volume serum plasma 3 hour post xxx challenge,0.0521123130818648,0.1744811
10446-3,bilirubin in plasma,leukocyte common ag presence tissue immune stain,0.0521123130818648,0.05200903
40181-0,bilirubin in plasma,glucose mole volume serum plasma 15 5 hour post xxx challenge,0.0521123130818648,0.17141905
72648-9,bilirubin in plasma,glucose serum glucose synovial fluid molar concentration difference,0.0521123130818648,0.16990146
18309-5,bilirubin in plasma,nucleated erythrocyte leukocyte ratio blood manual count,0.0521123130818648,0.084487215
13609-3,bilirubin in plasma,insulin mass volume serum plasma 2 5 hour post 75 g glucose po,0.0521123130818648,0.15993536
48287-7,bilirubin in plasma,deprecated suxamethonium triggered leukotriene release mass volume leukocyte,0.0521123130818648,0.08316806
42631-2,bilirubin in plasma,glucose mass volume urine 5 hour post dose lactose po,0.0521123130818648,0.07236477
47719-0,bilirubin in plasma,parathyrin mass volume serum plasma pre dose calcium,0.0521123130818648,0.16696852
11032-0,bilirubin in plasma,glucose mass volume serum plasma 45 minute post 50 g lactose po,0.0521123130818648,0.18095182
98989-7,bilirubin in plasma,band form neutrophil leukocyte pure number fraction blood automated count,0.0521123130818648,0.09106168
56771-9,bilirubin in plasma,eosinophil leukocyte bronchial specimen flow cytometry fc,0.0,0.0688149
14384-2,bilirubin in plasma,mononuclear cell leukocyte urine sediment manual count,0.0,0.066929385
50588-3,bilirubin in plasma,glucose tolerance 5 hour panel serum plasma,0.0,0.15433346
34985-2,bilirubin in plasma,unidentified cell leukocyte body fluid,0.0,0.07381011
30465-9,bilirubin in plasma,prolymphocytes leukocyte blood,0.0,0.09386409
49940-0,bilirubin in plasma,glutamate dehydrogenase enzymatic activity mass leukocyte,0.0,0.09743482
58090-2,bilirubin in plasma,glucose 6 phosphate dehydrogenase newborn screening comment discussion,0.0,0.061673235
68378-9,bilirubin in plasma,leukocyte disintegrated leukocyte blood,0.0,0.09115016
35020-7,bilirubin in plasma,monocyte macrophage leukocyte peritoneal fluid,0.0,0.07689017
5489-0,bilirubin in plasma,deprecated cd47 cell 100 cell blood,0.0,0.059812862
30457-6,bilirubin in plasma,nonhematic cell leukocyte body fluid,0.0,0.07179855
12208-5,bilirubin in plasma,eosinophil leukocyte cerebral spinal fluid manual count,0.0,0.06882264
5440-3,bilirubin in plasma,deprecated cd16 cd57 cell 100 cell blood,0.0,0.055532034
32177-8,bilirubin in plasma,granulocyte leukocyte vaginal fluid,0.0,0.07518866
95219-2,bilirubin in plasma,variant lymphocyte leukocyte stem cell product manual count,0.0,0.05679289
55598-7,bilirubin in plasma,leukocyte disintegrated leukocyte body fluid manual count,0.0,0.074502595
5526-9,bilirubin in plasma,deprecated cd72 cell 100 cell blood,0.0,0.06240067
41899-6,bilirubin in plasma,glucose meter device vendor serial number,0.0,0.030912386
10329-1,bilirubin in plasma,monocyte leukocyte cerebral spinal fluid manual count,0.0,0.0651329
32200-8,bilirubin in plasma,segmented neutrophil leukocyte blood automated count,0.0,0.088566914
56960-8,bilirubin in plasma,segmented neutrophil leukocyte bone marrow manual count,0.0,0.06635439
36934-8,bilirubin in plasma,ct heart calcium scoring,0.0,0.011282423
5415-5,bilirubin in plasma,deprecated cd10 cd20,0.0,0.043199692
713-8,bilirubin in plasma,eosinophil leukocyte blood automated count,0.0,0.078877494
13524-4,bilirubin in plasma,leukocyte leukocyte body fluid manual count,0.0,0.07240981
5462-7,bilirubin in plasma,deprecated cd31 cell 100 cell blood,0.0,0.060817193
5466-8,bilirubin in plasma,deprecated cd34 dr cell 100 cell blood,0.0,0.06046156
40490-5,bilirubin in plasma,macrophage leukocyte synovial fluid manual count,0.0,0.065726615
5529-3,bilirubin in plasma,deprecated cd77 cell 100 cell blood,0.0,0.060282115
5512-9,bilirubin in plasma,deprecated cd62l cell 100 cell blood,0.0,0.063358724
17800-4,bilirubin in plasma,myelocyte leukocyte body fluid,0.0,0.079960704
32540-7,bilirubin in plasma,glucosylceramidase enzymatic activity mass leukocyte,0.0,0.07817548
34923-3,bilirubin in plasma,monoblast leukocyte blood,0.0,0.09164394
57391-5,bilirubin in plasma,eosinophil leukocyte synovial fluid manual count,0.0,0.066399835
32833-6,bilirubin in plasma,monocyte macrophage leukocyte bronchial specimen,0.0,0.069248445
14857-7,bilirubin in plasma,leukocyte leukocyte pericardial fluid manual count,0.0,0.07878273
30427-9,bilirubin in plasma,macrophage leukocyte body fluid,0.0,0.07304469
51770-6,bilirubin in plasma,leukocyte area stool microscopy high power field,0.0,0.08342355
34982-9,bilirubin in plasma,unidentified cell leukocyte peritoneal fluid,0.0,0.07775388
49926-9,bilirubin in plasma,glucose 6 phosphate dehydrogenase enzymatic activity mass red blood cell method,0.0,0.08637604
5535-0,bilirubin in plasma,deprecated cd82 cell 100 cell blood,0.0,0.060475025
34921-7,bilirubin in plasma,lymphocyte plasmacytoid leukocyte blood,0.0,0.091955364
5517-8,bilirubin in plasma,deprecated cd66b cell 100 cell blood,0.0,0.06738103
26483-8,bilirubin in plasma,lymphocyte leukocyte synovial fluid,0.0,0.066186205
12230-9,bilirubin in plasma,macrophage leukocyte body fluid manual count,0.0,0.07778786
83289-9,bilirubin in plasma,ct calcium scoring wo contrast cta w contrast iv heart coronary artery,0.0,0.029171916
77355-6,bilirubin in plasma,non hematopoietic stem cell leukocyte body fluid manual count,0.0,0.065901294
75196-6,bilirubin in plasma,leukocyte count protein test performed csf test finding cdc component,0.0,0.052571114
5500-4,bilirubin in plasma,deprecated cd51 cell 100 cell blood,0.0,0.06490829
2794-6,bilirubin in plasma,phosphofructokinase f subunit phosphofructokinase total leukocyte,0.0,0.07177251
26506-6,bilirubin in plasma,segmented neutrophil leukocyte cerebral spinal fluid,0.0,0.07270017
26521-5,bilirubin in plasma,granulocyte leukocyte semen,0.0,0.082165316
53797-7,bilirubin in plasma,neutrophil immature leukocyte blood,0.0,0.092315905
30462-6,bilirubin in plasma,granulocyte leukocyte urine,0.0,0.08016432
11031-2,bilirubin in plasma,lymphocyte leukocyte body fluid,0.0,0.07359192
69017-2,bilirubin in plasma,immature granulocyte leukocyte synovial fluid,0.0,0.078579806
40653-8,bilirubin in plasma,myelocyte leukocyte body fluid manual count,0.0,0.07450246
63554-0,bilirubin in plasma,leukocyte 24 hour urine sediment microscopy,0.0,0.06383219
32013-5,bilirubin in plasma,eosinophil leukocyte pericardial fluid manual count,0.0,0.07315029
51385-3,bilirubin in plasma,plasma cell leukocyte cerebral spinal fluid manual count,0.0,0.08269487
40543-1,bilirubin in plasma,leukocyte leukocyte bronchial specimen manual count,0.0,0.06435719
26514-0,bilirubin in plasma,neutrophil leukocyte peritoneal fluid,0.0,0.083193
5533-5,bilirubin in plasma,deprecated cd80 cell 100 cell blood,0.0,0.059397686
26513-2,bilirubin in plasma,neutrophil leukocyte body fluid,0.0,0.078444086
9443-3,bilirubin in plasma,igm lymphocyte lymphocyte leukocyte,0.0,0.054818965
33388-0,bilirubin in plasma,band form neutrophil leukocyte pericardial fluid,0.0,0.07965473
4528-6,bilirubin in plasma,deprecated complement receptor 2,0.0,0.07913388
33369-0,bilirubin in plasma,variant lymphocyte leukocyte peritoneal fluid,0.0,0.07251638
66133-0,bilirubin in plasma,mononuclear cell atypical leukocyte body fluid manual count,0.0,0.06626197
5470-0,bilirubin in plasma,deprecated cd38 cell 100 cell blood,0.0,0.060063373
62850-3,bilirubin in plasma,deprecated phenx measure fasting plasma glucose diabetes screening blood draw,0.0,0.057932597
51384-6,bilirubin in plasma,mononuclear cell leukocyte blood manual count,0.0,0.087525
14822-1,bilirubin in plasma,lymphocyte leukocyte synovial fluid manual count,0.0,0.069841616
5994-9,bilirubin in plasma,platelet aggregation calcium ionophore induced platelet rich plasma,0.0,0.053656466
13047-6,bilirubin in plasma,plasma cell leukocyte blood,0.0,0.11253793
74437-5,bilirubin in plasma,galactokinase enzymatic activity mass leukocyte,0.0,0.09075612
5543-4,bilirubin in plasma,deprecated cd91 cell 100 cell blood,0.0,0.058363795
33857-4,bilirubin in plasma,sezary cell leukocyte blood manual count,0.0,0.08676366
5437-9,bilirubin in plasma,deprecated cd16 cell 100 cell blood,0.0,0.056308717
90422-7,bilirubin in plasma,taci cell cell cd19 blood,0.0,0.0568938
24078-8,bilirubin in plasma,cerebroside sulfatase enzymatic activity mass leukocyte,0.0,0.09095242
30436-0,bilirubin in plasma,monocyte macrophage leukocyte cerebral spinal fluid,0.0,0.064741835
97506-0,bilirubin in plasma,glucose management indicator,0.0,0.06966804
14830-4,bilirubin in plasma,mesothelial cell leukocyte peritoneal fluid manual count,0.0,0.090232305
55436-0,bilirubin in plasma,myeloblast leukocyte cerebral spinal fluid manual count,0.0,0.073073626
96798-4,bilirubin in plasma,cortisol glucose somatotropin post arginine stimulation panel serum plasma,0.0,0.12806824
5481-7,bilirubin in plasma,deprecated cd43 cell 100 cell blood,0.0,0.054683797
5542-6,bilirubin in plasma,deprecated cd9 cell 100 cell blood,0.0,0.05928538
14847-8,bilirubin in plasma,neutrophil leukocyte pericardial fluid manual count,0.0,0.08314106
40650-4,bilirubin in plasma,mesothelial cell leukocyte blood manual count,0.0,0.091286086
50608-9,bilirubin in plasma,glucose tolerance 3 hour gestational panel serum plasma,0.0,0.15369968
14829-6,bilirubin in plasma,mesothelial cell leukocyte pleural fluid manual count,0.0,0.08273693
62856-0,bilirubin in plasma,phenx oral glucose tolerance test protocol 141001,0.0,0.047280014
30423-8,bilirubin in plasma,lymphoma cell leukocyte blood,0.0,0.07802884
5491-6,bilirubin in plasma,deprecated cd49a cell 100 cell blood,0.0,0.056706138
5510-3,bilirubin in plasma,deprecated cd61 cell 100 cell blood,0.0,0.06150305
5484-1,bilirubin in plasma,deprecated cd45 cell 100 cell blood,0.0,0.054824766
9727-9,bilirubin in plasma,eosinophil leukocyte nose manual count,0.0,0.054289345
49224-9,bilirubin in plasma,leukocyte area semen microscopy high power field,0.0,0.08365099
5555-8,bilirubin in plasma,deprecated fmc7 cell 100 cell blood,0.0,0.06738351
59816-9,bilirubin in plasma,neutrophil immature leukocyte body fluid,0.0,0.0785066
26496-0,bilirubin in plasma,mononuclear cell leukocyte semen,0.0,0.07436107
27906-7,bilirubin in plasma,immature lymphocyte leukocyte amniotic fluid,0.0,0.074223764
770-8,bilirubin in plasma,neutrophil leukocyte blood automated count,0.0,0.08319859
5454-4,bilirubin in plasma,deprecated cd25 cell 100 cell blood,0.0,0.06002829
33228-8,bilirubin in plasma,wbc cast area urine computer assisted method,0.0,0.073790774
56774-3,bilirubin in plasma,lymphocyte leukocyte tissue,0.0,0.06142127
5544-2,bilirubin in plasma,deprecated cd93 cell 100 cell blood,0.0,0.05947698
51621-1,bilirubin in plasma,macrophage leukocyte dialysis fluid manual count,0.0,0.07112892
13046-8,bilirubin in plasma,variant lymphocyte leukocyte blood,0.0,0.087012164
34915-9,bilirubin in plasma,malignant cell leukocyte blood,0.0,0.08069325
74425-0,bilirubin in plasma,myelocyte neutrophilic leukocyte blood manual count,0.0,0.09070508
17802-0,bilirubin in plasma,prolymphocytes leukocyte body fluid,0.0,0.08009291
58089-4,bilirubin in plasma,glucose 6 phosphate dehydrogenase newborn screen interpretation,0.0,0.07057775
51927-2,bilirubin in plasma,cell leukocyte bronchial specimen manual count,0.0,0.07041074
14382-6,bilirubin in plasma,mononuclear cell leukocyte synovial fluid manual count,0.0,0.0723877
40491-3,bilirubin in plasma,neutrophil leukocyte synovial fluid manual count,0.0,0.06919499
101977-7,bilirubin in plasma,cortisol glucose somatotropin post glucagon stimulation panel serum plasma,0.0,0.11903698
70040-1,bilirubin in plasma,granulocyte leukocyte synovial fluid automated count,0.0,0.07404688
43151-0,bilirubin in plasma,glucose meter device panel,0.0,0.03117547
5421-3,bilirubin in plasma,deprecated cd106 cell 100 cell blood,0.0,0.05755893
5467-6,bilirubin in plasma,deprecated cd35 cell 100 cell blood,0.0,0.05621858
5429-6,bilirubin in plasma,deprecated cd120a cell 100 cell blood,0.0,0.058722332
30410-5,bilirubin in plasma,leukocyte leukocyte synovial fluid,0.0,0.07119633
30438-6,bilirubin in plasma,monocyte macrophage leukocyte synovial fluid,0.0,0.06803843
41900-2,bilirubin in plasma,glucose meter device vendor software version,0.0,0.03289439
24104-2,bilirubin in plasma,lymphoma cell leukocyte blood manual count,0.0,0.07745661
101978-5,bilirubin in plasma,glucose somatotropin post glucagon stimulation panel serum plasma,0.0,0.13101527
45060-1,bilirubin in plasma,protein glucose panel urine test strip,0.0,0.057497878
96077-3,bilirubin in plasma,hedis 2020 value set glucose test,0.0,0.04546205
41898-8,bilirubin in plasma,vendor device model code glucose meter,0.0,0.03249814
33837-6,bilirubin in plasma,malignant cell leukocyte blood manual count,0.0,0.07883191
68403-5,bilirubin in plasma,eosinophil leukocyte vitreous fluid manual count,0.0,0.06919982
5905-5,bilirubin in plasma,monocyte leukocyte blood automated count,0.0,0.082542785
21394-2,bilirubin in plasma,monocyte macrophage leukocyte body fluid manual count,0.0,0.06587111
5490-8,bilirubin in plasma,deprecated cd48 cell 100 cell blood,0.0,0.055540875
5556-6,bilirubin in plasma,deprecated gpa blood,0.0,0.05377768
97510-2,bilirubin in plasma,glucose measurement range total glucose measurement reporting period,0.0,0.061525498
74950-7,bilirubin in plasma,deprecated galactocerebrosidase enzymatic activity mass leukocyte,0.0,0.087279186
30439-4,bilirubin in plasma,monocyte macrophage leukocyte specimen,0.0,0.06408547
14326-3,bilirubin in plasma,eosinophil leukocyte stool manual count,0.0,0.06364674
74428-4,bilirubin in plasma,metamyelocytes neutrophilic leukocyte blood manual count,0.0,0.08584476
5541-8,bilirubin in plasma,deprecated cd89,0.0,0.048602823
5492-4,bilirubin in plasma,deprecated cd49b cell 100 cell blood,0.0,0.05933725
5418-9,bilirubin in plasma,deprecated cd103 cell 100 cell blood,0.0,0.056857467
14773-6,bilirubin in plasma,granulocyte leukocyte bronchial specimen manual count,0.0,0.083784506
5433-8,bilirubin in plasma,deprecated cd128 cell 100 cell blood,0.0,0.05669557
5558-2,bilirubin in plasma,deprecated myeloperoxidase cell 100 cell unspecified specimen,0.0,0.078251384
5523-6,bilirubin in plasma,deprecated cd7 cell 100 cell blood,0.0,0.059946578
5498-1,bilirubin in plasma,deprecated cd5 cd2 cell 100 cell blood,0.0,0.048763547
2352-3,bilirubin in plasma,glucose csf glucose plasma,0.0,0.17273764
14848-6,bilirubin in plasma,neutrophil leukocyte pleural fluid manual count,0.0,0.07630585
91551-2,bilirubin in plasma,cell leukocyte dialysis fluid manual count,0.0,0.09131703
34925-8,bilirubin in plasma,immature monocyte leukocyte blood,0.0,0.09208529
74141-3,bilirubin in plasma,granulocyte leukocyte peritoneal dialysis fluid,0.0,0.07841943
47413-0,bilirubin in plasma,plasma cell leukocyte cerebral spinal fluid,0.0,0.08662587
70037-7,bilirubin in plasma,mononuclear cell leukocyte pericardial fluid automated count,0.0,0.0740111
46702-7,bilirubin in plasma,leukocyte area urine sediment automated count,0.0,0.07034388
74451-6,bilirubin in plasma,cell leukocyte blood fetus,0.0,0.08618127
5447-8,bilirubin in plasma,deprecated cd2 cell 100 cell blood,0.0,0.05722906
92820-0,bilirubin in plasma,glucose post glucagon stimulation panel serum plasma,0.0,0.14674939
74403-7,bilirubin in plasma,normoblasts leukocyte cord blood,0.0,0.09025316
54414-8,bilirubin in plasma,leukocyte poor plateletpheresis unit given,0.0,0.06358513
24096-0,bilirubin in plasma,n acetylgalactosamine 6 sulfatase enzymatic activity mass leukocyte,0.0,0.09689829
30430-3,bilirubin in plasma,mesothelial cell leukocyte pericardial fluid,0.0,0.08205274
40541-5,bilirubin in plasma,plasma cell leukocyte cerebral spinal fluid microscopy,0.0,0.07766285
12233-3,bilirubin in plasma,mesothelial cell leukocyte cerebral spinal fluid manual count,0.0,0.08023505
5461-9,bilirubin in plasma,deprecated cd30 cell 100 cell blood,0.0,0.055251062
5414-8,bilirubin in plasma,deprecated cd10 cell 100 cell blood,0.0,0.0573768
67128-9,bilirubin in plasma,abnormal leukocyte leukocyte specimen flow cytometry fc,0.0,0.05569262
61458-6,bilirubin in plasma,deprecated phenx measure calcium intake,0.0,0.049442843
33389-8,bilirubin in plasma,monocyte leukocyte pericardial fluid,0.0,0.07455972
35058-7,bilirubin in plasma,hairy cell leukocyte blood,0.0,0.08705492
19023-1,bilirubin in plasma,granulocyte leukocyte blood automated count,0.0,0.089708
736-9,bilirubin in plasma,lymphocyte leukocyte blood automated count,0.0,0.07456787
30408-9,bilirubin in plasma,leukocyte leukocyte pleural fluid,0.0,0.068620056
34984-5,bilirubin in plasma,unidentified cell leukocyte synovial fluid,0.0,0.07007493
5488-2,bilirubin in plasma,deprecated cd46 cell 100 cell blood,0.0,0.060582153
40646-2,bilirubin in plasma,leukocyte leukocyte blood automated count,0.0,0.08210343
26505-8,bilirubin in plasma,segmented neutrophil leukocyte blood,0.0,0.09232268
33371-6,bilirubin in plasma,variant lymphocyte leukocyte synovial fluid,0.0,0.06322024
97505-2,bilirubin in plasma,glucose standard deviation calculated,0.0,0.0764788
749-2,bilirubin in plasma,myelocyte leukocyte blood manual count,0.0,0.08842656
13599-6,bilirubin in plasma,promonocytes leukocyte blood manual count,0.0,0.08294566
32027-5,bilirubin in plasma,monocyte macrophage leukocyte pericardial fluid manual count,0.0,0.07426935
49787-5,bilirubin in plasma,granulocyte leukocyte pericardial fluid,0.0,0.07925309
14107-7,bilirubin in plasma,segmented neutrophil leukocyte cerebral spinal fluid manual count,0.0,0.07625246
104072-4,bilirubin in plasma,mucopolysaccharidosis enzyme panel leukocyte,0.0,0.0618975
30366-9,bilirubin in plasma,metamyelocytes leukocyte cerebral spinal fluid,0.0,0.067986004
5458-5,bilirubin in plasma,deprecated cd29 cell 100 cell blood,0.0,0.058043797
30453-5,bilirubin in plasma,segmented neutrophil leukocyte body fluid,0.0,0.07638425
5501-2,bilirubin in plasma,deprecated cd52 cell 100 cell blood,0.0,0.072782986
12229-1,bilirubin in plasma,macrophage leukocyte cerebral spinal fluid manual count,0.0,0.073386304
95126-9,bilirubin in plasma,lipid glucose panel serum plasma,0.0,0.15819205
69006-5,bilirubin in plasma,immature granulocyte leukocyte cerebral spinal fluid,0.0,0.07361734
33831-9,bilirubin in plasma,lymphoblast leukocyte blood manual count,0.0,0.08371447
54234-0,bilirubin in plasma,cell count diff panel gluc prot body fluid,0.0,0.044981744
730-2,bilirubin in plasma,leukocyte leukocyte blood manual count,0.0,0.0804618
12209-3,bilirubin in plasma,eosinophil leukocyte body fluid manual count,0.0,0.07425561
40520-9,bilirubin in plasma,macrophage leukocyte pleural fluid manual count,0.0,0.062042825
9045-6,calcium in serum,calcium intake estimated,0.9865734505735015,0.47271505
2005-7,calcium in serum,calcium mole time 2 hour urine 12 hour fasting,0.9865734505735015,0.46506137
24518-3,calcium in serum,calcium creatinine molar ratio urine,0.9865734505735015,0.47638276
59473-9,calcium in serum,calcium ionized mass volume adjusted ph 7 4 venous blood ion selective membrane electrode ise,0.9865734505735015,0.44950062
16266-9,calcium in serum,calcium hydrogen phosphate crystal presence stone infrared spectroscopy,0.9865734505735015,0.44357276
59276-6,calcium in serum,calcium hydrogen phosphate dihydrate crystal presence stone x ray diffraction,0.9865734505735015,0.4411045
54439-5,calcium in serum,calcium bilirubinate total stone,0.9865734505735015,0.45644674
16272-7,calcium in serum,calcium mass volume serum plasma 2 hour post xxx challenge,0.9865734505735015,0.57614493
33794-9,calcium in serum,calcium mole volume urine 8th specimen post xxx challenge,0.9865734505735015,0.46886942
53296-0,calcium in serum,calcium oxalate crystal volume urine computer assisted method,0.9865734505735015,0.46171817
51950-4,calcium in serum,calcium mass volume serum plasma post dialysis,0.9865734505735015,0.58266777
40081-2,calcium in serum,calcium mass volume serum plasma 16 hour post xxx challenge,0.9865734505735015,0.57032394
40066-3,calcium in serum,calcium mass volume serum plasma 15 minute pre xxx challenge,0.9865734505735015,0.5715026
25584-4,calcium in serum,calcium mole volume urine 5 hour post 500 mg calcium po,0.9865734505735015,0.48388088
40615-7,calcium in serum,deprecated calcium oxalate crystal presence urine sediment microscopy low power field,0.9865734505735015,0.45485312
9321-1,calcium in serum,calcium creatinine mass ratio urine,0.9865734505735015,0.47915366
25149-6,calcium in serum,calcium phosphate crystal area urine sediment microscopy high power field,0.9865734505735015,0.46307757
27182-5,calcium in serum,calcium presence blood,0.9865734505735015,0.8051637
50839-0,calcium in serum,calcium creatinine molar ratio 24 hour urine,0.9865734505735015,0.47510248
57467-3,calcium in serum,calcitriol mass volume serum plasma pre dose calcium,0.9865734505735015,0.5867879
55178-8,calcium in serum,calcium phosphate crystal presence specimen light microscopy,0.9865734505735015,0.445602
42593-4,calcium in serum,calcium mole volume capillary blood,0.9865734505735015,0.81239325
29276-3,calcium in serum,calcium presence urine,0.9865734505735015,0.79374516
47839-6,calcium in serum,deprecated carnitine acyltransferase ii enzymatic activity mass leukocyte,0.9865734505735015,0.10872919
105896-5,calcium in serum,calcium oxalate crystal area urine sediment,0.9865734505735015,0.45190525
13454-4,calcium in serum,calcium phosphorus product mole volume 2 serum plasma,0.9865734505735015,0.58185345
21644-0,calcium in serum,cacna1s gene p arg528his presence blood tissue molecular genetics method,0.9865734505735015,0.08459572
40068-9,calcium in serum,calcium mass volume serum plasma 45 minute post xxx challenge,0.9865734505735015,0.5704495
1993-5,calcium in serum,calcium renal clearance 24 hour urine serum plasma,0.9865734505735015,0.56775194
33791-5,calcium in serum,calcium mole volume urine 5th specimen post xxx challenge,0.9865734505735015,0.46974716
57566-2,calcium in serum,25 hydroxyvitamin d3 mole volume serum plasma pre dose calcium,0.9865734505735015,0.5824805
32137-2,calcium in serum,calcium phosphate total stone,0.9865734505735015,0.45987138
40231-3,calcium in serum,calcium mole volume serum plasma 2 hour post xxx challenge,0.9865734505735015,0.5823763
54366-0,calcium in serum,calcium ionized mole volume adjusted ph 7 4 cord blood,0.9865734505735015,0.47032097
27916-6,calcium in serum,calcium mass volume serum plasma 2nd specimen post xxx challenge,0.9865734505735015,0.57334405
13959-2,calcium in serum,calcium ionized mole volume serum plasma calculation,0.9865734505735015,0.6034123
40225-5,calcium in serum,calcium mole volume serum plasma 15 minute pre xxx challenge,0.9865734505735015,0.58015454
40084-6,calcium in serum,calcium mass volume serum plasma 36 hour post xxx challenge,0.9865734505735015,0.5726696
35246-8,calcium in serum,calcium mass mole volume serum plasma,0.9865734505735015,0.910328
41645-3,calcium in serum,calcium ionized mole volume venous blood,0.9865734505735015,0.48032522
17864-0,calcium in serum,calcium ionized mass volume serum plasma ion selective membrane electrode ise,0.9865734505735015,0.5806057
10746-6,calcium in serum,calcium microscopic observation identifier tissue von kossa stain,0.9865734505735015,0.43530437
53299-4,calcium in serum,calcium phosphate crystal volume urine computer assisted method,0.9865734505735015,0.46264273
40236-2,calcium in serum,calcium mole volume serum plasma 6 5 hour post xxx challenge,0.9865734505735015,0.58099717
16518-3,calcium in serum,calcium mass time 2 hour urine,0.9865734505735015,0.8081856
16268-5,calcium in serum,calcium phosphate crystal presence stone infrared spectroscopy,0.9865734505735015,0.44822538
16524-1,calcium in serum,calcium mole volume serum plasma 6 hour post xxx challenge,0.9865734505735015,0.57986665
40237-0,calcium in serum,calcium mole volume serum plasma 7 5 hour post xxx challenge,0.9865734505735015,0.5808003
32541-5,calcium in serum,calcium molar amount urine collected unspecified duration,0.9865734505735015,0.8081425
40233-9,calcium in serum,calcium mole volume serum plasma 3 hour post xxx challenge,0.9865734505735015,0.5823838
48240-6,calcium in serum,candida albicans triggered leukotriene release mass volume leukocyte,0.9865734505735015,0.07209492
17863-2,calcium in serum,calcium ionized mass volume serum plasma,0.9865734505735015,0.5982882
45389-4,calcium in serum,calcium carbonate crystal area urine sediment microscopy low power field,0.9865734505735015,0.4449234
1994-3,calcium in serum,calcium ionized mole volume blood,0.9865734505735015,0.50366265
1380-5,calcium in serum,calcium phosphate parathyroid challenge test mass ratio serum,0.9865734505735015,0.63303626
57567-0,calcium in serum,25 hydroxyvitamin d3 mole volume serum plasma 2 hour post dose calcium,0.9865734505735015,0.5813367
53088-1,calcium in serum,calcium ionized mole volume nonbiological fluid ion selective membrane electrode ise,0.9865734505735015,0.4727395
16516-7,calcium in serum,calcium ionized mole volume serum plasma 6th specimen post xxx challenge,0.9865734505735015,0.57983446
5773-7,calcium in serum,calcium carbonate crystal presence urine sediment light microscopy,0.9865734505735015,0.4460609
105053-3,calcium in serum,calcium oxalate crystal presence urine sediment microscopy,0.9865734505735015,0.44818297
21642-4,calcium in serum,cacna1s gene p arg1239gly presence blood tissue molecular genetics method,0.9865734505735015,0.08658919
14417-0,calcium in serum,calcium mole volume peritoneal fluid,0.9865734505735015,0.82417476
57471-5,calcium in serum,calcitriol mole volume serum plasma 3 hour post dose calcium,0.9865734505735015,0.5917642
74909-3,calcium in serum,calcium oxalate dihydrate total stone,0.9865734505735015,0.46151772
2003-2,calcium in serum,deprecated calcium,0.9865734505735015,0.7998533
40073-9,calcium in serum,calcium mass volume serum plasma 5 hour post xxx challenge,0.9865734505735015,0.57358176
40243-8,calcium in serum,calcium mole volume serum plasma 20 hour post xxx challenge,0.9865734505735015,0.5791834
54367-8,calcium in serum,calcium ionized mole volume cord blood,0.9865734505735015,0.4827244
16271-9,calcium in serum,calcium mass volume serum plasma 30 minute post xxx challenge,0.9865734505735015,0.5717162
27172-6,calcium in serum,calcium mass mass 24 hour stool,0.9865734505735015,0.8046227
16264-4,calcium in serum,calcium oxalate monohydrate crystal presence stone infrared spectroscopy,0.9865734505735015,0.44570866
30527-6,calcium in serum,calcium mass volume total parental nutrition,0.9865734505735015,0.8040532
50676-6,calcium in serum,calcium phosphorus product panel serum plasma,0.9865734505735015,0.5556701
45388-6,calcium in serum,calcium phosphate crystal area urine sediment microscopy low power field,0.9865734505735015,0.44846678
63550-8,calcium in serum,calcium magnesium phosphate total stone,0.9865734505735015,0.45546326
27909-1,calcium in serum,calcium mass volume serum plasma 1st specimen post xxx challenge,0.9865734505735015,0.57383996
5775-2,calcium in serum,calcium phosphate crystal presence urine sediment light microscopy,0.9865734505735015,0.44953728
41644-6,calcium in serum,calcium ionized mole volume capillary blood,0.9865734505735015,0.48337087
25150-4,calcium in serum,calcium sulfate crystal area urine sediment microscopy high power field,0.9865734505735015,0.46627244
14848-6,calcium in serum,neutrophil leukocyte pleural fluid manual count,0.6567837651247603,0.0753373
30073-1,calcium in serum,voltage gated calcium channel ab presence serum,0.6567837651247603,0.6182095
47275-3,calcium in serum,s100 calcium binding protein b mass volume serum,0.6567837651247603,0.64218706
62856-0,calcium in serum,phenx oral glucose tolerance test protocol 141001,0.6567837651247603,0.06717258
94705-1,calcium in serum,voltage gated calcium channel p q type binding ab mole volume serum immunoassay,0.6567837651247603,0.64318866
71616-7,calcium in serum,neutrophil leukocyte pure number fraction pleural fluid manual count,0.6567837651247603,0.07598633
104637-4,calcium in serum,percentage time continuous glucose monitor device worn reporting period calculated,0.6567837651247603,0.07195284
33387-2,calcium in serum,segmented neutrophil leukocyte pericardial fluid,0.6567837651247603,0.06955394
94704-4,calcium in serum,voltage gated calcium channel n type binding ab mole volume serum immunoassay,0.6567837651247603,0.64741224
33388-0,calcium in serum,band form neutrophil leukocyte pericardial fluid,0.6567837651247603,0.0728984
62852-9,calcium in serum,phenx fasting plasma glucose diabetes screening glucometer protocol 140802,0.6567837651247603,0.05890716
30455-0,calcium in serum,neutrophil leukocyte pleural fluid,0.6567837651247603,0.071434066
12724-1,calcium in serum,voltage gated calcium channel igg ab unit volume serum,0.6567837651247603,0.6374768
71606-8,calcium in serum,neutrophil leukocyte pure number fraction pericardial fluid manual count,0.6567837651247603,0.07947805
41900-2,calcium in serum,glucose meter device vendor software version,0.6567837651247603,0.052131698
74236-1,calcium in serum,unidentified cell leukocyte pericardial fluid manual count,0.6567837651247603,0.07849243
61458-6,calcium in serum,deprecated phenx measure calcium intake,0.6567837651247603,0.4290086
62850-3,calcium in serum,deprecated phenx measure fasting plasma glucose diabetes screening blood draw,0.6567837651247603,0.06266065
33385-6,calcium in serum,segmented neutrophil leukocyte pleural fluid,0.6567837651247603,0.06487251
70035-1,calcium in serum,siderophages leukocyte cerebral spinal fluid manual count,0.5409431846884966,0.083150245
54246-4,calcium in serum,protein glucose panel mass volume body fluid,0.5409431846884966,0.097609565
30469-1,calcium in serum,unspecified cell leukocyte body fluid,0.5409431846884966,0.08468047
74425-0,calcium in serum,myelocyte neutrophilic leukocyte blood manual count,0.5409431846884966,0.08597862
14107-7,calcium in serum,segmented neutrophil leukocyte cerebral spinal fluid manual count,0.5409431846884966,0.08001154
30468-3,calcium in serum,unidentified cell leukocyte cerebral spinal fluid,0.5409431846884966,0.085902296
12238-2,calcium in serum,neutrophil leukocyte body fluid manual count,0.5409431846884966,0.073202096
44097-4,calcium in serum,unidentified cell leukocyte blood,0.5409431846884966,0.09186986
71657-1,calcium in serum,band form neutrophil leukocyte pure number fraction cerebral spinal fluid manual count,0.5409431846884966,0.081219696
100795-4,calcium in serum,s100 calcium binding protein b mass volume body fluid,0.5409431846884966,0.4528761
47413-0,calcium in serum,plasma cell leukocyte cerebral spinal fluid,0.5409431846884966,0.090332106
71666-2,calcium in serum,promyelocytes leukocyte pure number fraction blood manual count,0.5409431846884966,0.094073504
17800-4,calcium in serum,myelocyte leukocyte body fluid,0.5409431846884966,0.09320386
33990-3,calcium in serum,normoblasts leukocyte blood,0.5409431846884966,0.09563923
30453-5,calcium in serum,segmented neutrophil leukocyte body fluid,0.5409431846884966,0.071802616
13516-0,calcium in serum,neutrophil leukocyte cerebral spinal fluid manual count,0.5409431846884966,0.08230339
764-1,calcium in serum,band form neutrophil leukocyte blood manual count,0.5409431846884966,0.079936735
74403-7,calcium in serum,normoblasts leukocyte cord blood,0.5409431846884966,0.066767074
56960-8,calcium in serum,segmented neutrophil leukocyte bone marrow manual count,0.5409431846884966,0.07318766
749-2,calcium in serum,myelocyte leukocyte blood manual count,0.5409431846884966,0.091751546
747-6,calcium in serum,myeloblast leukocyte blood manual count,0.5409431846884966,0.08417875
30450-1,calcium in serum,neutrophil hypersegmented leukocyte blood,0.5409431846884966,0.07975619
23761-0,calcium in serum,neutrophil leukocyte blood manual count,0.5409431846884966,0.08389163
75658-5,calcium in serum,plasma cell leukocyte bronchial specimen,0.5409431846884966,0.08182529
77356-4,calcium in serum,non hematopoietic stem cell leukocyte cerebral spinal fluid manual count,0.5409431846884966,0.072744235
770-8,calcium in serum,neutrophil leukocyte blood automated count,0.5409431846884966,0.083123855
71650-6,calcium in serum,segmented neutrophil leukocyte pure number fraction body fluid manual count,0.5409431846884966,0.07523466
26508-2,calcium in serum,band form neutrophil leukocyte blood,0.5409431846884966,0.08983301
30467-5,calcium in serum,promyelocytes leukocyte cerebral spinal fluid,0.5409431846884966,0.08641085
53520-3,calcium in serum,neutrophil leukocyte dialysis fluid,0.5409431846884966,0.06986054
6746-2,calcium in serum,prolymphocytes leukocyte blood manual count,0.5409431846884966,0.095219634
56770-1,calcium in serum,neutrophil leukocyte bronchial specimen flow cytometry fc,0.5409431846884966,0.07192259
71637-3,calcium in serum,unspecified cell leukocyte pure number fraction body fluid manual count,0.5409431846884966,0.089064345
74820-2,calcium in serum,plasma cell centrocytes leukocyte blood manual count,0.5409431846884966,0.08550812
30447-7,calcium in serum,myelocyte leukocyte cerebral spinal fluid,0.5409431846884966,0.09092659
55437-8,calcium in serum,neoplastic cell leukocyte cerebral spinal fluid manual count,0.5409431846884966,0.0786562
767-4,calcium in serum,neutrophil hypersegmented leukocyte blood manual count,0.5409431846884966,0.07865074
11123-7,calcium in serum,deprecated promyelocytes 100 cell bone marrow microscopy,0.5409431846884966,0.088145725
34917-5,calcium in serum,plasma cell precursor leukocyte blood,0.5409431846884966,0.09257471
71663-9,calcium in serum,plasma cell leukocyte pure number fraction blood,0.5409431846884966,0.101668194
51830-8,calcium in serum,deprecated prolymphocytes 100 leukocyte blood automated count,0.5409431846884966,0.09261291
71654-8,calcium in serum,myelocyte leukocyte pure number fraction cerebral spinal fluid manual count,0.5409431846884966,0.09294222
30463-4,calcium in serum,deprecated promyelocytes 100 leukocyte blood,0.5409431846884966,0.08937122
48191-1,calcium in serum,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.0868281
75057-0,calcium in serum,sialidase enzymatic activity mass leukocyte,0.22128092382317538,0.116911314
24098-6,calcium in serum,n acetylglucosamine 6 sulfatase enzymatic activity mass leukocyte,0.22128092382317538,0.1134761
5562-4,calcium in serum,deprecated smig lambda,0.22128092382317538,0.055307973
17836-8,calcium in serum,neutrophil leukocyte synovial fluid,0.22128092382317538,0.07500183
95225-9,calcium in serum,band form neutrophil leukocyte stem cell product manual count,0.22128092382317538,0.06662155
48291-9,calcium in serum,potassium metabisulfite triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.09304161
47771-1,calcium in serum,somatotropin unit volume serum plasma 3 hour post dose glucose po,0.22128092382317538,0.20977943
48284-4,calcium in serum,pancuronium triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.09196372
97534-2,calcium in serum,somatotropin mass volume serum plasma 3 hour post dose glucose,0.22128092382317538,0.2049765
48182-0,calcium in serum,european hornet triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.08466175
33988-7,calcium in serum,thymidine phosphorylase enzymatic activity mass leukocyte,0.22128092382317538,0.114637695
48285-1,calcium in serum,propofol triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.092253536
48232-3,calcium in serum,tyrophagus putrescentiae triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.07690903
46407-3,calcium in serum,somatotropin mass volume serum plasma 1 5 hour post 1 g kg glucose po,0.22128092382317538,0.20794308
2648-4,calcium in serum,n acetylgalactosamine 4 sulfatase enzymatic activity volume leukocyte,0.22128092382317538,0.10055556
47881-8,calcium in serum,pyruvate carboxylase enzymatic activity mass leukocyte,0.22128092382317538,0.10844152
47769-5,calcium in serum,somatotropin unit volume serum plasma 30 minute post dose glucose po,0.22128092382317538,0.21257058
48293-5,calcium in serum,tartrazine triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.07943903
48299-2,calcium in serum,new coccine triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.08788043
47875-0,calcium in serum,propionyl coa carboxylase enzymatic activity mass leukocyte,0.22128092382317538,0.106985405
48298-4,calcium in serum,pigweed triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.08189892
48287-7,calcium in serum,deprecated suxamethonium triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.08913556
47719-0,calcium in serum,parathyrin mass volume serum plasma pre dose calcium,0.22128092382317538,0.5701069
48192-9,calcium in serum,sunset yellow fcf triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.089078434
48219-0,calcium in serum,sesame seed triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.08243089
48214-1,calcium in serum,shrimp triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.07420871
48258-8,calcium in serum,cultivated rye triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.07988611
1635-2,calcium in serum,somatotropin mass volume serum plasma pre 1 g kg glucose po,0.22128092382317538,0.2053693
48259-6,calcium in serum,kentucky blue grass triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.07963256
48222-4,calcium in serum,rye triggered leukotriene release mass volume leukocyte,0.22128092382317538,0.085849255
78970-1,calcium in serum,phosphomannomutase 1 enzymatic activity mass leukocyte,0.22128092382317538,0.11311169
95228-3,calcium in serum,promyelocytes leukocyte stem cell product manual count,0.22128092382317538,0.07208691
1628-7,calcium in serum,somatotropin mass volume serum plasma 1 hour post 1 g kg glucose po,0.22128092382317538,0.2082202
5563-2,calcium in serum,deprecated smig cd79,0.22128092382317538,0.060005218
57971-4,calcium in serum,glucose mass volume serum plasma 4th specimen post lactose,0.18810925521422278,0.20066853
40011-9,calcium in serum,glucose mass volume serum plasma 13 5 hour post xxx challenge,0.18810925521422278,0.20053205
9307-0,calcium in serum,insulin mass volume serum plasma 30 minute post 75 g glucose po,0.18810925521422278,0.19442138
53487-5,calcium in serum,glucose mole volume serum plasma 1 5 hour post dose betaxolol,0.18810925521422278,0.21675526
21309-0,calcium in serum,glucose mass volume serum plasma 45 minute post xxx challenge,0.18810925521422278,0.20573841
16915-1,calcium in serum,glucose mass volume serum plasma post meal,0.18810925521422278,0.2004232
26695-7,calcium in serum,glucose mass volume serum plasma 7th specimen post xxx challenge,0.18810925521422278,0.20463793
40169-5,calcium in serum,glucose mole volume serum plasma 8 hour post xxx challenge,0.18810925521422278,0.21141125
40323-8,calcium in serum,glucose mole volume serum plasma 2 hour post dose triple bolus,0.18810925521422278,0.20690796
47585-5,calcium in serum,component peptide mole volume serum plasma 15 minute post dose glucose,0.18810925521422278,0.21267377
40206-5,calcium in serum,glucose mole volume serum plasma 16 minute post xxx challenge,0.18810925521422278,0.21398489
40041-6,calcium in serum,glucose mass volume serum plasma 29 hour post xxx challenge,0.18810925521422278,0.20070742
40002-8,calcium in serum,glucose mass volume serum plasma 80 minute post xxx challenge,0.18810925521422278,0.20380081
44050-3,calcium in serum,glucose phosphate isomerase enzymatic activity mass red blood cell,0.18810925521422278,0.09931067
40025-9,calcium in serum,glucose mass volume serum plasma 3 minute post xxx challenge,0.18810925521422278,0.20275152
40215-6,calcium in serum,glucose mole volume serum plasma 26 hour post xxx challenge,0.18810925521422278,0.21500684
54255-5,calcium in serum,glucose mole volume serum plasma 6 minute post dose glucagon,0.18810925521422278,0.21135716
53474-3,calcium in serum,glucose mole volume serum plasma 4 specimen,0.18810925521422278,0.21149814
40000-2,calcium in serum,glucose mass volume serum plasma 5 minute pre xxx challenge,0.18810925521422278,0.2053782
47660-6,calcium in serum,insulin unit volume serum plasma 2 5 hour post dose glucose,0.18810925521422278,0.19695234
26554-6,calcium in serum,glucose mass volume serum plasma 2 5 hour post dose glucose,0.18810925521422278,0.21138334
59796-3,calcium in serum,glucose molar concentration difference serum plasma 4 hour post xxx challenge,0.18810925521422278,0.1999621
14753-8,calcium in serum,glucose mole volume serum plasma 1 hour post 100 g glucose po,0.18810925521422278,0.21850325
104873-5,calcium in serum,glucose dumping syndrome panel serum plasma blood,0.18810925521422278,0.1698949
45298-7,calcium in serum,glucose mole volume serum plasma 2 5 hour post 50 g lactose po,0.18810925521422278,0.21331845
53485-9,calcium in serum,glucose mole volume serum plasma 45 minute post dose betaxolol,0.18810925521422278,0.2173143
10579-1,calcium in serum,leukocyte volume semen,0.18810925521422278,0.0910239
30362-8,calcium in serum,insulin unit volume serum plasma 30 minute post 75 g glucose po,0.18810925521422278,0.19245194
25673-5,calcium in serum,glucose mole volume serum plasma 45 minute post dose glucose,0.18810925521422278,0.21771234
1572-7,calcium in serum,insulin mass volume serum plasma pre 75 g glucose po,0.18810925521422278,0.19613443
55352-9,calcium in serum,glucose mole volume serum plasma 45 minute post 75 g glucose po,0.18810925521422278,0.21308321
58514-1,calcium in serum,component peptide mass volume serum plasma 45 minute post dose glucose,0.18810925521422278,0.19651292
14764-5,calcium in serum,glucose mole volume serum plasma 3 hour post 100 g glucose po,0.18810925521422278,0.21953818
12623-5,calcium in serum,glucose mass volume serum plasma 11th specimen post xxx challenge,0.18810925521422278,0.19739446
1521-4,calcium in serum,glucose mass volume serum plasma 2 hour post meal,0.18810925521422278,0.1967419
1539-6,calcium in serum,glucose mass volume serum plasma 4 hour post 75 g glucose po,0.18810925521422278,0.20610757
16168-7,calcium in serum,glucose mass volume serum plasma 3 pm specimen,0.18810925521422278,0.20933628
26817-7,calcium in serum,glucose mass volume serum plasma 11 hour post xxx challenge,0.18810925521422278,0.20401797
58518-2,calcium in serum,component peptide mass volume serum plasma 5 hour post dose glucose,0.18810925521422278,0.19934656
72651-3,calcium in serum,glucose serum glucose pleural fluid molar concentration difference,0.18810925521422278,0.20778278
1540-4,calcium in serum,glucose mass volume serum plasma 5 hour post 100 g glucose po,0.18810925521422278,0.20873994
25668-5,calcium in serum,glucose mole volume serum plasma 2 hour post xxx challenge,0.18810925521422278,0.21274918
1545-3,calcium in serum,deprecated glucose mass volume serum plasma 6 hour post 100 g glucose po,0.18810925521422278,0.2778233
40192-7,calcium in serum,glucose mole volume serum plasma 1 day post xxx challenge,0.18810925521422278,0.20912693
1517-2,calcium in serum,glucose mass volume serum plasma 2 hour post 50 g lactose po,0.18810925521422278,0.20456603
48109-3,calcium in serum,glucose mole volume serum plasma 15 minute pre dose glucose,0.18810925521422278,0.21211554
40321-2,calcium in serum,glucose mole volume serum plasma 45 minute post dose triple bolus,0.18810925521422278,0.20744835
54259-7,calcium in serum,glucose mole volume serum plasma 2 5 hour post dose insulin iv,0.18810925521422278,0.21560843
55479-0,calcium in serum,insulin mole volume serum plasma 7 minute post dose glucose iv,0.18810925521422278,0.215364
53475-0,calcium in serum,glucose mole volume serum plasma pre dose betaxolol,0.18810925521422278,0.21513455
72902-0,calcium in serum,insulin mole volume serum plasma 1 hour post 75 g glucose po,0.18810925521422278,0.21089737
16914-4,calcium in serum,glucose mass volume serum plasma post xxx challenge,0.18810925521422278,0.20436096
40201-6,calcium in serum,glucose mole volume serum plasma 6 minute post xxx challenge,0.18810925521422278,0.21399906
14755-3,calcium in serum,glucose mole volume serum plasma 1 hour post 50 g lactose po,0.18810925521422278,0.21725442
14995-5,calcium in serum,glucose mole volume serum plasma 2 hour post 75 g glucose po,0.18810925521422278,0.21969332
27861-4,calcium in serum,insulin unit volume serum plasma 3 hour post 75 g glucose po,0.18810925521422278,0.19791558
1543-8,calcium in serum,glucose mass volume serum plasma 5 minute post 0 5 g kg glucose iv,0.18810925521422278,0.21055438
47584-8,calcium in serum,component peptide mole volume serum plasma 10 minute post dose glucose,0.18810925521422278,0.21333903
12644-1,calcium in serum,glucose mass volume serum plasma 9 hour post xxx challenge,0.18810925521422278,0.19943537
51597-3,calcium in serum,glucose mole volume serum plasma 1 hour post 75 g glucose po,0.18810925521422278,0.21283379
54257-1,calcium in serum,glucose mole volume serum plasma pre dose insulin iv,0.18810925521422278,0.21221045
48992-2,calcium in serum,glucose mass volume serum plasma 12 specimen,0.18810925521422278,0.20335843
40015-0,calcium in serum,glucose mass volume serum plasma 17 5 hour post xxx challenge,0.18810925521422278,0.20375565
55481-6,calcium in serum,insulin mole volume serum plasma 10 minute pre dose glucose,0.18810925521422278,0.21012588
1558-6,calcium in serum,fasting glucose mass volume serum plasma,0.18810925521422278,0.20746997
40164-6,calcium in serum,glucose mole volume serum plasma 5 hour post xxx challenge,0.18810925521422278,0.21197402
6777-7,calcium in serum,deprecated glucose mass volume serum plasma,0.18810925521422278,0.20672747
40155-4,calcium in serum,glucose mole volume serum plasma 15 minute post xxx challenge,0.18810925521422278,0.20803128
25663-6,calcium in serum,glucose mole volume serum plasma 15 minute post dose glucose,0.18810925521422278,0.21505824
40179-4,calcium in serum,glucose mole volume serum plasma 13 5 hour post xxx challenge,0.18810925521422278,0.2079194
59792-2,calcium in serum,glucose molar concentration difference serum plasma 1 hour post xxx challenge,0.18810925521422278,0.19992694
26543-9,calcium in serum,glucose mass volume serum plasma 5 hour post dose glucose,0.18810925521422278,0.21249467
48985-6,calcium in serum,glucose mass volume serum plasma 20 minute post dose glucose,0.18810925521422278,0.20599099
40152-1,calcium in serum,glucose mole volume serum plasma 5 minute pre xxx challenge,0.18810925521422278,0.20904432
34060-4,calcium in serum,glucose mole volume serum plasma pre post dose insulin,0.18810925521422278,0.21070115
54270-4,calcium in serum,glucose mole volume serum plasma 2 5 hour post dose ornithine alpha ketoglutarate,0.18810925521422278,0.19996838
26555-3,calcium in serum,glucose mass volume serum plasma 3 5 hour post dose glucose,0.18810925521422278,0.21115217
40186-9,calcium in serum,glucose mole volume serum plasma 19 5 hour post xxx challenge,0.18810925521422278,0.2085676
58508-3,calcium in serum,component peptide mass volume serum plasma 3 5 hour post dose glucose,0.18810925521422278,0.2005083
14377-6,calcium in serum,granulocyte leukocyte semen manual count,0.18810925521422278,0.089476205
47588-9,calcium in serum,component peptide mole volume serum plasma 2 hour post dose glucose,0.18810925521422278,0.21329641
58511-7,calcium in serum,component peptide mass volume serum plasma 3 hour post dose glucose,0.18810925521422278,0.19641672
59794-8,calcium in serum,glucose molar concentration difference serum plasma 2 hour post xxx challenge,0.18810925521422278,0.20110242
6749-6,calcium in serum,glucose mass volume serum plasma 2 5 hour post 75 g glucose po,0.18810925521422278,0.20664161
30263-8,calcium in serum,glucose mole volume serum plasma 20 minute post dose glucose,0.18810925521422278,0.21243355
47661-4,calcium in serum,insulin unit volume serum plasma 20 minute post dose glucose,0.18810925521422278,0.19423746
40166-1,calcium in serum,glucose mole volume serum plasma 6 5 hour post xxx challenge,0.18810925521422278,0.21041009
47593-9,calcium in serum,component peptide mole volume serum plasma 5 minute pre dose glucose,0.18810925521422278,0.21276562
53482-6,calcium in serum,glucose mole volume serum plasma 3 hour post dose betaxolol,0.18810925521422278,0.21640694
92670-9,calcium in serum,glucose mass volume serum plasma 2 hour post dose clonidine,0.18810925521422278,0.20008463
95102-0,calcium in serum,glucose post fasting meal stimulation panel serum plasma,0.18810925521422278,0.16971318
40280-0,calcium in serum,glucose mole volume serum plasma 3 hour post dose lactose po,0.18810925521422278,0.21335942
14996-3,calcium in serum,glucose mole volume serum plasma pre 75 g glucose po,0.18810925521422278,0.21943168
50206-2,calcium in serum,glucose mass volume serum plasma 1st specimen,0.18810925521422278,0.21175645
40318-8,calcium in serum,glucose mole volume serum plasma pre dose triple bolus,0.18810925521422278,0.20650141
27432-4,calcium in serum,glucose mass volume serum plasma 8th specimen post xxx challenge,0.18810925521422278,0.19993523
14766-0,calcium in serum,glucose mole volume serum plasma 4 hour post dose glucose,0.18810925521422278,0.21778156
40028-3,calcium in serum,glucose mass volume serum plasma 12 minute post xxx challenge,0.18810925521422278,0.20250286
72648-9,calcium in serum,glucose serum glucose synovial fluid molar concentration difference,0.18810925521422278,0.19799529
12616-9,calcium in serum,glucose mass volume serum plasma 2nd specimen post xxx challenge,0.18810925521422278,0.20009512
55495-6,calcium in serum,insulin mole volume serum plasma 45 minute post dose glucose iv,0.18810925521422278,0.2150833
12641-7,calcium in serum,glucose mass volume serum plasma 7 hour post xxx challenge,0.18810925521422278,0.2020178
40173-7,calcium in serum,glucose mole volume serum plasma 10 hour post xxx challenge,0.18810925521422278,0.21188582
49689-3,calcium in serum,glucose tolerance interpretation serum plasma narrative post 100 g glucose po,0.18810925521422278,0.17777216
32321-2,calcium in serum,glucose mole volume serum plasma 4 hour post 75 g glucose po,0.18810925521422278,0.2070831
47589-7,calcium in serum,component peptide mole volume serum plasma 30 minute post dose glucose,0.18810925521422278,0.21379544
40320-4,calcium in serum,glucose mole volume serum plasma 30 minute post dose triple bolus,0.18810925521422278,0.20695512
40261-0,calcium in serum,glucose mass volume serum plasma 13 minute pre xxx challenge,0.18810925521422278,0.2020035
43740-0,calcium in serum,glucose insulin mass ratio serum plasma,0.18810925521422278,0.20482945
40043-2,calcium in serum,glucose mass volume serum plasma 31 hour post xxx challenge,0.18810925521422278,0.20216988
40162-0,calcium in serum,glucose mole volume serum plasma 3 hour post xxx challenge,0.18810925521422278,0.21072021
32322-0,calcium in serum,glucose mole volume serum plasma 5 hour post 75 g glucose po,0.18810925521422278,0.21053068
1492-8,calcium in serum,glucose mass volume serum plasma 1 5 hour post 0 5 g kg glucose iv,0.18810925521422278,0.21544391
1561-0,calcium in serum,insulin mass volume serum plasma 1 hour post 75 g glucose po,0.18810925521422278,0.19507663
6752-0,calcium in serum,glucose mass volume serum plasma 3 5 hour post 75 g glucose po,0.18810925521422278,0.2044522
26521-5,calcium in serum,granulocyte leukocyte semen,0.18810925521422278,0.09246931
56751-1,calcium in serum,glucose mass volume serum plasma 2 17 hour post xxx challenge,0.18810925521422278,0.199053
29329-0,calcium in serum,glucose mass volume serum plasma 3 5 hour post xxx challenge,0.18810925521422278,0.20212741
12650-8,calcium in serum,glucose mass volume serum plasma 3 5 hour post dose lactose po,0.18810925521422278,0.2018655
40220-6,calcium in serum,glucose mole volume serum plasma 31 hour post xxx challenge,0.18810925521422278,0.21429074
12615-1,calcium in serum,glucose mass volume serum plasma 1st specimen post xxx challenge,0.18810925521422278,0.19941327
40150-5,calcium in serum,glucose mole volume serum plasma 15 minute pre xxx challenge,0.18810925521422278,0.21012484
40018-4,calcium in serum,glucose mass volume serum plasma 19 5 hour post xxx challenge,0.18810925521422278,0.20315598
3242-5,calcium in serum,recalcification time platelet poor plasma coagulation assay,0.18810925521422278,0.44534025
54269-6,calcium in serum,glucose mole volume serum plasma 2 hour post dose ornithine alpha ketoglutarate,0.18810925521422278,0.20136102
54251-4,calcium in serum,glucose mole volume serum plasma 20 minute post dose glucagon,0.18810925521422278,0.20927218
12656-5,calcium in serum,glucose mass volume serum plasma 4 minute post xxx challenge,0.18810925521422278,0.19949837
96798-4,calcium in serum,cortisol glucose somatotropin post arginine stimulation panel serum plasma,0.18810925521422278,0.17545095
40197-6,calcium in serum,glucose mole volume serum plasma 3 minute pre xxx challenge,0.18810925521422278,0.21022181
50587-5,calcium in serum,glucose tolerance 4 hour panel serum plasma,0.18810925521422278,0.17843923
50751-7,calcium in serum,glucose mass volume serum plasma 15 minute post 0 1 u kg insulin,0.18810925521422278,0.20716323
79196-2,calcium in serum,glucose mass volume serum plasma 1 hour post dose arginine insulin,0.18810925521422278,0.19537053
81637-1,calcium in serum,glucose meter reference method correlation ratio serum plasma blood calculation,0.18810925521422278,0.19369754
30267-9,calcium in serum,glucose mole volume serum plasma 2 3 hour post dose glucose,0.18810925521422278,0.21132948
34057-0,calcium in serum,glucose mole volume serum plasma pre post dose clonidine,0.18810925521422278,0.20852272
14754-6,calcium in serum,glucose mole volume serum plasma 1 hour post 50 g glucose po,0.18810925521422278,0.21989113
1535-4,calcium in serum,glucose mass volume serum plasma 40 minute post 0 5 g kg glucose iv,0.18810925521422278,0.21308266
40174-5,calcium in serum,glucose mole volume serum plasma 10 75 hour post xxx challenge,0.18810925521422278,0.20986839
50213-8,calcium in serum,glucose mass volume serum plasma 3rd specimen,0.18810925521422278,0.21065046
40163-8,calcium in serum,glucose mole volume serum plasma 4 hour post xxx challenge,0.18810925521422278,0.20981783
40285-9,calcium in serum,glucose mole volume serum plasma 75 minute post dose glucose,0.18810925521422278,0.21654093
74084-5,calcium in serum,glucose mole volume serum plasma 15 minute post 50 g lactose po,0.18810925521422278,0.21189044
32320-4,calcium in serum,glucose mole volume serum plasma 3 hour post 75 g glucose po,0.18810925521422278,0.20767683
14749-6,calcium in serum,glucose mole volume serum plasma,0.18810925521422278,0.23187101
69941-3,calcium in serum,glucose mole volume serum plasma 20 minute post dose lactose po,0.18810925521422278,0.2092523
25677-6,calcium in serum,glucose mole volume serum plasma 6 hour post dose glucose,0.18810925521422278,0.21747833
58513-3,calcium in serum,component peptide mole volume serum plasma 4 5 hour post dose glucose,0.18810925521422278,0.21019453
77677-3,calcium in serum,glucose mole volume serum plasma blood 2 hour post meal,0.18810925521422278,0.2092449
72896-4,calcium in serum,glucose mole volume serum plasma 15 minute post dose lactose po,0.18810925521422278,0.20925333
51766-4,calcium in serum,glucose mass volume serum plasma 2 5 hour post dose fructose po,0.18810925521422278,0.20594472
40190-1,calcium in serum,glucose mole volume serum plasma 22 hour post xxx challenge,0.18810925521422278,0.20885949
1500-8,calcium in serum,glucose mass volume serum plasma 1 hour post 0 05 0 15 u insulin kg iv post 12h cfst,0.18810925521422278,0.21475066
47622-6,calcium in serum,glucose mole volume serum plasma pre dose glucose,0.18810925521422278,0.21281487
1508-1,calcium in serum,deprecated glucose mass volume serum plasma 1 hour post 75 g glucose po,0.18810925521422278,0.27666178
48991-4,calcium in serum,glucose mass volume serum plasma 10 pm specimen,0.18810925521422278,0.20530908
69943-9,calcium in serum,glucose mole volume serum plasma 20 minute post 50 g lactose po,0.18810925521422278,0.21212985
12643-3,calcium in serum,glucose mass volume serum plasma 8 hour post xxx challenge,0.18810925521422278,0.20145509
1501-6,calcium in serum,glucose mass volume serum plasma 1 hour post 100 g glucose po,0.18810925521422278,0.20216104
53486-7,calcium in serum,glucose mole volume serum plasma 1 hour post dose betaxolol,0.18810925521422278,0.2162344
40221-4,calcium in serum,glucose mole volume serum plasma 36 hour post xxx challenge,0.18810925521422278,0.21431457
40202-4,calcium in serum,glucose mole volume serum plasma 8 minute post xxx challenge,0.18810925521422278,0.214245
95107-9,calcium in serum,glucose mass volume serum plasma 4 5 hour post meal,0.18810925521422278,0.19980393
54248-0,calcium in serum,glucose mole volume serum plasma 10 minute pre dose glucagon,0.18810925521422278,0.20985512
75637-9,calcium in serum,glucose mole volume serum plasma 45 minute post 50 g lactose po,0.18810925521422278,0.21339706
27872-1,calcium in serum,insulin unit volume serum plasma 6 hour post 75 g glucose po,0.18810925521422278,0.19951639
32546-4,calcium in serum,glucose 6 phosphate dehydrogenase enzymatic activity mass red blood cell,0.18810925521422278,0.08955439
20437-0,calcium in serum,glucose mass volume serum plasma 3 hour post dose glucose,0.18810925521422278,0.20385966
92667-5,calcium in serum,glucose mass volume serum plasma 30 minute post dose clonidine,0.18810925521422278,0.20095944
39563-2,calcium in serum,glucose mass volume serum plasma 3rd specimen post dose lactose,0.18810925521422278,0.20101097
55497-2,calcium in serum,insulin mole volume serum plasma 3 minute post dose glucose iv,0.18810925521422278,0.21289347
45052-8,calcium in serum,glucose mole volume serum plasma 12 specimen,0.18810925521422278,0.21062987
49688-5,calcium in serum,glucose tolerance interpretation serum plasma narrative post 75 g glucose po,0.18810925521422278,0.1770937
1512-3,calcium in serum,glucose mass volume serum plasma 1 minute post 0 5 g kg glucose iv,0.18810925521422278,0.210553
34058-8,calcium in serum,glucose mole volume serum plasma pre post dose glucagon,0.18810925521422278,0.20976333
12622-7,calcium in serum,glucose mass volume serum plasma 10th specimen post xxx challenge,0.18810925521422278,0.2011536
48993-0,calcium in serum,glucose mass volume serum plasma 3 specimen,0.18810925521422278,0.20240472
40165-3,calcium in serum,glucose mole volume serum plasma 6 hour post xxx challenge,0.18810925521422278,0.21144737
44919-9,calcium in serum,glucose mole volume serum plasma 1 5 hour post meal,0.18810925521422278,0.2146807
9377-3,calcium in serum,glucose mass volume serum plasma 4 5 hour post 100 g glucose po,0.18810925521422278,0.20714362
56906-1,calcium in serum,bilirubin direct mass volume peritoneal fluid,0.11387764450778962,0.09695617
1968-7,calcium in serum,bilirubin direct mass volume serum plasma,0.11387764450778962,0.20813331
15153-0,calcium in serum,deprecated indirect bilirubin mass volume serum plasma,0.11387764450778962,0.21677224
39461-9,calcium in serum,bilirubin total mole volume peritoneal fluid,0.11387764450778962,0.102978714
49763-6,calcium in serum,bilirubin total mass volume pericardial fluid,0.11387764450778962,0.09860568
56905-3,calcium in serum,bilirubin direct mass volume pleural fluid,0.11387764450778962,0.09098764
74434-2,calcium in serum,bilirubin total total stone infrared spectroscopy,0.11387764450778962,0.08877508
14152-3,calcium in serum,bilirubin direct mass volume body fluid,0.11387764450778962,0.103518695
11132-8,calcium in serum,deprecated bilirubin mass volume body fluid,0.11387764450778962,0.08614287
94392-8,calcium in serum,bordetella pertussis parapertussis bronchiseptica gida gene presence lower respiratory specimen naa probe detection,0.11387764450778962,0.05582005
1970-3,calcium in serum,bilirubin delta mass volume serum plasma,0.11387764450778962,0.20757392
33412-8,calcium in serum,blast leukocyte pericardial fluid,0.11387764450778962,0.07040777
1971-1,calcium in serum,bilirubin indirect mass volume serum plasma,0.11387764450778962,0.21271865
49649-7,calcium in serum,cacna1a gene allele 1 cag repeat entitic number blood tissue molecular genetics method,0.11387764450778962,0.1239607
42719-5,calcium in serum,bilirubin total mass volume blood,0.11387764450778962,0.11341656
97770-2,calcium in serum,bilirubin total mole volume capillary blood,0.11387764450778962,0.099871986
33373-2,calcium in serum,blast leukocyte pleural fluid,0.11387764450778962,0.06422858
27198-1,calcium in serum,bilirubin total unit volume amniotic fluid spectrophotometry direct,0.11387764450778962,0.09013132
1975-2,calcium in serum,bilirubin total mass volume serum plasma,0.11387764450778962,0.20904246
18264-2,calcium in serum,deprecated direct bilirubin mass volume serum plasma,0.11387764450778962,0.20853128
33898-8,calcium in serum,bilirubin conjugated indirect mass volume serum plasma,0.11387764450778962,0.21096776
74407-8,calcium in serum,basophil leukocyte cord blood,0.09131894116263592,0.067868724
53516-1,calcium in serum,basophil leukocyte dialysis fluid manual count,0.09131894116263592,0.062476233
71602-7,calcium in serum,basophil leukocyte pure number fraction pericardial fluid manual count,0.09131894116263592,0.07890609
35069-4,calcium in serum,basophil leukocyte peritoneal fluid,0.09131894116263592,0.07706975
71647-2,calcium in serum,basophil leukocyte pure number fraction body fluid manual count,0.09131894116263592,0.08094742
32350-1,calcium in serum,basophil eosinophil monocyte leukocyte blood,0.09131894116263592,0.07170986
50658-4,calcium in serum,basophil band form leukocyte bone marrow,0.09131894116263592,0.07836342
14625-8,calcium in serum,basophil leukocyte bronchial specimen manual count,0.09131894116263592,0.07175137
30180-4,calcium in serum,basophil leukocyte blood,0.09131894116263592,0.082459554
48303-2,calcium in serum,brilliant black bn triggered leukotriene release mass volume leukocyte,0.08744253348941265,0.075042576
1977-8,calcium in serum,bilirubin total presence urine,0.08744253348941265,0.07768978
68367-2,calcium in serum,bilirubin total mole volume urine automated test strip,0.08744253348941265,0.10740859
33870-7,calcium in serum,bilirubin total presence specimen,0.08744253348941265,0.06642297
50551-1,calcium in serum,bilirubin total presence urine automated test strip,0.08744253348941265,0.075106055
48238-0,calcium in serum,cockroach triggered leukotriene release mass volume leukocyte,0.08744253348941265,0.07604808
33655-2,calcium in serum,beta n acetylhexosaminidase mole volume leukocyte,0.06488383014425896,0.09897091
17833-5,calcium in serum,basophil leukocyte synovial fluid,0.06488383014425896,0.07453305
24059-8,calcium in serum,aspartylglucosaminidase enzymatic activity mass leukocyte,0.06488383014425896,0.10470295
48203-4,calcium in serum,celery triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.08291182
59244-4,calcium in serum,arylsulfatase component enzymatic activity mass leukocyte,0.06488383014425896,0.10670478
48282-8,calcium in serum,atracurium triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.092734255
24068-9,calcium in serum,beta mannosidase enzymatic activity mass leukocyte,0.06488383014425896,0.10902971
48211-7,calcium in serum,beef triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.08406216
1816-8,calcium in serum,acid alpha glucosidase enzymatic activity volume leukocyte,0.06488383014425896,0.10289092
24101-8,calcium in serum,acid sphingomyelinase enzymatic activity mass leukocyte,0.06488383014425896,0.11966495
48254-7,calcium in serum,mugwort triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.07412562
48249-7,calcium in serum,silver birch triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.08752272
12482-6,calcium in serum,ascorbate mass volume leukocyte,0.06488383014425896,0.08788472
48234-9,calcium in serum,acarus siro triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.081682116
1766-5,calcium in serum,aldosterone receptor leukocyte,0.06488383014425896,0.076955855
48239-8,calcium in serum,alternaria alternata triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.07951086
24075-4,calcium in serum,beta n acetylhexosaminidase enzymatic activity mass leukocyte,0.06488383014425896,0.1043364
24073-9,calcium in serum,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.06488383014425896,0.10253011
1650-1,calcium in serum,1 4 alpha glucan branching enzyme enzymatic activity volume leukocyte,0.06488383014425896,0.108404085
24051-5,calcium in serum,acid alpha glucosidase enzymatic activity mass leukocyte,0.06488383014425896,0.11463231
48186-1,calcium in serum,amylase triggered leukotriene release mass volume leukocyte,0.06488383014425896,0.09211906
47550-9,calcium in serum,adenosine deaminase entitic catalytic activity leukocyte,0.06488383014425896,0.09047874
24049-9,calcium in serum,alpha galactosidase enzymatic activity mass leukocyte,0.06488383014425896,0.11368123
48196-0,calcium in serum,cephalosporin component triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.09572791
68432-4,calcium in serum,leukocyte leukocyte vitreous fluid manual count,0.05169200605201987,0.07626517
5526-9,calcium in serum,deprecated cd72 cell 100 cell blood,0.05169200605201987,0.07202668
5471-8,calcium in serum,deprecated cd39 cell 100 cell blood,0.05169200605201987,0.06334049
26522-3,calcium in serum,granulocyte leukocyte synovial fluid,0.05169200605201987,0.08955923
2563-5,calcium in serum,leukocyte esterase enzymatic activity volume leukocyte,0.05169200605201987,0.09609792
75590-0,calcium in serum,fetal angelman syndrome risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.05169200605201987,0.0741107
48278-6,calcium in serum,mefenamate triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.088256925
48187-9,calcium in serum,chloramin triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.08709104
5476-7,calcium in serum,deprecated cd41 cell 100 cell blood,0.05169200605201987,0.06896665
48221-6,calcium in serum,barley triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.08075431
30405-5,calcium in serum,leukocyte volume urine,0.05169200605201987,0.10480469
5506-1,calcium in serum,deprecated cd57 cell 100 cell blood,0.05169200605201987,0.06634755
75577-7,calcium in serum,fetal 22q11 2 deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.05169200605201987,0.06690735
16913-6,calcium in serum,fasting glucose presence urine,0.05169200605201987,0.08098783
5528-5,calcium in serum,deprecated cd74 cell 100 cell blood,0.05169200605201987,0.070512615
6750-4,calcium in serum,glucose presence urine test strip 2 hour post 50 g lactose po,0.05169200605201987,0.082896344
5554-1,calcium in serum,deprecated cyig mu cell 100 cell blood,0.05169200605201987,0.0748112
48207-5,calcium in serum,egg yolk triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.09095166
51770-6,calcium in serum,leukocyte area stool microscopy high power field,0.05169200605201987,0.08528841
1532-1,calcium in serum,glucose mass volume urine 3 hour post 100 g glucose po,0.05169200605201987,0.10485096
48224-0,calcium in serum,codfish triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.08578281
48233-1,calcium in serum,lepidoglyphus destructor triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.06600062
74686-7,calcium in serum,glucose mole time 12 hour urine,0.05169200605201987,0.10997872
17235-3,calcium in serum,magnesium mole volume leukocyte,0.05169200605201987,0.12966152
5525-1,calcium in serum,deprecated cd71 cell 100 cell blood,0.05169200605201987,0.06782694
48235-6,calcium in serum,american house dust mite triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.07430768
12226-7,calcium in serum,leukocyte presence vaginal fluid wet preparation,0.05169200605201987,0.074600056
44092-5,calcium in serum,leukocyte area vaginal fluid wet preparation,0.05169200605201987,0.08348488
30415-4,calcium in serum,abnormal lymphocyte leukocyte synovial fluid,0.05169200605201987,0.072797626
105093-9,calcium in serum,leukocyte clump area urine sediment,0.05169200605201987,0.094247214
5546-7,calcium in serum,deprecated cd95 cell 100 cell blood,0.05169200605201987,0.068992205
42604-9,calcium in serum,glucose mass volume urine 3 hour post dose lactose po,0.05169200605201987,0.10197707
26542-1,calcium in serum,glucose mass volume urine 5 hour post dose glucose,0.05169200605201987,0.11025851
71619-1,calcium in serum,mononuclear cell leukocyte pure number fraction synovial fluid manual count,0.05169200605201987,0.07624009
5475-9,calcium in serum,deprecated cd40 cell 100 cell blood,0.05169200605201987,0.06888059
54487-4,calcium in serum,glucose mole volume water,0.05169200605201987,0.117051795
75595-9,calcium in serum,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.05169200605201987,0.06850043
105921-1,calcium in serum,leukocyte volume urethra wet preparation,0.05169200605201987,0.094368294
16910-2,calcium in serum,glucose presence urine 7th specimen post xxx challenge,0.05169200605201987,0.0773385
5509-5,calcium in serum,deprecated cd6 cell 100 cell blood,0.05169200605201987,0.06931026
48242-2,calcium in serum,cladosporium herbarum triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.07430803
72163-9,calcium in serum,leukocyte presence specimen gram stain,0.05169200605201987,0.07175648
75604-9,calcium in serum,fetal sex cell free maternal wbc dna dosage chromosome specific circulating cell free ccf dna,0.05169200605201987,0.07671094
5433-8,calcium in serum,deprecated cd128 cell 100 cell blood,0.05169200605201987,0.06881953
5421-3,calcium in serum,deprecated cd106 cell 100 cell blood,0.05169200605201987,0.06688256
2186-5,calcium in serum,cytochrome component oxidase enzymatic activity volume leukocyte,0.05169200605201987,0.09979601
50404-3,calcium in serum,cell leukocyte identifier synovial fluid,0.05169200605201987,0.056223553
5445-2,calcium in serum,deprecated cd19 kappa cell 100 cell blood,0.05169200605201987,0.070448525
75588-4,calcium in serum,fetal angelman syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.05169200605201987,0.06951699
42615-5,calcium in serum,glucose mass volume urine 30 minute post dose lactose po,0.05169200605201987,0.10115301
32142-2,calcium in serum,leukocyte presence synovial fluid light microscopy,0.05169200605201987,0.06249032
75553-8,calcium in serum,comment fetal trisomy 13 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.05169200605201987,0.07327745
5549-1,calcium in serum,deprecated cd98 cell 100 cell blood,0.05169200605201987,0.06844511
26553-8,calcium in serum,glucose presence urine test strip 1 5 hour post dose glucose,0.05169200605201987,0.0882061
18407-7,calcium in serum,leukocyte 12 hour urine sediment light microscopy,0.05169200605201987,0.08813875
45383-7,calcium in serum,leukocyte area urine sediment microscopy low power field,0.05169200605201987,0.08628522
53444-6,calcium in serum,citrate synthase enzymatic activity mass control leukocyte,0.05169200605201987,0.1147536
813-6,calcium in serum,leukocyte volume synovial fluid automated count,0.05169200605201987,0.081353344
32761-9,calcium in serum,leukocyte presence specimen wet preparation,0.05169200605201987,0.07758908
57850-0,calcium in serum,mesothelial cell leukocyte synovial fluid manual count,0.05169200605201987,0.083359934
48294-3,calcium in serum,food colorant mix triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.08710237
30381-8,calcium in serum,eosinophil leukocyte sputum,0.05169200605201987,0.067405134
75579-3,calcium in serum,comment fetal 22q11 2 deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.05169200605201987,0.07552102
48236-4,calcium in serum,european house dust mite triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.07753431
5426-2,calcium in serum,deprecated cd11a cell 100 cell blood,0.05169200605201987,0.07214237
74437-5,calcium in serum,galactokinase enzymatic activity mass leukocyte,0.05169200605201987,0.09748821
75602-3,calcium in serum,fetal 1p36 deletion risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.05169200605201987,0.07338796
48194-5,calcium in serum,lidocaine triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.079343714
34312-9,calcium in serum,glucose creatinine molar ratio urine,0.05169200605201987,0.1203631
5489-0,calcium in serum,deprecated cd47 cell 100 cell blood,0.05169200605201987,0.06681625
5482-5,calcium in serum,deprecated cd44 cell 100 cell blood,0.05169200605201987,0.06629637
5492-4,calcium in serum,deprecated cd49b cell 100 cell blood,0.05169200605201987,0.066410124
68423-3,calcium in serum,monocyte leukocyte vitreous fluid manual count,0.05169200605201987,0.07446565
26552-0,calcium in serum,glucose presence urine test strip 6 hour post dose glucose,0.05169200605201987,0.086665995
75578-5,calcium in serum,fetal 22q11 2 deletion risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.05169200605201987,0.07502483
16904-5,calcium in serum,glucose presence urine 1st specimen post xxx challenge,0.05169200605201987,0.07938308
5495-7,calcium in serum,deprecated cd49e cell 100 cell blood,0.05169200605201987,0.06738697
78963-6,calcium in serum,mannose 6 phosphate isomerase enzymatic activity mass leukocyte,0.05169200605201987,0.10610284
32174-5,calcium in serum,glucose presence 24 hour urine,0.05169200605201987,0.07714469
5553-3,calcium in serum,deprecated cyig cell 100 cell blood,0.05169200605201987,0.07094927
48206-7,calcium in serum,lactalbumin alpha triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.094357446
5469-2,calcium in serum,deprecated cd37 cell 100 cell blood,0.05169200605201987,0.06804112
94487-6,calcium in serum,galactosylceramidase enzymatic activity mass leukocyte confirmatory method,0.05169200605201987,0.10076167
5499-9,calcium in serum,deprecated cd50 cell 100 cell blood,0.05169200605201987,0.069040135
5418-9,calcium in serum,deprecated cd103 cell 100 cell blood,0.05169200605201987,0.06962183
48209-1,calcium in serum,orange triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.081978
40874-0,calcium in serum,glucose mass volume specimen 1st specimen,0.05169200605201987,0.10166633
48295-0,calcium in serum,food colorant mix ii triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.08831605
69017-2,calcium in serum,immature granulocyte leukocyte synovial fluid,0.05169200605201987,0.08447319
94489-2,calcium in serum,lysosomal storage disorder panel leukocyte,0.05169200605201987,0.06968565
5458-5,calcium in serum,deprecated cd29 cell 100 cell blood,0.05169200605201987,0.0684027
5417-1,calcium in serum,deprecated cd102 cell 100 cell blood,0.05169200605201987,0.06694334
5437-9,calcium in serum,deprecated cd16 cell 100 cell blood,0.05169200605201987,0.06672557
75597-5,calcium in serum,comment fetal 5p deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.05169200605201987,0.07766382
5467-6,calcium in serum,deprecated cd35 cell 100 cell blood,0.05169200605201987,0.06623054
61124-4,calcium in serum,granulocyte leukocyte specimen flow cytometry fc,0.05169200605201987,0.08798231
5466-8,calcium in serum,deprecated cd34 dr cell 100 cell blood,0.05169200605201987,0.071238674
5515-2,calcium in serum,deprecated cd64 cell 100 cell blood,0.05169200605201987,0.06786099
48248-9,calcium in serum,hazelnut pollen triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.07450025
5441-1,calcium in serum,deprecated cd16 cd57 cell 100 cell blood,0.05169200605201987,0.061237823
53317-4,calcium in serum,leukocyte clump presence urine automated,0.05169200605201987,0.075952284
96979-0,calcium in serum,trisomy 13 trisomy 18 triploidy risk interpretation plasma cell free wbc dna qualitative calculation,0.05169200605201987,0.066963024
47602-8,calcium in serum,citrate synthase enzymatic activity mass leukocyte,0.05169200605201987,0.11668276
4528-6,calcium in serum,deprecated complement receptor 2,0.05169200605201987,0.05353069
26497-8,calcium in serum,mononuclear cell leukocyte synovial fluid,0.05169200605201987,0.07439015
75583-5,calcium in serum,fetal prader willi syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.05169200605201987,0.060961064
75552-0,calcium in serum,fetal trisomy 13 risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.05169200605201987,0.071690865
75589-2,calcium in serum,fetal angelman syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.05169200605201987,0.06402469
5439-5,calcium in serum,deprecated cd16 cd57 cell 100 cell blood,0.05169200605201987,0.06314965
48213-3,calcium in serum,tomato triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.08360209
5457-7,calcium in serum,deprecated cd28 cell 100 cell blood,0.05169200605201987,0.0661496
5556-6,calcium in serum,deprecated gpa blood,0.05169200605201987,0.07917649
57797-3,calcium in serum,glucose mass volume stool post hydrolysis,0.05169200605201987,0.10864182
4496-6,calcium in serum,deprecated complement c3d c3d gg ic3b receptor presence leukocyte,0.05169200605201987,0.053488005
99602-5,calcium in serum,glucose creatinine molar ratio 24 hour urine,0.05169200605201987,0.10204331
72364-3,calcium in serum,lymphocyte leukocyte vitreous fluid manual count,0.05169200605201987,0.07909154
5503-8,calcium in serum,deprecated cd54 cell 100 cell blood,0.05169200605201987,0.06687455
75561-1,calcium in serum,fetal trisomy 21 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.05169200605201987,0.0684612
48216-6,calcium in serum,hazelnut triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.080694705
26483-8,calcium in serum,lymphocyte leukocyte synovial fluid,0.05169200605201987,0.07925738
48297-6,calcium in serum,chromotrope 2b triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.0926779
48266-1,calcium in serum,grass allergen mix e cocksfoot meadow fescue velvet grass perennial rye grass timothy kentucky blue grass triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.07777723
5470-0,calcium in serum,deprecated cd38 cell 100 cell blood,0.05169200605201987,0.06560982
95842-1,calcium in serum,lymphocyte leukocyte sputum manual count,0.05169200605201987,0.07529019
95220-0,calcium in serum,lymphocyte leukocyte stem cell product manual count,0.05169200605201987,0.07263504
48973-2,calcium in serum,leukocyte presence stool methylene blue stain 2nd specimen,0.05169200605201987,0.07137205
48204-2,calcium in serum,casein triggered leukotriene release mass volume leukocyte,0.05169200605201987,0.08905792
5539-2,calcium in serum,deprecated cd87 cell 100 cell blood,0.05169200605201987,0.06973594
32593-6,calcium in serum,eosinophil leukocyte specimen,0.05169200605201987,0.069423124
17834-3,calcium in serum,eosinophil leukocyte synovial fluid,0.05169200605201987,0.07269071
58997-8,calcium in serum,glucose mass time 18 hour urine,0.05169200605201987,0.10405722
104635-8,calcium in serum,continuous glucose monitor device date time reporting period end reported,0.024056587682309005,0.06776899
30413-9,calcium in serum,abnormal lymphocyte leukocyte blood,0.024056587682309005,0.090672344
46090-7,calcium in serum,leukocyte volume cerebral spinal fluid 4th tube,0.024056587682309005,0.09622438
46222-6,calcium in serum,glucose mole volume dialysis fluid 4 hour specimen,0.024056587682309005,0.10357851
55598-7,calcium in serum,leukocyte disintegrated leukocyte body fluid manual count,0.024056587682309005,0.0841045
51621-1,calcium in serum,macrophage leukocyte dialysis fluid manual count,0.024056587682309005,0.06770365
51586-6,calcium in serum,cell leukocyte blood manual count,0.024056587682309005,0.08633902
12631-8,calcium in serum,glucose mass volume peritoneal dialysis fluid 2nd specimen,0.024056587682309005,0.09424252
729-4,calcium in serum,leukocyte volume blood manual count,0.024056587682309005,0.098386385
58556-2,calcium in serum,corticotropin mass volume plasma 1 hour post dose glucose,0.024056587682309005,0.10401979
808-6,calcium in serum,leukocyte volume pleural fluid manual count,0.024056587682309005,0.08452506
30408-9,calcium in serum,leukocyte leukocyte pleural fluid,0.024056587682309005,0.07710394
35477-9,calcium in serum,ciliated columnar lining cell leukocyte ratio body fluid,0.024056587682309005,0.086899795
72649-7,calcium in serum,glucose serum glucose peritoneal fluid molar concentration difference,0.024056587682309005,0.21285154
16994-6,calcium in serum,hydrogen expired gas volume fraction exhaled gas 5 hour post dose glucose,0.024056587682309005,0.07451848
30378-4,calcium in serum,eosinophil leukocyte nose,0.024056587682309005,0.058613546
40544-9,calcium in serum,monocyte leukocyte bronchial specimen manual count,0.024056587682309005,0.06923319
14820-5,calcium in serum,lymphocyte leukocyte pleural fluid manual count,0.024056587682309005,0.08173171
75864-9,calcium in serum,hedis 2015 2018 value set glucose test,0.024056587682309005,0.054554153
56772-7,calcium in serum,macrophage leukocyte bronchial specimen flow cytometry fc,0.024056587682309005,0.0751381
71661-3,calcium in serum,eosinophil leukocyte pure number fraction cerebral spinal fluid manual count,0.024056587682309005,0.079538696
19048-8,calcium in serum,nucleated erythrocyte leukocyte ratio blood,0.024056587682309005,0.10480352
33287-4,calcium in serum,glucose 6 phosphate dehydrogenase presence db,0.024056587682309005,0.08262712
40366-7,calcium in serum,glucose mole time 24 hour body fluid,0.024056587682309005,0.10471759
30417-0,calcium in serum,variant lymphocyte leukocyte body fluid,0.024056587682309005,0.079677455
55784-3,calcium in serum,leukocyte volume corrected nucleated erythrocyte bone marrow,0.024056587682309005,0.09206636
55433-7,calcium in serum,immature cell leukocyte blood,0.024056587682309005,0.09261498
13523-6,calcium in serum,leukocyte leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.08852699
16991-2,calcium in serum,hydrogen expired gas volume fraction exhaled gas 4 5 hour post dose glucose,0.024056587682309005,0.07268028
40543-1,calcium in serum,leukocyte leukocyte bronchial specimen manual count,0.024056587682309005,0.07040708
2340-8,calcium in serum,glucose mass volume blood automated test strip,0.024056587682309005,0.10777169
56160-5,calcium in serum,glucose mass volume peritoneal dialysis fluid 4 hour post peritoneal dialysis,0.024056587682309005,0.09430876
59813-6,calcium in serum,glucose mole volume capillary blood glucometer 7 specimen,0.024056587682309005,0.10476435
1557-8,calcium in serum,fasting glucose mass volume venous blood,0.024056587682309005,0.08814711
70037-7,calcium in serum,mononuclear cell leukocyte pericardial fluid automated count,0.024056587682309005,0.07763205
74451-6,calcium in serum,cell leukocyte blood fetus,0.024056587682309005,0.08212298
99933-4,calcium in serum,leukocyte clump presence body fluid automated,0.024056587682309005,0.06651166
74244-5,calcium in serum,hedis 2014 value set glucose test,0.024056587682309005,0.05490558
66761-8,calcium in serum,lymphocyte leukocyte dialysis fluid manual count,0.024056587682309005,0.07246561
12612-8,calcium in serum,glucose mass volume dialysis fluid 2 hour specimen,0.024056587682309005,0.095453024
13350-4,calcium in serum,deprecated eosinophil 100 leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.07514072
14818-9,calcium in serum,lymphocyte leukocyte pericardial fluid manual count,0.024056587682309005,0.088149525
105273-7,calcium in serum,glucose mole volume reporting period mean interstitial fluid calculation,0.024056587682309005,0.11663511
6690-2,calcium in serum,leukocyte volume blood automated count,0.024056587682309005,0.09813801
51622-9,calcium in serum,mesothelial cell leukocyte dialysis fluid manual count,0.024056587682309005,0.07836756
50342-5,calcium in serum,ependymal choroid plexus cell leukocyte ratio cerebral spinal fluid,0.024056587682309005,0.08727048
43278-1,calcium in serum,glucose mass volume milk 2 hour post meal,0.024056587682309005,0.096635275
14379-2,calcium in serum,granulocyte leukocyte gastric fluid manual count,0.024056587682309005,0.08004283
740-1,calcium in serum,metamyelocytes leukocyte blood manual count,0.024056587682309005,0.08966234
13517-8,calcium in serum,variant lymphocyte leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.08523606
99775-9,calcium in serum,leukocyte volume peritoneal dialysis fluid automated count,0.024056587682309005,0.07963864
9727-9,calcium in serum,eosinophil leukocyte nose manual count,0.024056587682309005,0.06166163
12208-5,calcium in serum,eosinophil leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.07456766
72650-5,calcium in serum,glucose serum glucose pericard field molar concentration difference,0.024056587682309005,0.21342793
67830-0,calcium in serum,leukocyte volume pericardial fluid,0.024056587682309005,0.09411439
17790-7,calcium in serum,leukocyte left shift presence blood automated count,0.024056587682309005,0.07414213
30419-6,calcium in serum,lymphocyte clefted leukocyte blood,0.024056587682309005,0.086169526
26482-0,calcium in serum,lymphocyte leukocyte peritoneal fluid,0.024056587682309005,0.08806354
53227-5,calcium in serum,leukocyte area cervix wet preparation,0.024056587682309005,0.088708505
43151-0,calcium in serum,glucose meter device panel,0.024056587682309005,0.06342386
26451-5,calcium in serum,eosinophil leukocyte cerebral spinal fluid,0.024056587682309005,0.07944068
12244-0,calcium in serum,granulocyte leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.09010349
94240-9,calcium in serum,cdh1 gene deletion duplication full mutation analysis blood tissue molecular genetics method,0.024056587682309005,0.053583458
40533-2,calcium in serum,leukocyte volume peritoneal dialysis fluid manual count,0.024056587682309005,0.08169682
68430-8,calcium in serum,leukocyte volume pleural fluid manual count,0.024056587682309005,0.082888745
2344-0,calcium in serum,glucose mass volume body fluid,0.024056587682309005,0.106668375
46088-1,calcium in serum,leukocyte volume cerebral spinal fluid 2nd tube,0.024056587682309005,0.097729675
49782-6,calcium in serum,mononuclear cell leukocyte pericardial fluid,0.024056587682309005,0.07709047
71696-9,calcium in serum,granulocyte leukocyte body fluid automated count,0.024056587682309005,0.0885703
21372-8,calcium in serum,abnormal lymphocyte leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.08602959
35058-7,calcium in serum,hairy cell leukocyte blood,0.024056587682309005,0.09000645
58802-0,calcium in serum,mononuclear cell leukocyte peritoneal dialysis fluid,0.024056587682309005,0.06985501
33840-0,calcium in serum,monoblast leukocyte blood manual count,0.024056587682309005,0.082612954
11157-5,calcium in serum,leukocyte morphology bone marrow,0.024056587682309005,0.07040929
46221-8,calcium in serum,glucose mole volume dialysis fluid 2 hour specimen,0.024056587682309005,0.10227662
55376-8,calcium in serum,megaloblast leukocyte blood manual count,0.024056587682309005,0.0974199
71614-2,calcium in serum,monocyte leukocyte pure number fraction pleural fluid manual count,0.024056587682309005,0.078077056
74405-2,calcium in serum,eosinophil leukocyte cord blood,0.024056587682309005,0.0663117
33833-5,calcium in serum,lymphocyte immunoblastic leukocyte blood manual count,0.024056587682309005,0.08552587
19023-1,calcium in serum,granulocyte leukocyte blood automated count,0.024056587682309005,0.09650308
24106-7,calcium in serum,hairy cell leukocyte blood manual count,0.024056587682309005,0.091247685
88114-4,calcium in serum,leukocyte presence cerebral spinal fluid gram stain,0.024056587682309005,0.07814205
58557-0,calcium in serum,corticotropin mole volume plasma 1 hour post dose glucose,0.024056587682309005,0.11428158
14344-6,calcium in serum,eosinophil leukocyte pleural fluid manual count,0.024056587682309005,0.07228506
12229-1,calcium in serum,macrophage leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.0791957
62858-6,calcium in serum,micromegakaryocytes leukocyte blood manual count,0.024056587682309005,0.09157148
54234-0,calcium in serum,cell count diff panel gluc prot body fluid,0.024056587682309005,0.069571964
104598-8,calcium in serum,glucose mass volume arterial blood glucometer,0.024056587682309005,0.11462119
58528-1,calcium in serum,corticotropin mass volume plasma 1 5 hour post dose glucose,0.024056587682309005,0.103461646
39479-1,calcium in serum,glucose mole volume pericardial fluid,0.024056587682309005,0.11435928
809-4,calcium in serum,leukocyte volume peritoneal fluid automated count,0.024056587682309005,0.08913431
26471-3,calcium in serum,leukocyte leukocyte blood,0.024056587682309005,0.09678861
33765-9,calcium in serum,leukocyte volume blood product unit platelet pheresis automated count,0.024056587682309005,0.082325906
74141-3,calcium in serum,granulocyte leukocyte peritoneal dialysis fluid,0.024056587682309005,0.080805555
14748-8,calcium in serum,glucose mole volume peritoneal fluid,0.024056587682309005,0.12058751
30379-2,calcium in serum,eosinophil leukocyte pleural fluid,0.024056587682309005,0.06693229
42250-1,calcium in serum,variant lymphocyte leukocyte blood automated count,0.024056587682309005,0.07717674
73903-7,calcium in serum,cd3 cd57 cell leukocyte blood flow cytometry fc,0.024056587682309005,0.086012945
14773-6,calcium in serum,granulocyte leukocyte bronchial specimen manual count,0.024056587682309005,0.08897373
14375-0,calcium in serum,granulocyte leukocyte peritoneal fluid manual count,0.024056587682309005,0.0938118
61513-8,calcium in serum,many year take calcium alone combined something else bone health supplement antacid phenx,0.024056587682309005,0.44957423
41653-7,calcium in serum,glucose mass volume capillary blood glucometer,0.024056587682309005,0.10474916
66148-8,calcium in serum,mononuclear cell leukocyte pleural fluid fetus manual count,0.024056587682309005,0.07440894
56937-6,calcium in serum,hydrogen expired gas volume fraction exhaled gas 30 minute post dose glucose,0.024056587682309005,0.06757346
90996-0,calcium in serum,hedis 2019 2020 value set glucose test,0.024056587682309005,0.05385186
71605-0,calcium in serum,lymphocyte leukocyte pure number fraction pericardial fluid manual count,0.024056587682309005,0.08616041
71634-0,calcium in serum,lymphocyte leukocyte pure number fraction peritoneal fluid manual count,0.024056587682309005,0.08688045
66133-0,calcium in serum,mononuclear cell atypical leukocyte body fluid manual count,0.024056587682309005,0.077519946
26465-5,calcium in serum,leukocyte volume cerebral spinal fluid,0.024056587682309005,0.102306396
104878-4,calcium in serum,hematocrit volume fraction blood 2 hour post dose glucose,0.024056587682309005,0.09839916
57847-6,calcium in serum,leukocyte volume dialysis fluid manual count,0.024056587682309005,0.081253126
19252-6,calcium in serum,megakaryocyte leukocyte blood,0.024056587682309005,0.09800298
51648-4,calcium in serum,monocytoid cell leukocyte cerebral spinal fluid manual count,0.024056587682309005,0.07142419
33831-9,calcium in serum,lymphoblast leukocyte blood manual count,0.024056587682309005,0.08328831
29259-9,calcium in serum,monocyte abnormal leukocyte blood manual count,0.024056587682309005,0.08114013
97510-2,calcium in serum,glucose measurement range total glucose measurement reporting period,0.024056587682309005,0.08014609
94231-8,calcium in serum,g6pd gene full mutation analysis blood tissue sequencing,0.024056587682309005,0.054721717
58529-9,calcium in serum,corticotropin mole volume plasma 1 5 hour post dose glucose,0.024056587682309005,0.11274984
26487-9,calcium in serum,monocyte leukocyte body fluid,0.024056587682309005,0.08418434
30409-7,calcium in serum,leukocyte leukocyte peritoneal fluid,0.024056587682309005,0.08342431
97778-5,calcium in serum,glucose mole volume dialysis fluid 1 hour specimen,0.024056587682309005,0.10606886
88365-2,calcium in serum,glucose mass volume blood pre meal,0.024056587682309005,0.10322529
713-8,calcium in serum,eosinophil leukocyte blood automated count,0.024056587682309005,0.080526724
16989-6,calcium in serum,hydrogen expired gas volume fraction exhaled gas 3 5 hour post dose glucose,0.024056587682309005,0.07019656
58584-4,calcium in serum,corticotropin mole volume plasma 30 minute post dose glucose,0.024056587682309005,0.11411982
33263-5,calcium in serum,metamyelocytes leukocyte body fluid manual count,0.024056587682309005,0.080323316
87422-2,calcium in serum,glucose mass volume blood post meal,0.024056587682309005,0.10153662
49134-0,calcium in serum,glucose mass volume blood 2 hour post dose glucose,0.024056587682309005,0.105593525
58597-6,calcium in serum,corticotropin mole volume plasma 3 hour post dose glucose,0.024056587682309005,0.116101
71659-7,calcium in serum,monocyte leukocyte pure number fraction cerebral spinal fluid manual count,0.024056587682309005,0.086573444
16997-9,calcium in serum,hydrogen expired gas volume fraction exhaled gas post dose glucose,0.024056587682309005,0.073232345
30443-6,calcium in serum,mononuclear cell leukocyte gastric fluid,0.024056587682309005,0.06301421
71660-5,calcium in serum,lymphocyte leukocyte pure number fraction cerebral spinal fluid manual count,0.024056587682309005,0.08976353
18309-5,calcium in serum,nucleated erythrocyte leukocyte ratio blood manual count,0.024056587682309005,0.0926942
14760-3,calcium in serum,glucose mole volume capillary blood 2 hour post meal,0.024056587682309005,0.10325824
71629-0,calcium in serum,mononuclear cell leukocyte pure number fraction peritoneal fluid manual count,0.024056587682309005,0.08243725
737-7,calcium in serum,lymphocyte leukocyte blood manual count,0.024056587682309005,0.08213355
50724-4,calcium in serum,lymphoblast leukocyte bone marrow manual count,0.024056587682309005,0.08233716
48034-3,calcium in serum,leukocyte volume corrected nucleated erythrocyte cerebral spinal fluid,0.024056587682309005,0.09276479
104875-0,calcium in serum,hematocrit volume fraction blood 30 minute post dose glucose,0.024056587682309005,0.0993644
12209-3,calcium in serum,eosinophil leukocyte body fluid manual count,0.024056587682309005,0.07160888
71672-0,calcium in serum,monocyte leukocyte pure number fraction blood manual count,0.024056587682309005,0.09080012
73900-3,calcium in serum,cd3 cd8 cd57 cell leukocyte blood flow cytometry fc,0.024056587682309005,0.085592665
34469-7,calcium in serum,leukocyte presence bile fluid light microscopy,0.024056587682309005,0.06640888
71611-8,calcium in serum,leukocyte leukocyte pure number fraction pleural fluid manual count,0.024056587682309005,0.07993764
53126-9,calcium in serum,monocyte macrophage leukocyte blood,0.024056587682309005,0.08439121
58089-4,calcium in serum,glucose 6 phosphate dehydrogenase newborn screen interpretation,0.024056587682309005,0.08602807
32174-5,glucose in blood,glucose presence 24 hour urine,1.0,0.7801514
40160-4,glucose in blood,glucose mole volume serum plasma 75 minute post xxx challenge,1.0,0.450664
25428-4,glucose in blood,glucose presence urine test strip,1.0,0.76996773
40028-3,glucose in blood,glucose mass volume serum plasma 12 minute post xxx challenge,1.0,0.4676806
2344-0,glucose in blood,glucose mass volume body fluid,1.0,0.8146568
54251-4,glucose in blood,glucose mole volume serum plasma 20 minute post dose glucagon,1.0,0.46440563
54250-6,glucose in blood,glucose mole volume serum plasma 15 minute pre dose glucagon,1.0,0.46324998
102018-9,glucose in blood,glucose mass volume serum plasma 1 hour post dose glucagon,1.0,0.4752738
101476-0,glucose in blood,fasting glucose mole volume venous blood,1.0,0.44392818
59812-8,glucose in blood,glucose mole volume serum plasma 11 specimen,1.0,0.46241644
54397-5,glucose in blood,glucose mole volume serum plasma 3rd specimen post xxx challenge,1.0,0.45231482
26543-9,glucose in blood,glucose mass volume serum plasma 5 hour post dose glucose,1.0,0.48386154
97507-8,glucose in blood,average glucose mass volume interstitial fluid reporting period,1.0,0.80991614
2341-6,glucose in blood,glucose mass volume blood test strip manual,1.0,0.98618686
30267-9,glucose in blood,glucose mole volume serum plasma 2 3 hour post dose glucose,1.0,0.4663295
1512-3,glucose in blood,glucose mass volume serum plasma 1 minute post 0 5 g kg glucose iv,1.0,0.48534527
51596-5,glucose in blood,glucose mole volume capillary blood,1.0,0.7881648
76672-5,glucose in blood,glucose mole volume cerebral spinal fluid 4th tube,1.0,0.44237986
1552-9,glucose in blood,glucose mass volume serum plasma pre 75 g glucose po,1.0,0.4802422
40209-9,glucose in blood,glucose mole volume serum plasma 25 minute post xxx challenge,1.0,0.45569202
40203-2,glucose in blood,glucose mole volume serum plasma 9 minute post xxx challenge,1.0,0.45568216
42609-8,glucose in blood,glucose mass volume urine 6 hour post dose lactose po,1.0,0.4544914
92818-4,glucose in blood,glucose mass volume serum plasma 20 minute post dose glucagon,1.0,0.47561458
26540-5,glucose in blood,glucose mass volume urine 3 hour post dose glucose,1.0,0.47468945
59793-0,glucose in blood,glucose molar concentration difference serum plasma 1 5 hour post xxx challenge,1.0,0.4454531
25670-1,glucose in blood,glucose mass volume urine 30 minute post dose glucose,1.0,0.46803093
48810-6,glucose in blood,glucose mass volume serum plasma 5 hour post 50 g glucose po,1.0,0.47651398
102032-0,glucose in blood,glucose mass volume serum plasma 2 hour post dose insulin iv,1.0,0.46480983
14743-9,glucose in blood,glucose mole volume capillary blood glucometer,1.0,0.8124786
51595-7,glucose in blood,glucose presence stool,1.0,0.75969744
40850-0,glucose in blood,glucose mass volume urine test strip 2nd specimen post xxx challenge,1.0,0.4578056
33287-4,glucose in blood,glucose 6 phosphate dehydrogenase presence db,1.0,0.5057962
45205-2,glucose in blood,glucose mass volume urine test strip 4th specimen post xxx challenge,1.0,0.45731887
12646-6,glucose in blood,glucose mass volume serum plasma 1 hour post xxx challenge,1.0,0.47303042
14771-0,glucose in blood,fasting glucose mole volume serum plasma,1.0,0.4657928
14754-6,glucose in blood,glucose mole volume serum plasma 1 hour post 50 g glucose po,1.0,0.47268397
29331-6,glucose in blood,glucose mass volume serum plasma 5 hour post xxx challenge,1.0,0.46425423
45297-9,glucose in blood,glucose mole volume 24 hour dialysis fluid,1.0,0.7905158
53093-1,glucose in blood,glucose mole volume serum plasma post xxx challenge,1.0,0.45718336
26778-1,glucose in blood,glucose mass volume serum plasma 1 hour post dose lactose po,1.0,0.4623087
74686-7,glucose in blood,glucose mole time 12 hour urine,1.0,0.808135
45204-5,glucose in blood,glucose mass volume urine test strip 3rd specimen post xxx challenge,1.0,0.4578291
6777-7,glucose in blood,deprecated glucose mass volume serum plasma,1.0,0.8127553
87422-2,glucose in blood,glucose mass volume blood post meal,1.0,0.64599246
1518-0,glucose in blood,glucose mass volume serum plasma 2 hour post 75 g glucose po,1.0,0.47970194
40154-7,glucose in blood,glucose mole volume serum plasma 10 minute post xxx challenge,1.0,0.45142335
14756-1,glucose in blood,glucose mole volume serum plasma 1 hour post dose glucose,1.0,0.47161394
25680-0,glucose in blood,glucose mole volume serum plasma pre 50 g glucose po,1.0,0.47174725
6754-6,glucose in blood,glucose presence urine test strip 30 minute post 75 g glucose po,1.0,0.44009066
72648-9,glucose in blood,glucose serum glucose synovial fluid molar concentration difference,1.0,0.4502976
40004-4,glucose in blood,glucose mass volume serum plasma 100 minute post xxx challenge,1.0,0.46686807
1513-1,glucose in blood,glucose mass volume serum plasma 20 minute post 0 5 g kg glucose iv,1.0,0.4803161
12645-8,glucose in blood,glucose mass volume serum plasma 10 hour post xxx challenge,1.0,0.46839312
6755-3,glucose in blood,glucose presence urine test strip 3 hour post 75 g glucose po,1.0,0.44193363
1508-1,glucose in blood,deprecated glucose mass volume serum plasma 1 hour post 75 g glucose po,1.0,0.46608305
99602-5,glucose in blood,glucose creatinine molar ratio 24 hour urine,1.0,0.45492038
12642-5,glucose in blood,glucose mass volume serum plasma 7 5 hour post xxx challenge,1.0,0.46717584
40213-1,glucose in blood,glucose mole volume serum plasma 5 5 hour post xxx challenge,1.0,0.45454183
30263-8,glucose in blood,glucose mole volume serum plasma 20 minute post dose glucose,1.0,0.46369132
10449-7,glucose in blood,glucose mass volume serum plasma 1 hour post meal,1.0,0.4732408
48989-8,glucose in blood,glucose mass volume serum plasma 6 pm specimen,1.0,0.47807577
12632-6,glucose in blood,glucose mass volume peritoneal dialysis fluid 3rd specimen,1.0,0.46065822
32318-8,glucose in blood,glucose mole volume specimen,1.0,0.78909767
76629-5,glucose in blood,fasting glucose mole volume blood,1.0,0.6408004
54271-2,glucose in blood,glucose mole volume serum plasma 15 minute post dose ornithine alpha ketoglutarate,1.0,0.4399378
40167-9,glucose in blood,glucose mole volume serum plasma 7 hour post xxx challenge,1.0,0.45110992
72651-3,glucose in blood,glucose serum glucose pleural fluid molar concentration difference,1.0,0.46389812
54395-9,glucose in blood,glucose mole volume serum plasma 12th specimen post xxx challenge,1.0,0.4527445
26537-1,glucose in blood,glucose presence urine test strip 2 5 hour post dose glucose,1.0,0.44164526
39479-1,glucose in blood,glucose mole volume pericardial fluid,1.0,0.78378445
54257-1,glucose in blood,glucose mole volume serum plasma pre dose insulin iv,1.0,0.454056
12652-4,glucose in blood,glucose mass volume serum plasma 2 minute post xxx challenge,1.0,0.4662919
40183-6,glucose in blood,glucose mole volume serum plasma 17 5 hour post xxx challenge,1.0,0.4518142
48990-6,glucose in blood,glucose mass volume serum plasma 8 pm specimen,1.0,0.47750056
53084-0,glucose in blood,glucose mole volume nonbiological fluid,1.0,0.79105616
6756-1,glucose in blood,glucose mass volume serum plasma 4 5 hour post 75 g glucose po,1.0,0.47969255
12638-3,glucose in blood,glucose mass volume serum plasma pre dose lactose po,1.0,0.46350676
21309-0,glucose in blood,glucose mass volume serum plasma 45 minute post xxx challenge,1.0,0.46969658
40208-1,glucose in blood,glucose mole volume serum plasma 22 minute post xxx challenge,1.0,0.4532103
12620-1,glucose in blood,glucose mass volume serum plasma 6th specimen post xxx challenge,1.0,0.46870533
29329-0,glucose in blood,glucose mass volume serum plasma 3 5 hour post xxx challenge,1.0,0.46802318
12631-8,glucose in blood,glucose mass volume peritoneal dialysis fluid 2nd specimen,1.0,0.4602811
54260-5,glucose in blood,glucose mole volume serum plasma 15 minute post dose insulin iv,1.0,0.45389277
44919-9,glucose in blood,glucose mole volume serum plasma 1 5 hour post meal,1.0,0.4668787
40030-9,glucose in blood,glucose mass volume serum plasma 16 minute post xxx challenge,1.0,0.46572995
75405-1,glucose in blood,glucose mole volume serum plasma 1 5 hour post dose triple bolus,1.0,0.45873094
30252-1,glucose in blood,glucose mole volume serum plasma 3 3 hour post dose glucose,1.0,0.4661879
1530-5,glucose in blood,glucose mass volume serum plasma 3 hour post 100 g glucose po,1.0,0.4786369
54497-3,glucose in blood,glucose mole volume serum plasma 6th specimen post xxx challenge,1.0,0.45375976
54269-6,glucose in blood,glucose mole volume serum plasma 2 hour post dose ornithine alpha ketoglutarate,1.0,0.44544074
16906-0,glucose in blood,glucose presence urine 3rd specimen post xxx challenge,1.0,0.43105304
12639-1,glucose in blood,glucose mass volume serum plasma 15 minute post xxx challenge,1.0,0.46674183
40276-8,glucose in blood,glucose mole volume serum plasma 30 minute post dose lactose po,1.0,0.45170316
16903-7,glucose in blood,glucose mass volume vitreous fluid,1.0,0.8084692
6750-4,glucose in blood,glucose presence urine test strip 2 hour post 50 g lactose po,1.0,0.43158072
53094-9,glucose in blood,glucose mole volume serum plasma post meal,1.0,0.46415836
40009-3,glucose in blood,glucose mass volume serum plasma 12 5 hour post xxx challenge,1.0,0.46851027
25676-8,glucose in blood,glucose mole volume serum plasma 5 5 hour post dose glucose,1.0,0.4679928
13607-7,glucose in blood,glucose mass volume serum plasma 4 hour post 50 g lactose po,1.0,0.47040856
97778-5,glucose in blood,glucose mole volume dialysis fluid 1 hour specimen,1.0,0.44892657
92819-2,glucose in blood,glucose mass volume serum plasma 10 minute post dose glucagon,1.0,0.4769411
26549-6,glucose in blood,glucose presence urine test strip 3 hour post dose glucose,1.0,0.44413754
95104-6,glucose in blood,glucose mass volume serum plasma 3 5 hour post meal,1.0,0.47407115
54398-3,glucose in blood,glucose mole volume serum plasma 4th specimen post xxx challenge,1.0,0.45169127
13865-1,glucose in blood,glucose mass volume serum plasma 2 5 hour post 50 g lactose po,1.0,0.46989384
102021-3,glucose in blood,glucose mass volume serum plasma 2 5 hour post dose glucagon,1.0,0.47130036
40165-3,glucose in blood,glucose mole volume serum plasma 6 hour post xxx challenge,1.0,0.4533117
40319-6,glucose in blood,glucose mole volume serum plasma 15 minute post dose triple bolus,1.0,0.45517504
54262-1,glucose in blood,glucose mole volume serum plasma 3 hour pre dose insulin iv,1.0,0.45300207
48605-0,glucose in blood,glucose mass volume serum plasma 1 hour post dose fructose po,1.0,0.47129127
34058-8,glucose in blood,glucose mole volume serum plasma pre post dose glucagon,1.0,0.46663132
16912-8,glucose in blood,glucose presence urine 9th specimen post xxx challenge,1.0,0.42748865
30344-6,glucose in blood,glucose mass volume serum plasma 1 hour post 1 2 g kg lactose po,1.0,0.47093293
40153-9,glucose in blood,glucose mole volume serum plasma 5 minute post xxx challenge,1.0,0.4514304
2800-1,glucose in blood,deprecated glucose phosphate isomerase enzymatic activity volume serum,1.0,0.4696756
40172-9,glucose in blood,glucose mole volume serum plasma 9 5 hour post xxx challenge,1.0,0.4525668
48991-4,glucose in blood,glucose mass volume serum plasma 10 pm specimen,1.0,0.47685462
40176-0,glucose in blood,glucose mole volume serum plasma 12 hour post xxx challenge,1.0,0.45432052
21004-7,glucose in blood,glucose tolerance interpretation serum plasma,1.0,0.45927048
12656-5,glucose in blood,glucose mass volume serum plasma 4 minute post xxx challenge,1.0,0.46653047
40186-9,glucose in blood,glucose mole volume serum plasma 19 5 hour post xxx challenge,1.0,0.45029864
48787-6,glucose in blood,glucose mass volume peritoneal fluid 24 hour post peritoneal dialysis,1.0,0.45449182
69941-3,glucose in blood,glucose mole volume serum plasma 20 minute post dose lactose po,1.0,0.45367688
2348-1,glucose in blood,glucose mass volume synovial fluid,1.0,0.7917325
53475-0,glucose in blood,glucose mole volume serum plasma pre dose betaxolol,1.0,0.45205507
40024-2,glucose in blood,glucose mass volume serum plasma 1 day post xxx challenge,1.0,0.46832764
1542-0,glucose in blood,glucose mass volume serum plasma 5 hour post 75 g glucose po,1.0,0.4809934
20437-0,glucose in blood,glucose mass volume serum plasma 3 hour post dose glucose,1.0,0.4839853
40196-8,glucose in blood,glucose mole volume serum plasma 8 minute pre xxx challenge,1.0,0.4499211
50212-0,glucose in blood,glucose mass volume serum plasma 2nd specimen,1.0,0.48672375
15077-1,glucose in blood,glucose mole time 24 hour urine,1.0,0.8058263
12610-2,glucose in blood,glucose mass volume serum plasma 2 hour post xxx challenge,1.0,0.4700143
54392-6,glucose in blood,glucose mole volume serum plasma 1st specimen post xxx challenge,1.0,0.4556479
25667-7,glucose in blood,glucose mass volume urine 2 hour post dose glucose,1.0,0.4717731
29330-8,glucose in blood,glucose mass volume serum plasma 4 hour post xxx challenge,1.0,0.46372062
48984-9,glucose in blood,glucose mass volume serum plasma 10 minute post dose glucose,1.0,0.479148
40198-4,glucose in blood,glucose mole volume serum plasma 2 minute post xxx challenge,1.0,0.45093843
40169-5,glucose in blood,glucose mole volume serum plasma 8 hour post xxx challenge,1.0,0.45160237
2358-0,glucose in blood,glucose 6 phosphate dehydrogenase presence serum,1.0,0.43917596
1503-2,glucose in blood,glucose mass volume urine 1 hour post 100 g glucose po,1.0,0.47350976
25669-3,glucose in blood,glucose mole volume serum plasma 3 5 hour post dose glucose,1.0,0.47320253
9375-7,glucose in blood,glucose mass volume serum plasma 2 5 hour post 100 g glucose po,1.0,0.48165438
40324-6,glucose in blood,glucose mole volume serum plasma 3 hour post dose triple bolus,1.0,0.45593846
25664-4,glucose in blood,glucose mass volume urine 1 hour post dose glucose,1.0,0.4701008
54400-7,glucose in blood,glucose mole volume serum plasma pre dose glucagon,1.0,0.46807954
95108-7,glucose in blood,glucose mass volume serum plasma 4 hour post meal,1.0,0.47294727
21306-6,glucose in blood,glucose mass time 8 hour urine,1.0,0.81569076
40180-2,glucose in blood,glucose mole volume serum plasma 14 hour post xxx challenge,1.0,0.45056096
16170-3,glucose in blood,glucose mass volume serum plasma 5 pm specimen,1.0,0.48106122
42629-6,glucose in blood,glucose mass volume urine 4 hour post dose lactose po,1.0,0.45581427
1526-3,glucose in blood,glucose mass volume serum plasma 30 minute post 50 g lactose po,1.0,0.46878517
54487-4,glucose in blood,glucose mole volume water,1.0,0.7934153
6747-0,glucose in blood,glucose presence urine test strip 1 hour post 50 g lactose po,1.0,0.43655074
1522-2,glucose in blood,glucose mass volume serum plasma 30 minute post 0 5 g kg glucose iv,1.0,0.4803766
50208-8,glucose in blood,glucose mass volume serum plasma 10th specimen,1.0,0.48324463
50216-1,glucose in blood,glucose mass volume serum plasma 6th specimen,1.0,0.4865131
78535-2,glucose in blood,glucose mole volume peritoneal dialysis fluid 4 hour dwell specimen,1.0,0.44261146
96799-2,glucose in blood,glucose mass volume serum plasma 30 minute post dose arginine,1.0,0.45886064
41024-1,glucose in blood,glucose mass volume serum plasma 2 hour post 50 g glucose po,1.0,0.47754228
40211-5,glucose in blood,glucose mole volume serum plasma 3 5 hour post xxx challenge,1.0,0.45559573
14137-4,glucose in blood,glucose mass volume serum plasma 5 5 hour post 75 g glucose po,1.0,0.4749145
81637-1,glucose in blood,glucose meter reference method correlation ratio serum plasma blood calculation,1.0,0.54227734
53481-8,glucose in blood,glucose mole volume serum plasma 15 minute pre dose betaxolol,1.0,0.44694892
1534-7,glucose in blood,glucose mass volume serum plasma 3 minute post 0 5 g kg glucose iv,1.0,0.4805258
12658-1,glucose in blood,glucose mass volume serum plasma 50 minute post xxx challenge,1.0,0.46527728
39480-9,glucose in blood,glucose mole volume venous blood,1.0,0.7919455
40161-2,glucose in blood,glucose mole volume serum plasma 2 5 hour post xxx challenge,1.0,0.45252162
17865-7,glucose in blood,glucose mass volume serum plasma 8 hour fasting,1.0,0.4791904
21307-4,glucose in blood,glucose mass time 10 hour urine,1.0,0.8169055
1499-3,glucose in blood,glucose mass volume serum plasma 1 hour post 0 5 g kg glucose iv,1.0,0.4882745
40191-9,glucose in blood,glucose mole volume serum plasma 23 5 hour post xxx challenge,1.0,0.45162553
75637-9,glucose in blood,glucose mole volume serum plasma 45 minute post 50 g lactose po,1.0,0.45965147
34056-2,glucose in blood,glucose mole volume serum plasma pre post dose arginine,1.0,0.4473518
6689-4,glucose in blood,glucose mass volume blood 2 hour post meal,1.0,0.6533
54254-8,glucose in blood,glucose mole volume serum plasma 5 minute pre dose glucagon,1.0,0.46136218
25663-6,glucose in blood,glucose mole volume serum plasma 15 minute post dose glucose,1.0,0.4714819
54270-4,glucose in blood,glucose mole volume serum plasma 2 5 hour post dose ornithine alpha ketoglutarate,1.0,0.44153142
26854-0,glucose in blood,glucose unit volume serum plasma 8th specimen post xxx challenge,1.0,0.44426304
54401-5,glucose in blood,glucose mole volume serum plasma 10 minute post dose glucagon,1.0,0.4660105
79195-4,glucose in blood,glucose mass volume serum plasma 45 minute post dose arginine insulin,1.0,0.45809093
40005-1,glucose in blood,glucose mass volume serum plasma 110 minute post xxx challenge,1.0,0.46848238
14768-6,glucose in blood,glucose mole volume serum plasma baseline,1.0,0.47073898
10450-5,glucose in blood,glucose mass volume serum plasma 10 hour fasting,1.0,0.47131613
40148-9,glucose in blood,glucose mole volume serum plasma pre xxx challenge,1.0,0.45432675
12220-0,glucose in blood,glucose mass volume peritoneal fluid 12 hour post peritoneal dialysis,1.0,0.45749342
2345-7,glucose in blood,glucose mass volume serum plasma,1.0,0.8250268
53929-6,glucose in blood,glucose mass volume serum plasma 40 minute post 50 g lactose po,1.0,0.46779913
40184-4,glucose in blood,glucose mole volume serum plasma 18 hour post xxx challenge,1.0,0.45084408
41652-9,glucose in blood,glucose mass volume venous blood,1.0,0.80406463
6759-5,glucose in blood,glucose presence urine test strip 6 hour post 75 g glucose po,1.0,0.44307968
96802-4,glucose in blood,glucose mass volume serum plasma 1 5 hour post dose arginine,1.0,0.45955437
1554-5,glucose in blood,glucose mass volume serum plasma 12 hour fasting,1.0,0.47522378
6763-7,glucose in blood,glucose presence urine test strip 1 5 hour post 75 g glucose po,1.0,0.44125488
14750-4,glucose in blood,glucose mole volume synovial fluid,1.0,0.7804839
40152-1,glucose in blood,glucose mole volume serum plasma 5 minute pre xxx challenge,1.0,0.4506618
26817-7,glucose in blood,glucose mass volume serum plasma 11 hour post xxx challenge,1.0,0.46372503
30346-1,glucose in blood,glucose mass volume serum plasma 3 hour post 1 2 g kg lactose po,1.0,0.46922252
54498-1,glucose in blood,glucose mole volume serum plasma 7th specimen post xxx challenge,1.0,0.45131725
26552-0,glucose in blood,glucose presence urine test strip 6 hour post dose glucose,1.0,0.44390616
9307-0,glucose in blood,insulin mass volume serum plasma 30 minute post 75 g glucose po,0.9850515637274858,0.45597923
27940-6,glucose in blood,deprecated insulin unit volume serum plasma 1 5 hour post 75 g glucose po,0.9850515637274858,0.45104522
16985-4,glucose in blood,hydrogen expired gas volume fraction exhaled gas 1 5 hour post dose glucose,0.9850515637274858,0.4342743
55479-0,glucose in blood,insulin mole volume serum plasma 7 minute post dose glucose iv,0.9850515637274858,0.44974738
2437-2,glucose in blood,hydrogen expired gas volume fraction exhaled gas post 50 g glucose po,0.9850515637274858,0.42918286
72604-2,glucose in blood,insulin unit volume serum plasma 4 5 hour post 75 g glucose po,0.9850515637274858,0.44747227
48244-8,glucose in blood,red cedar triggered leukotriene release mass volume leukocyte,0.9850515637274858,0.08139582
55497-2,glucose in blood,insulin mole volume serum plasma 3 minute post dose glucose iv,0.9850515637274858,0.4488303
40294-1,glucose in blood,insulin mole volume serum plasma pre post dose glucose,0.9850515637274858,0.4564741
1572-7,glucose in blood,insulin mass volume serum plasma pre 75 g glucose po,0.9850515637274858,0.45975384
16991-2,glucose in blood,hydrogen expired gas volume fraction exhaled gas 4 5 hour post dose glucose,0.9850515637274858,0.43776697
55493-1,glucose in blood,insulin mole volume serum plasma 3 hour post dose glucose iv,0.9850515637274858,0.44953737
47658-0,glucose in blood,insulin unit volume serum plasma 1 5 hour post dose glucose,0.9850515637274858,0.44928345
16988-8,glucose in blood,hydrogen expired gas volume fraction exhaled gas 2 hour post dose glucose,0.9850515637274858,0.43477905
1564-4,glucose in blood,insulin mass volume serum plasma 2 hour post 75 g glucose po,0.9850515637274858,0.45793813
55485-7,glucose in blood,insulin mole volume serum plasma 1 hour post dose glucose iv,0.9850515637274858,0.4482794
47664-8,glucose in blood,insulin unit volume serum plasma 3 minute post dose glucose,0.9850515637274858,0.4491121
47589-7,glucose in blood,component peptide mole volume serum plasma 30 minute post dose glucose,0.9350633802862388,0.45637947
58624-8,glucose in blood,corticotropin mass volume plasma pre dose glucose,0.9350633802862388,0.45921344
58584-4,glucose in blood,corticotropin mole volume plasma 30 minute post dose glucose,0.9350633802862388,0.44359782
58519-0,glucose in blood,component peptide mole volume serum plasma 5 hour post dose glucose,0.9350633802862388,0.4512395
58597-6,glucose in blood,corticotropin mole volume plasma 3 hour post dose glucose,0.9350633802862388,0.44588685
101977-7,glucose in blood,cortisol glucose somatotropin post glucagon stimulation panel serum plasma,0.9350633802862388,0.42432198
104635-8,glucose in blood,continuous glucose monitor device date time reporting period end reported,0.9350633802862388,0.41795623
58509-1,glucose in blood,component peptide mole volume serum plasma 3 5 hour post dose glucose,0.9350633802862388,0.4490639
58528-1,glucose in blood,corticotropin mass volume plasma 1 5 hour post dose glucose,0.9350633802862388,0.45633167
47595-4,glucose in blood,component peptide mole volume serum plasma pre dose glucose,0.9350633802862388,0.45816588
47586-3,glucose in blood,component peptide mole volume serum plasma 1 hour post dose glucose,0.9350633802862388,0.45656312
58517-4,glucose in blood,component peptide mole volume serum plasma 4 hour post dose glucose,0.9350633802862388,0.4479485
58568-7,glucose in blood,corticotropin mole volume plasma 2 5 hour post dose glucose,0.9350633802862388,0.4442405
106793-3,glucose in blood,continuous glucose monitoring time range panel,0.9350633802862388,0.42576775
47587-1,glucose in blood,component peptide mole volume serum plasma 1 minute post dose glucose,0.9350633802862388,0.45560637
58518-2,glucose in blood,component peptide mass volume serum plasma 5 hour post dose glucose,0.9350633802862388,0.45522553
58500-0,glucose in blood,component peptide mass volume serum plasma 15 minute post dose glucose,0.9350633802862388,0.45940924
58522-4,glucose in blood,component peptide mass volume serum plasma pre dose glucose,0.9350633802862388,0.45684928
47591-3,glucose in blood,component peptide mole volume serum plasma 3 minute post dose glucose,0.9350633802862388,0.45565873
58494-6,glucose in blood,component peptide mass volume serum plasma 1 5 hour post dose glucose,0.9350633802862388,0.45587283
58515-8,glucose in blood,component peptide mole volume serum plasma 45 minute post dose glucose,0.9350633802862388,0.448304
58625-5,glucose in blood,corticotropin mole volume plasma pre dose glucose,0.9350633802862388,0.44737977
71608-4,glucose in blood,granulocyte leukocyte pure number fraction pleural fluid manual count,0.8480907193093173,0.0767128
48231-5,glucose in blood,glycyphagus domesticus triggered leukotriene release mass volume leukocyte,0.8480907193093173,0.08918397
71627-4,glucose in blood,granulocyte leukocyte pure number fraction peritoneal fluid manual count,0.8480907193093173,0.078279495
1943-0,glucose in blood,glucosylceramidase enzymatic activity volume leukocyte,0.8480907193093173,0.123123445
104878-4,glucose in blood,hematocrit volume fraction blood 2 hour post dose glucose,0.8480907193093173,0.6292718
58091-0,glucose in blood,glucose 6 phosphate dehydrogenase newborn screen panel,0.8251312484095968,0.508068
2355-6,glucose in blood,glucose 6 phosphatase enzymatic activity mass tissue,0.8251312484095968,0.4518205
24353-5,glucose in blood,glucose tolerance 2 hour gestational panel urine serum plasma,0.8251312484095968,0.4546482
33988-7,glucose in blood,thymidine phosphorylase enzymatic activity mass leukocyte,0.8034128384442925,0.08197869
74542-2,glucose in blood,pyruvate kinase glucose 6 phosphate dehydrogenase enzymatic activity ratio red blood cell,0.8034128384442925,0.4426395
34689-0,glucose in blood,sulfatidase enzymatic activity volume leukocyte,0.8034128384442925,0.09791119
48271-1,glucose in blood,tetracycline triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.07807871
48192-9,glucose in blood,sunset yellow fcf triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.07659041
83114-9,glucose in blood,s100 calcium binding protein b mass volume serum immunoassay,0.8034128384442925,0.073066995
48222-4,glucose in blood,rye triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.07929592
34546-2,glucose in blood,protein glucose panel mass volume cerebral spinal fluid,0.8034128384442925,0.44129762
48286-9,glucose in blood,rocuronium triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.0758877
17778-2,glucose in blood,zinc mass volume leukocyte,0.8034128384442925,0.08574931
48260-4,glucose in blood,timothy triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.0805451
79469-3,glucose in blood,uridine diphosphate glucose 4 epimerase enzymatic activity mass red blood cell,0.8034128384442925,0.4466566
48252-1,glucose in blood,saltwort triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.079818904
48292-7,glucose in blood,sodium salicylate triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.08113667
48223-2,glucose in blood,wheat triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.08058371
55507-8,glucose in blood,somatotropin mass volume serum plasma 2 hour post dose glucose,0.8034128384442925,0.4537087
82937-4,glucose in blood,sap xiap interpretation leukocyte flow cytometry fc,0.8034128384442925,0.06494614
48219-0,glucose in blood,sesame seed triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.075876795
48290-1,glucose in blood,sodium nitrite triggered leukotriene release mass volume leukocyte,0.8034128384442925,0.09182483
55510-2,glucose in blood,somatotropin mass volume serum plasma 1 5 hour post dose glucose,0.8034128384442925,0.45301402
47776-0,glucose in blood,somatotropin unit volume serum plasma pre dose glucose po,0.8034128384442925,0.43670842
48263-8,glucose in blood,cocksfoot triggered leukotriene release mass volume leukocyte,0.735371290940501,0.09192125
48224-0,glucose in blood,codfish triggered leukotriene release mass volume leukocyte,0.735371290940501,0.09059906
48264-6,glucose in blood,bermuda grass triggered leukotriene release mass volume leukocyte,0.735371290940501,0.084401496
92666-7,glucose in blood,growth hormone glucose post clonidine stimulation panel serum plasma,0.6732219677189143,0.4239261
71696-9,glucose in blood,granulocyte leukocyte body fluid automated count,0.6732219677189143,0.08109137
14377-6,glucose in blood,granulocyte leukocyte semen manual count,0.6732219677189143,0.078436285
5556-6,glucose in blood,deprecated gpa blood,0.6732219677189143,0.08516146
70036-9,glucose in blood,granulocyte leukocyte pericardial fluid automated count,0.6732219677189143,0.071183346
30396-6,glucose in blood,granulocyte leukocyte bronchial specimen,0.6732219677189143,0.0664131
74141-3,glucose in blood,granulocyte leukocyte peritoneal dialysis fluid,0.6732219677189143,0.07765732
90996-0,glucose in blood,hedis 2019 2020 value set glucose test,0.6732219677189143,0.4202775
14374-3,glucose in blood,granulocyte leukocyte pleural fluid manual count,0.6732219677189143,0.07350247
69004-0,glucose in blood,immature granulocyte leukocyte body fluid,0.6732219677189143,0.08072696
33963-0,glucose in blood,granulocyte leukocyte cerebral spinal fluid,0.6732219677189143,0.06836616
26520-7,glucose in blood,granulocyte leukocyte peritoneal fluid,0.6732219677189143,0.08384349
19023-1,glucose in blood,granulocyte leukocyte blood automated count,0.6732219677189143,0.26291463
30395-8,glucose in blood,granulocyte leukocyte blood,0.6732219677189143,0.2653536
70067-4,glucose in blood,granulocyte leukocyte pleural fluid automated count,0.6732219677189143,0.07267579
30157-2,glucose in blood,heterophils leukocyte blood,0.6732219677189143,0.2537462
30462-6,glucose in blood,granulocyte leukocyte urine,0.6732219677189143,0.08726317
48248-9,glucose in blood,hazelnut pollen triggered leukotriene release mass volume leukocyte,0.39368655761105065,0.07534026
4530-2,glucose in blood,deprecated complement receptor 4,0.39368655761105065,0.063758016
4527-8,glucose in blood,deprecated complement receptor 1,0.39368655761105065,0.064880595
79087-3,glucose in blood,ct heart coronary artery calcium scoring wo contrast,0.3477971533046693,0.03594061
74891-3,glucose in blood,medium chain acyl coa dehydrogenase enzymatic activity mass leukocyte,0.3477971533046693,0.08695843
48206-7,glucose in blood,lactalbumin alpha triggered leukotriene release mass volume leukocyte,0.3477971533046693,0.084554344
47718-2,glucose in blood,parathyrin mass volume serum plasma 4 hour post dose calcium,0.3477971533046693,0.08713497
48259-6,glucose in blood,kentucky blue grass triggered leukotriene release mass volume leukocyte,0.3477971533046693,0.08193062
24098-6,glucose in blood,n acetylglucosamine 6 sulfatase enzymatic activity mass leukocyte,0.3477971533046693,0.106600136
41900-2,glucose in blood,glucose meter device vendor software version,0.3477971533046693,0.10376555
104072-4,glucose in blood,mucopolysaccharidosis enzyme panel leukocyte,0.3477971533046693,0.06577234
48250-5,glucose in blood,pellitory parietaria judaica triggered leukotriene release mass volume leukocyte,0.3477971533046693,0.08361984
24819-5,glucose in blood,deprecated liver spleen nm w tc 99m calcium colloid iv,0.3477971533046693,0.04344102
48191-1,glucose in blood,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.3477971533046693,0.09497223
5560-8,glucose in blood,deprecated smig,0.3477971533046693,0.06051488
48233-1,glucose in blood,lepidoglyphus destructor triggered leukotriene release mass volume leukocyte,0.3477971533046693,0.08283736
24346-9,glucose in blood,parathyrin intact calcium panel serum plasma,0.3477971533046693,0.076547526
62875-0,glucose in blood,phenx assay human leukocyte antigen hla genotyping protocol 160601,0.3477971533046693,0.056252975
74935-8,glucose in blood,palmitoyl protein thioesterase enzymatic activity mass leukocyte,0.3477971533046693,0.07484193
58407-8,glucose in blood,leukocyte morphology panel blood,0.3477971533046693,0.25940034
24094-5,glucose in blood,n acetylgalactosamine 4 sulfatase enzymatic activity mass leukocyte,0.3477971533046693,0.095691726
24096-0,glucose in blood,n acetylgalactosamine 6 sulfatase enzymatic activity mass leukocyte,0.3477971533046693,0.10496175
48258-8,glucose in blood,cultivated rye triggered leukotriene release mass volume leukocyte,0.3477971533046693,0.07544711
48183-8,glucose in blood,paper wasp triggered leukotriene release mass volume leukocyte,0.3477971533046693,0.08024555
5564-0,glucose in blood,deprecated tcr cd3,0.3477971533046693,0.05315378
93704-5,glucose in blood,palmitoyl protein thioesterase 1 tripeptidyl peptidase 1 panel leukocyte,0.3477971533046693,0.053466663
50672-5,glucose in blood,leukocyte toxic vacuole presence blood light microscopy,0.20602639536240486,0.25471047
62858-6,glucose in blood,micromegakaryocytes leukocyte blood manual count,0.20602639536240486,0.2638311
13599-6,glucose in blood,promonocytes leukocyte blood manual count,0.20602639536240486,0.26387703
15197-7,glucose in blood,lymphocyte clefted leukocyte blood manual count,0.20602639536240486,0.25218248
29261-5,glucose in blood,abnormal lymphocyte leukocyte blood manual count,0.20602639536240486,0.24976112
99051-5,glucose in blood,leukocyte volume bronchoalveolar lavage manual count,0.20602639536240486,0.08849722
26471-3,glucose in blood,leukocyte leukocyte blood,0.20602639536240486,0.27026206
71673-8,glucose in blood,lymphocyte leukocyte pure number fraction blood manual count,0.20602639536240486,0.25748152
53797-7,glucose in blood,neutrophil immature leukocyte blood,0.20602639536240486,0.25344208
33857-4,glucose in blood,sezary cell leukocyte blood manual count,0.20602639536240486,0.25412768
26511-6,glucose in blood,neutrophil leukocyte blood,0.20602639536240486,0.26507
740-1,glucose in blood,metamyelocytes leukocyte blood manual count,0.20602639536240486,0.26552966
34920-9,glucose in blood,lymphocyte immunoblastic leukocyte blood,0.20602639536240486,0.25990427
4662-3,glucose in blood,lymphocyte monocyte leukocyte blood,0.20602639536240486,0.26587057
17790-7,glucose in blood,leukocyte left shift presence blood automated count,0.20602639536240486,0.24120921
30423-8,glucose in blood,lymphoma cell leukocyte blood,0.20602639536240486,0.25392067
34922-5,glucose in blood,lymphoblast leukocyte blood,0.20602639536240486,0.26786736
49550-7,glucose in blood,cd59 deficient leukocyte cell blood,0.20602639536240486,0.24823394
71678-7,glucose in blood,lymphocyte leukocyte pure number fraction blood automated count,0.20602639536240486,0.2567742
30466-7,glucose in blood,promonocytes leukocyte blood,0.20602639536240486,0.2636681
74457-3,glucose in blood,neutrophil leukocyte cord blood,0.20602639536240486,0.07643798
71671-2,glucose in blood,neutrophil leukocyte pure number fraction blood manual count,0.20602639536240486,0.2551624
26508-2,glucose in blood,band form neutrophil leukocyte blood,0.20602639536240486,0.26144075
30367-7,glucose in blood,deprecated myeloblast 100 leukocyte blood automated count,0.20602639536240486,0.25043482
30420-4,glucose in blood,large granular lymphocyte leukocyte blood,0.20602639536240486,0.25787452
71677-9,glucose in blood,monocyte leukocyte pure number fraction blood automated count,0.20602639536240486,0.2588137
71670-4,glucose in blood,band form neutrophil leukocyte pure number fraction blood manual count,0.20602639536240486,0.2564724
747-6,glucose in blood,myeloblast leukocyte blood manual count,0.20602639536240486,0.26373103
52999-0,glucose in blood,leukocyte disintegrated volume blood,0.20602639536240486,0.27251005
735-1,glucose in blood,variant lymphocyte leukocyte blood manual count,0.20602639536240486,0.2513462
33842-6,glucose in blood,immature monocyte leukocyte blood manual count,0.20602639536240486,0.2493818
11156-7,glucose in blood,leukocyte morphology finding identifier blood,0.20602639536240486,0.2571805
48189-5,glucose in blood,formaldehyde triggered leukotriene release mass volume leukocyte,0.19399446826531294,0.08954624
71679-5,glucose in blood,eosinophil leukocyte pure number fraction blood automated count,0.19399446826531294,0.24930817
71674-6,glucose in blood,eosinophil leukocyte pure number fraction blood manual count,0.19399446826531294,0.25030705
13353-8,glucose in blood,deprecated eosinophil 100 leukocyte body fluid manual count,0.19399446826531294,0.065826565
104636-6,glucose in blood,day continuous glucose monitor device worn reporting period estimated,0.19399446826531294,0.41345528
105269-5,glucose in blood,fractional excretion calcium ratio urine serum plasma collected unspecified duration,0.19399446826531294,0.09834501
62441-1,glucose in blood,nucleated erythrocyte leukocyte ratio cerebral spinal fluid automated count,0.19399446826531294,0.0709396
71603-5,glucose in blood,eosinophil leukocyte pure number fraction pericardial fluid manual count,0.19399446826531294,0.059744485
75551-2,glucose in blood,fetal trisomy 13 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.19399446826531294,0.056271486
40631-4,glucose in blood,nucleated erythrocyte leukocyte ratio cerebral spinal fluid manual count,0.19399446826531294,0.0829306
48300-8,glucose in blood,erythrosine triggered leukotriene release mass volume leukocyte,0.19399446826531294,0.084987134
30378-4,glucose in blood,eosinophil leukocyte nose,0.19399446826531294,0.051571272
30393-3,glucose in blood,deprecated nucleated erythrocyte 100 leukocyte ratio blood,0.19399446826531294,0.26023704
62442-9,glucose in blood,nucleated erythrocyte leukocyte ratio synovial fluid automated count,0.19399446826531294,0.069271035
12208-5,glucose in blood,eosinophil leukocyte cerebral spinal fluid manual count,0.19399446826531294,0.05396555
5552-5,glucose in blood,deprecated cycd79 cell 100 cell blood,0.19399446826531294,0.06549068
75555-3,glucose in blood,fetal trisomy 18 risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.19399446826531294,0.049753927
2223-6,glucose in blood,elastase leukocyte enzymatic activity volume plasma,0.19399446826531294,0.1076111
48245-5,glucose in blood,japanese cedar triggered leukotriene release mass volume leukocyte,0.19399446826531294,0.080137104
71646-4,glucose in blood,eosinophil leukocyte pure number fraction body fluid manual count,0.19399446826531294,0.06991041
75552-0,glucose in blood,fetal trisomy 13 risk interpretation based plasma cell free wbc dna dosage chromosome specific cfdna qualitative,0.19399446826531294,0.05780185
21653-1,glucose in blood,cdh1 gene mutation tested blood tissue molecular genetics method nominal,0.1918155180095621,0.14501798
74909-3,glucose in blood,calcium oxalate dihydrate total stone,0.1918155180095621,0.0638418
61435-4,glucose in blood,deprecated deprecated calcium intake daily protocol phenx,0.1918155180095621,0.03858091
14625-8,glucose in blood,basophil leukocyte bronchial specimen manual count,0.1918155180095621,0.06693947
82534-9,glucose in blood,casr gene full mutation analysis blood tissue sequencing,0.1918155180095621,0.12912479
74407-8,glucose in blood,basophil leukocyte cord blood,0.1918155180095621,0.0787473
99060-6,glucose in blood,cerebroventricular lining cell leukocyte cerebral spinal fluid,0.1918155180095621,0.058995567
54234-0,glucose in blood,cell count diff panel gluc prot body fluid,0.1918155180095621,0.43471867
26446-5,glucose in blood,blast leukocyte blood,0.1918155180095621,0.2589299
51586-6,glucose in blood,cell leukocyte blood manual count,0.1918155180095621,0.25771993
34911-8,glucose in blood,immature basophil leukocyte blood,0.1918155180095621,0.25429785
33786-5,glucose in blood,immature basophil leukocyte blood manual count,0.1918155180095621,0.25268593
9050-6,glucose in blood,calcium intake 12 hour,0.1918155180095621,0.08150019
53516-1,glucose in blood,basophil leukocyte dialysis fluid manual count,0.1918155180095621,0.070313975
9049-8,glucose in blood,calcium intake 10 hour,0.1918155180095621,0.07834131
13520-2,glucose in blood,deprecated basophil 100 leukocyte body fluid manual count,0.1918155180095621,0.077654004
95843-9,glucose in blood,neutrophil leukocyte sputum manual count,0.16590603148932537,0.06908683
13597-0,glucose in blood,neutrophil leukocyte nose,0.16590603148932537,0.06688325
33385-6,glucose in blood,segmented neutrophil leukocyte pleural fluid,0.16590603148932537,0.06287849
40491-3,glucose in blood,neutrophil leukocyte synovial fluid manual count,0.16590603148932537,0.05965725
32804-7,glucose in blood,neutrophil leukocyte bronchial specimen manual count,0.16590603148932537,0.057506785
17800-4,glucose in blood,myelocyte leukocyte body fluid,0.16590603148932537,0.09177102
14380-0,glucose in blood,mononuclear cell leukocyte pleural fluid manual count,0.16590603148932537,0.07002154
17287-4,glucose in blood,monocyte leukocyte urine manual count,0.16590603148932537,0.08905108
95221-8,glucose in blood,metamyelocytes leukocyte stem cell product manual count,0.16590603148932537,0.07475401
33387-2,glucose in blood,segmented neutrophil leukocyte pericardial fluid,0.16590603148932537,0.05926169
30437-8,glucose in blood,monocyte macrophage leukocyte body fluid,0.16590603148932537,0.07070939
30417-0,glucose in blood,variant lymphocyte leukocyte body fluid,0.16590603148932537,0.07050778
71614-2,glucose in blood,monocyte leukocyte pure number fraction pleural fluid manual count,0.16590603148932537,0.072400205
93952-0,glucose in blood,metamyelocytes neutrophilic leukocyte bone marrow manual count,0.16590603148932537,0.07278844
17801-2,glucose in blood,metamyelocytes leukocyte body fluid,0.16590603148932537,0.087309785
70037-7,glucose in blood,mononuclear cell leukocyte pericardial fluid automated count,0.16590603148932537,0.06598169
23904-6,glucose in blood,monocyte macrophage leukocyte cerebral spinal fluid manual count,0.16590603148932537,0.059541836
34985-2,glucose in blood,unidentified cell leukocyte body fluid,0.16590603148932537,0.081173144
40670-2,glucose in blood,smudge cell leukocyte body fluid manual count,0.16590603148932537,0.07460302
30468-3,glucose in blood,unidentified cell leukocyte cerebral spinal fluid,0.16590603148932537,0.06303679
71635-7,glucose in blood,neutrophil leukocyte pure number fraction peritoneal fluid manual count,0.16590603148932537,0.07321101
49782-6,glucose in blood,mononuclear cell leukocyte pericardial fluid,0.16590603148932537,0.07284432
95226-7,glucose in blood,segmented neutrophil leukocyte stem cell product manual count,0.16590603148932537,0.06786272
71598-7,glucose in blood,neutrophil leukocyte pure number fraction bronchial specimen manual count,0.16590603148932537,0.062829725
27930-7,glucose in blood,neutrophil leukocyte bronchial specimen,0.16590603148932537,0.06215071
26488-7,glucose in blood,monocyte leukocyte peritoneal fluid,0.16590603148932537,0.076827876
32807-0,glucose in blood,mononuclear cell leukocyte bronchial specimen,0.16590603148932537,0.06357837
53286-1,glucose in blood,wbc cast volume urine computer assisted method,0.16590603148932537,0.06933561
34982-9,glucose in blood,unidentified cell leukocyte peritoneal fluid,0.16590603148932537,0.07378877
17799-8,glucose in blood,promyelocytes leukocyte body fluid,0.16590603148932537,0.092478015
71625-8,glucose in blood,neutrophil leukocyte pure number fraction synovial fluid manual count,0.16590603148932537,0.065970294
71639-9,glucose in blood,monocyte macrophage leukocyte pure number fraction body fluid manual count,0.16590603148932537,0.07481196
71653-0,glucose in blood,promyelocytes leukocyte pure number fraction cerebral spinal fluid manual count,0.16590603148932537,0.076042354
70035-1,glucose in blood,siderophages leukocyte cerebral spinal fluid manual count,0.16590603148932537,0.05312042
17835-0,glucose in blood,monocyte leukocyte synovial fluid,0.16590603148932537,0.07383477
55437-8,glucose in blood,neoplastic cell leukocyte cerebral spinal fluid manual count,0.16590603148932537,0.05661531
33263-5,glucose in blood,metamyelocytes leukocyte body fluid manual count,0.16590603148932537,0.078086585
17803-8,glucose in blood,plasma cell leukocyte body fluid,0.16590603148932537,0.09412932
26494-5,glucose in blood,mononuclear cell leukocyte pleural fluid,0.16590603148932537,0.07532459
30230-7,glucose in blood,segmented neutrophil leukocyte body fluid manual count,0.16590603148932537,0.06884329
32805-4,glucose in blood,variant lymphocyte leukocyte bronchial specimen manual count,0.16590603148932537,0.051300246
33362-5,glucose in blood,monocyte leukocyte pleural fluid,0.16590603148932537,0.068440065
66132-2,glucose in blood,mononuclear mesothelial cell leukocyte body fluid manual count,0.16590603148932537,0.077523746
17802-0,glucose in blood,prolymphocytes leukocyte body fluid,0.16590603148932537,0.09464367
71610-0,glucose in blood,mononuclear cell leukocyte pure number fraction pleural fluid manual count,0.16590603148932537,0.07422211
58802-0,glucose in blood,mononuclear cell leukocyte peritoneal dialysis fluid,0.16590603148932537,0.068423
30454-3,glucose in blood,neutrophil leukocyte pericardial fluid,0.16590603148932537,0.064508446
70038-5,glucose in blood,mononuclear cell leukocyte peritoneal fluid automated count,0.16590603148932537,0.06884764
95228-3,glucose in blood,promyelocytes leukocyte stem cell product manual count,0.16590603148932537,0.080851905
13518-6,glucose in blood,variant lymphocyte leukocyte body fluid manual count,0.16590603148932537,0.07116725
10329-1,glucose in blood,monocyte leukocyte cerebral spinal fluid manual count,0.16590603148932537,0.06435719
26493-7,glucose in blood,mononuclear cell leukocyte body fluid,0.16590603148932537,0.084670655
21395-9,glucose in blood,monocyte macrophage leukocyte synovial fluid manual count,0.16590603148932537,0.062438242
99411-1,glucose in blood,voltage gated calcium channel ab mole volume cerebral spinal fluid immunoassay,0.16590603148932537,0.05853847
51386-1,glucose in blood,plasma cell leukocyte body fluid manual count,0.16590603148932537,0.08547953
30432-9,glucose in blood,mesothelial cell leukocyte peritoneal fluid,0.11539987630695031,0.07341607
71626-6,glucose in blood,mesothelial cell leukocyte pure number fraction peritoneal fluid manual count,0.11539987630695031,0.077998385
97770-2,glucose in blood,bilirubin total mole volume capillary blood,0.10717902058588963,0.07013122
71595-3,glucose in blood,basophil leukocyte pure number fraction bronchial specimen manual count,0.10717902058588963,0.06600462
1974-5,glucose in blood,bilirubin total mass volume body fluid,0.10717902058588963,0.09716966
46093-1,glucose in blood,calcium ionized mole volume dialysis fluid,0.10717902058588963,0.07674133
54366-0,glucose in blood,calcium ionized mole volume adjusted ph 7 4 cord blood,0.10717902058588963,0.06979292
49649-7,glucose in blood,cacna1a gene allele 1 cag repeat entitic number blood tissue molecular genetics method,0.10717902058588963,0.14525703
1997-6,glucose in blood,calcium mole volume cerebral spinal fluid,0.10717902058588963,0.07359544
14636-5,glucose in blood,calcium presence stone,0.10717902058588963,0.049300008
27182-5,glucose in blood,calcium presence blood,0.10717902058588963,0.24052343
41646-1,glucose in blood,calcium ionized mole volume mixed venous blood,0.10717902058588963,0.07543731
1384-7,glucose in blood,calcium mole volume blood post calcium infusion,0.10717902058588963,0.26064655
39463-5,glucose in blood,bilirubin indirect mole volume body fluid,0.10717902058588963,0.08783374
47994-9,glucose in blood,bilirubin total mole volume cord blood,0.10717902058588963,0.07589648
16266-9,glucose in blood,calcium hydrogen phosphate crystal presence stone infrared spectroscopy,0.10717902058588963,0.056696262
42719-5,glucose in blood,bilirubin total mass volume blood,0.10717902058588963,0.27797174
29210-2,glucose in blood,bilirubin indirect mass volume body fluid,0.10717902058588963,0.098435216
47596-2,glucose in blood,calcium ionized mole volume blood ion selective membrane electrode ise,0.10717902058588963,0.26123887
104294-4,glucose in blood,cdh1 gene rearrangement interpretation blood tissue molecular genetics method narrative,0.10717902058588963,0.14476416
43887-9,glucose in blood,bilirubin total presence amniotic fluid spectrophotometry direct,0.10717902058588963,0.05960676
59471-3,glucose in blood,calcium ionized mass volume venous blood,0.10717902058588963,0.08093762
12181-4,glucose in blood,calcium mole volume body fluid,0.10717902058588963,0.085117534
14424-6,glucose in blood,bilirubin total mass volume gastric fluid,0.10717902058588963,0.09608811
21755-4,glucose in blood,cacna1a gene cag repeat presence blood tissue molecular genetics method,0.10717902058588963,0.142751
43824-2,glucose in blood,bilirubin total presence body fluid,0.10717902058588963,0.05774466
53415-6,glucose in blood,bilirubin total presence cerebral spinal fluid,0.10717902058588963,0.0420479
35477-9,glucose in blood,ciliated columnar lining cell leukocyte ratio body fluid,0.10717902058588963,0.09594086
59827-6,glucose in blood,bilirubin total mass volume arterial blood,0.10717902058588963,0.08928163
47598-8,glucose in blood,calcium ionized mole volume adjusted ph 7 4 blood,0.10717902058588963,0.25888893
38643-3,glucose in blood,calcium cyanamide mass volume air,0.10717902058588963,0.062207554
53226-7,glucose in blood,leukocyte area urethra wet preparation,0.018837832203470156,0.06726644
32808-8,glucose in blood,leukocyte leukocyte bronchial specimen,0.018837832203470156,0.06452185
14823-9,glucose in blood,macrophage leukocyte bronchial specimen manual count,0.018837832203470156,0.060138453
68368-0,glucose in blood,leukocyte volume dialysis fluid automated count,0.018837832203470156,0.0824369
71611-8,glucose in blood,leukocyte leukocyte pure number fraction pleural fluid manual count,0.018837832203470156,0.07364331
71634-0,glucose in blood,lymphocyte leukocyte pure number fraction peritoneal fluid manual count,0.018837832203470156,0.075489596
30409-7,glucose in blood,leukocyte leukocyte peritoneal fluid,0.018837832203470156,0.07372619
11031-2,glucose in blood,lymphocyte leukocyte body fluid,0.018837832203470156,0.08399164
53316-6,glucose in blood,leukocyte presence urine automated,0.018837832203470156,0.06207342
13349-6,glucose in blood,leukocyte volume stool manual count,0.018837832203470156,0.085150346
71651-4,glucose in blood,macrophage leukocyte pure number fraction cerebral spinal fluid manual count,0.018837832203470156,0.06323551
99933-4,glucose in blood,leukocyte clump presence body fluid automated,0.018837832203470156,0.06370828
30410-5,glucose in blood,leukocyte leukocyte synovial fluid,0.018837832203470156,0.062450193
99604-1,glucose in blood,band form neutrophil leukocyte pleural fluid manual count,0.018837832203470156,0.06803518
57845-0,glucose in blood,leukocyte volume body fluid automated count,0.018837832203470156,0.09062047
12229-1,glucose in blood,macrophage leukocyte cerebral spinal fluid manual count,0.018837832203470156,0.061845426
26518-1,glucose in blood,deprecated polymorphonuclear cell 100 leukocyte body fluid,0.018837832203470156,0.07643308
50233-6,glucose in blood,leukocyte clump area urine sediment automated count,0.018837832203470156,0.069896385
88343-9,glucose in blood,leukocyte presence ear light microscopy,0.018837832203470156,0.06951278
12224-2,glucose in blood,leukocyte area nose microscopy high power field,0.018837832203470156,0.07540878
14811-4,glucose in blood,leukocyte volume pericardial fluid manual count,0.018837832203470156,0.08079126
26472-1,glucose in blood,leukocyte leukocyte cerebral spinal fluid,0.018837832203470156,0.0711629
68430-8,glucose in blood,leukocyte volume pleural fluid manual count,0.018837832203470156,0.0832352
18407-7,glucose in blood,leukocyte 12 hour urine sediment light microscopy,0.018837832203470156,0.092013314
72163-9,glucose in blood,leukocyte presence specimen gram stain,0.018837832203470156,0.07329555
34445-7,glucose in blood,leukocyte presence body fluid,0.018837832203470156,0.0739767
68406-8,glucose in blood,abnormal lymphocyte leukocyte vitreous fluid manual count,0.018837832203470156,0.070416406
32825-2,glucose in blood,leukocyte presence semen,0.018837832203470156,0.065404065
53964-3,glucose in blood,leukocyte presence urine visual,0.018837832203470156,0.06763313
59463-0,glucose in blood,lymphocyte leukocyte dialysis fluid,0.018837832203470156,0.07164991
46089-9,glucose in blood,leukocyte volume cerebral spinal fluid 3rd tube,0.018837832203470156,0.08558644
62239-9,glucose in blood,leukocyte volume blood fetus automated count,0.018837832203470156,0.18711326
68428-2,glucose in blood,leukocyte volume pericardial fluid manual count,0.018837832203470156,0.08048397
76674-1,glucose in blood,leukocyte volume cerebral spinal fluid 1st tube,0.018837832203470156,0.0868732
95842-1,glucose in blood,lymphocyte leukocyte sputum manual count,0.018837832203470156,0.07028476
30402-2,glucose in blood,leukocyte volume gastric fluid,0.018837832203470156,0.0916353
33388-0,glucose in blood,band form neutrophil leukocyte pericardial fluid,0.018837832203470156,0.06532657
40520-9,glucose in blood,macrophage leukocyte pleural fluid manual count,0.018837832203470156,0.065232776
12230-9,glucose in blood,macrophage leukocyte body fluid manual count,0.018837832203470156,0.073987894
30403-0,glucose in blood,leukocyte volume pericardial fluid,0.018837832203470156,0.078737214
26479-6,glucose in blood,lymphocyte leukocyte cerebral spinal fluid,0.018837832203470156,0.07083123
105104-4,glucose in blood,leukocyte area urine sediment,0.018837832203470156,0.07341794
9442-5,glucose in blood,igg lymphocyte lymphocyte leukocyte,0.018837832203470156,0.07169798
12234-1,glucose in blood,mesothelial cell leukocyte body fluid manual count,0.018837832203470156,0.08232328
13655-6,glucose in blood,leukocyte presence stool light microscopy,0.018837832203470156,0.07609754
30415-4,glucose in blood,abnormal lymphocyte leukocyte synovial fluid,0.018837832203470156,0.057533376
46420-6,glucose in blood,leukocyte clump area urine sediment microscopy high power field,0.018837832203470156,0.080899075
55598-7,glucose in blood,leukocyte disintegrated leukocyte body fluid manual count,0.018837832203470156,0.07628326
55599-5,glucose in blood,leukocyte disintegrated leukocyte cerebral spinal fluid manual count,0.018837832203470156,0.064244054
96712-5,glucose in blood,leukocyte area body fluid light microscopy,0.018837832203470156,0.09230804
70126-8,glucose in blood,leukocyte volume corrected nucleated erythrocyte pleural fluid,0.018837832203470156,0.07692132
26466-3,glucose in blood,leukocyte volume body fluid,0.018837832203470156,0.09587697
20494-1,glucose in blood,deprecated lymphocyte 100 leukocyte body fluid manual count,0.018837832203470156,0.07772093
17235-3,glucose in blood,magnesium mole volume leukocyte,0.018837832203470156,0.09814816
14860-1,glucose in blood,leukocyte leukocyte synovial fluid manual count,0.018837832203470156,0.067920804
14822-1,glucose in blood,lymphocyte leukocyte synovial fluid manual count,0.018837832203470156,0.06537886
99775-9,glucose in blood,leukocyte volume peritoneal dialysis fluid automated count,0.018837832203470156,0.08405014
809-4,glucose in blood,leukocyte volume peritoneal fluid automated count,0.018837832203470156,0.08688736
48034-3,glucose in blood,leukocyte volume corrected nucleated erythrocyte cerebral spinal fluid,0.018837832203470156,0.07313275
55784-3,glucose in blood,leukocyte volume corrected nucleated erythrocyte bone marrow,0.018837832203470156,0.0736257
71597-9,glucose in blood,lymphocyte leukocyte pure number fraction bronchial specimen manual count,0.018837832203470156,0.06458097
68432-4,glucose in blood,leukocyte leukocyte vitreous fluid manual count,0.018837832203470156,0.07502268
11157-5,glucose in blood,leukocyte morphology bone marrow,0.018837832203470156,0.06753118
26510-8,glucose in blood,band form neutrophil leukocyte body fluid,0.018837832203470156,0.082182586
14105-1,glucose in blood,leukocyte presence nose light microscopy,0.018837832203470156,0.06960381
32761-9,glucose in blood,leukocyte presence specimen wet preparation,0.018837832203470156,0.066285044
75559-5,glucose in blood,comment fetal trisomy 18 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.012761000207879958,0.06504905
87544-3,glucose in blood,beta n acetylhexosaminidase beta n acetylhexosaminidase panel enzymatic activity mass leukocyte,0.012761000207879958,0.08087359
48277-8,glucose in blood,acetaminophen triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.07365229
59148-7,glucose in blood,calcium mole volume serum plasma post dialysis,0.012761000207879958,0.09638787
35069-4,glucose in blood,basophil leukocyte peritoneal fluid,0.012761000207879958,0.07788808
68396-1,glucose in blood,basophil leukocyte vitreous fluid manual count,0.012761000207879958,0.07227961
2003-2,glucose in blood,deprecated calcium,0.012761000207879958,0.06728979
105897-3,glucose in blood,calcium oxalate crystal area urine,0.012761000207879958,0.054604713
24092-9,glucose in blood,alpha n acetylglucosaminidase enzymatic activity mass leukocyte,0.012761000207879958,0.0955529
6291-9,glucose in blood,complement ic3b receptor presence leukocyte,0.012761000207879958,0.05518876
1993-5,glucose in blood,calcium renal clearance 24 hour urine serum plasma,0.012761000207879958,0.09069251
35258-3,glucose in blood,calcium mass mole volume corrected total protein serum plasma,0.012761000207879958,0.08881445
75603-1,glucose in blood,comment fetal 1p36 deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.012761000207879958,0.0660529
75565-2,glucose in blood,comment fetal trisomy 21 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.012761000207879958,0.06435774
33412-8,glucose in blood,blast leukocyte pericardial fluid,0.012761000207879958,0.05778893
50183-3,glucose in blood,calcitonin mass volume serum plasma 1 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.012761000207879958,0.10359619
94839-8,glucose in blood,calcium mass volume urine fetus,0.012761000207879958,0.094759226
16524-1,glucose in blood,calcium mole volume serum plasma 6 hour post xxx challenge,0.012761000207879958,0.09192332
5536-8,glucose in blood,deprecated cd83 cell 100 cell blood,0.012761000207879958,0.064453885
47398-3,glucose in blood,beta mannosidase actual normal leukocyte,0.012761000207879958,0.0780055
5415-5,glucose in blood,deprecated cd10 cd20,0.012761000207879958,0.057459403
40238-8,glucose in blood,calcium mole volume serum plasma 8 hour post xxx challenge,0.012761000207879958,0.08434189
4523-7,glucose in blood,complement ic3b receptor entitic number leukocyte,0.012761000207879958,0.059112158
87477-6,glucose in blood,calcium specimen,0.012761000207879958,0.06004217
33235-3,glucose in blood,calcium phosphate crystal presence urine computer assisted method,0.012761000207879958,0.040457446
16273-5,glucose in blood,calcium mass mass red blood cell,0.012761000207879958,0.09033846
18281-6,glucose in blood,calcium mole volume corrected total protein serum plasma,0.012761000207879958,0.091084406
24073-9,glucose in blood,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.012761000207879958,0.09223351
5509-5,glucose in blood,deprecated cd6 cell 100 cell blood,0.012761000207879958,0.06957314
5426-2,glucose in blood,deprecated cd11a cell 100 cell blood,0.012761000207879958,0.07211819
5540-0,glucose in blood,deprecated cd88 cell 100 cell blood,0.012761000207879958,0.06799609
12913-0,glucose in blood,beta n acetylhexosaminidase enzymatic activity volume leukocyte,0.012761000207879958,0.10257445
82222-1,glucose in blood,amylo alpha 1 6 glucosidase enzymatic activity mass leukocyte,0.012761000207879958,0.102497645
1766-5,glucose in blood,aldosterone receptor leukocyte,0.012761000207879958,0.07479255
33657-8,glucose in blood,beta n acetylhexosaminidase mole volume leukocyte,0.012761000207879958,0.08401658
5498-1,glucose in blood,deprecated cd5 cd2 cell 100 cell blood,0.012761000207879958,0.065870695
2001-6,glucose in blood,calcium mole volume 24 hour stool,0.012761000207879958,0.07511973
50551-1,glucose in blood,bilirubin total presence urine automated test strip,0.012761000207879958,0.053763315
6294-3,glucose in blood,deprecated complement c3d c3d gg ic3b receptor entitic number leukocyte,0.012761000207879958,0.067522
5484-1,glucose in blood,deprecated cd45 cell 100 cell blood,0.012761000207879958,0.065517895
5433-8,glucose in blood,deprecated cd128 cell 100 cell blood,0.012761000207879958,0.06933789
5522-8,glucose in blood,deprecated cd69 cell 100 cell blood,0.012761000207879958,0.07096281
5547-5,glucose in blood,deprecated cd96 cell 100 cell blood,0.012761000207879958,0.06912765
57468-1,glucose in blood,calcitriol mole volume serum plasma pre dose calcium,0.012761000207879958,0.08042188
75352-5,glucose in blood,cell leukocyte pericardial fluid manual count,0.012761000207879958,0.07126098
31995-4,glucose in blood,basophil leukocyte pleural fluid manual count,0.012761000207879958,0.06823679
14630-8,glucose in blood,bilirubin indirect mole volume serum plasma,0.012761000207879958,0.10596678
48218-2,glucose in blood,peanut triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08973535
5451-0,glucose in blood,deprecated cd22 cd19 cell 100 cell blood,0.012761000207879958,0.07012825
33374-0,glucose in blood,blast leukocyte synovial fluid,0.012761000207879958,0.054764953
48196-0,glucose in blood,cephalosporin component triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08647218
1978-6,glucose in blood,bilirubin total mass volume urine,0.012761000207879958,0.10571585
24059-8,glucose in blood,aspartylglucosaminidase enzymatic activity mass leukocyte,0.012761000207879958,0.10119797
5412-2,glucose in blood,deprecated b b4 blood,0.012761000207879958,0.07573189
5499-9,glucose in blood,deprecated cd50 cell 100 cell blood,0.012761000207879958,0.06701897
48270-3,glucose in blood,cefazolin triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08142407
17864-0,glucose in blood,calcium ionized mass volume serum plasma ion selective membrane electrode ise,0.012761000207879958,0.10773418
24055-6,glucose in blood,alpha n acetylgalactosaminidase enzymatic activity mass leukocyte,0.012761000207879958,0.08881701
40083-8,glucose in blood,calcium mass volume serum plasma 1 day post xxx challenge,0.012761000207879958,0.09261394
27935-6,glucose in blood,calcium mass volume serum plasma 4th specimen post xxx challenge,0.012761000207879958,0.092038386
34736-9,glucose in blood,calcium oxalate index 24 hour urine,0.012761000207879958,0.07590711
50404-3,glucose in blood,cell leukocyte identifier synovial fluid,0.012761000207879958,0.06602099
99894-8,glucose in blood,calcium oxalate monohydrate crystal presence urine sediment computer assisted method,0.012761000207879958,0.042581942
50839-0,glucose in blood,calcium creatinine molar ratio 24 hour urine,0.012761000207879958,0.089068
33793-1,glucose in blood,calcium mole volume urine 7th specimen post xxx challenge,0.012761000207879958,0.071774304
5444-5,glucose in blood,deprecated cd19 cell 100 cell blood,0.012761000207879958,0.06796383
6707-4,glucose in blood,deprecated cd16 cd57,0.012761000207879958,0.06345984
35248-4,glucose in blood,calcium mass mole volume 24 hour urine,0.012761000207879958,0.08770272
16527-4,glucose in blood,calcium sodium mass ratio serum plasma,0.012761000207879958,0.0948006
53309-1,glucose in blood,calcium phosphate crystal area urine computer assisted method,0.012761000207879958,0.04872107
5494-0,glucose in blood,deprecated cd49d cell 100 cell blood,0.012761000207879958,0.06900809
44075-0,glucose in blood,bilirubin cast presence urine sediment light microscopy,0.012761000207879958,0.061794866
5772-9,glucose in blood,calcium carbonate crystal presence synovial fluid light microscopy,0.012761000207879958,0.050634764
48255-4,glucose in blood,giant ragweed triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08317967
1373-0,glucose in blood,calcitonin mass volume serum plasma 10 minute post 2 4 mg kg calcium short iv,0.012761000207879958,0.100208975
39461-9,glucose in blood,bilirubin total mole volume peritoneal fluid,0.012761000207879958,0.070976004
48186-1,glucose in blood,amylase triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.09618412
5414-8,glucose in blood,deprecated cd10 cell 100 cell blood,0.012761000207879958,0.068210684
40066-3,glucose in blood,calcium mass volume serum plasma 15 minute pre xxx challenge,0.012761000207879958,0.09436249
33789-9,glucose in blood,calcium mole volume urine 10th specimen post xxx challenge,0.012761000207879958,0.07241809
1969-5,glucose in blood,bilirubin total renal clearance 24 hour urine serum plasma,0.012761000207879958,0.09410065
48297-6,glucose in blood,chromotrope 2b triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08266745
94488-4,glucose in blood,acid alpha glucosidase enzymatic activity mass leukocyte confirmatory method,0.012761000207879958,0.09221866
1970-3,glucose in blood,bilirubin delta mass volume serum plasma,0.012761000207879958,0.107922465
48228-1,glucose in blood,bovine serum albumin bsa triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.09406501
9840-0,glucose in blood,cd11 cd20 cell volume leukocyte,0.012761000207879958,0.07526132
5489-0,glucose in blood,deprecated cd47 cell 100 cell blood,0.012761000207879958,0.06729683
75355-8,glucose in blood,cell leukocyte synovial fluid manual count,0.012761000207879958,0.066004135
5418-9,glucose in blood,deprecated cd103 cell 100 cell blood,0.012761000207879958,0.06887976
1379-7,glucose in blood,calcitonin mass volume serum plasma pre 2 4 mg kg calcium short iv,0.012761000207879958,0.09850774
5770-3,glucose in blood,bilirubin total presence urine test strip,0.012761000207879958,0.057276994
48249-7,glucose in blood,silver birch triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08758572
33870-7,glucose in blood,bilirubin total presence specimen,0.012761000207879958,0.03934661
33241-1,glucose in blood,calcium carbonate crystal presence urine computer assisted method,0.012761000207879958,0.04094224
57471-5,glucose in blood,calcitriol mole volume serum plasma 3 hour post dose calcium,0.012761000207879958,0.08053198
35672-5,glucose in blood,bilirubin direct bilirubin total serum plasma,0.012761000207879958,0.08906628
57333-7,glucose in blood,calcium ionized mass volume adjusted ph 7 4 serum plasma ion selective membrane electrode ise,0.012761000207879958,0.08946356
5469-2,glucose in blood,deprecated cd37 cell 100 cell blood,0.012761000207879958,0.06874459
40064-8,glucose in blood,calcium mass volume serum plasma pre xxx challenge,0.012761000207879958,0.0930805
58450-8,glucose in blood,bilirubin presence urine confirmatory method,0.012761000207879958,0.045980897
1976-0,glucose in blood,bilirubin total presence stool,0.012761000207879958,0.047388937
78441-3,glucose in blood,bilirubin conjugated mole volume peritoneal fluid,0.012761000207879958,0.08267712
5430-4,glucose in blood,deprecated cd120b cell 100 cell blood,0.012761000207879958,0.07163589
5503-8,glucose in blood,deprecated cd54 cell 100 cell blood,0.012761000207879958,0.07170482
57567-0,glucose in blood,25 hydroxyvitamin d3 mole volume serum plasma 2 hour post dose calcium,0.012761000207879958,0.07480104
21094-8,glucose in blood,basophil leukocyte sputum manual count,0.012761000207879958,0.07120621
105053-3,glucose in blood,calcium oxalate crystal presence urine sediment microscopy,0.012761000207879958,0.046418447
72264-5,glucose in blood,bilirubin excess oxyhemoglobin methemoglobin xanthochromia albumin quotient panel serum csf,0.012761000207879958,0.080150165
48187-9,glucose in blood,chloramin triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08183772
40075-4,glucose in blood,calcium mass volume serum plasma 6 5 hour post xxx challenge,0.012761000207879958,0.0961723
2005-7,glucose in blood,calcium mole time 2 hour urine 12 hour fasting,0.012761000207879958,0.09002143
50759-0,glucose in blood,beta n acetylhexosaminidase enzymatic activity mass leukocyte,0.012761000207879958,0.092817694
5485-8,glucose in blood,deprecated cd45ra cell 100 cell blood,0.012761000207879958,0.069129236
5470-0,glucose in blood,deprecated cd38 cell 100 cell blood,0.012761000207879958,0.06560713
16512-6,glucose in blood,calcium ionized mole volume serum plasma 2nd specimen post xxx challenge,0.012761000207879958,0.08915697
5419-7,glucose in blood,deprecated cd104 cell 100 cell blood,0.012761000207879958,0.06669814
5526-9,glucose in blood,deprecated cd72 cell 100 cell blood,0.012761000207879958,0.06885061
5534-3,glucose in blood,deprecated cd81,0.012761000207879958,0.056373984
5459-3,glucose in blood,deprecated cd3 cell 100 cell blood,0.012761000207879958,0.069048144
27091-8,glucose in blood,calcium mass time 4 hour urine,0.012761000207879958,0.089540504
25873-1,glucose in blood,calcium mole volume urine pre 500 mg calcium po,0.012761000207879958,0.07716887
5473-4,glucose in blood,deprecated cd4 cd8 cell 100 cell blood,0.012761000207879958,0.06365869
5542-6,glucose in blood,deprecated cd9 cell 100 cell blood,0.012761000207879958,0.070063464
48211-7,glucose in blood,beef triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.08415561
40223-0,glucose in blood,calcium mole volume serum plasma pre xxx challenge,0.012761000207879958,0.086179815
53443-8,glucose in blood,carnitine palmitoyltransferase 2 enzymatic activity mass control leukocyte,0.012761000207879958,0.092301264
16522-5,glucose in blood,calcium mole volume urine 4th specimen post xxx challenge,0.012761000207879958,0.07676288
57469-9,glucose in blood,calcitriol mole volume serum plasma 2 hour post dose calcium,0.012761000207879958,0.082723536
40079-6,glucose in blood,calcium mass volume serum plasma 13 hour post xxx challenge,0.012761000207879958,0.09818767
13444-5,glucose in blood,calcium albumin mass ratio serum plasma,0.012761000207879958,0.090125866
16516-7,glucose in blood,calcium ionized mole volume serum plasma 6th specimen post xxx challenge,0.012761000207879958,0.08840812
34442-4,glucose in blood,bilirubin conjugated bilirubin total serum plasma,0.012761000207879958,0.097857386
1999-2,glucose in blood,calcium mole volume semen,0.012761000207879958,0.081535965
32541-5,glucose in blood,calcium molar amount urine collected unspecified duration,0.012761000207879958,0.08523323
48220-8,glucose in blood,oat triggered leukotriene release mass volume leukocyte,0.012761000207879958,0.086056665
100849-9,white blood cells count,leukocyte volume amniotic fluid manual count,0.32820430508192966,0.12932853
52999-0,white blood cells count,leukocyte disintegrated volume blood,0.32820430508192966,0.29456827
104876-8,white blood cells count,hematocrit volume fraction blood 1 hour post dose glucose,0.32820430508192966,0.24181736
12227-5,white blood cells count,leukocyte volume corrected nucleated erythrocyte blood,0.32820430508192966,0.29732943
33028-2,white blood cells count,leukocyte volume blood blood product unit,0.32820430508192966,0.21797888
71674-6,white blood cells count,eosinophil leukocyte pure number fraction blood manual count,0.32820430508192966,0.29623005
51383-8,white blood cells count,leukocyte volume blood automated count,0.32820430508192966,0.31877038
729-4,white blood cells count,leukocyte volume blood manual count,0.32820430508192966,0.3304517
71668-8,white blood cells count,metamyelocytes leukocyte pure number fraction blood manual count,0.32820430508192966,0.301595
804-5,white blood cells count,leukocyte volume blood manual count,0.32820430508192966,0.3283325
71667-0,white blood cells count,myelocyte leukocyte pure number fraction blood manual count,0.32820430508192966,0.30440736
33842-6,white blood cells count,immature monocyte leukocyte blood manual count,0.2390467294422821,0.2857217
26524-9,white blood cells count,promyelocytes leukocyte blood,0.2390467294422821,0.27454558
74455-7,white blood cells count,blast leukocyte cord blood,0.2390467294422821,0.09627211
38184-8,white blood cells count,basophil leukocyte amniotic fluid manual count,0.2390467294422821,0.107937865
51384-6,white blood cells count,mononuclear cell leukocyte blood manual count,0.2390467294422821,0.29345348
30395-8,white blood cells count,granulocyte leukocyte blood,0.2390467294422821,0.26664683
73903-7,white blood cells count,cd3 cd57 cell leukocyte blood flow cytometry fc,0.2390467294422821,0.26375058
26511-6,white blood cells count,neutrophil leukocyte blood,0.2390467294422821,0.27638176
30367-7,white blood cells count,deprecated myeloblast 100 leukocyte blood automated count,0.2390467294422821,0.2940193
74814-5,white blood cells count,plasma cell centroblasts leukocyte blood manual count,0.2390467294422821,0.2954859
30445-1,white blood cells count,myeloblast leukocyte blood,0.2390467294422821,0.27085727
764-1,white blood cells count,band form neutrophil leukocyte blood manual count,0.2390467294422821,0.2937672
44097-4,white blood cells count,unidentified cell leukocyte blood,0.2390467294422821,0.27534962
40650-4,white blood cells count,mesothelial cell leukocyte blood manual count,0.2390467294422821,0.2894273
34920-9,white blood cells count,lymphocyte immunoblastic leukocyte blood,0.2390467294422821,0.26078668
714-6,white blood cells count,eosinophil leukocyte blood manual count,0.2390467294422821,0.28737023
58407-8,white blood cells count,leukocyte morphology panel blood,0.2390467294422821,0.2680209
6746-2,white blood cells count,prolymphocytes leukocyte blood manual count,0.2390467294422821,0.29153228
30441-0,white blood cells count,monocyte abnormal leukocyte blood,0.2390467294422821,0.2673065
4662-3,white blood cells count,lymphocyte monocyte leukocyte blood,0.2390467294422821,0.27196985
62858-6,white blood cells count,micromegakaryocytes leukocyte blood manual count,0.2390467294422821,0.29391176
74457-3,white blood cells count,neutrophil leukocyte cord blood,0.2390467294422821,0.099369094
51586-6,white blood cells count,cell leukocyte blood manual count,0.2390467294422821,0.30094284
33840-0,white blood cells count,monoblast leukocyte blood manual count,0.2390467294422821,0.2965926
58409-4,white blood cells count,cell leukocyte blood automated count,0.2390467294422821,0.303631
74820-2,white blood cells count,plasma cell centrocytes leukocyte blood manual count,0.2390467294422821,0.29531372
38518-7,white blood cells count,immature granulocyte leukocyte blood,0.2390467294422821,0.26613912
40646-2,white blood cells count,leukocyte leukocyte blood automated count,0.2390467294422821,0.29513496
5905-5,white blood cells count,monocyte leukocyte blood automated count,0.2390467294422821,0.29696137
749-2,white blood cells count,myelocyte leukocyte blood manual count,0.2390467294422821,0.30451074
70028-6,white blood cells count,megakaryocytic nucleus leukocyte blood manual count,0.2390467294422821,0.2943933
74405-2,white blood cells count,eosinophil leukocyte cord blood,0.2390467294422821,0.094740644
24104-2,white blood cells count,lymphoma cell leukocyte blood manual count,0.2390467294422821,0.2929828
74403-7,white blood cells count,normoblasts leukocyte cord blood,0.2390467294422821,0.09878546
49936-8,white blood cells count,calcium ionized calcium total corrected albumin blood,0.2390467294422821,0.21855132
31160-5,white blood cells count,granulocyte leukocyte blood manual count,0.2390467294422821,0.2983587
13599-6,white blood cells count,promonocytes leukocyte blood manual count,0.2390467294422821,0.29338926
27906-7,white blood cells count,immature lymphocyte leukocyte amniotic fluid,0.2390467294422821,0.082604945
44096-6,white blood cells count,unidentified cell leukocyte blood automated count,0.2390467294422821,0.29932097
30420-4,white blood cells count,large granular lymphocyte leukocyte blood,0.2390467294422821,0.27039748
6300-8,white blood cells count,glucose mass volume amniotic fluid,0.16590603148932537,0.07435921
42857-3,white blood cells count,calcium mole volume venous blood,0.16590603148932537,0.062322967
14770-2,white blood cells count,fasting glucose mole volume capillary blood glucometer,0.16590603148932537,0.08029845
89871-8,white blood cells count,bilirubin total mole volume venous blood,0.16590603148932537,0.06685956
104597-0,white blood cells count,glucose mass volume venous blood glucometer,0.16590603148932537,0.085492514
53553-4,white blood cells count,glucose mean value mole volume blood estimated glycated hemoglobin,0.16590603148932537,0.2684863
47598-8,white blood cells count,calcium ionized mole volume adjusted ph 7 4 blood,0.16590603148932537,0.23891059
74347-6,white blood cells count,leukocyte aggregate presence blood light microscopy,0.16590603148932537,0.28515553
47994-9,white blood cells count,bilirubin total mole volume cord blood,0.16590603148932537,0.070483886
89872-6,white blood cells count,bilirubin total mole volume arterial blood,0.16590603148932537,0.06390037
42593-4,white blood cells count,calcium mole volume capillary blood,0.16590603148932537,0.05629704
53139-2,white blood cells count,calcium ionized mole volume adjusted ph 7 4 capillary blood,0.16590603148932537,0.04649539
50672-5,white blood cells count,leukocyte toxic vacuole presence blood light microscopy,0.16590603148932537,0.27141336
49134-0,white blood cells count,glucose mass volume blood 2 hour post dose glucose,0.16590603148932537,0.25280583
1384-7,white blood cells count,calcium mole volume blood post calcium infusion,0.16590603148932537,0.23938572
14415-4,white blood cells count,calcium mole volume amniotic fluid,0.16590603148932537,0.05944721
17790-7,white blood cells count,leukocyte left shift presence blood automated count,0.16590603148932537,0.2870818
41644-6,white blood cells count,calcium ionized mole volume capillary blood,0.16590603148932537,0.058715355
13877-6,white blood cells count,bilirubin total presence amniotic fluid,0.16590603148932537,0.044894785
38230-9,white blood cells count,calcium ionized mass volume blood,0.16590603148932537,0.23552248
48623-3,white blood cells count,bilirubin direct mass volume cord blood,0.16590603148932537,0.08175871
27353-2,white blood cells count,glucose mean value mass volume blood estimated glycated hemoglobin,0.16590603148932537,0.27533254
41645-3,white blood cells count,calcium ionized mole volume venous blood,0.16590603148932537,0.06100057
47995-6,white blood cells count,glucose mole volume cord blood,0.16590603148932537,0.06551693
34469-7,white blood cells count,leukocyte presence bile fluid light microscopy,0.16590603148932537,0.10195621
54365-2,white blood cells count,calcium mole volume cord blood,0.16590603148932537,0.056932338
6689-4,white blood cells count,glucose mass volume blood 2 hour post meal,0.16590603148932537,0.24603471
42719-5,white blood cells count,bilirubin total mass volume blood,0.16590603148932537,0.26132658
1972-9,white blood cells count,bilirubin total mass volume amniotic fluid,0.16590603148932537,0.08040724
34581-9,white blood cells count,calcium ionized mole volume arterial blood,0.16590603148932537,0.05569034
12653-2,white blood cells count,glucose mass volume serum plasma 8 minute post xxx challenge,0.023886140618510104,0.08636174
15075-5,white blood cells count,glucose mole volume dialysis fluid,0.023886140618510104,0.066586114
14858-5,white blood cells count,leukocyte leukocyte pleural fluid manual count,0.023886140618510104,0.11899001
48193-7,white blood cells count,succinylcholine triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09307042
55496-4,white blood cells count,insulin mole volume serum plasma 2 hour post dose glucose iv,0.023886140618510104,0.06159056
68367-2,white blood cells count,bilirubin total mole volume urine automated test strip,0.023886140618510104,0.06760903
40222-2,white blood cells count,glucose mole volume serum plasma 2 day post xxx challenge,0.023886140618510104,0.075416245
14152-3,white blood cells count,bilirubin direct mass volume body fluid,0.023886140618510104,0.08376164
40279-2,white blood cells count,glucose mole volume serum plasma 2 hour post dose lactose po,0.023886140618510104,0.066557035
40168-7,white blood cells count,glucose mole volume serum plasma 7 5 hour post xxx challenge,0.023886140618510104,0.073256314
5470-0,white blood cells count,deprecated cd38 cell 100 cell blood,0.023886140618510104,0.093808696
48184-6,white blood cells count,yellow jacket triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10491879
26781-5,white blood cells count,glucose mass volume serum plasma 3 hour post dose lactose po,0.023886140618510104,0.07001504
55479-0,white blood cells count,insulin mole volume serum plasma 7 minute post dose glucose iv,0.023886140618510104,0.06512593
104635-8,white blood cells count,continuous glucose monitor device date time reporting period end reported,0.023886140618510104,0.033642683
30469-1,white blood cells count,unspecified cell leukocyte body fluid,0.023886140618510104,0.094495036
49926-9,white blood cells count,glucose 6 phosphate dehydrogenase enzymatic activity mass red blood cell method,0.023886140618510104,0.064968586
15153-0,white blood cells count,deprecated indirect bilirubin mass volume serum plasma,0.023886140618510104,0.09535909
40024-2,white blood cells count,glucose mass volume serum plasma 1 day post xxx challenge,0.023886140618510104,0.08595583
18186-7,white blood cells count,calcium mass time 12 hour urine,0.023886140618510104,0.04040461
48194-5,white blood cells count,lidocaine triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09455506
32013-5,white blood cells count,eosinophil leukocyte pericardial fluid manual count,0.023886140618510104,0.09978517
71628-2,white blood cells count,macrophage leukocyte pure number fraction peritoneal fluid manual count,0.023886140618510104,0.11892523
46099-8,white blood cells count,calcium mass volume corrected albumin serum plasma,0.023886140618510104,0.074971296
66132-2,white blood cells count,mononuclear mesothelial cell leukocyte body fluid manual count,0.023886140618510104,0.10612812
71594-6,white blood cells count,macrophage leukocyte pure number fraction bronchial specimen manual count,0.023886140618510104,0.11285523
57845-0,white blood cells count,leukocyte volume body fluid automated count,0.023886140618510104,0.14076574
58686-7,white blood cells count,component peptide mass volume serum plasma 2 hour post dose glucose,0.023886140618510104,0.06557936
10966-0,white blood cells count,glucose presence urine test strip 2 5 hour post 75 g glucose po,0.023886140618510104,0.05315212
1530-5,white blood cells count,glucose mass volume serum plasma 3 hour post 100 g glucose po,0.023886140618510104,0.08458771
55481-6,white blood cells count,insulin mole volume serum plasma 10 minute pre dose glucose,0.023886140618510104,0.06348602
40533-2,white blood cells count,leukocyte volume peritoneal dialysis fluid manual count,0.023886140618510104,0.12459558
16513-4,white blood cells count,calcium ionized mole volume serum plasma 3rd specimen post xxx challenge,0.023886140618510104,0.07137964
75054-7,white blood cells count,glutaryl coa dehydrogenase enzymatic activity mass leukocyte,0.023886140618510104,0.099679284
32318-8,white blood cells count,glucose mole volume specimen,0.023886140618510104,0.059682805
48189-5,white blood cells count,formaldehyde triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09995404
40011-9,white blood cells count,glucose mass volume serum plasma 13 5 hour post xxx challenge,0.023886140618510104,0.078277566
96077-3,white blood cells count,hedis 2020 value set glucose test,0.023886140618510104,0.039123863
48052-5,white blood cells count,leukocyte volume corrected nucleated erythrocyte body fluid,0.023886140618510104,0.119415544
54257-1,white blood cells count,glucose mole volume serum plasma pre dose insulin iv,0.023886140618510104,0.065464504
12614-4,white blood cells count,glucose mass volume serum plasma 7 hour post meal,0.023886140618510104,0.08059925
25676-8,white blood cells count,glucose mole volume serum plasma 5 5 hour post dose glucose,0.023886140618510104,0.07965404
54253-0,white blood cells count,glucose mole volume serum plasma 4 minute post dose glucagon,0.023886140618510104,0.084133096
48993-0,white blood cells count,glucose mass volume serum plasma 3 specimen,0.023886140618510104,0.08483946
95225-9,white blood cells count,band form neutrophil leukocyte stem cell product manual count,0.023886140618510104,0.11752699
53928-8,white blood cells count,glucose mass volume serum plasma 20 minute post 50 g lactose po,0.023886140618510104,0.08020977
9050-6,white blood cells count,calcium intake 12 hour,0.023886140618510104,0.03416975
18354-1,white blood cells count,glucose mass volume serum plasma 12 hour post 50 g lactose po,0.023886140618510104,0.081481464
16985-4,white blood cells count,hydrogen expired gas volume fraction exhaled gas 1 5 hour post dose glucose,0.023886140618510104,0.03662446
79451-1,white blood cells count,adenosine deaminase enzymatic activity mass leukocyte,0.023886140618510104,0.075709574
104073-2,white blood cells count,multiple sulfatase deficiency enzyme panel leukocyte,0.023886140618510104,0.067019865
48994-8,white blood cells count,glucose mass volume serum plasma 6 specimen,0.023886140618510104,0.086378664
1546-1,white blood cells count,glucose mass volume urine 6 hour post 100 g glucose po,0.023886140618510104,0.068332456
99308-9,white blood cells count,acid alpha glucosidase cross reactive immunologic material crim presence leukocyte immunoblot,0.023886140618510104,0.09183408
99933-4,white blood cells count,leukocyte clump presence body fluid automated,0.023886140618510104,0.09337218
58508-3,white blood cells count,component peptide mass volume serum plasma 3 5 hour post dose glucose,0.023886140618510104,0.06373709
59244-4,white blood cells count,arylsulfatase component enzymatic activity mass leukocyte,0.023886140618510104,0.08067501
33794-9,white blood cells count,calcium mole volume urine 8th specimen post xxx challenge,0.023886140618510104,0.053307872
12630-0,white blood cells count,glucose mass volume peritoneal dialysis fluid 1st specimen,0.023886140618510104,0.074444644
5422-1,white blood cells count,deprecated cd107a cell 100 cell blood,0.023886140618510104,0.099225916
40670-2,white blood cells count,smudge cell leukocyte body fluid manual count,0.023886140618510104,0.114322536
5499-9,white blood cells count,deprecated cd50 cell 100 cell blood,0.023886140618510104,0.09980582
53127-7,white blood cells count,monocyte macrophage leukocyte tissue,0.023886140618510104,0.082467705
13655-6,white blood cells count,leukocyte presence stool light microscopy,0.023886140618510104,0.09207652
59812-8,white blood cells count,glucose mole volume serum plasma 11 specimen,0.023886140618510104,0.078150265
24122-4,white blood cells count,leukocyte volume urine manual count,0.023886140618510104,0.111402094
27373-0,white blood cells count,calcium mass volume dialysis fluid,0.023886140618510104,0.056230806
33870-7,white blood cells count,bilirubin total presence specimen,0.023886140618510104,0.030295117
26473-9,white blood cells count,leukocyte leukocyte body fluid,0.023886140618510104,0.09394649
1508-1,white blood cells count,deprecated glucose mass volume serum plasma 1 hour post 75 g glucose po,0.023886140618510104,0.06324421
40187-7,white blood cells count,glucose mole volume serum plasma 20 hour post xxx challenge,0.023886140618510104,0.07274507
1491-0,white blood cells count,glucose mass volume urine 30 minute post 100 g glucose po,0.023886140618510104,0.07009226
40244-6,white blood cells count,calcium mole volume serum plasma 1 day post xxx challenge,0.023886140618510104,0.06670581
5446-0,white blood cells count,deprecated cd19 lambda cell 100 cell blood,0.023886140618510104,0.09601324
68428-2,white blood cells count,leukocyte volume pericardial fluid manual count,0.023886140618510104,0.13091063
33287-4,white blood cells count,glucose 6 phosphate dehydrogenase presence db,0.023886140618510104,0.12425452
17803-8,white blood cells count,plasma cell leukocyte body fluid,0.023886140618510104,0.09718472
48282-8,white blood cells count,atracurium triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10450244
72896-4,white blood cells count,glucose mole volume serum plasma 15 minute post dose lactose po,0.023886140618510104,0.06700364
54255-5,white blood cells count,glucose mole volume serum plasma 6 minute post dose glucagon,0.023886140618510104,0.082753025
47839-6,white blood cells count,deprecated carnitine acyltransferase ii enzymatic activity mass leukocyte,0.023886140618510104,0.0736163
58500-0,white blood cells count,component peptide mass volume serum plasma 15 minute post dose glucose,0.023886140618510104,0.063104965
32805-4,white blood cells count,variant lymphocyte leukocyte bronchial specimen manual count,0.023886140618510104,0.0955415
96978-2,white blood cells count,noninvasive prenatal fetal aneuploidy 22q11 2 deletion panel plasma cell free wbc dna dosage chromosome specific cfdna,0.023886140618510104,0.08112045
5771-1,white blood cells count,bilirubin crystal presence urine sediment light microscopy,0.023886140618510104,0.042287637
26466-3,white blood cells count,leukocyte volume body fluid,0.023886140618510104,0.11855709
105105-1,white blood cells count,leukocyte presence urine sediment,0.023886140618510104,0.06294141
50215-3,white blood cells count,glucose mass volume serum plasma 5th specimen,0.023886140618510104,0.09315855
12640-9,white blood cells count,glucose mass volume serum plasma 6 5 hour post xxx challenge,0.023886140618510104,0.0897071
40175-2,white blood cells count,glucose mole volume serum plasma 11 5 hour post xxx challenge,0.023886140618510104,0.07070256
40203-2,white blood cells count,glucose mole volume serum plasma 9 minute post xxx challenge,0.023886140618510104,0.07546783
35051-2,white blood cells count,leukocyte volume body fluid,0.023886140618510104,0.120633855
61435-4,white blood cells count,deprecated deprecated calcium intake daily protocol phenx,0.023886140618510104,0.028262416
40008-5,white blood cells count,glucose mass volume serum plasma 11 5 hour post xxx challenge,0.023886140618510104,0.07892757
79196-2,white blood cells count,glucose mass volume serum plasma 1 hour post dose arginine insulin,0.023886140618510104,0.065321945
54256-3,white blood cells count,glucose mole volume serum plasma 8 minute post dose glucagon,0.023886140618510104,0.08098396
16523-3,white blood cells count,calcium mole volume serum plasma 5 minute post xxx challenge,0.023886140618510104,0.074467994
75594-2,white blood cells count,fetal 5p deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.023886140618510104,0.07775236
40019-2,white blood cells count,glucose mass volume serum plasma 20 hour post xxx challenge,0.023886140618510104,0.08523696
17286-6,white blood cells count,monocyte leukocyte synovial fluid manual count,0.023886140618510104,0.11292147
26472-1,white blood cells count,leukocyte leukocyte cerebral spinal fluid,0.023886140618510104,0.09018699
99896-3,white blood cells count,calcium oxalate monohydrate crystal volume urine sediment computer assisted method,0.023886140618510104,0.032160465
54261-3,white blood cells count,glucose mole volume serum plasma 15 minute pre dose insulin iv,0.023886140618510104,0.058297213
40177-8,white blood cells count,glucose mole volume serum plasma 12 5 hour post xxx challenge,0.023886140618510104,0.07139615
62874-3,white blood cells count,deprecated phenx measure assay human leukocyte antigen hla genotyping,0.023886140618510104,0.0764473
805-2,white blood cells count,leukocyte volume cerebral spinal fluid automated count,0.023886140618510104,0.14411524
48191-1,white blood cells count,monosodium glutamate msg triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.112544425
40198-4,white blood cells count,glucose mole volume serum plasma 2 minute post xxx challenge,0.023886140618510104,0.07491756
5821-4,white blood cells count,leukocyte area urine sediment microscopy high power field,0.023886140618510104,0.087032884
58557-0,white blood cells count,corticotropin mole volume plasma 1 hour post dose glucose,0.023886140618510104,0.06309702
105896-5,white blood cells count,calcium oxalate crystal area urine sediment,0.023886140618510104,0.006956492
40209-9,white blood cells count,glucose mole volume serum plasma 25 minute post xxx challenge,0.023886140618510104,0.07502876
16908-6,white blood cells count,glucose presence urine 5th specimen post xxx challenge,0.023886140618510104,0.044629283
13595-4,white blood cells count,basophil leukocyte nose,0.023886140618510104,0.07754937
88976-6,white blood cells count,wbc cast area urine sediment,0.023886140618510104,0.064987026
54394-2,white blood cells count,glucose mole volume serum plasma 11th specimen post xxx challenge,0.023886140618510104,0.07698093
33655-2,white blood cells count,beta n acetylhexosaminidase mole volume leukocyte,0.023886140618510104,0.0856705
26549-6,white blood cells count,glucose presence urine test strip 3 hour post dose glucose,0.023886140618510104,0.05224186
5505-3,white blood cells count,deprecated cd56 cell 100 cell blood,0.023886140618510104,0.09465956
72648-9,white blood cells count,glucose serum glucose synovial fluid molar concentration difference,0.023886140618510104,0.07976082
9305-4,white blood cells count,mononuclear cell leukocyte body fluid manual count,0.023886140618510104,0.118740745
56751-1,white blood cells count,glucose mass volume serum plasma 2 17 hour post xxx challenge,0.023886140618510104,0.076805495
54250-6,white blood cells count,glucose mole volume serum plasma 15 minute pre dose glucagon,0.023886140618510104,0.07432882
16273-5,white blood cells count,calcium mass mass red blood cell,0.023886140618510104,0.05749394
1628-7,white blood cells count,somatotropin mass volume serum plasma 1 hour post 1 g kg glucose po,0.023886140618510104,0.08543926
40157-0,white blood cells count,glucose mole volume serum plasma 40 minute post xxx challenge,0.023886140618510104,0.07734389
48297-6,white blood cells count,chromotrope 2b triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10879218
5484-1,white blood cells count,deprecated cd45 cell 100 cell blood,0.023886140618510104,0.089586504
61124-4,white blood cells count,granulocyte leukocyte specimen flow cytometry fc,0.023886140618510104,0.091547035
1547-9,white blood cells count,glucose mass volume serum plasma baseline,0.023886140618510104,0.08824319
17227-0,white blood cells count,lymphocyte leukocyte synovial fluid automated count,0.023886140618510104,0.11397726
51426-5,white blood cells count,glucose mole volume serum plasma pre post xxx challenge,0.023886140618510104,0.07565577
70126-8,white blood cells count,leukocyte volume corrected nucleated erythrocyte pleural fluid,0.023886140618510104,0.11688472
59796-3,white blood cells count,glucose molar concentration difference serum plasma 4 hour post xxx challenge,0.023886140618510104,0.07947322
18227-9,white blood cells count,glucose mass time 6 hour urine,0.023886140618510104,0.057555065
33792-3,white blood cells count,calcium mole volume urine 6th specimen post xxx challenge,0.023886140618510104,0.056473307
53131-9,white blood cells count,calcium oxalate crystal area urine sediment microscopy low power field,0.023886140618510104,0.024558797
40526-6,white blood cells count,plasma cell leukocyte pericardial fluid manual count,0.023886140618510104,0.111540854
48212-5,white blood cells count,pork triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10448587
35054-6,white blood cells count,leukocyte volume peritoneal fluid,0.023886140618510104,0.11340979
105112-7,white blood cells count,eosinophil leukocyte urine sediment,0.023886140618510104,0.054703206
24073-9,white blood cells count,beta n acetylhexosaminidase b enzymatic activity mass leukocyte,0.023886140618510104,0.07883157
45298-7,white blood cells count,glucose mole volume serum plasma 2 5 hour post 50 g lactose po,0.023886140618510104,0.06630065
40544-9,white blood cells count,monocyte leukocyte bronchial specimen manual count,0.023886140618510104,0.09885246
40631-4,white blood cells count,nucleated erythrocyte leukocyte ratio cerebral spinal fluid manual count,0.023886140618510104,0.17038108
68433-2,white blood cells count,leukocyte volume vitreous fluid manual count,0.023886140618510104,0.13623095
13353-8,white blood cells count,deprecated eosinophil 100 leukocyte body fluid manual count,0.023886140618510104,0.10836367
24092-9,white blood cells count,alpha n acetylglucosaminidase enzymatic activity mass leukocyte,0.023886140618510104,0.08044965
75583-5,white blood cells count,fetal prader willi syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.023886140618510104,0.0807329
54439-5,white blood cells count,calcium bilirubinate total stone,0.023886140618510104,0.025036825
40217-2,white blood cells count,glucose mole volume serum plasma 28 hour post xxx challenge,0.023886140618510104,0.07505183
78442-1,white blood cells count,bilirubin indirect mole volume peritoneal fluid,0.023886140618510104,0.0614326
54401-5,white blood cells count,glucose mole volume serum plasma 10 minute post dose glucagon,0.023886140618510104,0.08286112
58529-9,white blood cells count,corticotropin mole volume plasma 1 5 hour post dose glucose,0.023886140618510104,0.062421806
48988-0,white blood cells count,glucose mass volume serum plasma 12 pm specimen,0.023886140618510104,0.08554853
40031-7,white blood cells count,glucose mass volume serum plasma 19 minute post xxx challenge,0.023886140618510104,0.08354304
1377-1,white blood cells count,calcitonin mass volume serum plasma 5 minute post 2 4 mg kg calcium short iv,0.023886140618510104,0.07393091
53050-1,white blood cells count,glucose mass volume total parental nutrition,0.023886140618510104,0.053771533
42567-8,white blood cells count,calcium ionized mass mole volume serum plasma,0.023886140618510104,0.048482783
47595-4,white blood cells count,component peptide mole volume serum plasma pre dose glucose,0.023886140618510104,0.05690402
40322-0,white blood cells count,glucose mole volume serum plasma 1 hour post dose triple bolus,0.023886140618510104,0.07499305
71630-8,white blood cells count,leukocyte leukocyte pure number fraction peritoneal fluid manual count,0.023886140618510104,0.119616054
14769-4,white blood cells count,glucose mole volume serum plasma pre 12 hour fast,0.023886140618510104,0.07892267
39998-0,white blood cells count,glucose mass volume serum plasma 30 minute pre xxx challenge,0.023886140618510104,0.07750295
5564-0,white blood cells count,deprecated tcr cd3,0.023886140618510104,0.081325166
5551-7,white blood cells count,deprecated cycd3 cell 100 cell blood,0.023886140618510104,0.09051224
40029-1,white blood cells count,glucose mass volume serum plasma 14 minute post xxx challenge,0.023886140618510104,0.08274356
72348-6,white blood cells count,leukocyte volume prostatic fluid manual count,0.023886140618510104,0.12962256
25675-0,white blood cells count,glucose mass volume urine 4 hour post dose glucose,0.023886140618510104,0.07272165
34445-7,white blood cells count,leukocyte presence body fluid,0.023886140618510104,0.0930651
14423-8,white blood cells count,bilirubin total mass volume synovial fluid,0.023886140618510104,0.07327144
6748-8,white blood cells count,glucose presence urine test strip 1 hour post 75 g glucose po,0.023886140618510104,0.04433864
102032-0,white blood cells count,glucose mass volume serum plasma 2 hour post dose insulin iv,0.023886140618510104,0.07465054
57467-3,white blood cells count,calcitriol mass volume serum plasma pre dose calcium,0.023886140618510104,0.06122035
5457-7,white blood cells count,deprecated cd28 cell 100 cell blood,0.023886140618510104,0.10081354
50725-1,white blood cells count,monoblast leukocyte bone marrow manual count,0.023886140618510104,0.11670327
53482-6,white blood cells count,glucose mole volume serum plasma 3 hour post dose betaxolol,0.023886140618510104,0.07815662
61513-8,white blood cells count,many year take calcium alone combined something else bone health supplement antacid phenx,0.023886140618510104,0.032370225
30427-9,white blood cells count,macrophage leukocyte body fluid,0.023886140618510104,0.086152814
74802-0,white blood cells count,glucose challenge hydrogen breath test interpretation exhaled gas,0.023886140618510104,0.052835166
50182-5,white blood cells count,calcitonin mass volume serum plasma 2 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.023886140618510104,0.071661584
21653-1,white blood cells count,cdh1 gene mutation tested blood tissue molecular genetics method nominal,0.023886140618510104,0.13301945
40653-8,white blood cells count,myelocyte leukocyte body fluid manual count,0.023886140618510104,0.112136915
1515-6,white blood cells count,deprecated glucose mass volume serum plasma 2 hour post 100 g glucose po,0.023886140618510104,0.06682102
70219-1,white blood cells count,basic metabolic 2008 panel ionized calcium serum plasma,0.023886140618510104,0.050743893
5454-4,white blood cells count,deprecated cd25 cell 100 cell blood,0.023886140618510104,0.09243616
12220-0,white blood cells count,glucose mass volume peritoneal fluid 12 hour post peritoneal dialysis,0.023886140618510104,0.067936756
5424-7,white blood cells count,deprecated cd115 cell 100 cell blood,0.023886140618510104,0.09169677
54249-8,white blood cells count,glucose mole volume serum plasma 15 minute post dose glucagon,0.023886140618510104,0.076087594
75356-6,white blood cells count,cell leukocyte pleural fluid manual count,0.023886140618510104,0.11939262
40286-7,white blood cells count,glucose mole volume serum plasma 105 minute post dose glucose,0.023886140618510104,0.07748645
13525-1,white blood cells count,nonhematic cell leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.11056829
35020-7,white blood cells count,monocyte macrophage leukocyte peritoneal fluid,0.023886140618510104,0.08335178
45190-6,white blood cells count,casr gene mutation found identifier blood tissue molecular genetics method nominal,0.023886140618510104,0.13163856
41201-5,white blood cells count,voltage gated calcium channel igg ab mole volume serum,0.023886140618510104,0.0499563
40171-1,white blood cells count,glucose mole volume serum plasma 9 hour post xxx challenge,0.023886140618510104,0.07283603
104072-4,white blood cells count,mucopolysaccharidosis enzyme panel leukocyte,0.023886140618510104,0.08339081
62875-0,white blood cells count,phenx assay human leukocyte antigen hla genotyping protocol 160601,0.023886140618510104,0.06928222
1970-3,white blood cells count,bilirubin delta mass volume serum plasma,0.023886140618510104,0.094165094
50407-6,white blood cells count,cell leukocyte identifier cerebral spinal fluid,0.023886140618510104,0.10495388
4528-6,white blood cells count,deprecated complement receptor 2,0.023886140618510104,0.08650023
40247-9,white blood cells count,calcium mole volume serum plasma 3 day post xxx challenge,0.023886140618510104,0.06356787
76350-8,white blood cells count,cell leukocyte body fluid,0.023886140618510104,0.09548065
1532-1,white blood cells count,glucose mass volume urine 3 hour post 100 g glucose po,0.023886140618510104,0.06485787
57468-1,white blood cells count,calcitriol mole volume serum plasma pre dose calcium,0.023886140618510104,0.047027428
48266-1,white blood cells count,grass allergen mix e cocksfoot meadow fescue velvet grass perennial rye grass timothy kentucky blue grass triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09595432
95102-0,white blood cells count,glucose post fasting meal stimulation panel serum plasma,0.023886140618510104,0.043051954
48186-1,white blood cells count,amylase triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09067697
25678-4,white blood cells count,glucose mass volume urine 1 5 hour post dose glucose,0.023886140618510104,0.068114124
35194-0,white blood cells count,bilirubin total mass mole volume serum plasma,0.023886140618510104,0.06772748
26483-8,white blood cells count,lymphocyte leukocyte synovial fluid,0.023886140618510104,0.083335556
54395-9,white blood cells count,glucose mole volume serum plasma 12th specimen post xxx challenge,0.023886140618510104,0.07618802
31994-7,white blood cells count,basophil leukocyte pericardial fluid manual count,0.023886140618510104,0.11066402
40009-3,white blood cells count,glucose mass volume serum plasma 12 5 hour post xxx challenge,0.023886140618510104,0.08167113
55480-8,white blood cells count,insulin mole volume serum plasma 5 minute pre dose glucose,0.023886140618510104,0.05749753
16990-4,white blood cells count,hydrogen expired gas volume fraction exhaled gas 3 hour post dose glucose,0.023886140618510104,0.039144307
53226-7,white blood cells count,leukocyte area urethra wet preparation,0.023886140618510104,0.07438622
16512-6,white blood cells count,calcium ionized mole volume serum plasma 2nd specimen post xxx challenge,0.023886140618510104,0.072667085
75588-4,white blood cells count,fetal angelman syndrome risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna,0.023886140618510104,0.07590601
53868-6,white blood cells count,glucose tetrasaccharide creatinine molar ratio urine,0.023886140618510104,0.05145199
10968-6,white blood cells count,glucose presence urine test strip 4 5 hour post 75 g glucose po,0.023886140618510104,0.051377602
33371-6,white blood cells count,variant lymphocyte leukocyte synovial fluid,0.023886140618510104,0.08042948
11032-0,white blood cells count,glucose mass volume serum plasma 45 minute post 50 g lactose po,0.023886140618510104,0.08404938
53083-2,white blood cells count,bilirubin conjugated mole volume dialysis fluid,0.023886140618510104,0.06264856
53481-8,white blood cells count,glucose mole volume serum plasma 15 minute pre dose betaxolol,0.023886140618510104,0.070277296
46406-5,white blood cells count,somatotropin mass volume serum plasma 30 minute post 1 g kg glucose po,0.023886140618510104,0.0819961
40208-1,white blood cells count,glucose mole volume serum plasma 22 minute post xxx challenge,0.023886140618510104,0.075171806
33370-8,white blood cells count,variant lymphocyte leukocyte pleural fluid,0.023886140618510104,0.08191301
48269-5,white blood cells count,cefamandole triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10217019
93704-5,white blood cells count,palmitoyl protein thioesterase 1 tripeptidyl peptidase 1 panel leukocyte,0.023886140618510104,0.043485433
101931-4,white blood cells count,calcium oxalate crystal energy difference urine,0.023886140618510104,0.026417928
13522-8,white blood cells count,blast leukocyte body fluid manual count,0.023886140618510104,0.10743898
50551-1,white blood cells count,bilirubin total presence urine automated test strip,0.023886140618510104,0.046977077
71601-9,white blood cells count,leukocyte leukocyte pure number fraction pericardial fluid manual count,0.023886140618510104,0.12076875
16521-7,white blood cells count,calcium mole volume urine 3rd specimen post xxx challenge,0.023886140618510104,0.060005635
53444-6,white blood cells count,citrate synthase enzymatic activity mass control leukocyte,0.023886140618510104,0.08158714
57840-1,white blood cells count,eosinophil leukocyte dialysis fluid manual count,0.023886140618510104,0.10017693
33384-9,white blood cells count,segmented neutrophil leukocyte peritoneal fluid,0.023886140618510104,0.079835
16993-8,white blood cells count,hydrogen expired gas volume fraction exhaled gas 5 5 hour post dose glucose,0.023886140618510104,0.037337117
26552-0,white blood cells count,glucose presence urine test strip 6 hour post dose glucose,0.023886140618510104,0.0546561
5432-0,white blood cells count,deprecated cd126 cell 100 cell blood,0.023886140618510104,0.09728294
71640-7,white blood cells count,mesothelial cell leukocyte pure number fraction body fluid manual count,0.023886140618510104,0.12006735
39563-2,white blood cells count,glucose mass volume serum plasma 3rd specimen post dose lactose,0.023886140618510104,0.07293666
18296-4,white blood cells count,glucose interpretation serum plasma post dose glucose,0.023886140618510104,0.075398974
53309-1,white blood cells count,calcium phosphate crystal area urine computer assisted method,0.023886140618510104,0.00829795
12233-3,white blood cells count,mesothelial cell leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.10292532
14752-0,white blood cells count,glucose mole volume serum plasma 1 5 hour post dose glucose,0.023886140618510104,0.083629444
26470-5,white blood cells count,leukocyte volume cerebral spinal fluid,0.023886140618510104,0.11844879
33898-8,white blood cells count,bilirubin conjugated indirect mass volume serum plasma,0.023886140618510104,0.08621532
40539-9,white blood cells count,eosinophil leukocyte peritoneal dialysis fluid manual count,0.023886140618510104,0.09417697
53484-2,white blood cells count,glucose mole volume serum plasma 30 minute pre dose betaxolol,0.023886140618510104,0.076321185
40075-4,white blood cells count,calcium mass volume serum plasma 6 5 hour post xxx challenge,0.023886140618510104,0.069480866
40199-2,white blood cells count,glucose mole volume serum plasma 3 minute post xxx challenge,0.023886140618510104,0.07448637
82883-0,white blood cells count,lysosomal acid lipase enzymatic activity mass leukocyte 4 mu palmitate substrate,0.023886140618510104,0.08120284
30264-6,white blood cells count,glucose mole volume serum plasma 40 minute post dose glucose,0.023886140618510104,0.08149134
15077-1,white blood cells count,glucose mole time 24 hour urine,0.023886140618510104,0.0616521
32028-3,white blood cells count,monocyte macrophage leukocyte pleural fluid manual count,0.023886140618510104,0.11014794
1529-7,white blood cells count,deprecated glucose mass volume serum plasma 30 minute post dose insulin iv,0.023886140618510104,0.06361801
75601-5,white blood cells count,fetal 1p36 deletion risk likelihood based plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.023886140618510104,0.08361287
16992-0,white blood cells count,hydrogen expired gas volume fraction exhaled gas 4 hour post dose glucose,0.023886140618510104,0.04308345
53302-6,white blood cells count,calcium carbonate crystal volume urine computer assisted method,0.023886140618510104,0.024214972
30527-6,white blood cells count,calcium mass volume total parental nutrition,0.023886140618510104,0.036914967
53443-8,white blood cells count,carnitine palmitoyltransferase 2 enzymatic activity mass control leukocyte,0.023886140618510104,0.078037135
62855-2,white blood cells count,deprecated phenx measure oral glucose tolerance test,0.023886140618510104,0.047754586
12913-0,white blood cells count,beta n acetylhexosaminidase enzymatic activity volume leukocyte,0.023886140618510104,0.09424141
48208-3,white blood cells count,baker yeast triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10531476
40004-4,white blood cells count,glucose mass volume serum plasma 100 minute post xxx challenge,0.023886140618510104,0.087429896
13524-4,white blood cells count,leukocyte leukocyte body fluid manual count,0.023886140618510104,0.119613156
53486-7,white blood cells count,glucose mole volume serum plasma 1 hour post dose betaxolol,0.023886140618510104,0.08010181
30417-0,white blood cells count,variant lymphocyte leukocyte body fluid,0.023886140618510104,0.083236165
16272-7,white blood cells count,calcium mass volume serum plasma 2 hour post xxx challenge,0.023886140618510104,0.07393243
71602-7,white blood cells count,basophil leukocyte pure number fraction pericardial fluid manual count,0.023886140618510104,0.11997894
40176-0,white blood cells count,glucose mole volume serum plasma 12 hour post xxx challenge,0.023886140618510104,0.07449514
40161-2,white blood cells count,glucose mole volume serum plasma 2 5 hour post xxx challenge,0.023886140618510104,0.07262116
33653-7,white blood cells count,beta galactosidase entitic catalytic activity leukocyte,0.023886140618510104,0.08363069
5467-6,white blood cells count,deprecated cd35 cell 100 cell blood,0.023886140618510104,0.08521382
49500-2,white blood cells count,calcium oxalate dihydrate total stone infrared spectroscopy,0.023886140618510104,0.014199344
5486-6,white blood cells count,deprecated cd45rb cell 100 cell blood,0.023886140618510104,0.0902198
50751-7,white blood cells count,glucose mass volume serum plasma 15 minute post 0 1 u kg insulin,0.023886140618510104,0.07145313
68423-3,white blood cells count,monocyte leukocyte vitreous fluid manual count,0.023886140618510104,0.10594536
71625-8,white blood cells count,neutrophil leukocyte pure number fraction synovial fluid manual count,0.023886140618510104,0.12114828
48211-7,white blood cells count,beef triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10395576
54364-5,white blood cells count,calcium mole volume nonbiological fluid,0.023886140618510104,0.046691686
20441-2,white blood cells count,glucose mass volume serum plasma post 50 g glucose,0.023886140618510104,0.09551394
5549-1,white blood cells count,deprecated cd98 cell 100 cell blood,0.023886140618510104,0.097384125
96977-4,white blood cells count,noninvasive prenatal fetal aneuploidy panel plasma cell free wbc dna dosage chromosome specific cfdna,0.023886140618510104,0.08313933
40197-6,white blood cells count,glucose mole volume serum plasma 3 minute pre xxx challenge,0.023886140618510104,0.07195271
34546-2,white blood cells count,protein glucose panel mass volume cerebral spinal fluid,0.023886140618510104,0.05440027
40152-1,white blood cells count,glucose mole volume serum plasma 5 minute pre xxx challenge,0.023886140618510104,0.07233024
12611-0,white blood cells count,glucose mass volume serum plasma 4 hour specimen,0.023886140618510104,0.09704272
5476-7,white blood cells count,deprecated cd41 cell 100 cell blood,0.023886140618510104,0.10036756
45206-0,white blood cells count,glucose mass volume urine test strip 5th specimen post xxx challenge,0.023886140618510104,0.08511001
40277-6,white blood cells count,glucose mole volume serum plasma 1 hour post dose lactose po,0.023886140618510104,0.06698782
50342-5,white blood cells count,ependymal choroid plexus cell leukocyte ratio cerebral spinal fluid,0.023886140618510104,0.08945355
53306-7,white blood cells count,calcium oxalate crystal area urine computer assisted method,0.023886140618510104,0.005739427
48229-9,white blood cells count,dog epithelium triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09669205
9377-3,white blood cells count,glucose mass volume serum plasma 4 5 hour post 100 g glucose po,0.023886140618510104,0.08165393
48298-4,white blood cells count,pigweed triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10021491
48290-1,white blood cells count,sodium nitrite triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09303899
5516-0,white blood cells count,deprecated cd66a cell 100 cell blood,0.023886140618510104,0.0978301
10832-4,white blood cells count,glucose mass volume serum plasma 15 minute post 50 g lactose po,0.023886140618510104,0.078233086
51385-3,white blood cells count,plasma cell leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.112113506
14375-0,white blood cells count,granulocyte leukocyte peritoneal fluid manual count,0.023886140618510104,0.11155239
54270-4,white blood cells count,glucose mole volume serum plasma 2 5 hour post dose ornithine alpha ketoglutarate,0.023886140618510104,0.06731231
14755-3,white blood cells count,glucose mole volume serum plasma 1 hour post 50 g lactose po,0.023886140618510104,0.076505594
12622-7,white blood cells count,glucose mass volume serum plasma 10th specimen post xxx challenge,0.023886140618510104,0.09025689
40002-8,white blood cells count,glucose mass volume serum plasma 80 minute post xxx challenge,0.023886140618510104,0.08547324
13717-4,white blood cells count,calcium creatinine mass ratio 24 hour urine,0.023886140618510104,0.041873775
97510-2,white blood cells count,glucose measurement range total glucose measurement reporting period,0.023886140618510104,0.051967796
26497-8,white blood cells count,mononuclear cell leukocyte synovial fluid,0.023886140618510104,0.09002468
54415-5,white blood cells count,transfuse leukocyte poor platelet unit,0.023886140618510104,0.08231174
71611-8,white blood cells count,leukocyte leukocyte pure number fraction pleural fluid manual count,0.023886140618510104,0.12427303
38251-5,white blood cells count,calcium oxalate mass time 24 hour urine,0.023886140618510104,0.023805737
30461-8,white blood cells count,granulocyte leukocyte stool,0.023886140618510104,0.077621266
16516-7,white blood cells count,calcium ionized mole volume serum plasma 6th specimen post xxx challenge,0.023886140618510104,0.07520807
20440-4,white blood cells count,glucose mass volume serum plasma 1 5 hour post dose glucose,0.023886140618510104,0.09020937
12244-0,white blood cells count,granulocyte leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.11176809
75547-0,white blood cells count,noninvasive prenatal fetal aneuploidy microdeletion panel based plasma cell free wbc dna dosage chromosome specific circulating cell free ccf dna,0.023886140618510104,0.07982754
4523-7,white blood cells count,complement ic3b receptor entitic number leukocyte,0.023886140618510104,0.0861803
53328-1,white blood cells count,glucose mass volume urine automated test strip,0.023886140618510104,0.07583839
12654-0,white blood cells count,glucose mass volume serum plasma 10 minute post xxx challenge,0.023886140618510104,0.08996066
26452-3,white blood cells count,eosinophil leukocyte body fluid,0.023886140618510104,0.08518446
26540-5,white blood cells count,glucose mass volume urine 3 hour post dose glucose,0.023886140618510104,0.06848288
9321-1,white blood cells count,calcium creatinine mass ratio urine,0.023886140618510104,0.033479337
12646-6,white blood cells count,glucose mass volume serum plasma 1 hour post xxx challenge,0.023886140618510104,0.08686457
5799-2,white blood cells count,leukocyte esterase presence urine test strip,0.023886140618510104,0.063743785
62418-9,white blood cells count,glucose insulin ratio serum plasma,0.023886140618510104,0.0711493
13519-4,white blood cells count,basophil leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.11130332
13354-6,white blood cells count,band form neutrophil leukocyte body fluid manual count,0.023886140618510104,0.11198407
20494-1,white blood cells count,deprecated lymphocyte 100 leukocyte body fluid manual count,0.023886140618510104,0.12335987
12659-9,white blood cells count,glucose mass volume serum plasma 70 minute post xxx challenge,0.023886140618510104,0.089904435
14765-2,white blood cells count,glucose mole volume serum plasma 3 hour post dose glucose,0.023886140618510104,0.08190099
26695-7,white blood cells count,glucose mass volume serum plasma 7th specimen post xxx challenge,0.023886140618510104,0.08678507
75565-2,white blood cells count,comment fetal trisomy 21 risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.023886140618510104,0.08572541
16261-0,white blood cells count,calcium bilirubinate crystal presence stone infrared spectroscopy,0.023886140618510104,0.017974311
32807-0,white blood cells count,mononuclear cell leukocyte bronchial specimen,0.023886140618510104,0.08151973
54487-4,white blood cells count,glucose mole volume water,0.023886140618510104,0.055706847
56769-3,white blood cells count,lymphocyte leukocyte bronchial specimen flow cytometry fc,0.023886140618510104,0.088238835
12218-4,white blood cells count,glucose mass volume peritoneal fluid 2 hour post peritoneal dialysis,0.023886140618510104,0.06602569
56937-6,white blood cells count,hydrogen expired gas volume fraction exhaled gas 30 minute post dose glucose,0.023886140618510104,0.036119845
34907-6,white blood cells count,calcium mass volume corrected total protein serum plasma,0.023886140618510104,0.073806174
71596-1,white blood cells count,eosinophil leukocyte pure number fraction bronchial specimen manual count,0.023886140618510104,0.104499474
40219-8,white blood cells count,glucose mole volume serum plasma 30 hour post xxx challenge,0.023886140618510104,0.07483606
48187-9,white blood cells count,chloramin triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10172663
38254-9,white blood cells count,carbonated calcium phosphate presence stone,0.023886140618510104,0.0035214142
48606-8,white blood cells count,glucose mass volume serum plasma pre dose fructose po,0.023886140618510104,0.06981398
75579-3,white blood cells count,comment fetal 22q11 2 deletion risk text plasma cell free wbc dna dosage chromosome specific cfdna narrative,0.023886140618510104,0.08153285
2005-7,white blood cells count,calcium mole time 2 hour urine 12 hour fasting,0.023886140618510104,0.04652951
27432-4,white blood cells count,glucose mass volume serum plasma 8th specimen post xxx challenge,0.023886140618510104,0.08721364
40205-7,white blood cells count,glucose mole volume serum plasma 14 minute post xxx challenge,0.023886140618510104,0.07658164
82877-2,white blood cells count,cytochrome component oxidase enzymatic activity mass leukocyte,0.023886140618510104,0.07646533
48279-4,white blood cells count,propyphenazone triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.097784236
25671-9,white blood cells count,glucose mole volume serum plasma 30 minute post xxx challenge,0.023886140618510104,0.08269376
1516-4,white blood cells count,glucose mass volume urine 2 hour post 100 g glucose po,0.023886140618510104,0.067173615
5412-2,white blood cells count,deprecated b b4 blood,0.023886140618510104,0.10002691
95223-4,white blood cells count,mononuclear cell leukocyte stem cell product manual count,0.023886140618510104,0.11816132
74542-2,white blood cells count,pyruvate kinase glucose 6 phosphate dehydrogenase enzymatic activity ratio red blood cell,0.023886140618510104,0.0676207
9047-2,white blood cells count,calcium intake 1 hour,0.023886140618510104,0.032175314
54251-4,white blood cells count,glucose mole volume serum plasma 20 minute post dose glucagon,0.023886140618510104,0.08343909
14418-8,white blood cells count,calcium mole volume synovial fluid,0.023886140618510104,0.054352403
5436-1,white blood cells count,deprecated cd15 cell 100 cell blood,0.023886140618510104,0.08731344
33768-3,white blood cells count,leukocyte clump volume urine automated count,0.023886140618510104,0.11495306
9051-4,white blood cells count,calcium intake mole time 24 hour,0.023886140618510104,0.03363122
12628-4,white blood cells count,glucose mass volume peritoneal dialysis fluid,0.023886140618510104,0.0720215
5531-9,white blood cells count,deprecated cd79b cell 100 cell blood,0.023886140618510104,0.100818925
32320-4,white blood cells count,glucose mole volume serum plasma 3 hour post 75 g glucose po,0.023886140618510104,0.07432094
48198-6,white blood cells count,amoxicillin triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10317763
11132-8,white blood cells count,deprecated bilirubin mass volume body fluid,0.023886140618510104,0.06326583
48234-9,white blood cells count,acarus siro triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.089664765
13606-9,white blood cells count,glucose mass volume serum plasma 3 hour post 50 g lactose po,0.023886140618510104,0.07973941
26519-9,white blood cells count,granulocyte leukocyte pleural fluid,0.023886140618510104,0.09476634
48292-7,white blood cells count,sodium salicylate triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.0928563
1536-2,white blood cells count,glucose mass volume serum plasma 45 minute post dose insulin iv,0.023886140618510104,0.076114595
1552-9,white blood cells count,glucose mass volume serum plasma pre 75 g glucose po,0.023886140618510104,0.077270605
50588-3,white blood cells count,glucose tolerance 5 hour panel serum plasma,0.023886140618510104,0.052585896
28544-5,white blood cells count,mesothelial cell leukocyte body fluid,0.023886140618510104,0.08945984
1534-7,white blood cells count,glucose mass volume serum plasma 3 minute post 0 5 g kg glucose iv,0.023886140618510104,0.08924821
2437-2,white blood cells count,hydrogen expired gas volume fraction exhaled gas post 50 g glucose po,0.023886140618510104,0.03788711
57391-5,white blood cells count,eosinophil leukocyte synovial fluid manual count,0.023886140618510104,0.09793902
62856-0,white blood cells count,phenx oral glucose tolerance test protocol 141001,0.023886140618510104,0.045925435
62442-9,white blood cells count,nucleated erythrocyte leukocyte ratio synovial fluid automated count,0.023886140618510104,0.12364982
95216-8,white blood cells count,eosinophil leukocyte stem cell product manual count,0.023886140618510104,0.111753166
16905-2,white blood cells count,glucose presence urine 2nd specimen post xxx challenge,0.023886140618510104,0.04358793
40492-1,white blood cells count,plasma cell leukocyte synovial fluid manual count,0.023886140618510104,0.11163541
1505-7,white blood cells count,glucose mass volume urine 1 hour post 50 g glucose po,0.023886140618510104,0.06687275
48259-6,white blood cells count,kentucky blue grass triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09875859
53480-0,white blood cells count,glucose mole volume serum plasma 2 5 hour post dose betaxolol,0.023886140618510104,0.08058951
88114-4,white blood cells count,leukocyte presence cerebral spinal fluid gram stain,0.023886140618510104,0.09489577
34984-5,white blood cells count,unidentified cell leukocyte synovial fluid,0.023886140618510104,0.08839893
63555-7,white blood cells count,leukocyte volume microscopy high power field urine sediment collected unspecified duration,0.023886140618510104,0.103797525
59795-5,white blood cells count,glucose molar concentration difference serum plasma 3 hour post xxx challenge,0.023886140618510104,0.07625909
53124-4,white blood cells count,calcium mole time 1 hour urine,0.023886140618510104,0.045040313
30416-2,white blood cells count,variant lymphocyte leukocyte cerebral spinal fluid,0.023886140618510104,0.07922906
97505-2,white blood cells count,glucose standard deviation calculated,0.023886140618510104,0.07036322
11123-7,white blood cells count,deprecated promyelocytes 100 cell bone marrow microscopy,0.023886140618510104,0.09507694
1973-7,white blood cells count,bilirubin total mass volume cerebral spinal fluid,0.023886140618510104,0.07733401
45056-9,white blood cells count,glucose mole volume serum plasma 8 pm specimen,0.023886140618510104,0.07769455
25705-5,white blood cells count,ketone presence urine 1 hour post 50 g glucose po,0.023886140618510104,0.03649268
11142-7,white blood cells count,glucose mass volume serum plasma 15 minute post 100 g glucose po,0.023886140618510104,0.08154294
812-8,white blood cells count,leukocyte volume semen manual count,0.023886140618510104,0.124639094
14762-9,white blood cells count,glucose mole volume serum plasma 30 minute post 50 g lactose po,0.023886140618510104,0.07750917
31996-2,white blood cells count,basophil leukocyte peritoneal fluid manual count,0.023886140618510104,0.11180898
30407-1,white blood cells count,leukocyte leukocyte pericardial fluid,0.023886140618510104,0.0833714
30396-6,white blood cells count,granulocyte leukocyte bronchial specimen,0.023886140618510104,0.07562027
30443-6,white blood cells count,mononuclear cell leukocyte gastric fluid,0.023886140618510104,0.08258885
58802-0,white blood cells count,mononuclear cell leukocyte peritoneal dialysis fluid,0.023886140618510104,0.08416238
47660-6,white blood cells count,insulin unit volume serum plasma 2 5 hour post dose glucose,0.023886140618510104,0.06805984
47587-1,white blood cells count,component peptide mole volume serum plasma 1 minute post dose glucose,0.023886140618510104,0.059625823
48288-5,white blood cells count,vecuronium triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.1073809
14756-1,white blood cells count,glucose mole volume serum plasma 1 hour post dose glucose,0.023886140618510104,0.08255052
48294-3,white blood cells count,food colorant mix triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10183527
63372-7,white blood cells count,ketone presence urine test strip 3 hour post dose glucose,0.023886140618510104,0.042269543
75057-0,white blood cells count,sialidase enzymatic activity mass leukocyte,0.023886140618510104,0.074684665
30410-5,white blood cells count,leukocyte leukocyte synovial fluid,0.023886140618510104,0.08701604
40065-5,white blood cells count,calcium mass volume serum plasma 45 minute pre xxx challenge,0.023886140618510104,0.069104575
58781-6,white blood cells count,calcium mass volume peritoneal dialysis fluid,0.023886140618510104,0.048889875
33228-8,white blood cells count,wbc cast area urine computer assisted method,0.023886140618510104,0.06246069
35052-0,white blood cells count,leukocyte volume pleural fluid,0.023886140618510104,0.1174622
61153-3,white blood cells count,glucose mass volume peritoneal dialysis fluid baseline,0.023886140618510104,0.06122325
12633-4,white blood cells count,glucose mass volume peritoneal dialysis fluid 4th specimen,0.023886140618510104,0.07544677
95221-8,white blood cells count,metamyelocytes leukocyte stem cell product manual count,0.023886140618510104,0.11632637
74458-1,white blood cells count,large unstained cell leukocyte blood fetus automated count,0.023886140618510104,0.21240778
50724-4,white blood cells count,lymphoblast leukocyte bone marrow manual count,0.023886140618510104,0.1112768
21681-2,white blood cells count,g6pd gene mutation tested blood tissue molecular genetics method nominal,0.023886140618510104,0.1381307
21395-9,white blood cells count,monocyte macrophage leukocyte synovial fluid manual count,0.023886140618510104,0.11009199
74434-2,white blood cells count,bilirubin total total stone infrared spectroscopy,0.023886140618510104,0.037387468
26538-9,white blood cells count,glucose presence urine test strip 3 5 hour post dose glucose,0.023886140618510104,0.05111217
74244-5,white blood cells count,hedis 2014 value set glucose test,0.023886140618510104,0.041830815
54269-6,white blood cells count,glucose mole volume serum plasma 2 hour post dose ornithine alpha ketoglutarate,0.023886140618510104,0.06759507
99928-4,white blood cells count,leukocyte presence body fluid automated,0.023886140618510104,0.09434232
47771-1,white blood cells count,somatotropin unit volume serum plasma 3 hour post dose glucose po,0.023886140618510104,0.06698492
53487-5,white blood cells count,glucose mole volume serum plasma 1 5 hour post dose betaxolol,0.023886140618510104,0.07906122
5511-1,white blood cells count,deprecated cd62e cell 100 cell blood,0.023886140618510104,0.09766061
12658-1,white blood cells count,glucose mass volume serum plasma 50 minute post xxx challenge,0.023886140618510104,0.089829355
55495-6,white blood cells count,insulin mole volume serum plasma 45 minute post dose glucose iv,0.023886140618510104,0.061973963
86915-6,white blood cells count,calcium goal mass volume serum plasma,0.023886140618510104,0.06615243
74516-6,white blood cells count,calcium mole volume saliva oral fluid,0.023886140618510104,0.051064443
79469-3,white blood cells count,uridine diphosphate glucose 4 epimerase enzymatic activity mass red blood cell,0.023886140618510104,0.054614797
1504-0,white blood cells count,glucose mass volume serum plasma 1 hour post 50 g glucose po,0.023886140618510104,0.085819416
17863-2,white blood cells count,calcium ionized mass volume serum plasma,0.023886140618510104,0.07366838
47398-3,white blood cells count,beta mannosidase actual normal leukocyte,0.023886140618510104,0.08093969
5471-8,white blood cells count,deprecated cd39 cell 100 cell blood,0.023886140618510104,0.09362974
5434-6,white blood cells count,deprecated cd13 cell 100 cell blood,0.023886140618510104,0.0888599
34056-2,white blood cells count,glucose mole volume serum plasma pre post dose arginine,0.023886140618510104,0.059419446
5529-3,white blood cells count,deprecated cd77 cell 100 cell blood,0.023886140618510104,0.09310592
59148-7,white blood cells count,calcium mole volume serum plasma post dialysis,0.023886140618510104,0.06891374
29760-6,white blood cells count,bilirubin conjugated mole volume serum plasma,0.023886140618510104,0.08071957
57972-2,white blood cells count,glucose mass volume serum plasma 5th specimen post lactose,0.023886140618510104,0.07999441
95105-3,white blood cells count,glucose mass volume serum plasma 30 min post meal,0.023886140618510104,0.07190581
50589-1,white blood cells count,glucose tolerance 6 hour panel serum plasma,0.023886140618510104,0.05719508
105053-3,white blood cells count,calcium oxalate crystal presence urine sediment microscopy,0.023886140618510104,0.013540633
26522-3,white blood cells count,granulocyte leukocyte synovial fluid,0.023886140618510104,0.091443084
48973-2,white blood cells count,leukocyte presence stool methylene blue stain 2nd specimen,0.023886140618510104,0.08193442
54267-0,white blood cells count,glucose mole volume serum plasma 1 5 hour post dose insulin iv,0.023886140618510104,0.069027565
50586-7,white blood cells count,glucose tolerance 3 hour panel serum plasma,0.023886140618510104,0.054620598
71614-2,white blood cells count,monocyte leukocyte pure number fraction pleural fluid manual count,0.023886140618510104,0.12186183
12648-2,white blood cells count,glucose mass volume serum plasma 15 minute post dose lactose po,0.023886140618510104,0.073910885
25677-6,white blood cells count,glucose mole volume serum plasma 6 hour post dose glucose,0.023886140618510104,0.08387167
50183-3,white blood cells count,calcitonin mass volume serum plasma 1 minute post 2 mg kg calcium 0 5 ug kg pentagastrin iv,0.023886140618510104,0.071185075
40158-8,white blood cells count,glucose mole volume serum plasma 50 minute post xxx challenge,0.023886140618510104,0.0758243
40202-4,white blood cells count,glucose mole volume serum plasma 8 minute post xxx challenge,0.023886140618510104,0.07630281
5495-7,white blood cells count,deprecated cd49e cell 100 cell blood,0.023886140618510104,0.1021771
5559-0,white blood cells count,rfd9 unit volume leukocyte,0.023886140618510104,0.10111799
40034-1,white blood cells count,glucose mass volume serum plasma 27 minute post xxx challenge,0.023886140618510104,0.079956904
94349-8,white blood cells count,voltage gated calcium channel p q type binding igg igm ab mole volume serum immunoassay,0.023886140618510104,0.039236236
92666-7,white blood cells count,growth hormone glucose post clonidine stimulation panel serum plasma,0.023886140618510104,0.039004788
40166-1,white blood cells count,glucose mole volume serum plasma 6 5 hour post xxx challenge,0.023886140618510104,0.07380804
24098-6,white blood cells count,n acetylglucosamine 6 sulfatase enzymatic activity mass leukocyte,0.023886140618510104,0.08517141
58568-7,white blood cells count,corticotropin mole volume plasma 2 5 hour post dose glucose,0.023886140618510104,0.05954888
48268-7,white blood cells count,minor determinant mixture triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.105415605
32177-8,white blood cells count,granulocyte leukocyte vaginal fluid,0.023886140618510104,0.08851974
14385-9,white blood cells count,mononuclear cell leukocyte gastric fluid manual count,0.023886140618510104,0.11005062
40263-6,white blood cells count,glucose mass volume serum plasma 30 minute post xxx challenge,0.023886140618510104,0.07975964
49966-5,white blood cells count,granulocyte leukocyte pericardial fluid manual count,0.023886140618510104,0.108540766
24075-4,white blood cells count,beta n acetylhexosaminidase enzymatic activity mass leukocyte,0.023886140618510104,0.07676564
54276-1,white blood cells count,glucose mole volume serum plasma 1 hour post dose ornithine alpha ketoglutarate,0.023886140618510104,0.06766
40220-6,white blood cells count,glucose mole volume serum plasma 31 hour post xxx challenge,0.023886140618510104,0.07531202
48284-4,white blood cells count,pancuronium triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.109928295
27862-2,white blood cells count,insulin unit volume serum plasma 4 hour post 75 g glucose po,0.023886140618510104,0.07107588
1495-1,white blood cells count,glucose mass volume urine 1 5 hour post 100 g glucose po,0.023886140618510104,0.070101246
33352-6,white blood cells count,glucose creatinine mass ratio urine,0.023886140618510104,0.04383741
68429-0,white blood cells count,leukocyte volume peritoneal fluid manual count,0.023886140618510104,0.13530065
30404-8,white blood cells count,leukocyte volume stool,0.023886140618510104,0.1092939
48607-6,white blood cells count,glucose mass volume serum plasma 30 minute post dose fructose po,0.023886140618510104,0.07493262
16517-5,white blood cells count,calcium ionized mole volume serum plasma 7th specimen post xxx challenge,0.023886140618510104,0.07354689
57797-3,white blood cells count,glucose mass volume stool post hydrolysis,0.023886140618510104,0.06026402
71641-5,white blood cells count,macrophage leukocyte pure number fraction body fluid manual count,0.023886140618510104,0.12244961
42629-6,white blood cells count,glucose mass volume urine 4 hour post dose lactose po,0.023886140618510104,0.06128928
26495-2,white blood cells count,mononuclear cell leukocyte peritoneal fluid,0.023886140618510104,0.08899514
27940-6,white blood cells count,deprecated insulin unit volume serum plasma 1 5 hour post 75 g glucose po,0.023886140618510104,0.0731304
77355-6,white blood cells count,non hematopoietic stem cell leukocyte body fluid manual count,0.023886140618510104,0.11884069
48291-9,white blood cells count,potassium metabisulfite triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09796029
24047-3,white blood cells count,alpha fucosidase enzymatic activity mass leukocyte,0.023886140618510104,0.087746926
13527-7,white blood cells count,unidentified cell leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.11432323
30442-8,white blood cells count,monocyte leukocyte urine,0.023886140618510104,0.08064981
40013-5,white blood cells count,glucose mass volume serum plasma 15 5 hour post xxx challenge,0.023886140618510104,0.07610106
3242-5,white blood cells count,recalcification time platelet poor plasma coagulation assay,0.023886140618510104,0.04094887
40235-4,white blood cells count,calcium mole volume serum plasma 5 hour post xxx challenge,0.023886140618510104,0.062101603
48192-9,white blood cells count,sunset yellow fcf triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10725008
12225-9,white blood cells count,leukocyte area sputum microscopy high power field,0.023886140618510104,0.10203779
57470-7,white blood cells count,calcitriol mass volume serum plasma 2 hour post dose calcium,0.023886140618510104,0.06529529
68406-8,white blood cells count,abnormal lymphocyte leukocyte vitreous fluid manual count,0.023886140618510104,0.10835118
12641-7,white blood cells count,glucose mass volume serum plasma 7 hour post xxx challenge,0.023886140618510104,0.08864462
71613-4,white blood cells count,eosinophil leukocyte pure number fraction pleural fluid manual count,0.023886140618510104,0.11425112
58625-5,white blood cells count,corticotropin mole volume plasma pre dose glucose,0.023886140618510104,0.057596505
26545-4,white blood cells count,glucose mass volume urine 6 hour post dose glucose,0.023886140618510104,0.07115558
53049-3,white blood cells count,glucose mass volume serum plasma pre meal,0.023886140618510104,0.07219051
53316-6,white blood cells count,leukocyte presence urine automated,0.023886140618510104,0.0627177
5413-0,white blood cells count,deprecated cd1 cell 100 cell blood,0.023886140618510104,0.09663742
96973-3,white blood cells count,cdh1 gene deletion duplication mutation analysis identifier blood tissue molecular genetics method nominal,0.023886140618510104,0.13232972
54260-5,white blood cells count,glucose mole volume serum plasma 15 minute post dose insulin iv,0.023886140618510104,0.062020447
2354-9,white blood cells count,glucose 6 phosphatase enzymatic activity volume serum,0.023886140618510104,0.07843062
71634-0,white blood cells count,lymphocyte leukocyte pure number fraction peritoneal fluid manual count,0.023886140618510104,0.11836217
14759-5,white blood cells count,glucose mole volume serum plasma 2 hour post dose glucose,0.023886140618510104,0.08059365
72902-0,white blood cells count,insulin mole volume serum plasma 1 hour post 75 g glucose po,0.023886140618510104,0.064706124
47664-8,white blood cells count,insulin unit volume serum plasma 3 minute post dose glucose,0.023886140618510104,0.06679926
25674-3,white blood cells count,glucose mole volume serum plasma 45 minute post xxx challenge,0.023886140618510104,0.08249934
34985-2,white blood cells count,unidentified cell leukocyte body fluid,0.023886140618510104,0.093540296
47585-5,white blood cells count,component peptide mole volume serum plasma 15 minute post dose glucose,0.023886140618510104,0.053994283
40015-0,white blood cells count,glucose mass volume serum plasma 17 5 hour post xxx challenge,0.023886140618510104,0.078057505
70037-7,white blood cells count,mononuclear cell leukocyte pericardial fluid automated count,0.023886140618510104,0.11469378
40875-7,white blood cells count,glucose mass volume specimen 3rd specimen,0.023886140618510104,0.06365324
54254-8,white blood cells count,glucose mole volume serum plasma 5 minute pre dose glucagon,0.023886140618510104,0.07669802
57471-5,white blood cells count,calcitriol mole volume serum plasma 3 hour post dose calcium,0.023886140618510104,0.049274035
40181-0,white blood cells count,glucose mole volume serum plasma 15 5 hour post xxx challenge,0.023886140618510104,0.06660414
40285-9,white blood cells count,glucose mole volume serum plasma 75 minute post dose glucose,0.023886140618510104,0.07500307
95217-6,white blood cells count,nucleated erythrocyte leukocyte stem cell product manual count,0.023886140618510104,0.12086061
30368-5,white blood cells count,myelocyte leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.1033905
39478-3,white blood cells count,glucose mole volume vitreous fluid,0.023886140618510104,0.056504525
5546-7,white blood cells count,deprecated cd95 cell 100 cell blood,0.023886140618510104,0.0958175
59815-1,white blood cells count,glucose mole volume serum plasma 3 pm specimen,0.023886140618510104,0.07663669
11157-5,white blood cells count,leukocyte morphology bone marrow,0.023886140618510104,0.09804781
48289-3,white blood cells count,sodium benzoate triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.09588346
54486-6,white blood cells count,glucose mass volume water,0.023886140618510104,0.0595973
105093-9,white blood cells count,leukocyte clump area urine sediment,0.023886140618510104,0.071763664
14629-0,white blood cells count,bilirubin direct mole volume serum plasma,0.023886140618510104,0.085535266
77145-1,white blood cells count,fasting glucose mole volume serum plasma blood,0.023886140618510104,0.16908439
48302-4,white blood cells count,indigo carmine triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10115156
104873-5,white blood cells count,glucose dumping syndrome panel serum plasma blood,0.023886140618510104,0.15520012
32359-2,white blood cells count,glucose mole volume serum plasma 10 minute post dose glucose,0.023886140618510104,0.08329695
16915-1,white blood cells count,glucose mass volume serum plasma post meal,0.023886140618510104,0.0737782
30467-5,white blood cells count,promyelocytes leukocyte cerebral spinal fluid,0.023886140618510104,0.0803955
71615-9,white blood cells count,lymphocyte leukocyte pure number fraction pleural fluid manual count,0.023886140618510104,0.12093431
5515-2,white blood cells count,deprecated cd64 cell 100 cell blood,0.023886140618510104,0.09285195
47859-4,white blood cells count,glucose mole volume serum plasma 5 minute post dose glucose,0.023886140618510104,0.07941458
39561-6,white blood cells count,glucose mass volume serum plasma 1st specimen post dose lactose,0.023886140618510104,0.07443505
5492-4,white blood cells count,deprecated cd49b cell 100 cell blood,0.023886140618510104,0.105052926
24049-9,white blood cells count,alpha galactosidase enzymatic activity mass leukocyte,0.023886140618510104,0.079142995
53964-3,white blood cells count,leukocyte presence urine visual,0.023886140618510104,0.069002904
56771-9,white blood cells count,eosinophil leukocyte bronchial specimen flow cytometry fc,0.023886140618510104,0.08290346
10559-3,white blood cells count,deprecated calcium molecule volume semen,0.023886140618510104,0.042894546
40660-3,white blood cells count,promyelocytes leukocyte body fluid manual count,0.023886140618510104,0.110444106
29276-3,white blood cells count,calcium presence urine,0.023886140618510104,0.014541236
26544-7,white blood cells count,glucose mass volume serum plasma 6 hour post dose glucose,0.023886140618510104,0.09050056
53485-9,white blood cells count,glucose mole volume serum plasma 45 minute post dose betaxolol,0.023886140618510104,0.07847676
4659-9,white blood cells count,leukocyte phosphatase enzymatic activity volume leukocyte,0.023886140618510104,0.14198177
61125-1,white blood cells count,monocyte leukocyte specimen flow cytometry fc,0.023886140618510104,0.088118516
76671-7,white blood cells count,glucose mole volume cerebral spinal fluid 3rd tube,0.023886140618510104,0.06184646
26492-9,white blood cells count,mononuclear cell leukocyte cerebral spinal fluid,0.023886140618510104,0.0910228
1567-7,white blood cells count,insulin mass volume serum plasma 3 hour post 75 g glucose po,0.023886140618510104,0.06237394
12629-2,white blood cells count,glucose mass volume 24 hour peritoneal dialysis fluid,0.023886140618510104,0.07176816
53483-4,white blood cells count,glucose mole volume serum plasma 30 minute post dose betaxolol,0.023886140618510104,0.077568226
79195-4,white blood cells count,glucose mass volume serum plasma 45 minute post dose arginine insulin,0.023886140618510104,0.06438537
46090-7,white blood cells count,leukocyte volume cerebral spinal fluid 4th tube,0.023886140618510104,0.10939944
20439-6,white blood cells count,glucose mass volume serum plasma 30 minute post dose glucose,0.023886140618510104,0.08792215
12625-0,white blood cells count,glucose mass volume serum plasma 13th specimen post xxx challenge,0.023886140618510104,0.08802831
48240-6,white blood cells count,candida albicans triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.111688174
48992-2,white blood cells count,glucose mass volume serum plasma 12 specimen,0.023886140618510104,0.087496065
35672-5,white blood cells count,bilirubin direct bilirubin total serum plasma,0.023886140618510104,0.062487904
40182-8,white blood cells count,glucose mole volume serum plasma 16 hour post xxx challenge,0.023886140618510104,0.071031325
13517-8,white blood cells count,variant lymphocyte leukocyte cerebral spinal fluid manual count,0.023886140618510104,0.10295764
50608-9,white blood cells count,glucose tolerance 3 hour gestational panel serum plasma,0.023886140618510104,0.05419106
27860-6,white blood cells count,insulin unit volume serum plasma 2 hour post 75 g glucose po,0.023886140618510104,0.07024249
48230-7,white blood cells count,cat dander triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.0970577
48244-8,white blood cells count,red cedar triggered leukotriene release mass volume leukocyte,0.023886140618510104,0.10255387
47719-0,white blood cells count,parathyrin mass volume serum plasma pre dose calcium,0.023886140618510104,0.059277575
14137-4,white blood cells count,glucose mass volume serum plasma 5 5 hour post 75 g glucose po,0.023886140618510104,0.083980456
5539-2,white blood cells count,deprecated cd87 cell 100 cell blood,0.023886140618510104,0.0930508
40214-9,white blood cells count,glucose mole volume serum plasma 25 hour post xxx challenge,0.023886140618510104,0.07475435
14381-8,white blood cells count,mononuclear cell leukocyte peritoneal fluid manual count,0.023886140618510104,0.11046724
16997-9,white blood cells count,hydrogen expired gas volume fraction exhaled gas post dose glucose,0.023886140618510104,0.040320206
5517-8,white blood cells count,deprecated cd66b cell 100 cell blood,0.023886140618510104,0.097179264
40998-7,white blood cells count,calcium hydrogen phosphate dihydrate total stone,0.023886140618510104,0.014696434
12234-1,white blood cells count,mesothelial cell leukocyte body fluid manual count,0.023886140618510104,0.1093035
25666-9,white blood cells count,glucose mole volume serum plasma 2 5 hour post dose glucose,0.023886140618510104,0.08100005
12635-9,white blood cells count,glucose mass volume peritoneal dialysis fluid 6th specimen,0.023886140618510104,0.077011876
2352-3,white blood cells count,glucose csf glucose plasma,0.023886140618510104,0.05935687
98020-1,white blood cells count,leukocyte volume lower respiratory specimen manual count,0.023886140618510104,0.12903471
50213-8,white blood cells count,glucose mass volume serum plasma 3rd specimen,0.023886140618510104,0.08899017
25362-5,white blood cells count,calcium mole volume 24 hour urine,0.023886140618510104,0.05170492
55804-9,white blood cells count,leukocyte phosphatase presence leukocyte,0.023886140618510104,0.11197391
58522-4,white blood cells count,component peptide mass volume serum plasma pre dose glucose,0.023886140618510104,0.06437963
88335-5,white blood cells count,predominant leukocyte identified type ear light microscopy,0.023886140618510104,0.08594063
13609-3,white blood cells count,insulin mass volume serum plasma 2 5 hour post 75 g glucose po,0.023886140618510104,0.06660449
51767-2,white blood cells count,glucose mass volume serum plasma 1 5 hour post dose fructose po,0.023886140618510104,0.07230993
1969-5,white blood cells count,bilirubin total renal clearance 24 hour urine serum plasma,0.023886140618510104,0.08124912
47662-2,white blood cells count,insulin unit volume serum plasma 3 hour post dose glucose,0.023886140618510104,0.066265635
40032-5,white blood cells count,glucose mass volume serum plasma 22 minute post xxx challenge,0.023886140618510104,0.082312435
1506-5,white blood cells count,glucose mass volume serum plasma 1 hour post 50 g lactose po,0.023886140618510104,0.07872644
40173-7,white blood cells count,glucose mole volume serum plasma 10 hour post xxx challenge,0.023886140618510104,0.07394086
5487-4,white blood cells count,deprecated cd45ro cell 100 cell blood,0.023886140618510104,0.08668188
16904-5,white blood cells count,glucose presence urine 1st specimen post xxx challenge,0.023886140618510104,0.043589797
31995-4,white blood cells count,basophil leukocyte pleural fluid manual count,0.023886140618510104,0.115833215
1997-6,white blood cells count,calcium mole volume cerebral spinal fluid,0.023886140618510104,0.05390995
30378-4,white blood cells count,eosinophil leukocyte nose,0.023886140618510104,0.059285104
105104-4,white blood cells count,leukocyte area urine sediment,0.023886140618510104,0.071294546
